{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# CrossBee workflow notebook tutorial based on Python script modules for LBD\n",
    "\n",
    "CrossBee is a system that recommends bridging terms (*b-terms*) through an ensemble-based ranking method. It aids experts in uncovering hidden connections between unrelated domains. CrossBee facilitates the ranking, exploration, and investigation of these cross-domain bridging terms. In a broader sense it implements the Swanson's `ABC` model: it looks for $b$-terms that bridge the literature on a selected $a$-term and $c$-term; $b$-terms are the candidates that can possibly explain the link.\n",
    "\n",
    "<hr>\n",
    "\n",
    "[1] Petrič, I., Urbančič, T., Cestnik, B., Macedoni-Lukšič, M. (2009). Literature mining method RaLoLink for uncovering relations between biomedical concepts. Journal of Biomedical Informatics, 42(2), 219–227.\n",
    "\n",
    "[2] Juršič, M., Cestnik, B., Urbančič, T., Lavrač, N. (2012a). Cross-domain Literature Mining: Finding Bridging Concepts with CrossBee, *Proceedings of the 3rd International Conference on Computational Creativity*, 33-40.\n",
    "\n",
    "[3] Juršič, M., Cestnik, B., Urbančič, T., Lavrač, N. (2012b). Bisociative literature mining by ensemble heuristics. In M. R. Berthold (Ed.), *Bisociative Knowledge Discovery*, 338–358. Springer.\n",
    "\n",
    "<hr>\n",
    "\n",
    "Note that **our motive** was to **re-implement parts** of the tools such as **CrossBee**, RaJoLink and OntoGen so that we can generally **repeat the results** with the tools from the past experiments, and not so much to optimize the written Python code. The fucus was on understanding the learning processes and visualizing the workflows in terms of repeatability of the results obtained; the efficiency and elegance of the programming can be addressed in future versions of the scripts."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Import and initialize `logging` library to track the execution of the scripts."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 209,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "import logging\n",
    "\n",
    "# Initialize logging with a basic configuration\n",
    "logging.basicConfig(level=logging.INFO,\n",
    "                    format='%(asctime)s: %(levelname)s - %(message)s',\n",
    "                    datefmt='%Y-%m-%d %H:%M:%S')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Import LBD components from the framework notebooks. The description of the individual components from the framework notebooks can be found in the respective notebooks.\n",
    "\n",
    "The purpose of the **import_ipynb** library is to allow the direct import of Jupyter notebooks as modules so that code, functions and classes defined in one notebook can be easily reused in other notebooks or Python scripts.\n",
    "If the **import_ipynb** library is omitted (or commented out), the corresponding modules will be imported from **.py** files exported from the **.ipynb** files. Note that importing from **.py** files is usually much faster and therefore more suitable for running scripts in production."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 210,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "# import import_ipynb\n",
    "import LBD_01_data_acquisition\n",
    "import LBD_02_data_preprocessing\n",
    "import LBD_03_feature_extraction\n",
    "import LBD_04_text_mining\n",
    "import LBD_05_results_analysis\n",
    "import LBD_06_visualization"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Import additional Python libraries."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 211,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "import nltk\n",
    "import numpy as np\n",
    "import itertools\n",
    "import pandas as pd\n",
    "import spacy\n",
    "from sklearn.metrics.pairwise import cosine_distances\n",
    "from typing import List, Dict"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Define the name of the domains $C$ and $A$, then load the responding text from the input file. The expected file format is as follows:\n",
    "\n",
    "1. The file is encoded in Ascii (if it is in UTF-8 or other encoding, it should be converted to Ascii).\n",
    "2. Each line in the file represents one document. The words in each document are separated by spaces. The length of the individual documents may vary.\n",
    "3. The first word in each line is the **unique id**, followed by a semicolon. Normally **pmid** (pubmed id) can be used for this purpose, alhough any unique id (e.g. **sequential count**) suffices.\n",
    "4. The second word in each line can optionally stand for a predefined domain (or class) of the document. In this case, the second word is preceded by **!**. For example, if the file contains documents that originate from two domains, e.g. *migraine* and *magnesium*, the second word in each line is either **!migraine** or **!magnesium**. If the file contains documents that originate from *autism* and *calcineurin*, the second word in each line will be either **!autism** or **!calcineurin**.\n",
    "5. If the second word is not preceded by **!**, it will be considered the first word of the document. In this case, the document will be given the domain **!NA** (**not applicable** or **not available**).\n",
    "\n",
    "\n",
    "**A background story for this experiment**\n",
    "\n",
    "First, we selected *autism* and *calcineurin* as our domains of interest.\n",
    "\n",
    "*Autism*  belongs to a group of pervasive developmental disorders that are portrayed by an\n",
    "early delay and abnormal development of cognitive, communication and social\n",
    "interaction skills of a person. It is a very complex and not yet sufficiently understood\n",
    "domain, where precise causes are still unknown; research suggests that it may be\n",
    "related to genetic mutations, environmental factors, and brain structure and function. \n",
    "*Calcineurin* is a protein phosphatase with a high prevalence in the brain.\n",
    "\n",
    "The dataset from the input file was constructed using the following PubMed query:\n",
    "\n",
    "1. autis* [TIAB] AND 1900/01/01:2007/12/31 [PDAT]\n",
    "2. calcineurin [TIAB] AND 1900/01/01:2007/12/31 [PDAT]\n",
    "\n",
    "The input file *input/f_autism_calcineurin.txt* was prepared for the experiments described in [1]. It contains 13.623 titles and abstracts, 9.403 from *autism* and 4.220 from *calcineurin*."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 222,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "# Set the global variable CONTEXT_SWITCH to the following values, depending on which domain pairs you would like to set as a context:\n",
    "# 1 for Autism-Calcineurin\n",
    "# 2 for Autism-Calcineurin on outlier documents\n",
    "# 11 for Alzheimer-Macrobiota\n",
    "# 12 for Alzheimer-Macrobiota on outlier documents\n",
    "# 21 for Migraine-Magnesium\n",
    "\n",
    "CONTEXT_SWITCH = 12"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 223,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2024-12-13 15:35:37: INFO - Loaded 766 lines from \"input/f_alzheimer_gimb_outliers.txt\".\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "['26578392: !Alzheimer Early inflammation-associated factors blunt sterol regulatory element-binding proteins...',\n",
       " '26575203: !Alzheimer Big Data and Adverse Drug Reaction Detection. Big Data holds the promise of fundamenta...',\n",
       " '26574544: !Alzheimer Proteolytic processing of Neuregulin 1 type III by three intramembrane cleaving protea...',\n",
       " '26567748: !Alzheimer Metabolic Control of Glia-Mediated Neuroinflammation. to a variety of insults, which h...',\n",
       " '26560688: !Alzheimer A new role for an old drug: Ambroxol triggers lysosomal exocytosis via pH-dependent Ca...',\n",
       " '26560048: !Alzheimer Discovery of a marine-derived bis-indole alkaloid fascaplysin, as a new class of  pote...',\n",
       " '26548612: !Alzheimer Bioorthogonal Labeling of Ghrelin Receptor to Facilitate Studies of Ligand-Dependent C...']"
      ]
     },
     "execution_count": 223,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "if CONTEXT_SWITCH == 1:\n",
    "    domainName = 'Autism-Calcineurin'\n",
    "    fileName = 'input/f_autism_calcineurin.txt'\n",
    "elif CONTEXT_SWITCH == 2:\n",
    "    domainName = 'Autism-Calcineurin'\n",
    "    fileName = 'input/f_autism_calcineurin_outliers.txt'\n",
    "elif CONTEXT_SWITCH == 11:\n",
    "    domainName = 'Alzheimer-Macrobiota'\n",
    "    fileName = 'input/f_alzheimer_gimb.txt'\n",
    "elif CONTEXT_SWITCH == 12:\n",
    "    domainName = 'Alzheimer-Macrobiota'\n",
    "    fileName = 'input/f_alzheimer_gimb_outliers.txt'\n",
    "elif CONTEXT_SWITCH == 21:\n",
    "    domainName = 'Migraine-Magnesium'\n",
    "    fileName = 'input/Magnesium_Migraine_before1988.txt'\n",
    "    \n",
    "lines = LBD_01_data_acquisition.load_data_from_file(fileName)\n",
    "# display the first 7 lines of the document\n",
    "[LBD_02_data_preprocessing.truncate_with_ellipsis(line, 110) for line in lines[:7]]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 224,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[]"
      ]
     },
     "execution_count": 224,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# display a few middle lines of the document\n",
    "[LBD_02_data_preprocessing.truncate_with_ellipsis(line, 110) for line in lines[9400:9407]]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 225,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['24333791: !GIMB Cognitive decline, dietary factors and gut-brain interactions. Cognitive decline in elderly...',\n",
       " \"24268527: !GIMB ABO histo-blood group might modulate predisposition to Crohn's disease and affect disease b...\",\n",
       " '24162593: !GIMB HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B:...',\n",
       " '24106984: !GIMB Clinical differences in Clostridium difficile infection based on age: a multicenter study. ...',\n",
       " '23676440: !GIMB Treatment of patients with dual hepatitis C and B by peginterferon alpha and ribavirin redu...',\n",
       " '23582194: !GIMB [Post-appendectomy surgical site infection: overall rate and type according to open/laparos...',\n",
       " '23376290: !GIMB Genetic susceptibility to increased bacterial translocation influences the response to biol...']"
      ]
     },
     "execution_count": 225,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# display the last lines of the document\n",
    "[LBD_02_data_preprocessing.truncate_with_ellipsis(line, 110) for line in lines[-7:]]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**Preprocess the documents into a dictionary - might take a few minutes for longer files**\n",
    "\n",
    "The script in the next cell is used to prepare text data for further analysis in Literature-Based Discovery (LBD). The aim is to clean, standardize and structure the documents so that they are suitable for further tasks such as feature extraction, topic modeling and the discovery of hidden relationships in the literature. The script prepares the documents stored in `lines` in a dictionary.\n",
    "\n",
    "**Functionality**\n",
    "\n",
    "1. *Creating a dictionary from raw data*: The script starts by converting a list of rows into a structured dictionary. \n",
    "    - *`construct_dict_from_list`*: this function takes the raw list of text lines (`lines`) and creates a dictionary (`docs_dict`) in which each entry typically represents a document, with a unique identifier as the key and the text of the document as the value.\n",
    "    - This conversion is important because it puts the text data into a more manageable format that allows efficient processing and retrieval.\n",
    "\n",
    "2. *Preprocessing of documents*: the script then applies various pre-processing steps to the documents:\n",
    "    - *Cleaning*: the text is cleaned to remove unwanted characters, punctuation and other errors.\n",
    "    - *Remove stop words*: frequent words that do not provide meaningful information (e.g. \"the\", \"and\") are removed.\n",
    "    - *Lemmatization*: words are reduced to their base or root form (e.g. \"running\" becomes \"run\") to ensure consistency.\n",
    "    - *Minimum word length*: words shorter than four characters are filtered out.\n",
    "    - *Keep only nouns*: the parameter `keep_only_nouns=True` ensures that only nouns (and proper nouns) are considered in further analysis, removing other word types like adjactives and verbs. \n",
    "    A trained pipeline from *spacy* named *en_core_web_md* is used for the task [https://spacy.io/models/en#en_core_web_md]. Note that this filter uses functions from an external *spacy* library to check every word in the vocabulary of the documents and is therefore time-consuming.\n",
    "    - *MeSH-specific filtering*: the parameter `keep_only_mesh=False` skips the MeSH filtering in this preprocessing.\n",
    "\n",
    "3. *Extract document IDs and processed text*:  the script then extracts lists of document IDs and the corresponding preprocessed text:\n",
    "    - *`extract_ids_list`*: returns a list of document IDs from the preprocessed dictionary to facilitate document lookup and management.\n",
    "    - *`extract_preprocessed_documents_list`*: extracts the cleaned and processed text for each document to prepare it for feature extraction or other analysis.\n",
    "By extracting these lists, the script organizes the data in a format that is easy to manipulate in subsequent steps, such as creating a Bag of Words (BoW) model or calculating TF-IDF scores.\n",
    "\n",
    "**Practical applications**\n",
    "\n",
    "- *Biomedical research and discovery*: This pre-processing approach is valuable in the biomedical field, where ensuring the relevance and accuracy of terms is critical to discovering new relationships between diseases, drugs and other biological concepts. By focusing on specific vocabularies such as MeSH, researchers can more effectively search the literature for new hypotheses or overlooked relationships.\n",
    "- *Data preparation for machine learning*: The cleaned and structured data generated by this script can be fed directly into machine learning models for tasks such as document classification or clustering.\n",
    "\n",
    "**Use**\n",
    "\n",
    "To use this script effectively:\n",
    "1. *Prepare the data*: Make sure you have a list of raw text lines (`lines`).\n",
    "2. *Execute the preprocessing steps*: Run the script to clean, filter and structure the text data.\n",
    "3. *Extract and analyze*: Use the extracted IDs and processed text for further analysis, e.g. to create models and visualizations or for exploratory research."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 226,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2024-12-13 15:35:41: INFO - Text cleaning ...\n",
      "2024-12-13 15:35:41: INFO - Removing stopwords ...\n",
      "2024-12-13 15:35:41: INFO - Lemmatization ...\n",
      "2024-12-13 15:35:42: INFO - Keeping only longer words (>= 5 characters)...\n",
      "2024-12-13 15:35:42: INFO - Preprocessing finished.\n"
     ]
    }
   ],
   "source": [
    "# 1. Creating a dictionary from raw data\n",
    "docs_dict = LBD_02_data_preprocessing.construct_dict_from_list(lines)\n",
    "\n",
    "# 2. Preprocessing of documents\n",
    "keep_list = []\n",
    "# Normally, the original domain names are removed from the vocabulary. If \"migraine\" and \"magnesium\" were added to the vocabulary during the comparison, \n",
    "# they might dominate the analysis because they are the focus of the study. The alorithms might attach extra importance to these terms \n",
    "# and push less obvious but potentially important terms or concepts into the background.\n",
    "\n",
    "if (CONTEXT_SWITCH == 1) or (CONTEXT_SWITCH == 2):\n",
    "    remove_list = ['autism', 'calcineurin']\n",
    "    min_word_length = 4\n",
    "elif (CONTEXT_SWITCH == 11) or (CONTEXT_SWITCH == 12):\n",
    "    remove_list = ['alzheimer', 'gut', 'microbiota']\n",
    "    min_word_length = 5\n",
    "elif (CONTEXT_SWITCH == 21):\n",
    "    keep_list = [\"p\"]\n",
    "    remove_list = [\"migraine\", \"magnesium\"]\n",
    "    min_word_length = 0\n",
    "else:\n",
    "    remove_list = []\n",
    "    min_word_length = 0\n",
    "\n",
    "prep_docs_dict = LBD_02_data_preprocessing.preprocess_docs_dict(\n",
    "    docs_dict, keep_list = keep_list, remove_list = remove_list, mesh_word_list = [], \\\n",
    "    cleaning = True, remove_stopwords = True, lemmatization = True, \\\n",
    "    min_word_length = min_word_length, keep_only_nouns = False, keep_only_mesh = False, stemming = False, stem_type = None)\n",
    "\n",
    "# 3. Extract document IDs and processed text\n",
    "ids_list = LBD_02_data_preprocessing.extract_ids_list(prep_docs_dict)\n",
    "prep_docs_list = LBD_02_data_preprocessing.extract_preprocessed_documents_list(prep_docs_dict)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The next three cells show the first dictionary entries, the document IDs (PubMed or a counter) and the pre-processed documents.\n",
    "\n",
    "When displaying the first few dictionary entries, we can observe the difference between the original and the pre-processed documents."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 227,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'26578392': {'domain': 'Alzheimer',\n",
       "  'document': 'Early inflammation-associated factors blunt sterol regulatory element-binding proteins-1-mediated lipogenes...',\n",
       "  'preprocessed': 'early inflammationassociated factor blunt sterol regulatory elementbinding proteins1mediated lipogenesis hi...'},\n",
       " '26575203': {'domain': 'Alzheimer',\n",
       "  'document': 'Big Data and Adverse Drug Reaction Detection. Big Data holds the promise of fundamentally transforming the ...',\n",
       "  'preprocessed': 'adverse reaction detection promise fundamentally transform manner which adverse reactions identify evaluate...'},\n",
       " '26574544': {'domain': 'Alzheimer',\n",
       "  'document': 'Proteolytic processing of Neuregulin 1 type III by three intramembrane cleaving proteases. Numerous membran...',\n",
       "  'preprocessed': 'proteolytic process neuregulin three intramembrane cleave proteases numerous membranebound proteins undergo...'},\n",
       " '26567748': {'domain': 'Alzheimer',\n",
       "  'document': 'Metabolic Control of Glia-Mediated Neuroinflammation. to a variety of insults, which have crucial implicati...',\n",
       "  'preprocessed': 'metabolic control gliamediated neuroinflammation variety insult which crucial implications reactive gliosis...'},\n",
       " '26560688': {'domain': 'Alzheimer',\n",
       "  'document': 'A new role for an old drug: Ambroxol triggers lysosomal exocytosis via pH-dependent Ca release from acidic ...',\n",
       "  'preprocessed': 'ambroxol trigger lysosomal exocytosis phdependent release acidic store ambroxol frequently prescribe facili...'},\n",
       " '26560048': {'domain': 'Alzheimer',\n",
       "  'document': 'Discovery of a marine-derived bis-indole alkaloid fascaplysin, as a new class of potent P-glycoprotein indu...',\n",
       "  'preprocessed': 'discovery marinederived bisindole alkaloid fascaplysin class potent pglycoprotein inducer establishment str...'},\n",
       " '26548612': {'domain': 'Alzheimer',\n",
       "  'document': 'Bioorthogonal Labeling of Ghrelin Receptor to Facilitate Studies of Ligand-Dependent Conformational Dynamic...',\n",
       "  'preprocessed': 'bioorthogonal label ghrelin receptor facilitate study liganddependent conformational dynamics ghrelin recep...'}}"
      ]
     },
     "execution_count": 227,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# display the first 7 dictionary items\n",
    "truncated_dict = {\n",
    "    key: {sub_key: LBD_02_data_preprocessing.truncate_with_ellipsis(value, 110) for sub_key, value in sub_dict.items()}\n",
    "    for key, sub_dict in itertools.islice(prep_docs_dict.items(), 7)\n",
    "}\n",
    "truncated_dict"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 228,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['26578392',\n",
       " '26575203',\n",
       " '26574544',\n",
       " '26567748',\n",
       " '26560688',\n",
       " '26560048',\n",
       " '26548612']"
      ]
     },
     "execution_count": 228,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# display the ids of the first 7 documents\n",
    "ids_list[:7]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 229,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['early inflammationassociated factor blunt sterol regulatory elementbinding proteins1mediated lipogenesis hi...',\n",
       " 'adverse reaction detection promise fundamentally transform manner which adverse reactions identify evaluate...',\n",
       " 'proteolytic process neuregulin three intramembrane cleave proteases numerous membranebound proteins undergo...',\n",
       " 'metabolic control gliamediated neuroinflammation variety insult which crucial implications reactive gliosis...',\n",
       " 'ambroxol trigger lysosomal exocytosis phdependent release acidic store ambroxol frequently prescribe facili...',\n",
       " 'discovery marinederived bisindole alkaloid fascaplysin class potent pglycoprotein inducer establishment str...',\n",
       " 'bioorthogonal label ghrelin receptor facilitate study liganddependent conformational dynamics ghrelin recep...']"
      ]
     },
     "execution_count": 229,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# display the preprocessed text for the first 7 documents\n",
    "[LBD_02_data_preprocessing.truncate_with_ellipsis(line, 110) for line in prep_docs_list[:7]]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 230,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Oprionally: open the file in write mode ('w') and write each string to the file\n",
    "# with open('prep_lines.txt', 'w', encoding=\"ascii\") as file:\n",
    "#     for line in prep_docs_list:\n",
    "#         file.write(line + '\\n')  # Add a newline character after each string"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**Construct BoW model from important words and n-grams**\n",
    "\n",
    "The next script continues the feature extraction process and focuses on refining a Bag of Words (BoW) model by filtering out less important terms and n-grams. It creates a Bag of Words matrix from the list of pre-processed documents. It then removes n-gram words that occur less than *min_ngram_count* times (in our case 3) in the entire document corpus. The words that are not contained in the MESH list *mesh_word_list* are also removed. This step is important to improve the quality and relevance of the text representation by reducing the vocabulary so that the following steps can be carried out more efficiently (in terms of time).\n",
    "\n",
    "**Functionality**\n",
    "\n",
    "1. *Set parameters*: The script starts by setting the parameters for the n-gram size and the minimum document frequency:\n",
    "    - *`ngram_size`*: Specifies that the model considers pairs of consecutive words (bigrams) as features.\n",
    "    - *`min_df`*: Specifies the minimum number of documents in which a word or n-gram must occur in order to be included in the initial vocabulary.\n",
    "\n",
    "2. *Create Bag of Words representation*: The next step is to create the BoW model using the specified n-gram size.\n",
    "This function creates a vocabulary (`word_list`) from all terms and n-grams found in the preprocessed documents (`prep_docs_list`), together with the corresponding frequency matrix (`bow_matrix`). The output vocabulary includes all n-grams without filtering.\n",
    "\n",
    "3. *Filtering low-frequency n-grams*: The script then filters out n-grams that occur less frequently than a certain threshold:\n",
    "    - *`min_count_ngram`*: Specifies the minimum number of occurrences of n-grams to keep.\n",
    "    - The script calculates two important metrics:\n",
    "        - *document frequency*: How many documents contain each word or n-gram.\n",
    "        - *total frequency*: How often each word or n-gram appears in all documents.\n",
    "\n",
    "4. *Filtering based on specific criteria*: The script applies a more sophisticated filtering process to refine the vocabulary. The loop evaluates each term or n-gram in the vocabulary:\n",
    "   - *Non-n-grams*: Will only be retained if they are in a predefined `mesh_word_list`.\n",
    "   - *n-grams*: Are retained if:\n",
    "       - They fulfill the minimum frequency criteria.\n",
    "       - All partial words are contained in `mesh_word_list`.\n",
    "       - The n-gram does not consist of repeated words (e.g. \"word word\").\n",
    "\n",
    "\n",
    "5. *Applying the filters*: The script then filters both the rows and the columns of the BoW matrix. \n",
    "   - *`filter_matrix_columns`*: Refines the BoW matrix by retaining only the selected words or n-grams that meet the filter criteria.\n",
    "   - The updated vocabulary and matrix are then stored in `word_list` and `bow_matrix`, respectively.\n",
    "\n",
    "**Practical applications**\n",
    "\n",
    "- *Biomedical research and discovery*: This filtering method is particularly useful in medical research, where the focus is on extracting and analyzing relevant biomedical terms and concepts.\n",
    "- *Document analysis and classification*: By refining the feature set, this script can improve the performance of classifiers used in the categorization of scientific literature or other text corpora.\n",
    "- *Network analysis*: The filtered vocabulary can serve as a node in a network graph representing meaningful terms and their co-occurrence, which can be analyzed to detect hidden connections.\n",
    "\n",
    "**Use**\n",
    "\n",
    "To use this script effectively, you need to make sure you have a preprocessed document list (`prep_docs_list`). Adjust the parameters like `ngram_size`, `min_df` and `min_count_ngram` to your specific needs. After running the script, you will get a filtered vocabulary and a corresponding BoW matrix, which is more suitable for further analysis such as clustering, topic modeling or discovering new hypotheses in biomedical research."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 231,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of terms in initial vocabulary with all n-grams:  155490\n",
      "Number of terms in preprocessed vocabulary after removing infrequent n-grams:  15274\n"
     ]
    }
   ],
   "source": [
    "# 1. Set parameters\n",
    "if (CONTEXT_SWITCH == 1) or (CONTEXT_SWITCH == 2):\n",
    "    ngram_size = 2 # to reduce the vocabulary, only a single words and bigrams are used for further analysis\n",
    "    min_df = 2\n",
    "elif (CONTEXT_SWITCH == 11) or (CONTEXT_SWITCH == 12):\n",
    "    ngram_size = 3\n",
    "    min_df = 1\n",
    "elif (CONTEXT_SWITCH == 21):\n",
    "    ngram_size = 3\n",
    "    min_df = 1\n",
    "\n",
    "# 2. Create Bag of Words representation\n",
    "word_list, bow_matrix = LBD_03_feature_extraction.create_bag_of_words(prep_docs_list, ngram_size, min_df)\n",
    "print('Number of terms in initial vocabulary with all n-grams: ', len(word_list))\n",
    "\n",
    "# 3. Filtering low-frequency n-grams\n",
    "#    remove n-grams with frequency count less than min_count_ngram from vocabulary word_list and bow_matrix\n",
    "if (CONTEXT_SWITCH == 1) or (CONTEXT_SWITCH == 2):\n",
    "    min_count_ngram = 3\n",
    "elif (CONTEXT_SWITCH == 11) or (CONTEXT_SWITCH == 12):\n",
    "    min_count_ngram = 3\n",
    "elif (CONTEXT_SWITCH == 21):\n",
    "    min_count_ngram = 2\n",
    "\n",
    "tmp_sum_count_docs_containing_word = LBD_03_feature_extraction.sum_count_documents_containing_each_word(word_list, bow_matrix)\n",
    "\n",
    "tmp_sum_count_word_in_docs = LBD_03_feature_extraction.sum_count_each_word_in_all_documents(word_list, bow_matrix)\n",
    "\n",
    "# 4. Filtering based on specific criteria\n",
    "tmp_filter_columns = []\n",
    "for i, word in enumerate(word_list):\n",
    "    if not LBD_03_feature_extraction.word_is_nterm(word):\n",
    "        tmp_filter_columns.append(i)\n",
    "    else:\n",
    "        if tmp_sum_count_word_in_docs[word] >= min_count_ngram:\n",
    "            tmp_filter_columns.append(i)\n",
    "\n",
    "# 5. Applying the filters\n",
    "#    keep the original order of rows\n",
    "tmp_filter_rows = []\n",
    "for i, id in enumerate(ids_list):\n",
    "    tmp_filter_rows.append(i)\n",
    "\n",
    "tmp_filtered_word_list, tmp_filtered_bow_matrix = LBD_03_feature_extraction.filter_matrix_columns(\n",
    "    word_list, bow_matrix, tmp_filter_rows, tmp_filter_columns)\n",
    "\n",
    "word_list = tmp_filtered_word_list\n",
    "bow_matrix = tmp_filtered_bow_matrix\n",
    "print('Number of terms in preprocessed vocabulary after removing infrequent n-grams: ', len(word_list))\n",
    "\n",
    "# Output the lists for checking the order\n",
    "#LBD_02_data_preprocessing.save_list_to_file(word_list, \"output/_list.txt\")\n",
    "#LBD_02_data_preprocessing.save_list_to_file(prep_docs_list, \"output/_prep_list.txt\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**Calculate relevant indicators for the BoW matrix**\n",
    "\n",
    "The script in the next cell is a continuation of the text preprocessing pipeline that calculates the margins for the Bag of Words (BoW) matrix and optimizes the BoW matrix for better interpretability and analysis. By arranging the matrix to highlight the most important terms and documents, this script helps to recognize patterns in the data, which is a crucial step in LBD.\n",
    "\n",
    "**Functionality**\n",
    "\n",
    "1. *Counting word frequencies*: The script begins by calculating various frequency counts that provide insight into how words are distributed across documents:\n",
    "   - *`sum_count_docs_containing_word`*: counts how many documents each word appears in\n",
    "   - *`sum_count_word_in_docs`*: counts the occurrences of each word across all documents\n",
    "   - *`sum_count_words_in_doc`*: counts the total number of words in each document\n",
    "\n",
    "   These metrics are essential for understanding the significance and distribution of terms within the corpus, which can guide further analysis.\n",
    "\n",
    "2. *Displaying frequency counts*: The script then prints a subset of these frequency counts to give an overview of the data:\n",
    "   - *`islice`* from `itertools` is used to print just the first few items, making it easier to inspect the data without overwhelming output.\n",
    "   - These print statements help users quickly assess the distribution and frequency of words and documents in the BoW model.\n",
    "\n",
    "3. *Optimizing the BoW matrix*: The script proceeds to rearrange the BoW matrix so that the most frequent words and documents are positioned at the top-left corner of the matrix:\n",
    "   - *sorting*: The words and documents are sorted by their frequencies in descending order.\n",
    "   - *filtering*: The indices of these sorted words and documents are then used to rearrange the BoW matrix.\n",
    "\n",
    "   This step ensures that the most significant terms and documents are easily accessible, facilitating further analysis such as clustering, topic modeling, or visualization.\n",
    "\n",
    "4. *Rearranging the matrix*: Finally, the script filters the matrix according to the computed order:\n",
    "   - *`filter_matrix`*: This function reorders the BoW matrix based on the sorted indices, ensuring that the most relevant terms and documents are emphasized.\n",
    "\n",
    "   The script then prints out the first few items in the reordered lists:\n",
    "   - This output allows users to verify that the matrix has been rearranged as intended, highlighting the most important elements of the dataset.\n",
    "\n",
    "**Use**\n",
    "\n",
    "To use this script, you must have a BoW matrix (`bow_matrix`) and the corresponding lists of words (`word_list`) and document IDs (`ids_list`). The script processes these inputs to calculate the frequency counts, reorder the matrix and output the reordered BoW matrix. This optimized matrix can be used for various downstream tasks, e.g. for creating visualizations, for deeper statistical analysis or as a basis for machine learning models for predictions."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 232,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of documents in which each word is present:  {'0000the': 1, '0001multivariate': 1, '009015mugml': 1, '023x105': 1, '100000mm3': 1, '100000year': 1, '1000fold': 1}\n",
      "Number of occurences of each word in all documents:  {'0000the': 1, '0001multivariate': 1, '009015mugml': 1, '023x105': 1, '100000mm3': 1, '100000year': 1, '1000fold': 1}\n",
      "Number of words in each document:  {'26578392': 175, '26575203': 39, '26574544': 136, '26567748': 334, '26560688': 102, '26560048': 150, '26548612': 57}\n",
      "The first few documents in the rows of the filtered bow matrix:  ['26027681', '26018232', '26215835', '26413854', '26490886', '25569373', '26567748']\n",
      "The first few words in the columns of the filtered bow matrix:  ['disease', 'cells', 'study', 'patients', 'effect', 'result', 'diseases']\n"
     ]
    }
   ],
   "source": [
    "# 1. Counting word frequencies\n",
    "sum_count_docs_containing_word = LBD_03_feature_extraction.sum_count_documents_containing_each_word(word_list, bow_matrix)\n",
    "\n",
    "sum_count_word_in_docs = LBD_03_feature_extraction.sum_count_each_word_in_all_documents(word_list, bow_matrix)\n",
    "\n",
    "sum_count_words_in_doc = LBD_03_feature_extraction.sum_count_all_words_in_each_document(ids_list, bow_matrix)\n",
    "\n",
    "# 2. Displaying frequency counts\n",
    "print('Number of documents in which each word is present: ', dict(itertools.islice(sum_count_docs_containing_word.items(), 7)))\n",
    "print('Number of occurences of each word in all documents: ', dict(itertools.islice(sum_count_word_in_docs.items(), 7)))\n",
    "print('Number of words in each document: ', dict(itertools.islice(sum_count_words_in_doc.items(), 7)))\n",
    "\n",
    "# 3. Optimizing the BoW matrix\n",
    "#    Compute the order of rows (documents) and columns (words) in the bow matrix so that the most frequent words are in the top-left corner. \n",
    "filter_columns = LBD_02_data_preprocessing.get_index_list_of_dict1_keys(\n",
    "    LBD_02_data_preprocessing.sort_dict_by_value(sum_count_word_in_docs, reverse=True), word_list)\n",
    "filter_rows = LBD_02_data_preprocessing.get_index_list_of_dict1_keys(\n",
    "    LBD_02_data_preprocessing.sort_dict_by_value(sum_count_words_in_doc, reverse=True), ids_list) \n",
    "\n",
    "# 4. Rearranging the matrix\n",
    "#    Rearange (filter) the BoW matrix according to the previously computed order.\n",
    "filtered_ids_list, filtered_word_list, filtered_bow_matrix = LBD_03_feature_extraction.filter_matrix(\n",
    "    ids_list, word_list, bow_matrix, filter_rows, filter_columns)\n",
    "\n",
    "print('The first few documents in the rows of the filtered bow matrix: ', filtered_ids_list[:7])\n",
    "print('The first few words in the columns of the filtered bow matrix: ', filtered_word_list[:7])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**Visualize a part of BoW matrix**\n",
    "\n",
    "Visualize the upper left part of the Bag of Words (BoW) matrix. In the BoW matrix, each row corresponds to a document and each column to a word (or n-gram). The values in the matrix represent the frequency of the word in the corresponding document.\n",
    "As the BoW matrix mainly contains zeros, the displayed matrix is sorted so that the higher values in the cells are moved to the top left-hand corner of the matrix."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 233,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1500x900 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "first_row = 0\n",
    "last_row = 20\n",
    "first_column = 0\n",
    "last_column = 15\n",
    "LBD_06_visualization.plot_bow_tfidf_matrix('Filtered Bag of Words', \\\n",
    "                                           filtered_bow_matrix[first_row:last_row,first_column:last_column], \\\n",
    "                                           filtered_ids_list[first_row:last_row], \\\n",
    "                                           filtered_word_list[first_column:last_column], as_int = True)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**Construct TF-IDF matrix from important words and n-grams**\n",
    "\n",
    "The next script is designed to create a Term Frequency-Inverse Document Frequency (TF-IDF) matrix from a set of preprocessed documents and then refine this matrix by filtering out less relevant terms.\n",
    "\n",
    "**Functionality**\n",
    "\n",
    "1. *Creating the TF-IDF matrix*:<br>\n",
    "   The script begins by generating a TF-IDF matrix using a list of preprocessed documents:\n",
    "   - *TF-IDF matrix*: This matrix represents the importance of each word (or n-gram) across all documents in the corpus.\n",
    "   - *`ngram_size`*: Specifies the size of word sequences to consider (e.g., unigrams, bigrams).\n",
    "   - *`min_df`*: Filters out terms that appear in fewer than a specified number of documents, reducing noise in the analysis.\n",
    "\n",
    "   This step is essential for transforming raw text data into a structured format that highlights important terms.\n",
    "\n",
    "2. *Rearranging the TF-IDF matrix*:\n",
    "   The script then refines the TF-IDF matrix by rearranging and filtering the terms:\n",
    "   - *filtering*: The matrix is filtered based on criteria such as the importance of terms, ensuring that only the most relevant words remain.\n",
    "   - *rearranging*: The matrix is reorganized according to a predefined order, based on the significance of terms or their relevance to specific documents.\n",
    "\n",
    "   This refinement process is crucial for improving the quality of the analysis by focusing on the most impactful terms, which can lead to more accurate and insightful results.\n",
    "\n",
    "**Use**\n",
    "\n",
    "Users can apply this script as part of a larger text mining workflow where the TF-IDF matrix serves as an important step in structuring and analyzing the data. By filtering and refining the matrix, users can ensure that their analysis focuses on the most relevant and meaningful terms, leading to more meaningful insights. In the context of LBD, this script is an essential tool for turning raw text data into actionable insights."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 234,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of terms in initial vocabulary with all n-grams:  155490\n",
      "Number of terms in preprocessed vocabulary after removing infrequent n-grams:  15274\n"
     ]
    }
   ],
   "source": [
    "# 1. Creating the TF-IDF matrix\n",
    "word_list, tfidf_matrix = LBD_03_feature_extraction.create_tfidf(prep_docs_list, ngram_size, min_df)\n",
    "print('Number of terms in initial vocabulary with all n-grams: ', len(word_list))\n",
    "\n",
    "# 2. Rearranging the TF-IDF matrix\n",
    "#    Rearange (filter) the TF-IDF matrix according to the previously computed order from bow matrix.\n",
    "tmp_filtered_word_list, tmp_filtered_tfidf_matrix = LBD_03_feature_extraction.filter_matrix_columns(\n",
    "    word_list, tfidf_matrix, tmp_filter_rows, tmp_filter_columns)\n",
    "\n",
    "word_list = tmp_filtered_word_list\n",
    "tfidf_matrix = tmp_filtered_tfidf_matrix\n",
    "print('Number of terms in preprocessed vocabulary after removing infrequent n-grams: ', len(word_list))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**Compute margins for TF-IDF matrix**\n",
    "\n",
    "This script is designed to analyze and manipulate Term Frequency-Inverse Document Frequency (TF-IDF) data for a corpus of documents. It computes various statistics related to the TF-IDF values for both words and documents, then filters the TF-IDF matrix to reorder it based on the most important words and documents.\n",
    "\n",
    "**Functionality**\n",
    "\n",
    "1. *Summing and maximizing TF-IDF values*:\n",
    "   - `sum_count_each_word_in_all_documents`: calculates the sum of TF-IDF scores for each word across all documents, providing insight into the overall importance of words in the entire corpus\n",
    "   - `max_tfidf_each_word_in_all_documents`: finds the maximum TF-IDF score for each word, indicating the document where each word is most important\n",
    "   - `sum_count_all_words_in_each_document`: computes the sum of TF-IDF scores for all words in each document, which can be used to determine the \"weight\" or importance of the document itself\n",
    "   - `max_tfidf_all_words_in_each_document`: identifies the highest TF-IDF score for each document, which can help isolate which document contains particularly important terms\n",
    "\n",
    "2. *Output statistics*:\n",
    "   - The script uses Python's `itertools.islice` function to print a preview of the top 7 values from each TF-IDF statistic. This offers a quick way to inspect the data without overwhelming the output with large lists.\n",
    "\n",
    "3. *Sorting and filtering the TF-IDF matrix*:\n",
    "   - After calculating the TF-IDF statistics, the script computes an ordering for the rows (documents) and columns (words) based on the maximum TF-IDF values. This ensures that the most important terms and documents are given priority in subsequent analyses.\n",
    "   - The `filter_matrix` function then reorders the original TF-IDF matrix based on these computed rankings, allowing for a focused view of the most significant content in the corpus.\n",
    "\n",
    "**Practical applications**\n",
    "\n",
    "- *Document analysis and classification*: By identifying the most important terms and documents in a corpus, this technique can assist in classifying documents into relevant categories.\n",
    "- *Term and key concept extraction*: Researchers can use the sum and max TF-IDF scores to isolate critical keywords that may represent novel concepts or ideas in the context of Literature-Based Discovery.\n",
    "- *Summarization and information retrieval*: By filtering out less important words and documents, this script can help narrow down a large corpus to the most relevant data, making retrieval tasks more efficient.\n",
    "\n",
    "**Use**\n",
    "\n",
    "This script is a practical tool for analyzing TF-IDF data in text mining applications. By summing and maximizing TF-IDF scores for words and documents, users can highlight the most significant elements of their corpus. The filtered matrix provides a more focused view of the most important terms, which is highly useful in fields like Literature-Based Discovery and NLP."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 235,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Sum of TF-IDF for each word:  {'0000the': 0.03131585577796436, '0001multivariate': 0.05178920826570667, '009015mugml': 0.0465261109157432, '023x105': 0.04135440740991562, '100000mm3': 0.040019721995073844, '100000year': 0.04940950154247733, '1000fold': 0.06397122586044375}\n",
      "Max of TF-IDF for each word:  {'0000the': 0.03131585577796436, '0001multivariate': 0.05178920826570667, '009015mugml': 0.0465261109157432, '023x105': 0.04135440740991562, '100000mm3': 0.040019721995073844, '100000year': 0.04940950154247733, '1000fold': 0.06397122586044375}\n",
      "Sum of TF-IDF for each document:  {'26578392': 5.893032502934008, '26575203': 3.284395753855353, '26574544': 5.057697129035433, '26567748': 6.630723872566392, '26560688': 4.401642342151689, '26560048': 4.609067219828064, '26548612': 3.5888128190679796}\n",
      "Max of TF-IDF for each document:  {'26578392': 0.21088183077053105, '26575203': 0.2224231040166397, '26574544': 0.1782472202775803, '26567748': 0.13176229724719266, '26560688': 0.23669054252472027, '26560048': 0.3429499168951926, '26548612': 0.16697737418816666}\n"
     ]
    }
   ],
   "source": [
    "# 1. Summing and maximizing TF-IDF values\n",
    "sum_word_tfidf = LBD_03_feature_extraction.sum_count_each_word_in_all_documents(word_list, tfidf_matrix)\n",
    "max_word_tfidf = LBD_03_feature_extraction.max_tfidf_each_word_in_all_documents(word_list, tfidf_matrix)\n",
    "\n",
    "sum_doc_tfidf = LBD_03_feature_extraction.sum_count_all_words_in_each_document(ids_list, tfidf_matrix)\n",
    "max_doc_tfidf = LBD_03_feature_extraction.max_tfidf_all_words_in_each_document(ids_list, tfidf_matrix)\n",
    "\n",
    "# 2. Output statistics\n",
    "print('Sum of TF-IDF for each word: ', dict(itertools.islice(sum_word_tfidf.items(), 7)))\n",
    "print('Max of TF-IDF for each word: ', dict(itertools.islice(max_word_tfidf.items(), 7)))\n",
    "\n",
    "print('Sum of TF-IDF for each document: ', dict(itertools.islice(sum_doc_tfidf.items(), 7)))\n",
    "print('Max of TF-IDF for each document: ', dict(itertools.islice(max_doc_tfidf.items(), 7)))\n",
    "\n",
    "# 3. Sorting and filtering the TF-IDF matrix\n",
    "#    Compute the order of rows (documents) and columns (words) in the tfidf matrix so that the most important words are in the top-left corner. \n",
    "filter_columns = LBD_02_data_preprocessing.get_index_list_of_dict1_keys(\n",
    "    LBD_02_data_preprocessing.sort_dict_by_value(max_word_tfidf, reverse=True), word_list)\n",
    "filter_rows = LBD_02_data_preprocessing.get_index_list_of_dict1_keys(\n",
    "    LBD_02_data_preprocessing.sort_dict_by_value(max_doc_tfidf, reverse=True), ids_list) \n",
    "\n",
    "#    Rearange (filter) the TF-IDF matrix according to the previously computed order.\n",
    "filtered_ids_list, filtered_word_list, filtered_tfidf_matrix = LBD_03_feature_extraction.filter_matrix(\n",
    "    ids_list, word_list, tfidf_matrix, filter_rows, filter_columns)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**Visualize a part of TF-IDF matrix**\n",
    "\n",
    "Visualize the upper left part of the TF-IDF matrix. In the TF-IDF matrix, each row corresponds to a document and each column to a word (or n-gram). The values in the matrix represent the Term Frequency Inverse Document Frequency (abbreviated TF-IDF) of the word (term) in the corresponding document and document corpus. TF-IDF is a measure of how relevant a word in a document is in relation to a corpus: the measure increases proportionally to the number of occurrences of a word in the text, but is compensated for by the word frequency in the entire corpus."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 236,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1500x900 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "first_row = 0\n",
    "last_row = 20\n",
    "first_column = 0\n",
    "last_column = 25\n",
    "LBD_06_visualization.plot_bow_tfidf_matrix('Filtered TfIdf', filtered_tfidf_matrix[first_row:last_row,first_column:last_column], \\\n",
    "                                           filtered_ids_list[first_row:last_row], filtered_word_list[first_column:last_column], as_int = False)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Create a list of domain names of all documents (from the dictionary containing the documents) and a list of unique domain names. In the first context (CONTEXT_SWITCH = 1 or 2) there are two distinct domains: *Autism* and *Calcineurin*."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 237,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Domain names for the first few documents:  ['Alzheimer', 'Alzheimer', 'Alzheimer', 'Alzheimer', 'Alzheimer', 'Alzheimer', 'Alzheimer']\n",
      "A list of all uniques domain names in all the documents:  ['Alzheimer', 'GIMB']\n"
     ]
    }
   ],
   "source": [
    "domains_list = LBD_02_data_preprocessing.extract_domain_names_list(prep_docs_dict)\n",
    "print('Domain names for the first few documents: ', domains_list[:7])\n",
    "unique_domains_list = LBD_02_data_preprocessing.extract_unique_domain_names_list(prep_docs_dict)\n",
    "print('A list of all uniques domain names in all the documents: ', unique_domains_list)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Find outlier documents. Next, move the *find_document_outliers* function to LBD_04_text_mining.ipynb."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 238,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Matrix rows, columns:  (766, 15274)\n",
      "Outlier docs indeces:  [328 199 482 437 160 152 467 593 504  51 436 255  85  67 122 479 439 555\n",
      " 414  32]\n",
      "Outlier docs ids:  ['25229860', '25661086', '24708721', '24889810', '25791048', '25831610', '24753468', '24309505', '24619869', '26331911', '24903697', '25492566', '26145695', '26221675', '25982958', '24717089', '24872596', '24429454', '24983592', '26418600']\n",
      "Representative docs indeces:  [428 545  12 512 649 715 209 256 462 497 583 704  37 637  81 271 427 575\n",
      " 459 596 302 765 349 119 444 617 614 630 696  93 374  97 624 503 251 289\n",
      "  38  24 310 663 484 229 382 686 441 571 376 508 634 725 401 691 727 239\n",
      " 357 751 706  15 128 343 276 483 755 694 115 361 159  71 736 201 341 597\n",
      " 588 282 450 321 670 242 607 601 613 294 366 726  79 550 494 680 277 498\n",
      " 419 676 367  77 753 604 268 312 718  56 284 700 656 752 724 184 326 626\n",
      " 117 646 407 238 273 679  28 739 290 693  99 245 645 240 647 300 288 625\n",
      "  57 445  52 451 232   3 394 448 759 369 628 266 431 299 348 633 281 221\n",
      "  78 757 720 669 416 365 187 488 468 426 519   8 233 346 458 492 390 651\n",
      " 666 731 760 471 665 442 661 259 332 590 362 610 741 763  84 748 322 217\n",
      " 205 307 370 722 564 737 552 681 215 189 329 261 463 747 570 138 644 274\n",
      " 673 481 650   0  13 220 529 683 309  89 632 358 378  25 703 100 354  39\n",
      " 402 207 652 641 291 554 432 337  95 743 351  41 383 690 172 297  20 660\n",
      " 235 616 729 591 306 275 434 734 511 203 182 685 449 500 169 219 246  90\n",
      " 657 413 619 744 301 742  94 728 543 473 305 469 334   2 589 754 558 263\n",
      " 107 197  63 230 186 756 324 247 600 502 640 723 565 762 602 490 336 528\n",
      " 620 544 689 653 648 446  21 202 465 404 592 606 226 688 740 170 563  92\n",
      " 531 142 311 452 487 254  68 542 430 712 318 509 120 303 257 352 371 183\n",
      " 470 359 454 236 315 190 325 478 721 121  23 631 253 418 224 711 101 687\n",
      "  62  55 133 486 231 295 377 541 738 264 110 112  66 567 211 180 412 134\n",
      " 222 258 109 314 692 248 398 611 516 162 699 745 443 702  44 455 585 671\n",
      " 372 621 707 655 173 701  88 161 684  64 525 379 557 131 353 536 659 397\n",
      " 392 333 566 210 675 476 218 664 191  91  33  22 562 764 627 164  76 560\n",
      " 447  72 408 713 194 111 140 163 113 584 176 518 574 396 262  70 662 733\n",
      " 472 380 578 174 381  65  60 393 400 735 150 615 438 320 672 368  54 677\n",
      " 485 716 717 265 355 296 356 192 581 667 421 517 171 697 335  59 587 342\n",
      " 147 682 267 429 116 168 286 524 480 559 148 123 749 323 283 331 308 149\n",
      " 422 477 292 522  49 146 674 730 135 166  31 538 573 141 523 243 151 405\n",
      " 200  30 389 710 399 537 208  35  58 206  42 466 507  45  40 530 214 410\n",
      " 279 435 433 750 639 216 338 167  14 198 622 609 298  18  75 118 568 363\n",
      " 714 196 501 719 618 698 409 599 460 124 304 489 582 732 179 249 638 746\n",
      " 520 175 185 317 177 204 193 533 108 569 594 546 375  74   5 758 654 635\n",
      " 319 612 705 125  27 580 188 539 153 708 155 384 499 598 387 406 391 388\n",
      "  29 532  19 608 417 272 223 285   4 234 556 761 440  10 157  43 411 114\n",
      " 287 195 129  17 420 347 213   6 106 386 158 623 496  50 178 143 642 695\n",
      " 453 527 658 586 579 521 316 228   7 603 576 385 475 280 553 678  46 225\n",
      " 595 103 495  53 540  26 252 551 515 360 534 629 154  82 270 241 344 293\n",
      " 212  47 506 424 105 423 136 137 313 457  86 535 514 395 547 327  11  16\n",
      " 227 139  87 165 144 605 415  69 269 350 549  96 181 464 130 340  73 132\n",
      " 102 345  48 577 260 403 373 548 474  98 493 491 156 278   9 461 126   1\n",
      "  34 513 572  83 456 145 328 199 482 437 160 152 467 593 504  51 436 255\n",
      "  85  67 122 479 439 555 414  32]\n",
      "Representative docs ids:  ['24946875', '24485162', '26510982', '24587236', '26520194', '25223604', '25624418', '25491510', '24792094', '24646317', '24345324', '25382824', '26398393', '23848536', '26159205', '25451577', '24951896', '24373826', '24799715', '24293237', '25339862', '23376290', '25168262', '25985800', '24849358', '24157626', '24184094', '23981537', '25574107', '26101165', '25104975', '26082680', '24081375', '24631516', '25505410', '25393935', '26398384', '26442698', '25311587', '26374599', '24694195', '25575172', '25071571', '25801839', '24858540', '24379109', '25101284', '24590001', '23880505', '24978103', '25032889', '25705750', '24948202', '25553456', '25146189', '24627606', '25344727', '26497928', '25959626', '25182609', '25435019', '24705924', '24568717', '25589730', '26003084', '25134730', '25801844', '26214710', '24811052', '25651446', '25190571', '24293102', '24327518', '25410365', '24833295', '25245568', '26181430', '25543667', '24249638', '24290604', '24184575', '25374107', '25125469', '24969283', '26163986', '24465270', '24656052', '25865191', '25428252', '24638131', '24969117', '25914466', '25124962', '26166611', '24608416', '24274269', '25460644', '25305052', '25167923', '26312549', '25409785', '25444145', '26439212', '24627602', '24996842', '25714965', '25233067', '24059310', '25991443', '26557831', '25003233', '25554493', '25446614', '25866138', '26432480', '24751327', '25389957', '25599331', '26068914', '25537010', '26577887', '25552693', '26554714', '25345893', '25403412', '24067533', '26303081', '24848532', '26330682', '24831964', '25569096', '26567748', '25051175', '24841380', '24333791', '25112168', '24011544', '25465297', '24929105', '25348714', '25168594', '23899502', '25413004', '25590687', '26164000', '24516700', '25141579', '26186531', '24980597', '25125470', '25709784', '24685625', '24748223', '24958380', '24567336', '26544103', '25566531', '25175064', '24801214', '24662962', '25061055', '26496305', '26288277', '24874459', '24268527', '24743900', '26359672', '24858130', '26402520', '25482632', '25219254', '24316057', '25134358', '24210759', '24747448', '23676440', '26151013', '24636517', '25243877', '25596488', '25636690', '25326131', '25109373', '25087692', '24401672', '24803814', '24456080', '25851437', '25602932', '25703279', '25221582', '25481814', '24786080', '24641100', '24380849', '25915600', '26578751', '25444248', '26049770', '24713701', '26520057', '26578392', '26510981', '25590729', '24524620', '25826362', '25312618', '26125436', '23900790', '25143259', '25099695', '26439962', '25387415', '26061736', '25147790', '26397759', '25024695', '25633677', '26479726', '23551178', '25385071', '24439402', '24919190', '25203772', '26084734', '24726430', '25161917', '26388873', '25070503', '25741143', '25752887', '25364723', '26477928', '26408987', '25558244', '24161280', '24912660', '24315728', '25326841', '25437463', '24911293', '24853844', '24588281', '25646590', '25716692', '25808540', '24835770', '24636189', '25762608', '25593125', '25529971', '26119316', '26438800', '24983737', '24121965', '24720679', '25342134', '24735654', '26100639', '24929795', '24495863', '24742402', '25327901', '24746790', '25217383', '26574544', '24323769', '24590688', '24417981', '25477508', '26037109', '25661372', '26262991', '25572750', '25713167', '24556151', '25237865', '25523933', '24291096', '24633750', '23583830', '24997042', '24398134', '24106984', '24283221', '24680754', '25206842', '24525100', '24121112', '24493126', '25743457', '26457003', '26523278', '24847081', '26468457', '25651436', '24766626', '25024339', '24311544', '24262988', '25580119', '25759970', '24748976', '25761244', '24402873', '26111032', '24511465', '25904163', '25306655', '24821282', '24686253', '25497098', '26218331', '24498199', '24929655', '25248313', '25259414', '24589379', '25984755', '25337079', '25491230', '25153931', '25108625', '25714974', '24746619', '25138702', '24811002', '25557390', '25281130', '25701707', '25236746', '24719319', '25091346', '25983190', '26453763', '23943274', '25497154', '24973211', '25582438', '25278708', '26056033', '25780308', '26264026', '26315944', '25930988', '24690593', '25569373', '25365441', '25101076', '24499319', '24753353', '25477292', '26027681', '26018232', '26249687', '24395390', '25616486', '25725931', '24987548', '25926691', '25590369', '25484187', '26032409', '25288153', '25672169', '25523365', '25034304', '24200971', '24577474', '25776136', '25459686', '24716676', '24857034', '25396737', '26372824', '24807822', '24344333', '26163607', '25107315', '24117490', '25339806', '26445114', '25751960', '25403367', '26131930', '25790165', '25822311', '26259518', '24548007', '25097638', '24418609', '25940071', '25152362', '24507620', '26411174', '25036600', '25057188', '25217641', '24396150', '25623279', '25944654', '24721836', '25595257', '26370263', '25689303', '26111662', '26413119', '26454161', '24405708', '23582194', '24037034', '25772995', '26177386', '24413832', '24842139', '26209890', '25002271', '25238468', '25683482', '26025363', '25912737', '25776008', '26015450', '24345046', '25737095', '24570004', '24374297', '25041794', '25479244', '26215835', '26378866', '24858189', '24742562', '25091425', '24366863', '25747452', '25079798', '26257034', '26289578', '25055921', '25033982', '24815676', '25855658', '24172649', '24882360', '25249537', '26098103', '25122912', '26321143', '25906546', '24690897', '25197003', '25196096', '25470254', '25147110', '25364765', '25147109', '25686616', '24360558', '26221003', '24964362', '26064851', '25760599', '25565500', '25206904', '26291160', '24333375', '25182736', '25870785', '25849831', '25463479', '24932636', '25997382', '25764435', '25407074', '24556925', '24713870', '24414229', '25864199', '25977458', '24632770', '25239520', '25410364', '25219467', '25317174', '25857346', '24963152', '24721672', '25377320', '24560029', '26346361', '25877296', '25970936', '24900788', '25918421', '25767272', '26420648', '24504367', '24374923', '25908520', '24557020', '25538615', '25840008', '25023914', '25660508', '26426026', '25061748', '25287170', '25034052', '24506877', '25624420', '26400108', '26296892', '25636055', '26377309', '24755222', '24607730', '26369811', '26390057', '24517390', '25609250', '24988985', '25417106', '24906069', '24913894', '24629207', '23590716', '25600944', '25199867', '25767117', '26502816', '25661257', '24090990', '24211396', '25362514', '26487858', '26192069', '25988171', '24393377', '25131448', '25232265', '25673856', '24634197', '25143343', '24145049', '25545766', '24998676', '24291393', '24794747', '25975497', '25336646', '24685507', '24359503', '24869615', '25725942', '25506810', '23707056', '24688254', '24567324', '25740212', '25714385', '25273029', '25735846', '25644714', '25685150', '24509645', '26033527', '24381170', '24296976', '24479629', '25102813', '26195099', '26560048', '24497336', '26454487', '23879547', '25249622', '24190951', '25353827', '25971966', '26435014', '24361548', '25708447', '24503615', '25831608', '25336488', '25826665', '25068731', '24637985', '24291721', '25064444', '25005067', '25059768', '25062725', '26427704', '24510122', '26483131', '24247244', '24974339', '25451329', '25582787', '25407569', '26560688', '25558551', '24424441', '24162593', '24865990', '26527417', '25820388', '26375798', '24988102', '26013033', '25403541', '25674632', '25957402', '26489065', '24964789', '25169757', '25610425', '26548612', '26039159', '25064643', '25809810', '24085630', '24650665', '26344557', '25735176', '25889712', '23311593', '25586058', '24812499', '24531479', '26413854', '24343761', '24363376', '24564336', '25275896', '25577016', '26547631', '24275679', '26237255', '25065914', '24732790', '25416110', '24440524', '25897019', '26367073', '25582330', '24296089', '26041917', '24653693', '26322610', '24503514', '26438097', '25499431', '24458838', '24581495', '25136126', '24508524', '24004341', '25833944', '26158767', '25455094', '25549552', '25178013', '25375876', '25612739', '26362768', '24610822', '24962281', '26040724', '24963128', '25918405', '25915614', '25290579', '24806347', '26141124', '24507774', '24584938', '25042600', '24473150', '25230328', '26526912', '26490886', '25579468', '25915564', '26138814', '25771972', '25885958', '24274264', '24983378', '26216268', '25455483', '25165047', '24467234', '26083892', '25717427', '24781778', '25950934', '25194196', '26195563', '25938869', '26052025', '25175670', '26354853', '25796851', '25482235', '25024584', '25105774', '24472591', '24735001', '26071842', '24657571', '24676799', '25823906', '25427833', '26527844', '24794626', '25962668', '26575203', '26400689', '24585073', '24378048', '26158758', '24806729', '25879769', '25229860', '25661086', '24708721', '24889810', '25791048', '25831610', '24753468', '24309505', '24619869', '26331911', '24903697', '25492566', '26145695', '26221675', '25982958', '24717089', '24872596', '24429454', '24983592', '26418600']\n",
      "Outlier words:  ['ambiguities', 'strengths', 'omissions', 'yokohama', 'neurodegenerationnew', 'prospects20th', 'paths', 'pathogenicity', 'perinatal', 'dohad', 'priority', 'hemiarthroplasty', 'resuscitation', 'foramen', 'ovale', 'circuitry', 'reprogram', 'neurod1', 'profession', 'aptitude']\n",
      "Representative words:  ['disease', 'study', 'result', 'which', 'include', 'alzheimers', 'increase', 'alzheimers disease', 'effect', 'cells', 'suggest', 'however', 'treatment', 'human', 'methods', 'investigate', 'associate', 'diseases', 'protein', 'potential']\n"
     ]
    }
   ],
   "source": [
    "# Prepare a list of outlier documents based ob TF-IDF matrix; by the same token, a list of outlier words can be identified\n",
    "\n",
    "# utility for finding outlier documents from TF-IDF matrix\n",
    "\n",
    "def find_document_outliers(tfidf_matrix, n_outliers=1):\n",
    "    \"\"\"\n",
    "    Identify outliers based on cosine distance from the centroid of all document vectors.\n",
    "    \n",
    "    Parameters:\n",
    "    - tfidf_matrix: 2D numpy array of shape (n_docs, n_features), the TF-IDF matrix.\n",
    "    - outlier_fraction: float, the fraction of documents to consider as outliers.\n",
    "    \n",
    "    Returns:\n",
    "    - outlier_indices: List of indices of the documents identified as outliers.\n",
    "    \"\"\"\n",
    "    \n",
    "    # Step 1: Compute the centroid of the TF-IDF vectors\n",
    "    centroid = np.mean(tfidf_matrix, axis=0)\n",
    "    # print(centroid)\n",
    "    \n",
    "    # Step 2: Compute cosine distances between each document vector and the centroid\n",
    "    # Since we are computing cosine distance from the centroid, reshape centroid to (1, -1)\n",
    "    distances = cosine_distances(tfidf_matrix, centroid.reshape(1, -1)).flatten()\n",
    "    # print(distances)\n",
    "    \n",
    "    # Step 3: Determine the number of outliers to select\n",
    "    # n_docs = tfidf_matrix.shape[0]\n",
    "    # n_outliers = int(np.ceil(outlier_fraction * n_docs))\n",
    "    \n",
    "    # Step 4: Find the indices of the top N documents with the highest distances\n",
    "    if n_outliers < 0:\n",
    "        outlier_indices = np.argsort(distances)[-n_outliers:]\n",
    "    else:\n",
    "        outlier_indices = np.argsort(distances)[-n_outliers:]\n",
    "    \n",
    "    return outlier_indices\n",
    "\n",
    "# Example usage:\n",
    "# Assuming tfidf_matrix is a numpy array of shape (n_docs, n_features) representing the TF-IDF matrix\n",
    "# outliers = find_outliers(tfidf_matrix, outlier_fraction=0.1)\n",
    "# print(outliers)  # List of indices of the 10% most outlier documents\n",
    "\n",
    "\n",
    "# utility for finding outlier words from TF-IDF matrix\n",
    "\n",
    "def find_word_outliers(tfidf_matrix, vocabulary, n_outliers=1):\n",
    "    \"\"\"\n",
    "    Identify outlier words based on cosine distance from the centroid of all word vectors.\n",
    "    \n",
    "    Parameters:\n",
    "    - tfidf_matrix: 2D numpy array of shape (n_docs, n_features), the TF-IDF matrix.\n",
    "    - vocabulary: List of words corresponding to the columns (features) in the TF-IDF matrix.\n",
    "    - outlier_fraction: float, the fraction of words to consider as outliers.\n",
    "    \n",
    "    Returns:\n",
    "    - outlier_words: List of words identified as outliers.\n",
    "    \"\"\"\n",
    "    \n",
    "    # Step 1: Compute the centroid of the word vectors (columns)\n",
    "    centroid = np.mean(tfidf_matrix, axis=1)  # Centroid of columns (words)\n",
    "    # print(centroid)\n",
    "    \n",
    "    # Step 2: Compute cosine distances between each word vector and the centroid\n",
    "    # Since we are calculating cosine distance for words (columns), we transpose the matrix\n",
    "    distances = cosine_distances(tfidf_matrix.T, centroid.reshape(1, -1)).flatten()\n",
    "    # print(distances)\n",
    "    \n",
    "    # Step 3: Determine the number of outlier words to select\n",
    "    # n_words = tfidf_matrix.shape[1]\n",
    "    # n_outliers = int(np.ceil(outlier_fraction * n_words))\n",
    "    \n",
    "    # Step 4: Find the indices of the top N words with the highest distances\n",
    "    if n_outliers < 0:\n",
    "        outlier_indices = np.argsort(distances)[:-n_outliers]\n",
    "    else:\n",
    "        outlier_indices = np.argsort(distances)[-n_outliers:]\n",
    "    \n",
    "    # Step 5: Retrieve the corresponding outlier words using the vocabulary\n",
    "    outlier_words = [vocabulary[i] for i in outlier_indices]\n",
    "    \n",
    "    return outlier_words\n",
    "\n",
    "# Example usage:\n",
    "# Assuming tfidf_matrix is a numpy array of shape (n_docs, n_features) representing the TF-IDF matrix\n",
    "# and vocabulary is a list of words corresponding to the columns of the TF-IDF matrix\n",
    "# outliers = find_word_outliers(tfidf_matrix, vocabulary, outlier_fraction=0.1)\n",
    "# print(outliers)  # List of 10% most outlier words\n",
    "\n",
    "# prep_docs_list, ids_list, word_list, tfidf_matrix\n",
    "\n",
    "print('Matrix rows, columns: ', tfidf_matrix.shape) # rows, columns\n",
    "tfidf_matrix = np.asarray(tfidf_matrix)\n",
    "# print(type(tfidf_matrix))\n",
    "\n",
    "# Find outlier documents\n",
    "outlier_docs = find_document_outliers(tfidf_matrix,  n_outliers=20)\n",
    "print('Outlier docs indeces: ', outlier_docs) # list of documents is lines and preprocessed in prep_docs_list; ids_list contains document ids\n",
    "outlier_docs_list = outlier_docs.astype(int).tolist()\n",
    "print('Outlier docs ids: ', [ids_list[i] for i in outlier_docs_list])\n",
    "\n",
    "# Find representative documents\n",
    "representative_docs = find_document_outliers(tfidf_matrix,  n_outliers=-20)\n",
    "print('Representative docs indeces: ', representative_docs) # list of documents is lines and preprocessed in prep_docs_list; ids_list contains document ids\n",
    "representative_docs_list = representative_docs.astype(int).tolist()\n",
    "print('Representative docs ids: ', [ids_list[i] for i in representative_docs_list])\n",
    "\n",
    "# Find outlier words\n",
    "outlier_words = find_word_outliers(tfidf_matrix, word_list,  n_outliers=20)\n",
    "print('Outlier words: ', outlier_words)\n",
    "\n",
    "# Find representative words\n",
    "representative_words = find_word_outliers(tfidf_matrix, word_list,  n_outliers=-20)\n",
    "print('Representative words: ', representative_words)\n",
    "\n",
    "\n",
    "# Find again outlier documents, this time with the proper size for furter processing\n",
    "outlier_docs = find_document_outliers(tfidf_matrix,  n_outliers=7000)\n",
    "outlier_docs_list = outlier_docs.astype(int).tolist()\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**Aggregating Bag-of-Words matrix by domain**\n",
    "\n",
    "This script helps users aggregate a Bag-of-Words (BoW) matrix based on domain information, which collapses individual document representations into aggregated domain-level representations, allowing for easier analysis of textual data categorized by domains.\n",
    "\n",
    "**Functionality**\n",
    "\n",
    "This script processes a Bag-of-Words matrix (`bow_matrix`), grouping documents by their associated domain names from a `domains_list`. Each unique domain name in `unique_domains_list` will have all its corresponding documents' BoW vectors summed into a single domain-level vector. Here's a step-by-step breakdown:\n",
    "\n",
    "1. *Create binary martix from BoW matrix*:  \n",
    "   `binary_matrix = (bow_matrix > 0).astype(int)` creates binary matrix contaiong only 0 and 1 from the BoW matrix; the binary matrix is used to count number of documents that contain a word.\n",
    "\n",
    "2. *Initialize empty matrix*:  \n",
    "   `domains_bow_matrix = np.empty((0, bow_matrix.shape[1]))` initializes an empty matrix that will store the aggregated BoW vectors for each domain.\n",
    "\n",
    "3. *Count documents per domain*:  \n",
    "   The dictionary `no_documents_in_domain = {}` is created to track how many documents belong to each domain. This is useful for understanding the distribution of documents across domains.\n",
    "\n",
    "4. *Iterate through domains*:  \n",
    "   The script iterates over each unique domain in `unique_domains_list`. For each domain:\n",
    "   - *Find domain documents*:  \n",
    "     `domain_docs_indices` stores the indices of all documents in `domains_list` that belong to the current domain.\n",
    "   - *Count and record document count*:  \n",
    "     The length of `domain_docs_indices` is stored in the dictionary `no_documents_in_domain[domain_name]`.\n",
    "   - *Aggregate BoW vectors*:  \n",
    "     Using the document indices, the script selects the corresponding rows from `bow_matrix`, sums them (`tmp = (bow_matrix[domain_docs_indices,:]).sum(axis=0)`), and appends the result to `domains_bow_matrix`.\n",
    "\n",
    "5. *Output*:  \n",
    "   After processing all domains, the script prints two outputs:\n",
    "   - `domains_bow_matrix`: The BoW matrix, now aggregated by domains.\n",
    "   - `no_documents_in_domain`: A dictionary showing how many documents were grouped under each domain.\n",
    "\n",
    "**Practical Applications**\n",
    "\n",
    "This script is highly useful in various NLP and text mining fields, particularly when dealing with large collections of text that can be grouped into domains or categories:\n",
    "\n",
    "- *Biomedical research and discovery*: Researchers can use the aggregated domain-level BoW vectors to study relationships between different knowledge domains and detect novel hypotheses or cross-disciplinary insights.\n",
    "- *Topic modeling and clustering*: Aggregating BoW vectors by domain enables better analysis of domain-specific topics, which could be useful in extracting themes from large bodies of literature. Grouping documents by domain can facilitate clustering, allowing users to investigate how text clusters vary across different domains.\n",
    "\n",
    "**Use**\n",
    "\n",
    "To use this script:\n",
    "1. *Prepare Input*: Ensure you have a Bag-of-Words matrix (`bow_matrix`), where each row represents a document's word vector. You also need a list of domains (`domains_list`) with the same length as the number of documents, and a list of unique domain names (`unique_domains_list`).\n",
    "2. *Run the Script*: Execute the script in a Python environment (after importing `numpy` as `np`), and it will return two key outputs:\n",
    "   - `domains_bow_matrix`: The BoW vectors aggregated by domain.\n",
    "   - `no_documents_in_domain`: The count of documents per domain.\n",
    "   \n",
    "These outputs can be used in further analysis, such as domain-specific topic modeling, clustering, or visualization tasks. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 239,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Aggregated BoW matrix for the domains:\n",
      "[[0. 0. 1. ... 1. 1. 1.]\n",
      " [1. 1. 0. ... 0. 0. 0.]]\n",
      "Aggregated binary matrix for the domains:\n",
      "[[0. 0. 1. ... 1. 1. 1.]\n",
      " [1. 1. 0. ... 0. 0. 0.]]\n",
      "Aggregated outliers BoW matrix for the domains:\n",
      "[[0. 0. 1. ... 1. 1. 1.]\n",
      " [1. 1. 0. ... 0. 0. 0.]]\n",
      "Aggregated outliers binary matrix for the domains:\n",
      "[[0. 0. 1. ... 1. 1. 1.]\n",
      " [1. 1. 0. ... 0. 0. 0.]]\n",
      "\n",
      "Aggregated sum TF-IDF matrix for the domains:\n",
      "[[0.         0.         0.04652611 ... 0.04399054 0.05452788 0.05432076]\n",
      " [0.03131586 0.05178921 0.         ... 0.         0.         0.        ]]\n",
      "Aggregated max TF-IDF matrix for the domains:\n",
      "[[0.         0.         0.04652611 ... 0.04399054 0.05452788 0.05432076]\n",
      " [0.03131586 0.05178921 0.         ... 0.         0.         0.        ]]\n",
      "Aggregated outliers sum TF-IDF matrix for the domains:\n",
      "[[0.         0.         0.04652611 ... 0.04399054 0.05452788 0.05432076]\n",
      " [0.03131586 0.05178921 0.         ... 0.         0.         0.        ]]\n",
      "Aggregated outliers max TF-IDF matrix for the domains:\n",
      "[[0.         0.         0.04652611 ... 0.04399054 0.05452788 0.05432076]\n",
      " [0.03131586 0.05178921 0.         ... 0.         0.         0.        ]]\n",
      "\n",
      "Number of documents in each domain:  {'Alzheimer': 644, 'GIMB': 122}\n",
      "Number of outlier documents in each domain:  {'Alzheimer': 644, 'GIMB': 122}\n"
     ]
    }
   ],
   "source": [
    "# 1. Create binary martix from BoW matrix \n",
    "binary_matrix = (bow_matrix > 0).astype(int)\n",
    "\n",
    "# 2. Initialize empty matrices\n",
    "domains_bow_matrix = np.empty((0, bow_matrix.shape[1]))\n",
    "domains_binary_matrix = np.empty((0, binary_matrix.shape[1]))\n",
    "\n",
    "domains_outlier_bow_matrix = np.empty((0, bow_matrix.shape[1]))\n",
    "domains_outlier_binary_matrix = np.empty((0, binary_matrix.shape[1]))\n",
    "\n",
    "domains_sum_tfidf_matrix = np.empty((0, tfidf_matrix.shape[1]))\n",
    "domains_max_tfidf_matrix = np.empty((0, tfidf_matrix.shape[1]))\n",
    "\n",
    "domains_outlier_sum_tfidf_matrix = np.empty((0, tfidf_matrix.shape[1]))\n",
    "domains_outlier_max_tfidf_matrix = np.empty((0, tfidf_matrix.shape[1]))\n",
    "\n",
    "# 3. Count documents per domain\n",
    "no_documents_in_domain = {}\n",
    "no_outlier_documents_in_domain = {}\n",
    "\n",
    "# 4. Iterate through domains\n",
    "for i, domain_name in enumerate(unique_domains_list):\n",
    "    domain_docs_indices = [i for i, label in enumerate(domains_list) if label == domain_name]\n",
    "    no_documents_in_domain[domain_name] = len(domain_docs_indices)\n",
    "\n",
    "    domain_outlier_docs_indices = [i for i, label in enumerate(domains_list) if (label == domain_name) and (i in outlier_docs)]\n",
    "    no_outlier_documents_in_domain[domain_name] = len(domain_outlier_docs_indices)\n",
    "\n",
    "    tmp0 = (bow_matrix[domain_docs_indices,:]).sum(axis=0)\n",
    "    domains_bow_matrix = np.vstack((domains_bow_matrix, tmp0))\n",
    "\n",
    "    tmp1 = (binary_matrix[domain_docs_indices,:]).sum(axis=0)\n",
    "    domains_binary_matrix = np.vstack((domains_binary_matrix, tmp1))\n",
    "\n",
    "    tmp2 = (bow_matrix[domain_outlier_docs_indices,:]).sum(axis=0)\n",
    "    domains_outlier_bow_matrix = np.vstack((domains_outlier_bow_matrix, tmp2))\n",
    "\n",
    "    tmp3 = (binary_matrix[domain_outlier_docs_indices,:]).sum(axis=0)\n",
    "    domains_outlier_binary_matrix = np.vstack((domains_outlier_binary_matrix, tmp3))\n",
    "\n",
    "\n",
    "    tmp4 = (tfidf_matrix[domain_docs_indices,:]).sum(axis=0)\n",
    "    domains_sum_tfidf_matrix = np.vstack((domains_sum_tfidf_matrix, tmp4))\n",
    "\n",
    "    tmp5 = (tfidf_matrix[domain_docs_indices,:]).max(axis=0)\n",
    "    domains_max_tfidf_matrix = np.vstack((domains_max_tfidf_matrix, tmp5))\n",
    "\n",
    "    tmp6 = (tfidf_matrix[domain_outlier_docs_indices,:]).sum(axis=0)\n",
    "    domains_outlier_sum_tfidf_matrix = np.vstack((domains_outlier_sum_tfidf_matrix, tmp6))\n",
    "\n",
    "    tmp7 = (tfidf_matrix[domain_outlier_docs_indices,:]).max(axis=0)\n",
    "    domains_outlier_max_tfidf_matrix = np.vstack((domains_outlier_max_tfidf_matrix, tmp7))\n",
    "\n",
    "# 5. Output\n",
    "print('Aggregated BoW matrix for the domains:')\n",
    "print(domains_bow_matrix)\n",
    "print('Aggregated binary matrix for the domains:')\n",
    "print(domains_binary_matrix)\n",
    "print('Aggregated outliers BoW matrix for the domains:')\n",
    "print(domains_outlier_bow_matrix)\n",
    "print('Aggregated outliers binary matrix for the domains:')\n",
    "print(domains_outlier_binary_matrix)\n",
    "print()\n",
    "print('Aggregated sum TF-IDF matrix for the domains:')\n",
    "print(domains_sum_tfidf_matrix)\n",
    "print('Aggregated max TF-IDF matrix for the domains:')\n",
    "print(domains_max_tfidf_matrix)\n",
    "print('Aggregated outliers sum TF-IDF matrix for the domains:')\n",
    "print(domains_outlier_sum_tfidf_matrix)\n",
    "print('Aggregated outliers max TF-IDF matrix for the domains:')\n",
    "print(domains_outlier_max_tfidf_matrix)\n",
    "print()\n",
    "print('Number of documents in each domain: ', no_documents_in_domain)\n",
    "print('Number of outlier documents in each domain: ', no_outlier_documents_in_domain)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "We have created eight matrices that have two rows (one for each domain) and *len(word_list)* columns (one for each word in the vocabulary):\n",
    "\n",
    "1. domains_bow_matrix: frequency of words in domains (domain documents)\n",
    "2. domains_binary_matrix: frequency of documents containing word in domains (each word is counted as 1 if present in a docuemnt)\n",
    "3. domains_outlier_bow_matrix: in outlier documents only, frequency of words in domains (domain documents)\n",
    "4. domains_outlier_binary_matrix: in outlier documents only, frequency of documents containing word in domains\n",
    "5. domains_sum_tfidf_matrix: for each word, sum of TF-IDFs in domains \n",
    "6. domains_max_tfidf_matrix: for each word, max of TF-IDFs in domains\n",
    "7. domains_outlier_sum_tfidf_matrix: in outlier documents only, for each word, sum of TF-IDFs in domains\n",
    "8. domains_outlier_max_tfidf_matrix: in outlier documents only, for each word, max of TF-IDFs in domains\n",
    "\n",
    "These matrices are used to compute heuristics defined in the following cells.\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "**Retrieving word frequency for a specific domain in a matrix**\n",
    "\n",
    "This function, `cell_value_in_a_matrix()`, allows users to easily extract the frequency of a specific word within a particular domain from an aggregated matrix (BoW or TF-IDF). \n",
    "\n",
    "**Functionality**\n",
    "\n",
    "The `cell_value_in_a_matrix()` function takes three inputs:\n",
    "1. `a_matrix`: The Bag-of-Words matrix where rows correspond to unique domains, and columns correspond to words.\n",
    "2. `domain_name`: The name of the domain for which the user wants to retrieve the word frequency.\n",
    "3. `word`: The specific word for which the user wants to check its frequency in the given domain.\n",
    "\n",
    "Here’s how the function works step-by-step:\n",
    "\n",
    "1. *Locate Domain Index*:  \n",
    "   `line_idx = unique_domains_list.index(domain_name)`  \n",
    "   This line finds the index of the domain name in the `unique_domains_list`, which corresponds to the row in the `bow_matrix`.\n",
    "\n",
    "2. *Locate Word Index*:  \n",
    "   `column_idx = word_list.index(word)`  \n",
    "   Similarly, this line retrieves the index of the word from `word_list`, representing the column in the BoW matrix.\n",
    "\n",
    "3. *Return Word Frequency*:  \n",
    "   `return(a_matrix[line_idx, column_idx])`  \n",
    "   The function then returns the value from the BoW matrix at the specified row (domain) and column (word), which represents how many times the word appears in the documents grouped under that domain.\n",
    "\n",
    "**Practical applications**\n",
    "\n",
    "This function is useful in various NLP and text mining tasks, especially for domain-specific text analysis:\n",
    "\n",
    "- *Biomedical research and discovery*: By retrieving the frequency of specific words across different domains, researchers can identify domain-specific terminology or emerging trends in literature.\n",
    "- *Word frequency analysis*: Users can easily extract how often a particular word is used in different domains, which can help in understanding language patterns or keyword presence across domains.\n",
    "\n",
    "**Use**\n",
    "\n",
    "To use this function:\n",
    "1. *Prepare Input*: Ensure you have the following inputs ready:\n",
    "   - `a_matrix`: The Bag-of-Words or TF-IDF matrix, where rows represent domains, and columns represent words.\n",
    "   - `unique_domains_list`: A list of unique domain names corresponding to the rows of the BoW matrix.\n",
    "   - `word_list`: A list of all words corresponding to the columns of the BoW matrix.\n",
    "   \n",
    "2. *Call the Function*:  \n",
    "   For example, to find how often the word `\"vcfs\"` appears in the domain `\"Autism\"`, call:\n",
    "   ```python\n",
    "   frequency = cell_value_in_a_matrix(bow_matrix, \"Autism\", \"vcfs\")\n",
    "   print(frequency)\n",
    "   ```\n",
    "\n",
    "The output will be the frequency of the word \"vcfs\" in the `\"Autism\"` domain, based on the aggregated data in the `bow_matrix`."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 240,
   "metadata": {},
   "outputs": [
    {
     "ename": "ValueError",
     "evalue": "'Autism' is not in list",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mValueError\u001b[0m                                Traceback (most recent call last)",
      "\u001b[1;32m~\\AppData\\Local\\Temp\\ipykernel_15764\\370467755.py\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[0;32m     14\u001b[0m         \u001b[1;32mreturn\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;36m0.0\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     15\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 16\u001b[1;33m \u001b[0mprint\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m'Frequency of calmodulin in Autism: '\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mcell_value_in_a_matrix\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mdomains_bow_matrix\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;34m'Autism'\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;34m'calmodulin'\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     17\u001b[0m \u001b[0mprint\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m'Frequency of calmodulin in Calcineurin: '\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mcell_value_in_a_matrix\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mdomains_bow_matrix\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;34m'Calcineurin'\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;34m'calmodulin'\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     18\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m~\\AppData\\Local\\Temp\\ipykernel_15764\\370467755.py\u001b[0m in \u001b[0;36mcell_value_in_a_matrix\u001b[1;34m(a_matrix, domain_name, word)\u001b[0m\n\u001b[0;32m      7\u001b[0m         \u001b[0mword\u001b[0m\u001b[1;33m:\u001b[0m \u001b[0mthe\u001b[0m \u001b[0mspecific\u001b[0m \u001b[0mword\u001b[0m \u001b[1;32mfor\u001b[0m \u001b[0mwhich\u001b[0m \u001b[0mthe\u001b[0m \u001b[0muser\u001b[0m \u001b[0mwants\u001b[0m \u001b[0mto\u001b[0m \u001b[0mcheck\u001b[0m \u001b[0mits\u001b[0m \u001b[0mfrequency\u001b[0m \u001b[1;32min\u001b[0m \u001b[0mthe\u001b[0m \u001b[0mgiven\u001b[0m \u001b[0mdomain\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m      8\u001b[0m     \"\"\"\n\u001b[1;32m----> 9\u001b[1;33m     \u001b[0mline_idx\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0munique_domains_list\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mindex\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mdomain_name\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     10\u001b[0m     \u001b[1;32mif\u001b[0m \u001b[0mword\u001b[0m \u001b[1;32min\u001b[0m \u001b[0mword_list\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     11\u001b[0m         \u001b[0mcolumn_idx\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mword_list\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mindex\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mword\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;31mValueError\u001b[0m: 'Autism' is not in list"
     ]
    }
   ],
   "source": [
    "def cell_value_in_a_matrix(a_matrix: np.ndarray, domain_name: str, word: str) -> float:\n",
    "    \"\"\"\n",
    "    This function extracts the frequency of a specific word within a particular domain from an aggregated Bag-of-Words (BoW) matrix. \n",
    "    The `cell_value_in_a_matrix()` function takes three inputs:\n",
    "        a_matrix: the Bag-of-Words or TF-IDF matrix where rows correspond to unique domains, and columns correspond to words\n",
    "        domain_name: the name of the domain for which the user wants to retrieve the word frequency\n",
    "        word: the specific word for which the user wants to check its frequency in the given domain\n",
    "    \"\"\"\n",
    "    line_idx = unique_domains_list.index(domain_name)\n",
    "    if word in word_list:\n",
    "        column_idx = word_list.index(word)\n",
    "        return(a_matrix[line_idx, column_idx])\n",
    "    else:\n",
    "        return(0.0)\n",
    "\n",
    "print('Frequency of calmodulin in Autism: ', cell_value_in_a_matrix(domains_bow_matrix, 'Autism', 'calmodulin'))\n",
    "print('Frequency of calmodulin in Calcineurin: ', cell_value_in_a_matrix(domains_bow_matrix, 'Calcineurin', 'calmodulin'))\n",
    "\n",
    "print('Number of documents that contain calmodulin in Autism: ', cell_value_in_a_matrix(domains_binary_matrix, 'Autism', 'calmodulin'))\n",
    "print('Number of documents that contain calmodulin in Calcineurin: ', cell_value_in_a_matrix(domains_binary_matrix, 'Calcineurin', 'calmodulin'))\n",
    "\n",
    "print()\n",
    "\n",
    "print('Frequency of vcfs in Autism: ', cell_value_in_a_matrix(domains_bow_matrix, 'Autism', 'vcfs'))\n",
    "print('Frequency of vcfs in Calcineurin: ', cell_value_in_a_matrix(domains_bow_matrix, 'Calcineurin', 'vcfs'))\n",
    "\n",
    "print('Number of documents that contain vcfs in Autism: ', cell_value_in_a_matrix(domains_binary_matrix, 'Autism', 'vcfs'))\n",
    "print('Number of documents that contain vcfs in Calcineurin: ', cell_value_in_a_matrix(domains_binary_matrix, 'Calcineurin', 'vcfs'))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 241,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "15274\n",
      "['0000the', '0001multivariate', '009015mugml', '023x105', '100000mm3', '100000year', '1000fold', '1000mul', '1008mmaa', '100mumol', '101000mum', '1014chlorobenzyl1h123triazol4ylmethyl2methoxyacridin910hone', '10403mm', '106along', '10day', '10fold', '10kda', '10mgkgd1', '10mgkgday', '10mumoll', '10sup8sup10sup6sup', '111e2', '111inpn', '116mugg', '11cco2', '11cmethyl', '11cpbb3', '11diphenyl2picrylhydraxyl', '11diphenyl2picrylhydrazyl', '1201mm', '123triazole', '125ihplc', '12benzothiazolyl3hydroxy2methyl41hpyridinone', '12item', '12myristate', '12week', '131mugml', '137trimethylxanthine', '13acetate', '13c3labeled', '13ccarbon', '13cisotope', '13dipolar', '13ene26dione', '140min', '144033x104', '14aminophenyl3hydroxy2methyl41hpyridinone', '14beta', '14diazines', '14fold', '14monthold', '14q3231', '14weekold', '14yearsold', '1500mul', '156012x103', '15bed', '15day', '15fold', '15lipoxygenase', '15lox', '15nlabeled', '15q133', '16carbon', '1704gt', '170nm', '17p133', '17vamp8snap29', '186gene', '18amino', '18cineole', '18ft808', '18monthold', '1960s', '1970s', '1980s', '1990s', '19fold', '1bace1', '1betadribofuranoside', '1carbon', '1h13c', '1induced', '1methyl4phenyl1236tetrahydropyridineprobenecid', '1naphthaleneacetic', '1s3s7s10r11s12s16r3acetyl711dihydroxy88101216pentamethyl417', '1week', '1x1018mol', '1x104', '2003kcalmol', '209mugml', '20day', '20fold', '20mul', '20mumoll', '213mugg', '21day', '21days', '21e3e4611cmethylaminopyridin3ylbuta13dienylbenzodthiazol6', '21hydroxyl4oxocyclohexyl', '21x37', '22azinobis3ethylbenzothiazoline6sulfonic', '22diphenyl1picrylhydrazyl', '2378tetrachlorodibenzopdioxin', '23fold', '23z34zheptatriacontadienoic', '245trichlorophenoxyacetic', '2462mum', '24bed', '24dichlorophenoxyacetic', '24hour', '24hour rhythms', '24hour rhythms expression', '24hour rhythms methylation', '24hours', '24methoxyphenyl7methyl7hpyrazolo43e124triazolo15cpyrimidine', '24week', '250times', '2535induced', '2554mugg', '25dihydroxyvitamin', '25fold', '25hydroxycholesterol', '25hydroxylase', '25hydroxyvitamin', '25kda', '25ohc', '25ohcdriven', '26diamino4hydroxy5formamidopyrimidine', '26may', '2765gc', '27dichlorofluoresceindiacetate', '28days', '28fold', '2acetylbenzobthiophene3olate', '2aminophenols', '2back', '2bottle', '2bromobenzoic', '2ddige', '2e15chlorothiophen2yl34dimethylaminophenylprop2en1one', '2hetaryl', '2heteroaryl', '2hindazoles', '2methylbenzyl', '2methylthio3phenylsulfonyl4hpyrido12apyrimidin4imine', '2nonenal', '2phenoxyindan1one', '2photon', '2propyl', '2ptoluidinonaphthalene6sulfonic', '2styryl', '2week', '2weeks', '2yearold', '2years', '300kda', '306vqivyk311', '3125fold', '325521mum', '33342pi', '335nm', '338mv', '345were', '347trimethyl', '34dihydroxyphenylacetic', '34fold', '350166bp', '35fold', '36min', '37370gbqmumol', '374ta', '380ml', '395mugml', '39kda', '3amino5bromothieno23bpyridine2carbonitrile', '3arylsulfonylpyrido12apyrimidin4imines', '3beta', '3beta4alpha', '3demethylcolchicine', '3fold', '3hpentazocine', '3hqnb', '3hydroxy2methyl1phenyl41hpyridinone', '3hydroxy4pyridiones', '3kinase', '3kinasebeclin1bcell', '3methoxy4hydroxyphenylglycol', '3methyladenine', '3oacetylolean12ene2328dinitrile', '3t3l1', '3t3l1 cells', '3untranslated', '3untranslated region', '3x1018mol', '3xtgad', '40min', '420nm', '429tc', '45caffeoyl', '45difluoro', '45years', '479x104526x102', '491kcalmol', '4aminopyridine', '4caffeoylquinic', '4hydroxy', '4hydroxynonenal', '4methylumbelliferone', '4nndimethylaminosulfonyl7n2aminoethylamino213benzoxadiazole', '4omethylnorbelladine', '4omethyltransferase', '4pentenoic', '4s7r8s9s16sz16acetyl48dihydroxy557913pentamethyloxacyclohexadec', '4s7r8s9s16sz16acetyl557913pentamethyl48bistriethylsilyloxyox', '4week', '4weeks', '4year', '4z15zoctadecadienoic', '500mum', '5060hz', '50mul', '51adjuvanted', '54chlorophenyl6ethylpyrimidine24diamine', '54yearold', '5500mum', '5582mugml', '55fold', '55min', '568ngr', '56dimethoxy1indanone', '56dimethoxyindan1one', '576554bp', '5adenylyl', '5aminoimidazole4carboxamide', '5bromo2chloronicotinonitrile', '5chloro7iodo8hydroxyquinoline', '5hiaa', '5ht3ion', '5htinduced', '5htrgpcr', '5hydroxy3indoleacetic', '5hydroxymethylcytosine', '5hydroxytryptamine', '5hydroxytryptophan', '5lipoxygenase', '5membered', '5methylcytosine', '5mgkg', '5monthold', '5xfad', '5year', '5year mortality', '61yearold', '64yearold', '661250pgml', '66pgml', '67yearold', '68ga3', '68gabdhc2', '68gadac2', '68gal2', '68galabeled', '68ge68ga', '6fold', '6hydroxydopamine', '6position', '6weeks', '724dichlorophenylpyrido3245thieno32dpyrimidin4amine', '73fold', '7500times', '765gc', '76yearold', '79122mum', '79yearold', '7alphahydroxy4cholesten3one', '7meota', '80mgkg', '80yearold', '824dichlorophenylpyrido3245thieno32dpyrimidin4amine', '869mz', '86yearold', '8701mm', '87yearold', '8arylpyrido3245thieno32dpyrimidin4amines', '8cineole', '8hydroxypyrene136trisulfonic', '8hydroxyquinolate', '8week', '8year', '911day', '91mugml', '95cis', '962ngr', '9amino', '9bhcl', '9hcarbazole', '9ing41', '9lauryl', '9months', 'a1ab1b', 'a1ab1b subunit', 'a1atmediated', 'a4250', 'a4250treated', 'aaaatpase', 'aauaaa', 'abandon', 'abbvie', 'abca2', 'abca2 overexpression', 'abdominal', 'aberrant', 'aberrantly', 'aberration', 'aberrations', 'abeta', 'abeta peptide', 'abeta110', 'abeta140', 'abeta140 peptide', 'abeta142', 'abeta142induced', 'abeta142insulted', 'abeta142mediated', 'abeta142transgenic', 'abeta142treated', 'abeta16', 'abeta16 peptide', 'abeta16wwa', 'abeta2535', 'abeta2535 treat', 'abeta2535 treat cells', 'abeta2535induced', 'abeta2535treated', 'abeta40', 'abeta42', 'abeta42 antibody', 'abeta42 immunization', 'abeta42immunized', 'abeta42induced', 'abeta42induced neurotoxicity', 'abetaabad', 'abetabinding', 'abetaevoked', 'abetaf', 'abetah2o2', 'abetainduced', 'abetainduced reduction', 'abetainduced reduction sappalpha', 'abetamediated', 'abetao', 'abetapp', 'abetappinduced', 'abetappps1', 'abetatreated', 'abetax42', 'abide', 'abilities', 'ability', 'abiotic', 'ablate', 'ablation', 'abnormal', 'abnormal aggregation', 'abnormalities', 'abnormally', 'abolish', 'abort', 'abovementioned', 'abreast', 'abrogate', 'abrogation', 'abscess', 'abscesses', 'abscise', 'absence', 'absent', 'absolute', 'absolutely', 'absorb', 'absorbance', 'absorption', 'abstention', 'abstinence', 'abstract', 'abt267', 'abt333', 'abt450', 'abt450r', 'abt450rombitasvir', 'abundance', 'abundant', 'abundantly', 'abuse', 'ac1mmyr2', 'academic', 'academy', 'acanthopanax', 'acaracidal', 'acat1', 'acat2', 'acats', 'accelerate', 'accelerate angiogenesis', 'accentuate', 'accept', 'acceptable', 'acceptance', 'access', 'accessibility', 'accessible', 'accessory', 'accidental', 'accidents', 'accommodate', 'accompany', 'accompanyied', 'accomplish', 'accord', 'accord baseline', 'accord baseline cytology', 'accordance', 'accordingly', 'account', 'accrue', 'accumulate', 'accumulate evidence', 'accumulation', 'accumulation betaamyloid', 'accumulation trisomy', 'accumulation trisomy cells', 'accuracy', 'accurate', 'accurate measurement', 'accurately', 'accustom', 'accutase', 'aceiarb', 'acetaminophen', 'acetate', 'acetic', 'acetlycholinesterase', 'acetone', 'acetyl', 'acetyl cholinesterase', 'acetyl cholinesterase inhibitory', 'acetylate', 'acetylation', 'acetylation bace1', 'acetylation methylation', 'acetylation promoter', 'acetylation promoter regions', 'acetylcholine', 'acetylcholine receptor', 'acetylcholine receptor antagonist', 'acetylcholine receptor nachr', 'acetylcholine receptors', 'acetylcholinestease', 'acetylcholinesterase', 'acetylcholinesterase butyrylcholinesterase', 'acetylcholinesterase butyrylcholinesterase inhibitory', 'acetylcholinesterase inhibitor', 'acetylcholinesterase inhibitors', 'acetylcholinesterase inhibitory', 'acetylcholinestrase', 'acetylcoa', 'acetylthiocholine', 'acetyltransferase', 'acheselective', 'achieve', 'achievement', 'achievements', 'acholesterol', 'achsensing', 'acidcontaining', 'acidic', 'acidinduced', 'acidintoxicated', 'acidocaldarius', 'acidosis', 'acidotropic', 'acidproducing', 'acids', 'acids include', 'acidschiff', 'acini', 'acknowledge', 'aclpffdnh2', 'aclpffnnh2', 'acquire', 'acquisition', 'acridine', 'acridone', 'across', 'acrylamide', 'actin', 'actinobacteria', 'action', 'action modulation', 'action modulation inflammation', 'activate', 'activate cells', 'activate microglia', 'activation', 'activation microglia', 'activation signal', 'activator', 'activators', 'active', 'active compound', 'active constituents', 'active crohns', 'active crohns disease', 'active disease', 'active immunotherapy', 'active inactive', 'actively', 'activeregimen', 'activeregimen group', 'activesite', 'activin', 'activin effect', 'activin signal', 'activites', 'activities', 'activity', 'activity assay', 'activity extract', 'activity human', 'activity index', 'activity inhibition', 'activity level', 'activity modifications', 'activity patients', 'activity reduce', 'activity submicroliter', 'activity submicroliter human', 'activity value', 'activitydependent', 'activitydependent neuroprotective', 'activitydependent neuroprotective protein', 'activityhuman', 'actrn12613000493741', 'actual', 'actuaries', 'acupuncture', 'acupunctureea', 'acute', 'acute chronic', 'acute gastroenteritis', 'acute kidney', 'acute kidney injury', 'acute myocardial', 'acute myocardial infarction', 'acutely', 'acutephase', 'acvr1b', 'acvr2a', 'acyclohexadec13ene26dione', 'acylcoa', 'acylcoenzyme', 'acyltransferase', 'acyltransferases', 'acyltransferasesoat', 'adalimumabtreated', 'adam10', 'adam17', 'adam8', 'adapt', 'adaptability', 'adaptable', 'adaptation', 'adaptive', 'adaptive immune', 'adaptor', 'adaptor protein', 'adaptors', 'adasd', 'adassociated', 'adautismcancerassociated', 'adbrain', 'adcpg', 'adcpgabeta31010', 'addavax', 'addendum', 'addiction', 'addictionlike', 'addison', 'addition', 'addition effect', 'addition increase', 'additional', 'additionally', 'additive', 'additives', 'addon', 'address', 'adduct', 'adduct formation', 'adductor', 'adenocarcinoma', 'adenocarcinomas', 'adenoma', 'adenosine', 'adenoviral', 'adenovirus', 'adenylate', 'adequate', 'adequately', 'adhere', 'adherence', 'adhesion', 'adhesive', 'adipocytes', 'adipocytokine', 'adipogenesis', 'adipogenesisrelated', 'adipogenic', 'adipokine', 'adipokines', 'adiponectin', 'adipose', 'adipose tissue', 'adiposederived', 'adiposederived cells', 'adjacent', 'adjunct', 'adjust', 'adjustment', 'adjustments', 'adjustments traditional', 'adjuvant', 'adjuvanted', 'adjuvantladen', 'adjuvants', 'adlike', 'adlinked', 'administer', 'administration', 'administrator', 'admission', 'admissions', 'admissions bipolar', 'admissions bipolar disorder', 'admit', 'adnpcontrolled', 'adolescents', 'adopt', 'adorable', 'adpbound', 'adrelated', 'adrenal', 'adrenocorticotropic', 'adsorb', 'adsorption', 'adspecific', 'adult', 'adult mental', 'adult mental health', 'adult neurogenesis', 'adult offspring', 'adult onset', 'adult ts65dn', 'adulthood', 'adults', 'advance', 'advance glycation', 'advance glycation products', 'advancement', 'advantage', 'advent', 'adverse', 'adverse clinical', 'adverse effect', 'adverse events', 'adverse health', 'adverse health effect', 'adverse outcomes', 'adverse reactions', 'adversely', 'advisable', 'advise', 'advocate', 'advresistant', 'adxcmvabeta31010cpg', 'aerial', 'aerobic', 'aerobic glycolysis', 'aestivum', 'aetiology', 'af40431', 'affairs', 'affect', 'affect disease', 'affect stability', 'affect viability', 'affective', 'afferent', 'afferents', 'affinities', 'affinity', 'affinity chromatography', 'affinityenhancing', 'affinityincreasing', 'affinityselection', 'affirm', 'afflict', 'afford', 'aforementioned', 'african', 'aftertreatment', 'agachanwexner', 'agcontaining', 'age461', 'age50', 'ageassociated', 'ageassociated diseases', 'agedependence', 'agedependent', 'ageingrelated', 'agematched', 'agencies', 'agent', 'agent orange', 'agent orange exposure', 'agents', 'agents discuss', 'ageprone', 'agerelated', 'agerelated chronic', 'agerelated diseases', 'agerelated macular', 'agerelated macular degeneration', 'agespecific', 'agestandardized', 'aggravate', 'aggravation', 'aggregate', 'aggregation', 'aggregationprone', 'aggression', 'aggressive', 'agingrelated', 'agingrelated diseases', 'agitate', 'agitation', 'agnps', 'agnuside', 'agonist', 'agonists', 'agree', 'agreeableness', 'agreement', 'agsio2', 'ah1n1', 'ah3n2', 'ahead', 'ahmad', 'ahvaz', 'aicar', 'aicarinduced', 'aicdgrb2', 'aicdmediated', 'aicdregulated', 'aicdtransfected', 'aiche', 'ailments', 'airborne', 'airway', 'aktmediated', 'al3induced', 'ala119', 'alanine', 'alassumes', 'albeit', 'albidoflavus', 'albino', 'albumin', 'albuminuria', 'alcff', 'alcohol', 'alcohol consumption', 'alcontaining', 'aldehyde', 'aldehydemodified', 'aldehydemodified proteins', 'aldehydes', 'aldose', 'aldose reductase', 'aleaf', 'alexa', 'alflvf', 'alg2interacting', 'algal', 'alginate', 'algorithm', 'algorithmically', 'algorithmligandbased', 'algorithms', 'alh2o6', 'alhxf', 'alhydrogel', 'align', 'alignmentfree', 'aliphatic', 'aliva', 'alivatm', 'alive', 'alkaline', 'alkalinization', 'alkaloid', 'alkaloids', 'alkenylphenol', 'alkylenethiourea', 'allata', 'allatom', 'allcancer', 'allcause', 'allcause mortality', 'allele', 'alleles', 'allelic', 'allelic expression', 'allelopathic', 'allergic', 'allergies', 'allergy', 'allesame', 'alleviate', 'allocate', 'allocation', 'allograft', 'allopregnanolone', 'allopurinol', 'allosteric', 'allow', 'allow identification', 'alltransretinoic', 'almef', 'almef mugml', 'almost', 'alo2h2o42', 'alo2h2o52', 'alone', 'along', 'alongside', 'aloud', 'alox15', 'aloysia', 'alpha', 'alpha1antitrypsin', 'alpha1beta1deltaepsilon', 'alpha2adrenoceptors', 'alpha47', 'alpha7', 'alpha7 nicotinic', 'alpha7 nicotinic acetylcholine', 'alpha7 nicotinic receptor', 'alpha7 subunits', 'alpha73beta22nachrs', 'alpha74beta21', 'alpha75', 'alpha75nachrs', 'alpha7alpha7', 'alpha7beta2', 'alpha7beta2nachr', 'alpha7beta2nachrs', 'alpha7beta2nicotinic', 'alpha7nachr', 'alpha7nachrs', 'alphaa', 'alphaamino3hydroxy5methyl4isoxazolepropionate', 'alphaasgm1', 'alphabetahydrolase', 'alphabetaunsaturated', 'alphabungarotoxin', 'alphacleavage', 'alphaconotoxin', 'alphaconotoxins', 'alphacterminal', 'alphadependent', 'alphahelical', 'alphahelix', 'alphaigcd40', 'alphaketoglutaramate', 'alphaketoglutarate', 'alphaketoglutarate dehydrogenase', 'alphaketoglutaratedependent', 'alphalinolenic', 'alphalipoic', 'alphapeptides', 'alphasyn', 'alphasynmediated', 'alphasynuclein', 'alphasynucleinbound', 'alphatocopherol', 'already', 'alreadyexisting', 'alspf', 'altast', 'alter', 'alter expression', 'alter mental', 'alter mental status', 'alter splice', 'alteration', 'alterations', 'altercation', 'alternate', 'alternative', 'alternative polyadenylation', 'alternative source', 'alternative source different', 'alternative splice', 'alternatively', 'alternatives', 'although', 'altogether', 'alubased', 'alumediated', 'aluminum', 'aluminum hypothesis', 'aluminuminduced', 'aluminums', 'alurich', 'always', 'alwtf', 'alzehimers', 'alzheimer039s', 'alzheimerdiseaseassociated', 'alzheimerdiseases', 'alzheimerlike', 'alzheimers', 'alzheimers disease', 'alzheimers disease brain', 'alzheimers disease cancer', 'alzheimers disease characterize', 'alzheimers disease chronic', 'alzheimers disease however', 'alzheimers disease model', 'alzheimers disease parkinsons', 'alzheimers disease patients', 'alzheimers disease previous', 'alzheimers disease study', 'alzheimers disease support', 'alzheimers diseases', 'alzheimers neurological', 'alzheimers neurological disorder', 'alzheimers parkinsons', 'alzheimertype', 'alzheimertype dementia', 'alzheimertype dementia arteriosclerosis', 'amadori', 'amantadine', 'amaryllidaceae', 'ambient', 'ambiguities', 'ambroxol', 'ameliorate', 'amelioration', 'ameliorative', 'ameliorative effect', 'ameliorator', 'amend', 'america', 'american', 'americans', 'amide', 'amides', 'amidopropyl', 'amine', 'amines', 'amines metabolites', 'amino', 'amino acids', 'amino sequence', 'aminobutyric', 'aminocarbonylation', 'aminoguanidine', 'aminoimidazole', 'aminoterminal', 'aminotransferase', 'aminotransferasealanine', 'ammonia', 'ammonis', 'amnesia', 'among', 'among others', 'among patients', 'among patients prior', 'amongst', 'amount', 'ampactivated', 'ampaevoked', 'ampar', 'ampars', 'ampelopsin', 'amphipathic', 'amphiphilic', 'amphiphilicity', 'amphiphysin', 'amphipols', 'ampicillin', 'ampkinduced', 'ampkmediated', 'ampks485a', 'ampkser485', 'ampkthr172', 'ample', 'amplification', 'amplify', 'amplitude', 'ampullate', 'amputation', 'amurensis', 'amygdala', 'amyloid', 'amyloid deposition', 'amyloid plaques', 'amyloid precursor', 'amyloid precursor protein', 'amyloid precursorlike', 'amyloidbeta', 'amyloidbeta 2535induced', 'amyloidbeta abeta', 'amyloidbeta peptide', 'amyloidbeta precursor', 'amyloidbeta precursor protein', 'amyloidbeta protein', 'amyloidbeta protein precursor', 'amyloidbeta140', 'amyloidbeta42', 'amyloidbetadegrading', 'amyloidbetainduced', 'amyloidbetatreated', 'amyloidinduced', 'amyloidlike', 'amyloidlike fibrils', 'amyloidogenesis', 'amyloidogenic', 'amyloidogenicity', 'amyloidosis', 'amyloids', 'amyloidtau', 'amyotrophic', 'amyotrophic lateral', 'amyotrophic lateral sclerosis', 'anacardic', 'anaerobes', 'anaerobic', 'analgesia', 'analgesic', 'analog', 'analogous', 'analogs', 'analogue', 'analogues', 'analogy', 'analyse', 'analyse reveal', 'analyses68gacur2', 'analysis', 'analysis expression', 'analysis human', 'analysis perform', 'analysis result', 'analysis reveal', 'analytes', 'analytical', 'analyze', 'analyze follow', 'analyze result', 'anamorsin', 'anaphylactic', 'anastomose', 'anastomosis', 'anatomical', 'anatomy', 'ancestry', 'anchor', 'ancient', 'ancova', 'andersengill', 'andor', 'andprobiotic', 'andthe', 'anemia', 'anergy', 'anesthetics', 'aneuploidy', 'aneurism', 'aneurysm', 'angcopper', 'angeles', 'angina', 'angiogenesis', 'angiogenic', 'angiogenin', 'angiographically', 'angiography', 'angiomyogenesis', 'angiomyogenic', 'angiopathy', 'angiotensin', 'angiotensinconverting', 'angle', 'angptl8', 'anhedonia', 'anhydrase', 'aniline', 'animal', 'animal model', 'animal study', 'animals', 'anion', 'anionic', 'anisotropy', 'ankyrin', 'annals', 'annexin', 'annexin stain', 'anniversary', 'annotate', 'annotation', 'annotations', 'annual', 'anomalies', 'anorectal', 'anoscopy', 'anosognosia', 'another', 'anova', 'anoxic', 'answer', 'antagonist', 'antagonist kynurenic', 'antagonistic', 'antagonists', 'antagonize', 'antemortem', 'antennae', 'anterior', 'anthocyanin', 'anthocyanins', 'anthracenepolyamine', 'anthraquinonepolyamine', 'anthropometric', 'anti5lipoxygenase', 'antiabeta', 'antiabeta antibody', 'antiacetylcholinesterase', 'antiache', 'antiache activity', 'antiacne', 'antiad', 'antiad antiinflammatory', 'antiadalimumab', 'antiadipogenic', 'antiaging', 'antialpha7', 'antialzheimer', 'antialzheimer compound', 'antialzheimer properties', 'antialzheimers', 'antialzheimers disease', 'antiamyloid', 'antiang', 'antianginal', 'antiangiogenic', 'antiapoptosis', 'antiapoptotic', 'antiasialo', 'antiaterogenic', 'antiatherosclerosis', 'antiatherosclerotic', 'antiatrophy', 'antibace1', 'antibace1 fragment', 'antibacterial', 'antibacterial antifungal', 'antibetaamyloid', 'antibiotic', 'antibioticalone', 'antibiotics', 'antibioticsteroid', 'antibodies', 'antibodiestoadalimumab', 'antibody', 'antibody response', 'antibody responses', 'antibraf', 'anticancer', 'anticancer activities', 'anticancer antialzheimer', 'anticancerantitumor', 'anticell', 'anticholesterol', 'anticholinesterase', 'anticholinestrase', 'anticipate', 'anticipation', 'anticoagulant', 'anticonvulsant', 'anticonvulsants', 'antidepressant', 'antidiabetes', 'antidiabetic', 'antidiabetic antiad', 'antidiabetic antiinflammatory', 'antidiabetic effect', 'antidiabetics', 'antidiarrhoeal', 'antidrug', 'antiebv', 'antiendomysial', 'antifungal', 'antigen', 'antigen present', 'antigen present cells', 'antigenic', 'antigenotoxic', 'antigenpresenting', 'antigens', 'antigliadin', 'antiglycation', 'antihalphasyn', 'antihbc', 'antihbs', 'antihttgdeamidated', 'antihttgdgp', 'antihuman', 'antihyperglycemic', 'antihypertensive', 'antiinfective', 'antiinflammatory', 'antiinflammatory activities', 'antiinflammatory activity', 'antiinflammatory cytokines', 'antiinflammatory effect', 'antiinfluenza', 'antiintegrin', 'antiinterferential', 'antiinvasive', 'antimalarial', 'antimdashproliferative', 'antimdashtumor', 'antimetastatic', 'antimicrobial', 'antimicrotubule', 'antimirna125b', 'antimitotic', 'antimuscle', 'antimycin', 'antimycobacterial', 'antinerve', 'antineuroinflammatory', 'antinfkb', 'antingf', 'antinmdareceptor', 'antinociceptive', 'antinocicetive', 'antinueroinflammatory', 'antiobesity', 'antioxidant', 'antioxidant activities', 'antioxidant activity', 'antioxidant agents', 'antioxidant antiinflammatory', 'antioxidant capacity', 'antioxidant effect', 'antioxidant enzymes', 'antioxidant properties', 'antioxidants', 'antioxidative', 'antiperspirants', 'antiproliferative', 'antiproliferatives', 'antiprotozoal', 'antipsychotic', 'antiremicade', 'antiremicade antibodies', 'antiremsima', 'antiretroviral', 'antiretroviralnaive', 'antirheumatic', 'antisaccharomyces', 'antisense', 'antisera', 'antistress', 'antitnf', 'antitnf antibodies', 'antitnfalpha', 'antitransglutaminase', 'antituberculous', 'antitumor', 'antitumoral', 'antitumorigenic', 'antitumour', 'antitussive', 'antiviral', 'antiviral treatment', 'antixanthine', 'antral', 'antrum', 'antrumu', 'anxiety', 'anxietylike', 'anxietylike behavior', 'anxiolytic', 'aomdss', 'aomdssinduced', 'aortic', 'ap180', 'apart', 'apde9', 'aphasia', 'apiaceae', 'apigenin', 'aplp1', 'aplp1 aplp2', 'aplp1aplp2', 'aplp1aplp2dko', 'aplp2', 'aplp2751', 'aplp2ctfs', 'aplps', 'apoe33', 'apoe4', 'apoe44', 'apoe44dependent', 'apoer2', 'apoer2 density', 'apoer2 density lipoprotein', 'apoer2 vldlr', 'apolipoprotein', 'apolipoprotein receptor', 'apolipoprotein receptor apoer2', 'apolipoproteins', 'apollonbruce', 'apoptosis', 'apoptosis cells', 'apoptosis induce', 'apoptosis which', 'apoptosisrelated', 'apoptotic', 'apoptotic death', 'apoptotosis', 'app23', 'app695', 'appalpha', 'appaplp1', 'appaplp2', 'appaplp2dko', 'appaplps', 'apparent', 'apparently', 'appcleaving', 'appeal', 'appear', 'appear major', 'appear promise', 'appear specifically', 'appearance', 'appearances', 'append', 'appendicectomy', 'appendicitis', 'appetiteregulating', 'appexpressing', 'appfamily', 'appgal4', 'appinduced', 'appkd', 'appko', 'applicability', 'applicable', 'application', 'applications', 'applications include', 'applike', 'apply', 'apply clinical', 'appmediated', 'appneprilysin', 'apposition', 'appps1', 'appraisal', 'appraisal skills', 'appraise', 'appreciable', 'appreciate', 'appreciation', 'apprehension', 'approach', 'approach result', 'approach treat', 'appropriate', 'appropriately', 'approval', 'approve', 'approximate', 'approximately', 'approximation', 'appsalpha', 'appsgames', 'appstimulated', 'appsw', 'appsw cells', 'appswdihunos2tgmnos2', 'appswdimnos2', 'appswe', 'appsweps1de9', 'apptgcebpd', 'april', 'aptitude', 'apyrogenicity', 'aqpcs', 'aquaporin4', 'aqueous', 'aquilaria', 'arabia', 'arachidonic', 'arachnoid', 'araneus', 'arbitrary', 'archaea', 'archaeal', 'archaellum', 'archeobacterial', 'architectural', 'architecture', 'architecture early', 'architecture early onset', 'architecture spast', 'archive', 'arduini', 'areas', 'areas cover', 'areaspecific', 'arena', 'arg526', 'arg98', 'argue', 'arhgap24', 'arid3b', 'arise', 'aristides', 'armoury', 'aroma', 'aroma fraction', 'aromatic', 'aromatic residues', 'aromatic stack', 'aromatic stack interactions', 'aromaticity', 'aromaticpolyamine', 'around', 'arrangement', 'array', 'arrest', 'arrestinlike', 'arrestinmediated', 'arrhythmia', 'arrhythmogenic', 'arrival', 'arrowarg228', 'arrowhis110', 'arrowl', 'arrowval120', 'arsenal', 'artemisia', 'artemisia tridentata', 'arterial', 'arterial disease', 'arteries', 'arteriosclerosis', 'arteriovenous', 'artery', 'artery disease', 'arthritis', 'article', 'article describe', 'article discuss', 'article highlight', 'article present', 'article protect', 'article protect copyright', 'article review', 'article special', 'article special issue', 'articulate', 'artifactual', 'artificial', 'artsbased', 'artsbased approach', 'arttreated', 'artwork', 'arylnitrile', 'arylnitrile oxides', 'ascarids', 'ascend', 'ascertain', 'ascorbate', 'ascorbic', 'ascribe', 'asdassociated', 'asdlike', 'asian', 'asians', 'asn421', 'asnglyarg', 'asp251toglu', 'asp70', 'asparagine', 'asparaginelinked', 'aspartate', 'aspartatebased', 'aspartatenacetylaspartylglutamic', 'aspartates', 'aspartic', 'aspartyl', 'aspbased', 'aspect', 'aspects', 'aspects tissue', 'aspects tissue availability', 'aspergillus', 'aspirate', 'aspiration', 'assay', 'assay could', 'assay demonstrate', 'assay detect', 'assay develop', 'assemble', 'assembly', 'assess', 'assess effect', 'assessment', 'assessmentbased', 'assessments', 'assign', 'assignment', 'assist', 'assistance', 'associata', 'associate', 'associate alzheimers', 'associate alzheimers disease', 'associate cancer', 'associate cardiovascular', 'associate cardiovascular disease', 'associate chronic', 'associate complications', 'associate disease', 'associate disease activity', 'associate firsttime', 'associate higher', 'associate incidence', 'associate increase', 'associate neurodegenerative', 'associate neurodegenerative diseases', 'associate pathogenesis', 'associate protease', 'associate reduce', 'associate regulation', 'associate serum', 'association', 'association study', 'associations', 'assume', 'assumption', 'astarich', 'astaxanthin', 'asteraceae', 'asthma', 'asthmatic', 'astonish', 'astrocyte', 'astrocytes', 'astrocytic', 'astroglia', 'astroglial', 'astroglioma', 'astrogliosis', 'asyetunexpected', 'asymmetric', 'asymptomatic', 'ataxia', 'ataxia telangiectasia', 'atg16l1', 'atg16l1 variants', 'atg16l1variant', 'atherosclerosis', 'atherosclerosis alzheimers', 'atherosclerosis alzheimers disease', 'atherosclerotic', 'athlete', 'athletes', 'atinegative', 'atmospheric', 'atmospheric pressure', 'atmospheric pressure photoionization', 'atomic', 'atoms', 'atopy', 'atorvastatin', 'atpase', 'atpbinding', 'atpcontrolled', 'atpdependent', 'atpdeprived', 'atprelated', 'atpsensitive', 'atpsensitive channel', 'atrftir', 'atrial', 'atrioventricular', 'atriplex', 'atrisk', 'atrophic', 'atrophy', 'atropine', 'attach', 'attachment', 'attack', 'attain', 'attainment', 'attempt', 'attend', 'attendees', 'attention', 'attentiondeficit', 'attenuate', 'attenuation', 'attest', 'attitude', 'attitudes', 'attomole', 'attract', 'attractive', 'attractive option', 'attractive option investigate', 'attribute', 'attrition', 'attwell', 'atxn2', 'atypical', 'auc95', 'audience', 'auditory', 'augment', 'august', 'auranofin', 'aureus', 'austerity', 'austin', 'australia', 'australian', 'australis', 'auten67', 'authentic', 'author', 'authorities', 'autism', 'autism spectrum', 'autism spectrum disorder', 'autistic', 'autoantibodies', 'autographic', 'autography', 'autoimmune', 'autoimmune cells', 'autoimmune disease', 'autoimmune disorder', 'autoimmunity', 'autologous', 'autolysosome', 'automate', 'autonomic', 'autonomie', 'autophagic', 'autophagic process', 'autophagosomelysosome', 'autophagosomes', 'autophagy', 'autophagyenhancing', 'autophagyinducing', 'autophagyrelated', 'autophosphorylation', 'autopsy', 'autoreactive', 'autoreceptormediated', 'autoreceptors', 'autoregulation', 'autoregulatory', 'autosomal', 'autosomaldominant', 'autumn', 'auxiliary', 'auxin', 'av1955', 'av1959', 'availability', 'availability limit', 'availability limit widespread', 'available', 'available nowadays', 'available nowadays properties', 'avenues', 'average', 'avermitilis', 'aversive', 'avidity', 'avmisp', 'avoid', 'avoidance', 'awareness', 'axenic', 'axillary', 'axinduced', 'axonal', 'axonal transport', 'axonal transport impairment', 'axonopathy', 'axons', 'ayurvedic', 'azathioprine', 'azevedo', 'azide', 'azidealkyne', 'azido', 'azoxymethanedextran', 'azure', 'b6requiring', 'bacbased', 'baccata', 'bace1', 'bace1 activity', 'bace1 cells', 'bace1 exosite', 'bace1 inhibition', 'bace1 promoters', 'bace1 sirna', 'bace1deficient', 'bace1expressing', 'bace1inhibiting', 'bace1mediated', 'bace2', 'bacillus', 'backbone', 'backdrop', 'background', 'backgroundaims', 'bacteremia', 'bacteria', 'bacteriabacterial', 'bacteriainduced', 'bacterial', 'bacterial infection', 'bacterial overgrowth', 'bactericidal', 'bacteriostatic', 'bacterium', 'bacteroides', 'bacteroidetes', 'bafilomycin', 'bagsday', 'baidu', 'balance', 'balbc', 'barely', 'barnes', 'barretts', 'barrier', 'barrier permeability', 'barrierrelated', 'barriers', 'barriers access', 'basais', 'basal', 'baseexcision', 'baseindependent', 'baseline', 'baseline antihbc', 'baseline cytology', 'baselines', 'basement', 'baseprotonated', 'basic', 'basically', 'basis', 'batch', 'battery', 'battle', 'bavinol', 'bavinum', 'bayesian', 'bcell', 'bcell function', 'bcell lymphoma', 'bcl2l2', 'bclxl', 'bcrcd40', 'bcrcd40activated', 'bcsfb', 'bd1047', 'bdnfpi3kakt', 'beagle', 'beamline', 'beclin1', 'become', 'become attractive', 'become attractive option', 'become clear', 'become important', 'bedside', 'beeing', 'beforeafter', 'beggmazumdar', 'begin', 'behave', 'behave similarly', 'behavior', 'behavioral', 'behavioral disorder', 'behavioral parameters', 'behaviorally', 'behaviors', 'behaviour', 'behavioural', 'behaviours', 'behind', 'belgian', 'belgium', 'belief', 'believe', 'belong', 'belong family', 'beneficial', 'beneficial effect', 'beneficial patients', 'beneficial patients greatly', 'beneficial several', 'beneficial several mechanisms', 'beneficiaries', 'benefit', 'bengal', 'benign', 'bentelan', 'benth', 'benzannulated', 'benzene', 'benzoapyrene', 'benzodiazepine', 'benzopyrones', 'benzoxazoles', 'benzyl', 'benzylpiperidine', 'berberine', 'berberis', 'berry', 'berry fruit', 'beside', 'besides', 'beststudied', 'beta2', 'betaalanine', 'betaamyloid', 'betaamyloid fragment', 'betaamyloid peptide', 'betaamyloid42', 'betaamyloidinduced', 'betaasarone', 'betaasarone eugenol', 'betablocker', 'betabloquers', 'betacarbolinium', 'betacatenin', 'betacell', 'betacells', 'betacleavage', 'betacleavages', 'betacleaved', 'betagammaimidodiphosphate', 'betahairpin', 'betaine', 'betaine associate', 'betaine choline', 'betaine level', 'betaine level associate', 'betaine predict', 'betamethasone', 'betanacetylglucosamine', 'betanacetylhexosaminidase', 'betapeptide', 'betapropeller', 'betasecretase', 'betasheet', 'betasheet breaker', 'betasheet breakers', 'betasite', 'betasite amyloid', 'betasite amyloid precursor', 'betasmall', 'betastrands', 'betasubunit', 'betasubunitlike', 'betathalassemia', 'betel', 'better', 'better understand', 'beverage', 'bexarotene', 'beyond', 'bh3only', 'bi2536', 'bibliographic', 'bicarbonate', 'bidentate', 'bidirectional', 'bienzymatic', 'bifunctional', 'bilayer', 'bilayers', 'bilirubin', 'biliverdin', 'billion', 'biloba', 'bilobed', 'bimolecular', 'binaries', 'binder', 'binders', 'bioactive', 'bioactive constituents', 'bioactivities', 'bioactivity', 'bioadhesive', 'bioadhesiveness', 'bioanalytical', 'bioassay', 'bioavailability', 'bioavailability antiinflammatory', 'bioavailability antiinflammatory activity', 'biobank', 'biobanking', 'biocat', 'biochem', 'biochemical', 'biochemical pathways', 'biochemically', 'biochemistry', 'biocompatibility', 'biocompatible', 'bioconductor', 'biodegradable', 'biodistribution', 'biodistribution metabolite', 'biodistribution metabolite analysis', 'biodiversity', 'bioelectrically', 'bioenergetic', 'bioenergetic medicine', 'bioenergetics', 'biofunctionalized', 'biogenesis', 'biogenic', 'biogenic amines', 'biogenic amines metabolites', 'bioinformatic', 'bioinformatic analysis', 'bioinformatics', 'bioinformatics analysis', 'bioinspired', 'biologic', 'biological', 'biological activities', 'biological activity', 'biological applications', 'biological entities', 'biological function', 'biological pathways', 'biological process', 'biological relevance', 'biological sample', 'biological systems', 'biologically', 'biologically active', 'biologics', 'biologists', 'biology', 'biologyas', 'biomarker', 'biomarkers', 'biomass', 'biomaterial', 'biomedical', 'biomedical research', 'biomedically', 'biomolecular', 'biomolecules', 'bioorthogonal', 'bioorthogonal label', 'bioparticles', 'biopharmaceuticals', 'biophysical', 'biophysics', 'biopolymerbased', 'bioprocessing', 'bioproduction', 'bioproducts', 'biopsies', 'biopsies patients', 'biopsy', 'biopsy specimens', 'biopsyproved', 'bioreductive', 'biorelevant', 'biosensing', 'biosensor', 'biosimilar', 'biostatistics', 'biosynthesis', 'biosynthetic', 'biosynthetic pathway', 'biotechnol', 'biotechnological', 'biotechnology', 'biotic', 'biotinylated', 'bipartite', 'biphasic', 'biphenyls', 'bipolar', 'bipolar disorder', 'birth', 'biscuits', 'bisdehydroxycurcumin', 'bisindole', 'bisphenol', 'bistriethylsilyl', 'bitopicdualsteric', 'black', 'blackberry', 'bladder', 'bladder cancer', 'blast', 'blatantly', 'bleed', 'blind', 'blindlike', 'blineage', 'bloat', 'block', 'blockade', 'blockage', 'blocker', 'blockers', 'blood', 'blood brain', 'blood brain barrier', 'blood cells', 'blood plasma', 'blood pressure', 'blood sample', 'blood significantly', 'blood urine', 'bloodbrain', 'bloodbrain barrier', 'bloodbrain barrier permeability', 'bloodcerebrospinal', 'bloodcerebrospinal fluid', 'bloodcerebrospinal fluid barrier', 'blueshift', 'blunt', 'bmdcs', 'bmderived', 'bmdms', 'bmpr1b', 'board', 'bodily', 'boiss', 'bombardment', 'boophone', 'boophone disticha', 'boost', 'borborygmi', 'borden', 'border', 'bornmulleriana', 'botanical', 'bottle', 'bottomup', 'boundaries', 'boundary', 'bowel', 'bowel disease', 'bowel disease patients', 'bowel diseases', 'bowel syndrome', 'bptfexpressing', 'braak', 'braaks', 'brachiocephalic', 'bradford', 'bradshaw', 'bradycardia', 'braftargeted', 'brain', 'brain alzheimers', 'brain alzheimers disease', 'brain barrier', 'brain bulbectomized', 'brain cells', 'brain development', 'brain diseases', 'brain disorder', 'brain endothelial', 'brain function', 'brain health', 'brain injury', 'brain microstructure', 'brain parenchyma', 'brain pathologies', 'brain patients', 'brain proteome', 'brain proteome project', 'brain provide', 'brain provide proof', 'brain region', 'brain regions', 'brain sample', 'brain serum', 'brain serum colon', 'brain structure', 'brain tissue', 'brain uptake', 'braincontrolling', 'brainderived', 'brainenriched', 'braingutmicrobiota', 'brainimmune', 'brainmicrovascular', 'brainperiphery', 'brainresident', 'brainstem', 'branch', 'branchingpoint', 'branchpointspecific', 'brasfield', 'brazil', 'brca1', 'break', 'breakdown', 'breaker', 'breakers', 'breakpoint', 'breakthrough', 'breast', 'breast cancer', 'breath', 'breathe', 'breathhold', 'breathlessness', 'breed', 'bridge', 'brief', 'brief overview', 'briefly', 'bright', 'brine', 'bring', 'brisbane', 'bristol', 'bristolmyers', 'british', 'brittleness', 'broad', 'broad spectrum', 'broader', 'broadly', 'bromide', 'bromides', 'bromodomain', 'bromodomain phdfinger', 'bromodomain phdfinger transcription', 'bromodomainligand', 'bromodomains', 'bromopyruvate', 'bronchial', 'bronchiectasis', 'bronchiolitis', 'bronchitis', 'bronchus', 'bronchus cancers', 'broth', 'brownsequard', 'brush', 'bryostatin', 'btype', 'buccal', 'buche', 'buche activity', 'buffer', 'build', 'buildup', 'bulbar', 'bulbectomized', 'bulbs', 'bulge', 'buona', 'burden', 'burial', 'burst', 'busiest', 'busulfan', 'butyl', 'butylidenephthalide', 'butyrate', 'butyrateproducing', 'butyricum', 'butyrivibrio', 'butyrylcholinesterase', 'butyrylcholinesterase inhibitory', 'butyrylcholinesterases', 'butyrylcholinestrase', 'bv2conditioned', 'bypass', 'byproduct', 'bystander', 'bystanders', 'c1511ga', 'c15h14clnos', 'c208c', 'c260induced', 'c331ga', 'c361ct', 'c410y', 'c482ct', 'c57bl6', 'c57bl6j', 'ca2atpases', 'ca2dependent', 'ca2flux', 'ca2pump', 'ca2sensitive', 'cadm1', 'caenorhabditis', 'caenorhabditis elegans', 'caffeate', 'caffeic', 'caffeine', 'caffeoyl', 'cagcgg', 'cainduced', 'calcify', 'calcify plaque', 'calcineurin', 'calcineurinnfat', 'calcium', 'calcium score', 'calciumchannel', 'calciumdependent', 'calciumsensing', 'calculate', 'calculation', 'calculations', 'calendar', 'calibration', 'california', 'caloric', 'calorie', 'calories', 'calorimetry', 'calpain', 'calpain activity', 'calpro', 'calprotectin', 'calprotectin elisa', 'calyculin', 'camkiialpha', 'camkiibeta', 'campaign', 'canada', 'canadian', 'canal', 'cancer', 'cancer alzheimers', 'cancer alzheimers disease', 'cancer cardiovascular', 'cancer cells', 'cancer diabetes', 'cancer disease', 'cancer incidence', 'cancer mortality', 'cancer study', 'cancer therapy', 'cancerassociated', 'cancerautismassociated', 'cancerdetecting', 'cancerfree', 'cancerous', 'cancerrelated', 'cancers', 'candida', 'candidate', 'candidates', 'canine', 'cannabinoid', 'cannabinoids', 'cannot', 'cannot exclude', 'canonical', 'capabilities', 'capability', 'capable', 'capacities', 'capacitor', 'capacitormanufacturing', 'capacity', 'capacity judgement', 'capillaries', 'capillary', 'capillarybore', 'capitalize', 'capsule', 'captazione', 'captivate', 'capture', 'carbachol', 'carbacholstimulated', 'carbacholstimulated gtpgamma35s', 'carbazole', 'carbazolecontaining', 'carbohydrates', 'carbon', 'carbonic', 'carbonyl', 'carbonyl stress', 'carbonylative', 'carboxyl', 'carboxylase', 'carboxylesterase', 'carboxylesterases', 'carboxyls', 'carboxylterminal', 'carboxypeptidaselike', 'carcinogen', 'carcinogenesis', 'carcinogenic', 'carcinogenicity', 'carcinogens', 'carcinoma', 'cardiac', 'cardiology', 'cardiometabolic', 'cardiomir', 'cardiomirnas', 'cardiomirs', 'cardiomyocyte', 'cardiomyocytes', 'cardiomyopathy', 'cardioprotective', 'cardiopulmonary', 'cardiorenal', 'cardiovascular', 'cardiovascular disease', 'cardiovascular disease cancer', 'cardiovascular disease patients', 'cardiovascular diseases', 'cardiovascular diseases cancer', 'cardiovascular diseases diabetes', 'cardiovascular events', 'cardiovascular factor', 'cardiovascularrelated', 'careful', 'carefully', 'caregivers', 'cargo', 'cargo molecules', 'cargos', 'caries', 'carnitine', 'carotenoid', 'carotid', 'carrier', 'carriers', 'carry', 'carthamus', 'caryophyllene', 'cascade', 'casecontrol', 'casecontrol study', 'casei01', 'caseseries', 'casitas', 'casp1', 'casp3', 'casp6', 'casp6overexpressing', 'caspase', 'caspase3', 'caspase3mediated', 'caspase6', 'caspase8', 'caspasemdashindependent', 'caspasepositive', 'caspases', 'cassette', 'castor', 'catabolism', 'catabolites', 'catabolize', 'catalase', 'catalpol', 'catalysis', 'catalyst', 'catalytic', 'catalytic mechanisms', 'catalytic subunit', 'catalytically', 'catalyze', 'cataract', 'cataracts', 'catechin', 'catechins', 'catecholaminergic', 'catecholamines', 'categorical', 'categories', 'categorize', 'category', 'cathadifferentiated', 'cathepsin', 'catheter', 'cation', 'cations', 'catylase', 'caucasian', 'caucasians', 'caudate', 'causal', 'causality', 'causally', 'causation', 'cause', 'cause alzheimers', 'cause alzheimers disease', 'cause death', 'cause dyspepsia', 'causespecific', 'caution', 'cautiously', 'cav11', 'caveolae', 'cavity', 'cay10593', 'cbmediated', 'ccaatenhancerbinding', 'ccaatenhancerbinding protein', 'cccpinduced', 'cck1r', 'cck1rmembrane', 'cck1rnabbs', 'ccl21', 'ccnd1', 'cd116', 'cd116 cd131', 'cd117', 'cd131', 'cd19iggigdcd27', 'cd200', 'cd200cd200', 'cd200cd200r', 'cd200r', 'cd206', 'cd2ap', 'cd2associated', 'cd307d', 'cd33siglec3related', 'cd4cd25foxp3', 'cd95l', 'cdc48', 'cdc48dependent', 'cdc48p97vcp', 'cdk5p25', 'cdkn2a', 'cdocker', 'cdpatients', 'cdrelated', 'cease', 'cebpd', 'cebpdmir135athbs1', 'cecal', 'cecum', 'cedrus', 'cedrus libani', 'celastrol', 'celastrol increase', 'celebrate', 'celecoxib', 'celf1', 'celiac', 'celiac disease', 'celiac disease patients', 'celladhesion', 'cellautonomous', 'cellbased', 'cellbased therapies', 'cellbased therapies beneficial', 'cellbased therapy', 'cellbased therapy provide', 'cellcell', 'cellcycle', 'celldamaging', 'cellderived', 'cellecm', 'cellfree', 'cellmatrix', 'cellmediated', 'cellpenetrating', 'cellpermeable', 'cells', 'cells accumulate', 'cells activate', 'cells addition', 'cells adopt', 'cells affect', 'cells alzheimers', 'cells alzheimers disease', 'cells analyze', 'cells available', 'cells available nowadays', 'cells background', 'cells brain', 'cells brain provide', 'cells carry', 'cells cause', 'cells cellbased', 'cells cellbased therapies', 'cells cells', 'cells compare', 'cells could', 'cells culture', 'cells damage', 'cells evaluate', 'cells express', 'cells follow', 'cells hbmecs', 'cells however', 'cells human', 'cells important', 'cells include', 'cells increase', 'cells indicate', 'cells induce', 'cells inflammation', 'cells inhibit', 'cells inhibition', 'cells involve', 'cells involvement', 'cells isolate', 'cells macrophages', 'cells major', 'cells microglia', 'cells might', 'cells moreover', 'cells mouse', 'cells neuroinflammation', 'cells neuron', 'cells observe', 'cells overexpression', 'cells oxidative', 'cells primary', 'cells propose', 'cells reduce', 'cells result', 'cells significantly', 'cells suggest', 'cells tissue', 'cells transfected', 'cells treat', 'cells trem2', 'cells which', 'cells2', 'cellsmm3', 'cellsmul', 'cellsnamely', 'cellspecific', 'cellsubstrate', 'cellsurface', 'celltype', 'cellular', 'cellular function', 'cellular mechanisms', 'cellular model', 'cellular molecular', 'cellular prion', 'cellular prion protein', 'cellular process', 'cellular senescence', 'cellular signal', 'cellular stress', 'cellular uptake', 'cellules', 'cellulose', 'centenarian', 'centenaries', 'centenary', 'centennial', 'center', 'central', 'central blood', 'central nervous', 'central nervous system', 'central nervous systems', 'central peripheral', 'centralacting', 'centrally', 'centrallyacting', 'centre', 'centronuclear', 'centrosomesmitotic', 'centuries', 'century', 'cephalosporin', 'cephalosporins', 'ceramidase', 'ceramide', 'ceramide1phosphate', 'ceramideinduced', 'ceramides', 'ceratamine', 'ceratamines', 'cerc160', 'cerebellar', 'cerebellum', 'cerebral', 'cerebrale', 'cerebrali', 'cerebrolysin', 'cerebrospinal', 'cerebrospinal fluid', 'cerebrovascular', 'cerebrum', 'cereport', 'cerevisiae', 'cermediated', 'certain', 'certificate', 'certification', 'ceruloplasmin', 'cervical', 'cervical lymph', 'cesarean', 'cessation', 'cevimeline', 'cflip', 'cfrelated', 'cfructose', 'cfructoselabeled', 'cfukg', 'cgisi', 'cglyceraldehyde', 'cglycosides', 'cglycosylated', 'cglycosylated derivatives', 'cglycosylation', 'ch25h', 'chaetomium', 'chaetomium globosum', 'chaetomium globosum jn711454', 'chagas', 'chagas disease', 'chain', 'chain fatty', 'chain fatty acids', 'chain reaction', 'chain3i', 'chain3ii', 'chalcone', 'challenge', 'chamaedrys', 'chamber', 'change', 'change brain', 'change composition', 'change could', 'change expression', 'channel', 'channel blocker', 'channel surface', 'channel surface expression', 'channeltargeting', 'chanzymes', 'chaperome', 'chaperon', 'chaperone', 'chaperone activity', 'chaperonelike', 'chapter', 'chapters', 'character', 'characterisation', 'characterise', 'characteristic', 'characteristics', 'characterization', 'characterize', 'characterize progressive', 'characterize progressive dopaminergic', 'characterize subject', 'charge', 'charlson', 'chart', 'cheapest', 'check', 'checkpoint', 'checkpoints', 'cheese', 'chelate', 'chelation', 'chelator', 'chelators', 'chemical', 'chemical constituents', 'chemical engineer', 'chemical structure', 'chemicalbased', 'chemicalinduced', 'chemically', 'chemically define', 'chemically define xenofree', 'chemicals', 'chemistry', 'chemists', 'chemokine', 'chemokines', 'chemokines which', 'chemoprevention', 'chemosensory', 'chemotaxis', 'chemotherapeutic', 'chemotherapy', 'chemotypes', 'chemtech', 'chenodeoxycholic', 'chest', 'chief', 'chiefly', 'child', 'childhood', 'childhood obesity', 'children', 'children adults', 'childrens', 'childturcottepugh', 'chimeric', 'chimerism', 'chimpanzees', 'china', 'chinensis', 'chinensis franch', 'chinese', 'chinese medicine', 'chineseeuropean', 'chiral', 'chiral metabolomics', 'chisquare', 'chisquared', 'chitosan', 'chlamydia', 'chlamydia pneumoniae', 'chlamydiaspecific', 'chlamydophila', 'chloride', 'chlorine', 'chloro', 'chloroform', 'chloroform extract', 'chlorogenic', 'chloroquine', 'choabetapp695', 'chocolate', 'choice', 'choices', 'choke', 'cholangitis', 'cholecystokinin', 'cholestadiene', 'cholestatic', 'cholesterol', 'cholesterol metabolism', 'cholesterolfree', 'cholesterolloaded', 'cholesteryl', 'cholic', 'choline', 'choline acetyltransferase', 'choline betaine', 'choline betaine level', 'cholinederived', 'cholinergic', 'cholinergic nerve', 'cholinergic signal', 'cholinergic synapses', 'cholinergic system', 'cholinesterase', 'cholinesterase inhibition', 'cholinesterase inhibitors', 'cholinesterase inhibitory', 'cholinesterase inhibitory antioxidant', 'cholinesteraseinhibiting', 'cholinesterases', 'cholinesupplemented', 'cholineunsupplemented', 'chondrodysplasia', 'chondroitinase', 'choose', 'chordata', 'chordataspecific', 'choreograph', 'choroid', 'choroid plexus', 'chowt', 'chr12q1311', 'chrfam7a', 'chrna7', 'chroman4one', 'chromatin', 'chromatin immunoprecipitation', 'chromatin immunoprecipitation experiment', 'chromatin remodel', 'chromatindirected', 'chromatinmediated', 'chromatinremodeling', 'chromatogram', 'chromatographed', 'chromatographic', 'chromatography', 'chromatographymass', 'chromatographymass spectrometry', 'chromatographytandem', 'chromatographytriple', 'chromatolysis', 'chromium', 'chromoendoscopy', 'chromosomal', 'chromosome', 'chromotography', 'chronic', 'chronic aluminum', 'chronic condition', 'chronic disease', 'chronic diseases', 'chronic fatigue', 'chronic fatigue syndrome', 'chronic fluorosis', 'chronic hepatitis', 'chronic infection', 'chronic inflammation', 'chronic inflammatory', 'chronic kidney', 'chronic kidney disease', 'chronic neurodegenerative', 'chronic neurodegenerative diseases', 'chronic neuroinflammation', 'chronic obstructive', 'chronic obstructive pulmonary', 'chronic patients', 'chronic periodontitis', 'chronic renal', 'chronic restraint', 'chronic restraint stress', 'chronic stress', 'chronic systolic', 'chronically', 'chronicdegenerative', 'chronicstressinduced', 'chronological', 'chuanxiong', 'chymase', 'chymase inhibitors', 'ci103', 'ci105', 'ci130', 'cialis', 'cierny', 'cigarette', 'cilengitide', 'cilium', 'cilostazol', 'cinahl', 'cindr', 'cinnamon', 'circadian', 'circuit', 'circuitry', 'circular', 'circular dichroism', 'circulate', 'circulation', 'circulatory', 'circumstances', 'circumstantial', 'cirrhosis', 'cirrhosisrelated', 'cirrhotic', 'cirrhotics', 'cisacting', 'cisautophosphorylation', 'cisgenetic', 'cisorientated', 'cisregulatory', 'cistrans', 'cistransdirected', 'citalopram', 'citations', 'citotoxicity', 'citrate', 'citratus', 'citric', 'citrodora', 'civil', 'civilizations', 'ck1deltaepsilon', 'ckdmbd', 'cl4176', 'clabeled', 'claim', 'clamp', 'clarification', 'clarify', 'clash', 'class', 'classic', 'classical', 'classically', 'classification', 'classify', 'clathrinmediated', 'claude', 'clean', 'cleanly', 'clear', 'clear association', 'clearance', 'clearly', 'cleavage', 'cleavages', 'cleave', 'cleave enzyme', 'cleave enzyme bace1', 'cleave proteases', 'clec2b', 'clerodane', 'click', 'client', 'clients', 'climatic', 'clinic', 'clinica', 'clinical', 'clinical application', 'clinical applications', 'clinical differences', 'clinical endoscopic', 'clinical evaluation', 'clinical evidence', 'clinical feature', 'clinical hence', 'clinical hence alternative', 'clinical outcome', 'clinical outcomes', 'clinical parameters', 'clinical phenotypes', 'clinical potential', 'clinical practice', 'clinical presentation', 'clinical prognostic', 'clinical prognostic index', 'clinical progression', 'clinical relevance', 'clinical remission', 'clinical research', 'clinical significance', 'clinical study', 'clinical study involve', 'clinical trial', 'clinical trials', 'clinical utility', 'clinical variables', 'clinically', 'clinically relevant', 'clinically useful', 'clinicaltrialgov', 'clinicaltrialsgov', 'clinicians', 'clinico', 'clinicopathologic', 'clinicopathological', 'clioquinol', 'clioquinolinduced', 'clioquinols', 'clique', 'clobe', 'clobes', 'clock', 'clonal', 'clone', 'clonidine', 'close', 'closely', 'closely associate', 'closeout', 'closer', 'closest', 'clostridium', 'closure', 'cloud', 'cluster', 'clusterin', 'cmass', 'cmvpcr', 'cmvpositive', 'cnpase', 'cnsintrinsic', 'cnsis', 'cnspermeable', 'cnsrelated', 'cnvmirna', 'coadministration', 'coagulase', 'coagulation', 'coassembly', 'cocaine', 'cochaperone', 'cochran', 'cochrane', 'cochrans', 'coconut', 'cocos', 'cocrystallization', 'coculture', 'cocultures', 'codingnoncoding', 'codingsequence', 'codon', 'codrug', 'coefficient', 'coeliac', 'coeliac disease', 'coelution', 'coenzyme', 'coeruleus', 'coexist', 'coexistence', 'coexposure', 'coexpress', 'coexpressed', 'coexpression', 'cofactor', 'cofactors', 'coffee', 'coffeedrinking', 'cofilin', 'coformulated', 'cognition', 'cognitionenhancing', 'cognitionlike', 'cognitionstrengthening', 'cognitive', 'cognitive behavior', 'cognitive decline', 'cognitive deficits', 'cognitive dysfunction', 'cognitive function', 'cognitive impairment', 'cognitively', 'coherence', 'cohesin', 'cohesive', 'cohort', 'cohort median', 'cohort patients', 'cohort study', 'cohorts', 'cohortsthe', 'coimmobilizing', 'coimmunoprecipitated', 'coimmunoprecipitation', 'coincidence', 'coincident', 'coincubation', 'coions', 'col18a1', 'colchicine', 'colchicineinduced', 'colchicineinjected', 'coldness', 'colectomy', 'coleoptile', 'coleotile', 'colitis', 'colitis patients', 'colitisassociated', 'colitislike', 'collaboration', 'collaborative', 'collaboratories', 'collagen', 'collagenous', 'collapse', 'colleagues', 'collect', 'collect information', 'collection', 'collective', 'collectively', 'college', 'colocalization', 'colocalized', 'colon', 'colonic', 'colonization', 'colonize', 'colonoscopic', 'colonoscopy', 'colons', 'colony', 'colonystimulating', 'colonystimulating factor', 'color', 'colorectal', 'colorectal cancer', 'colorimetric', 'colormatched', 'column', 'columns', 'combat', 'combination', 'combination therapy', 'combinations', 'combinatorial', 'combine', 'combustion', 'comet', 'comfortable', 'command', 'commensal', 'comment', 'commentaries', 'commentary', 'commercial', 'commercially', 'commerciallyavailable', 'common', 'common cause', 'common feature', 'common health', 'common structural', 'commonalities', 'commonality', 'commonest', 'commonly', 'commonlyused', 'commons', 'communicate', 'communication', 'communications', 'communis', 'communities', 'community', 'comorbid', 'comorbidities', 'comorbidity', 'compacta', 'compacta current', 'compacta current pharmacological', 'company', 'comparable', 'comparably', 'comparative', 'comparative analysis', 'compare', 'compare control', 'compare control group', 'compare effect', 'compare either', 'compare healthy', 'compare healthy control', 'compare hivinfected', 'compare hivinfected persons', 'compare normal', 'compare patients', 'compare placebo', 'compare probiotics', 'compare probiotics placebo', 'compare result', 'compare wildtype', 'comparison', 'comparisons', 'compartment', 'compartmentalization', 'compartments', 'compatibility', 'compatible', 'compel', 'compensate', 'compensate advance', 'compensate dehydrogenase', 'compensatory', 'compete', 'competency', 'competent', 'competition', 'competitive', 'competitively', 'compile', 'complain', 'complaint', 'complaints', 'complement', 'complement activation', 'complementarily', 'complementary', 'complementary source', 'complementation', 'complete', 'completely', 'completely understand', 'completeness', 'complex', 'complex contain', 'complex diseases', 'complex disorder', 'complex formation', 'complex function', 'complex network', 'complexation', 'complexdependent', 'complexes', 'complexities', 'complexity', 'compliance', 'complicate', 'complication', 'complications', 'component', 'components', 'components immune', 'compose', 'composite', 'composition', 'compositions', 'compound', 'compound evaluate', 'compound include', 'compound plant', 'compound which', 'comprehend', 'comprehensive', 'comprehensive analysis', 'comprehensively', 'comprise', 'compromise', 'compromise integrity', 'computational', 'compute', 'compute tomography', 'computeraided', 'computerize', 'concanavalin', 'concatenate', 'conceivable', 'concentrate', 'concentration', 'concentration dependent', 'concentration endogenous', 'concentration increase', 'concentration mugml', 'concentration range', 'concentrationdependent', 'concentrationdependently', 'concentrations', 'concept', 'concept replacement', 'concept replacement therapy', 'concepts', 'concern', 'concert', 'concise', 'conclude', 'conclusion', 'conclusion result', 'conclusion study', 'conclusion study demonstrate', 'conclusions', 'conclusions analysis', 'conclusions result', 'conclusions suggest', 'concomitant', 'concomitantly', 'concordant', 'condense', 'condition', 'condition characterize', 'condition conclusion', 'condition discuss', 'condition diseases', 'condition include', 'condition increase', 'condition media', 'condition medium', 'conditional', 'conditionalknockout', 'conditionranging', 'conduct', 'conductance', 'conductive', 'conductivity', 'confer', 'confidence', 'confidence interval', 'confine', 'confirm', 'confirm diagnosis', 'confirmation', 'confirmatory', 'conflict', 'confocal', 'conform', 'conformation', 'conformation prpsc', 'conformational', 'conformational change', 'conformational dynamics', 'conformational restriction', 'conformationally', 'conformations', 'conformer', 'conformers', 'confound', 'confounders', 'confront', 'congenital', 'congo', 'congress', 'congruent', 'conifer', 'coniferous', 'conjecture', 'conjugate', 'conjugation', 'conjugationinvariant', 'conjunction', 'conjunctiva', 'conjunctival', 'connect', 'connection', 'connections', 'connective', 'connectivity', 'connote', 'conotoxin', 'conscience', 'conscientious', 'conscientiousness', 'conscious', 'conscious normotensive', 'consecutive', 'consensus', 'consequence', 'consequences', 'consequent', 'consequently', 'conservation', 'conservative', 'conserve', 'consider', 'consider important', 'consider potential', 'considerable', 'considerably', 'consideration', 'considerations', 'consist', 'consistencies', 'consistency', 'consistent', 'consistently', 'consolidate', 'conspicuous', 'conspire', 'constant', 'constantly', 'constants', 'constipation', 'constituent', 'constituents', 'constitute', 'constitution', 'constitutive', 'constitutively', 'constitutively active', 'constrain', 'constraints', 'constrictor', 'construct', 'construction', 'consultations', 'consume', 'consumer', 'consumers', 'consumption', 'contact', 'contactin2', 'contain', 'contain curcumin', 'contain multiple', 'contain three', 'contain vaccine', 'contain vaccine peptides', 'contained24', 'contaminants', 'contaminate', 'contamination', 'contaminations', 'contemplate', 'contend', 'content', 'context', 'contextdependent', 'contexts', 'contextspecific', 'contextualised', 'contiguous', 'continental', 'contingency', 'continually', 'continuation', 'continue', 'continuous', 'continuously', 'contraception', 'contraceptives', 'contract', 'contraction', 'contradiction', 'contraindicate', 'contrary', 'contrast', 'contribute', 'contribute development', 'contribute factor', 'contribute pathogenesis', 'contribute significantly', 'contribution', 'contributions', 'contributor', 'contributors', 'contributory', 'contrivance', 'control', 'control active', 'control active disease', 'control cells', 'control expression', 'control group', 'control level', 'control materials', 'control patients', 'control study', 'control trial', 'control trials', 'controllable', 'controllers', 'controltreated', 'controversial', 'controversies', 'conus', 'convenience', 'convenient', 'conveniently', 'convention', 'conventional', 'converge', 'convergence', 'conversely', 'conversion', 'conversions', 'convert', 'convertase', 'convex', 'convince', 'convulsion', 'cooperate', 'cooperative', 'cooperativity', 'coordinate', 'coordination', 'copdrelated', 'copdrelated mortality', 'copiesml', 'copine3', 'copolymer', 'coppede', 'copper', 'copper complexes', 'copper essential', 'copper homeostasis', 'copper metabolism', 'copperang', 'copperbinding', 'copperii', 'copperinduced', 'copperrelated', 'coprimary', 'coptidis', 'coptis', 'coptis chinensis', 'coptis chinensis franch', 'copynumber', 'copyright', 'copyright right', 'copyright right reserve', 'coq10', 'coreang', 'coreang group', 'coreangiotensin', 'coreceptor', 'coreceptors', 'coregulation', 'coreshell', 'coriander', 'coriandrum', 'corner', 'corneum', 'cornu', 'coronal', 'coronary', 'coronary artery', 'coronary artery disease', 'coronary heart', 'coronary heart disease', 'corpora', 'correct', 'correction', 'correlate', 'correlate tumor', 'correlation', 'correlations', 'correspond', 'correspondence', 'corroborate', 'cortex', 'cortex hippocampus', 'cortex hippocampus striatum', 'cortex wistar', 'cortical', 'cortical neurons', 'cortical tissue', 'corticale', 'corticosteroids', 'corticosterone', 'cortisol', 'cortisol level', 'cosegregating', 'cosine', 'cosmetics', 'costeffective', 'costefficient', 'costimulation', 'cotransfected', 'cotransfection', 'cotranslationally', 'cotreated', 'cotreatment', 'cough', 'could', 'could affect', 'could block', 'could contribute', 'could effective', 'could explain', 'could potential', 'could potentially', 'could regulate', 'could significantly', 'could useful', 'coumarin', 'coumarins', 'counsel', 'count', 'counter', 'counteract', 'counterbalance', 'countermeasure', 'countermeasures', 'counterpart', 'counterparts', 'countries', 'country', 'countrywide', 'countrywide populationbased', 'couple', 'course', 'cousins', 'covalent', 'covalently', 'covariance', 'covariate', 'covariates', 'cover', 'coverage', 'covert', 'coworkers', 'coxii', 'coxregression', 'cpeptide', 'creactive', 'creactive protein', 'create', 'creation', 'creative', 'credibility', 'credit', 'crelated', 'crenarchaeon', 'crest', 'creutzfeldtjakob', 'creutzfeldtjakob disease', 'creuzfeldtjacob', 'cribriform', 'crimeancongo', 'crises', 'criteria', 'critical', 'critical appraisal', 'critical appraisal skills', 'critical roles', 'critically', 'crnd8', 'croatia', 'crocin', 'crocus', 'crocus sativus', 'crohn', 'crohns', 'crohns disease', 'crohns disease methods', 'crohns disease patients', 'cromakalim', 'cromakaliminduced', 'cross', 'cross bloodbrain', 'cross bloodbrain barrier', 'crosscoupling', 'crossimmunogenicity', 'crosslinked', 'crosslinking', 'crossotus', 'crossover', 'crosspopulation', 'crossreact', 'crossreactive', 'crossreactivity', 'crossroads', 'crosssectional', 'crosssectional study', 'crossseeding', 'crossspecies', 'crosstalk', 'crossvalidated', 'croton', 'crowd', 'crucial', 'crude', 'crude extract', 'crude methanolic', 'crude methanolic extract', 'crural', 'crush', 'cruzi', 'cryodiffraction', 'cryofreezing', 'cryogenic', 'cryomicroscopy', 'cryosections', 'cryptic', 'cryptoglandular', 'crystal', 'crystal structure', 'crystalline', 'crystallize', 'crystallographic', 'crystallography', 'crystals', 'cssrs', 'ctail', 'ctddephosphorylation', 'cterminal', 'cterminal fragment', 'cterminal region', 'ctermini', 'cterminus', 'ctp13', 'cu2alphasynucleinascorbate', 'cu2alphasynucleinmediated', 'cu2ascorbate', 'cu2induced', 'cu2mediated', 'cuabeta', 'cuabeta16', 'cuaq2', 'cugbinding', 'cuisine', 'culinary', 'culminate', 'culprits', 'cultivate', 'cultivation', 'cultural', 'culture', 'culture cells', 'culture human', 'culture microglia', 'culture systems', 'culturebased', 'cumulative', 'cumulative exposure', 'cumulative incidence', 'cumulatively', 'cupet', 'cupressus', 'cupric', 'curative', 'curcuma', 'curcuma longa', 'curcumene', 'curcumin', 'curcumin derivatives', 'curcumin natural', 'curcumin solid', 'curcumin solid dispersion', 'curcuminlike', 'curcuminoid', 'curcuminoids', 'current', 'current concepts', 'current knowledge', 'current pharmacological', 'current pharmacological treatments', 'current remarkable', 'current remarkable clinical', 'current review', 'current study', 'current understand', 'currently', 'currents', 'curvature', 'curvaturepreserving', 'curvatures', 'curve', 'custom', 'customize', 'cutaneous', 'cutoff', 'cuttingedge', 'cuzd1', 'cvad10', 'cvnad', 'cxcl13', 'cyanoamidine', 'cyclase', 'cycle', 'cycle reentry', 'cycle regulation', 'cyclerelated', 'cyclic', 'cyclical', 'cyclindependent', 'cyclization', 'cycloaddition', 'cycloaddition reaction', 'cycloaddition reaction various', 'cyclodextrins', 'cyclooxygenase', 'cyclooxygenase2', 'cyclooxygenaseinduced', 'cyclooxygenases', 'cyclophilin', 'cyclosporine', 'cyclothiazide', 'cyclotron', 'cyclotronproduced', 'cymbopogon', 'cynical', 'cyp3a4', 'cyp450', 'cyp450s', 'cyranose', 'cyrillic', 'cys112', 'cys113', 'cys119', 'cys163', 'cys319', 'cys34', 'cysbased', 'cystathionine', 'cystatin', 'cysteine', 'cysteine residues', 'cysteinebased', 'cystic', 'cystic fibrosis', 'cystine', 'cysts', 'cytoarchitectural', 'cytochrome', 'cytohistological', 'cytokine', 'cytokine production', 'cytokines', 'cytokines chemokines', 'cytokines include', 'cytokines tnfalpha', 'cytokinesis', 'cytokinins', 'cytologic', 'cytological', 'cytology', 'cytology screen', 'cytomegalovirus', 'cytomegaloviruspositive', 'cytometer', 'cytometric', 'cytometry', 'cytoplasm', 'cytoplasmic', 'cytoprotection', 'cytoprotective', 'cytoscape', 'cytoscape plugin', 'cytosine', 'cytoskeletal', 'cytoskeleton', 'cytosol', 'cytosolic', 'cytostatic', 'cytotoxic', 'cytotoxic effect', 'cytotoxicity', 'cytotoxicity induce', 'cytotoxicityselectivity', 'cytotoxins', 'd1819', 'd1819 picalm', 'd251e', 'd289n', 'd6choline', 'd9choline', 'dabigatran', 'daf16', 'daffodil', 'daily', 'dairy', 'dalpha', 'dalphaasp', 'damage', 'damage induce', 'damage repair', 'damageassociated', 'damino', 'damino acids', 'daminoacid', 'daminoacidcontaining', 'danger', 'dangerous', 'danish', 'dap12', 'dap12 stabilize', 'dap12associated', 'darifenacin', 'darwin', 'dasabuvir', 'daspartate', 'database', 'databases', 'databases search', 'datadriven', 'dataset', 'datasets', 'david', 'dbeta', 'dcfhda', 'deacetylase', 'deacetylase inhibitor', 'deactivate', 'deadenylation', 'deadliest', 'deafness', 'deamidate', 'deamidation', 'deamination', 'death', 'death cause', 'death certificate', 'death induce', 'deathdefying', 'deaths', 'deaths3984', 'deaths47', 'deathsurvival', 'deathtransplantation', 'debate', 'debris', 'dec50385265', 'decade', 'decades', 'decarboxylase', 'decarboxylation', 'decay', 'decaycorrected', 'decedents', 'december', 'decide', 'deciliter', 'decipher', 'decision', 'decisionmaking', 'decisions', 'decisive', 'decisively', 'declare', 'decline', 'decompensation', 'decompose', 'decorate', 'decouple', 'decoy', 'decoy peptide', 'decoysenhanced', 'decrease', 'decrease concentration', 'decrease expression', 'decrease level', 'decrease neuronal', 'decrease serum', 'decrease significantly', 'decrypt', 'dedicate', 'deduce', 'deepen', 'deeper', 'deeply', 'default', 'defecation', 'defecations', 'defect', 'defect associate', 'defective', 'defence', 'defend', 'defense', 'defenses', 'deficiencies', 'deficiency', 'deficiencyassociated', 'deficiencyinduced', 'deficient', 'deficit', 'deficits', 'define', 'define xenofree', 'definite', 'definition', 'definition personal', 'definition personal utility', 'definitions', 'degeneration', 'degenerations', 'degenerative', 'degenerative diseases', 'degenerative disorder', 'deglutition', 'deglycosylation', 'degradation', 'degradationreconstruction', 'degradative', 'degrade', 'degree', 'degrees', 'degrees degrees', 'dehydrogenase', 'dehydrogenase complex', 'dehydrogenases', 'delay', 'delete', 'deleterious', 'deletion', 'deletion gsk3alpha', 'deletion gsk3alpha gsk3beta', 'deletions', 'deliberately', 'delicate', 'delineate', 'delineation', 'deliver', 'delivery', 'delivery antialzheimer', 'delle', 'delphi', 'delta', 'deltaauac024', 'deltadeltagtheor', 'deltae9', 'deltamir135athrombospondin', 'deltaopioid', 'deltapsim', 'demand', 'dementia', 'dementia arteriosclerosis', 'dementiaalzheimer', 'dementialike', 'dementias', 'demethylase', 'demethylases', 'demethylation', 'demografic', 'demographic', 'demographics', 'demonstrate', 'demonstrate cells', 'demonstrate important', 'demonstrate increase', 'demonstrate significant', 'demonstration', 'demonstrations', 'demostrated', 'demyelinate', 'denature', 'dendrimer', 'dendritelike', 'dendritic', 'dendritic spine', 'dendritic spine formation', 'denote', 'density', 'density lipoprotein', 'density lipoprotein receptor', 'dental', 'dentate', 'denticola', 'dentures', 'denver', 'deoxyribonucleic', 'depalmitoylation', 'department', 'depend', 'dependence', 'dependent', 'dephosphorylated', 'dephosphorylation', 'depict', 'deplete', 'depletion', 'depolarization', 'depolarize', 'deposit', 'deposition', 'depot', 'depress', 'depress patients', 'depression', 'depressionlike', 'depressionrelated', 'depressive', 'depressive disorder', 'depressive symptoms', 'depressivelike', 'deprivation', 'deprotection', 'depth', 'derangements', 'deregulate', 'deregulation', 'derivates', 'derivation', 'derivation cohort', 'derivative', 'derivatives', 'derivatives prepare', 'derivatization', 'derivatized', 'derive', 'dersimonianlaird', 'descent', 'describe', 'describe believe', 'describe which', 'description', 'descriptions', 'descriptive', 'descriptive study', 'descritto', 'desensitization', 'deserve', 'design', 'design investigate', 'design investigate whether', 'design synthesize', 'designable', 'designate', 'designation', 'designmethods', 'desirable', 'desire', 'desmethyl', 'desolvation', 'desorption', 'despite', 'destabilisation', 'destabilization', 'destabilize', 'destroy', 'destruction', 'destructive', 'desulfation', 'detail', 'detect', 'detect patients', 'detectable', 'detection', 'detection limit', 'detector', 'detergent', 'detergentsolubilized', 'deteriorate', 'deterioration', 'determinant', 'determinants', 'determination', 'determine', 'determine potential', 'determine whether', 'detoxification', 'detoxify', 'detrimental', 'detrimental effect', 'deubiquitinating', 'deuteration', 'deuteriumlabeled', 'devastate', 'develop', 'develop assay', 'develop comprehensive', 'develop countries', 'develop deliver', 'develop possible', 'develop possible therapy', 'develop treatment', 'develop validate', 'development', 'development alzheimers', 'development alzheimers disease', 'development disease', 'development function', 'development novel', 'development treatment', 'developmental', 'developmental biology', 'developmentally', 'developments', 'developped', 'deviate', 'deviation', 'deviations', 'devices', 'devise', 'devoid', 'devote', 'dfahs', 'dhaderived', 'dhatreated', 'dhcr24', 'diabetes', 'diabetes breast', 'diabetes cancer', 'diabetes cancer disease', 'diabetes cardiovascular', 'diabetes chronic', 'diabetes disease', 'diabetes mellitus', 'diabetes obesity', 'diabetes therapy', 'diabetesrelated', 'diabetic', 'diacetate', 'diacetylcurcumin', 'diacyl', 'diacylglycerol', 'diacylglycerols', 'diagnose', 'diagnose patients', 'diagnosis', 'diagnosis colitis', 'diagnostic', 'diagnostic criteria', 'diagnostic early', 'diagnostic therapeutic', 'diagnostic workup', 'diagnostics', 'dialysis', 'diameter', 'diamondcopper', 'diaphragm', 'diaries', 'diarrhea', 'diarrheal', 'diarrhoea', 'diary', 'diastole', 'diastolic', 'diastolic dysfunction', 'dibenzo145thiadiazepine', 'dibenzo145thiadiazepines', 'dibenzocyclooctynemodified', 'dibomodified', 'dicaffeoyl', 'dichloromethane', 'dichotomous', 'dichotomy', 'dichroism', 'dicrotophos', 'dicrotophos paraoxon', 'diego', 'diesims', 'dietary', 'dietary intake', 'dietary phosphatidylcholine', 'dietary supplement', 'dieter', 'dietfed', 'dietgene', 'dietinduced', 'dietresponding', 'diffeomorphisms', 'differ', 'difference', 'difference compare', 'differences', 'different', 'different aspects', 'different cells', 'different cells available', 'different cells cellbased', 'different diseases', 'different human', 'different mechanisms', 'different neurodegenerative', 'different pathologies', 'different position', 'different stress', 'different tissue', 'differential', 'differential expression', 'differentially', 'differentially express', 'differentially regulate', 'differentiate', 'differentiate cells', 'differentiation', 'differently', 'difficile', 'difficileassociated', 'difficult', 'difficulties', 'difficulty', 'diffraction', 'diffuse', 'diffusion', 'diffusivity', 'digestion', 'digestive', 'digital', 'digitonin', 'dihydrolipoic', 'dihydroprogesterone', 'diisopropylfluorophosphate', 'diisopropylfluorophosphate dicrotophos', 'diisopropylfluorophosphate dicrotophos paraoxon', 'dilute', 'dilution', 'dimension', 'dimensional', 'dimensionality', 'dimer', 'dimeric', 'dimerization', 'dimers', 'diminish', 'dimorphism', 'dimple', 'dinaciclib', 'dinitrated', 'dinucleotides', 'dioxabicyclo1410heptadecane59dione', 'dipeptidyl', 'direct', 'direct evidence', 'direct infusion', 'directindirect', 'direction', 'directional', 'directionality', 'directions', 'directives', 'directly', 'disability', 'disable', 'disabled1', 'disadvantage', 'disaggregates', 'disappear', 'disappearance', 'discernible', 'discharge', 'discipline', 'disclose', 'discomfort', 'disconnection', 'discontinue', 'discordant', 'discover', 'discoveries', 'discovery', 'discovery novel', 'discrepancies', 'discrepancy', 'discriminant', 'discriminate', 'discrimination', 'discriminative', 'discuss', 'discuss include', 'discuss possible', 'discuss potential', 'discuss recent', 'discuss review', 'discussion', 'discussions', 'disease', 'disease activity', 'disease activity patients', 'disease although', 'disease alzheimers', 'disease alzheimers disease', 'disease antidiabetic', 'disease article', 'disease associate', 'disease background', 'disease beyond', 'disease brain', 'disease cancer', 'disease characterize', 'disease characterize progressive', 'disease chronic', 'disease common', 'disease compare', 'disease compound', 'disease condition', 'disease demonstrate', 'disease diabetes', 'disease diabetes mellitus', 'disease disease', 'disease evidence', 'disease genes', 'disease however', 'disease include', 'disease inflammatory', 'disease mechanism', 'disease mechanisms', 'disease methods', 'disease model', 'disease molecular', 'disease moreover', 'disease multiple', 'disease objective', 'disease parkinson', 'disease parkinson disease', 'disease parkinsons', 'disease parkinsons disease', 'disease pathogenesis', 'disease patients', 'disease patients chronic', 'disease phenotype', 'disease potential', 'disease present', 'disease prevention', 'disease previous', 'disease previously', 'disease primary', 'disease process', 'disease progression', 'disease recent', 'disease recently', 'disease relate', 'disease result', 'disease review', 'disease schizophrenia', 'disease severity', 'disease state', 'disease stimulate', 'disease stroke', 'disease study', 'disease study investigate', 'disease suggest', 'disease summary', 'disease support', 'disease susceptibility', 'disease therapy', 'disease understand', 'diseaseassociated', 'diseasecausing', 'diseased', 'diseasefree', 'diseasegene', 'diseaselike', 'diseasemodifying', 'diseaseneither', 'diseaserelated', 'diseaserelevant', 'diseases', 'diseases affect', 'diseases although', 'diseases alzheimers', 'diseases alzheimers disease', 'diseases associate', 'diseases cancer', 'diseases cancer alzheimers', 'diseases determine', 'diseases diabetes', 'diseases diabetes mellitus', 'diseases disease', 'diseases focus', 'diseases human', 'diseases include', 'diseases include alzheimers', 'diseases increase', 'diseases induce', 'diseases involve', 'diseases multiple', 'diseases multiple sclerosis', 'diseases neurodegenerative', 'diseases obesity', 'diseases parkinson', 'diseases present', 'diseases recently', 'diseases relate', 'diseases review', 'diseases rheumatoid', 'diseases rheumatoid arthritis', 'diseases several', 'diseases study', 'diseases which', 'diseasespecific', 'disenfranchise', 'disfunction', 'disinhibition', 'disintegrate', 'disintegration', 'disintegrin', 'disintegrin metalloproteinase', 'dislike', 'dislodge', 'dismutase', 'dismutase catalase', 'disomic', 'disorder', 'disorder alzheimers', 'disorder alzheimers disease', 'disorder associate', 'disorder background', 'disorder central', 'disorder central nervous', 'disorder chronic', 'disorder however', 'disorder include', 'disorder include alzheimers', 'disorder increase', 'disorder technology', 'disorder technology become', 'disorder which', 'disorganization', 'disparate', 'disparities', 'dispensable', 'dispersion', 'dispersions', 'displace', 'displacements', 'display', 'disposable', 'disposal', 'disposition', 'dispute', 'disrupt', 'disruption', 'disruptions', 'dissect', 'dissection', 'disseminate', 'dissemination', 'dissipate', 'dissociate', 'dissociation', 'dissolution', 'dissolve', 'distal', 'distance', 'distant', 'distension', 'disticha', 'distillation', 'distinct', 'distinction', 'distinctive', 'distinctively', 'distinguish', 'distinguish patients', 'distortion', 'distribute', 'distribution', 'disturb', 'disturbance', 'disturbances', 'disulfide', 'disulfideoxidized', 'disynaptic', 'diterpenenes', 'diterpenes', 'diterpenoids', 'dithiothreitol', 'diuretic', 'diurnal', 'divergence', 'divergent', 'diverse', 'diverse neurological', 'diverse neurological disorder', 'diversify', 'diversity', 'diversityoriented', 'divert', 'divide', 'divide group', 'divinatory', 'division', 'divisions', 'dixon', 'dlactic', 'dleucinamides', 'dllimonene', 'dmfdma', 'dmt3srapy', 'dmtsrproosu', 'dnabinding', 'dnacapped', 'dnadependent', 'dnaimmunized', 'dnhsc70', 'docosahexaenoic', 'docosahexaneoic', 'document', 'documentation', 'dodecasaccharide', 'dogma', 'dohad', 'domain', 'domain contain', 'domainbinding', 'domaincontaining', 'domaindisease', 'domainrbf', 'domains', 'domicile', 'dominance', 'dominant', 'dominant negative', 'dominate', 'domination', 'donepezil', 'donepezilferulic', 'donepezilinduced', 'donna', 'donor', 'donor similarity', 'donoracceptor', 'donors', 'dopac', 'dopamine', 'dopaminergic', 'dopaminergic neurons', 'dopaminergic neurons substantia', 'dopant', 'dormant', 'dorsal', 'dorsolateral', 'dorsolateral prefrontal', 'dorsolateral prefrontal cortex', 'dosage', 'dosedependent', 'dosedependent manner', 'doseg', 'doseresponse', 'dosesystolic', 'double', 'doubleblind', 'doubleblind randomize', 'doubleblinded', 'doublegene', 'doublesandwich', 'doublevariant', 'doubt', 'download', 'downloadable', 'downmdashregulation', 'downpour', 'downregulate', 'downregulated', 'downregulates', 'downregulating', 'downregulation', 'downstream', 'downstream signal', 'downward', 'downward arrowhis110', 'dozen', 'dpp10', 'dprotected', 'dpscs', 'drain', 'drainage', 'dramatic', 'dramatically', 'drastic', 'drastically', 'drawbacks', 'drift', 'dring', 'drink', 'drink water', 'drinkers', 'drive', 'drive 24hour', 'driver', 'drivers', 'drool', 'droplets', 'drosophila', 'drugdelivery', 'drugdrug', 'druglike', 'druglipid', 'drugresistant', 'drugresponsive', 'drupal', 'dserine', 'dsvd209', 'dualinfected', 'duallyinfected', 'dualspecificity', 'ductal', 'ducts', 'dunal', 'duodenal', 'duodenal aspirate', 'duodenal mucosa', 'duodenitis', 'duodenum', 'dupalpha7', 'duplex', 'duplicate', 'duplication', 'duplications', 'durability', 'durable', 'dural', 'duration', 'durationcontrollable', 'durations', 'duzhong', 'dxylose', 'dynamic', 'dynamic change', 'dynamical', 'dynamically', 'dynamics', 'dynamics around', 'dynamics simulations', 'dynamogeniques', 'dyrk1a', 'dyrk1amediated', 'dysbiosis', 'dysfunction', 'dysfunctional', 'dysfunctions', 'dyshomeostasis', 'dyslipidaemia', 'dyslipidemia', 'dyslipidemias', 'dysmenorrhea', 'dysmorphology', 'dyspepsia', 'dyspeptic', 'dyspeptic patients', 'dysphagia', 'dysplasia', 'dysplasiacancer', 'dysregulated', 'dysregulating', 'dysregulation', 'dysregulations', 'dystonia', 'dystrophies', 'dystrophy', 'e123dibromobenzyl47ethoxy4oxochroman3ylidenemethylpyridinium', 'e1aassociated', 'e2212', 'e22heparin2', 'earlier', 'earliest', 'early', 'early detection', 'early genes', 'early onset', 'early phase', 'earlyonset', 'earlystage', 'easily', 'eberhard', 'ebvinduced', 'ec503485463mum', 'ec50974123mum', 'ecadherin', 'ecadherin expression', 'ecdysozoa', 'echocardiographic', 'echogenicity', 'ecmdegrading', 'ecmtargeting', 'ecological', 'ecological study', 'economic', 'economics', 'ectoderm', 'ectodomain', 'ectodomains', 'ectoenzymatic', 'ectopic', 'ectopically', 'edema', 'edible', 'editor', 'editorcurated', 'editors', 'edmondsonsteiner', 'edmondsonsteiner grade', 'edmondsonsteiner grade stage', 'education', 'educational', 'effect', 'effect bace1', 'effect benzene', 'effect brain', 'effect cardiovascular', 'effect cells', 'effect cglycosylation', 'effect compound', 'effect could', 'effect curcumin', 'effect different', 'effect direct', 'effect health', 'effect human', 'effect include', 'effect inflammation', 'effect inflammatory', 'effect insulin', 'effect luteolin', 'effect mediate', 'effect nicotine', 'effect observe', 'effect oxidative', 'effect oxidative stress', 'effect paeoniflorin', 'effect plant', 'effect progesterone', 'effect receptor', 'effect several', 'effect simvastatin', 'effect treatment', 'effect various', 'effectalpha', 'effective', 'effective antioxidant', 'effective treatment', 'effectively', 'effectiveness', 'effector', 'effectors', 'effectual', 'efferent', 'efferents', 'effetti', 'efficacious', 'efficacy', 'efficacy probiotics', 'efficiency', 'efficient', 'efficiently', 'efflux', 'effort', 'efforts', 'effusion', 'egfpgammaglutamyl', 'eggers', 'egists', 'eheath', 'eicosanoids', 'eicosapentaenoic', 'eif4e', 'eight', 'eightcountry', 'eighteen', 'eighty', 'either', 'ekcal', 'elaborate', 'elastase', 'elasticity', 'elastin', 'elastinlike', 'elderly', 'elderly patients', 'elderly people', 'elections', 'elective', 'electric', 'electrical', 'electricity', 'electroacupuncture', 'electrocardiogram', 'electrochemical', 'electrochemical detection', 'electrochemical immunosensor', 'electroconvulsive', 'electrode', 'electrodeposited', 'electrodepositing', 'electrodes', 'electromagnetic', 'electromigration', 'electron', 'electron microscopy', 'electrondonating', 'electronic', 'electronic formulation', 'electronic formulation variables', 'electronically', 'electrophiles', 'electrophoresis', 'electrophoresisbased', 'electrophoretic', 'electrophysiological', 'electrospray', 'electrostatic', 'elegans', 'element', 'elemental', 'elementbinding', 'elements', 'elevate', 'elevate hivinfected', 'elevate hivinfected persons', 'elevate level', 'elevate patients', 'elevate plasma', 'elevatedplus', 'elevation', 'elevations', 'elfemf', 'elfemfs', 'elicit', 'elicitation', 'eligible', 'eliminate', 'elimination', 'elisa', 'elisas', 'elispot', 'elixir', 'ellman', 'ellmans', 'elongation', 'elpscoated', 'elsevier', 'elsewhere', 'elucidate', 'elucidation', 'elusive', 'embase', 'embed', 'embolism', 'embrogenesis', 'embryogenesis', 'embryonic', 'embryonic cells', 'embryos', 'emerge', 'emerge evidence', 'emerge evidence suggest', 'emergence', 'emergency', 'emergency department', 'emergent', 'emission', 'emissione', 'emmissive', 'emodin', 'emodin amyloidbeta', 'emodin amyloidbeta 2535induced', 'emotion', 'emotional', 'emotionlike', 'emphasis', 'emphasize', 'emphysema', 'empiric', 'empirical', 'empiricalbased', 'employ', 'employees', 'empower', 'empty', 'emulsion', 'emulsions', 'en5bromo2cyanothieno23bpyridin3ylnndimethylformimidamide', 'enable', 'enantiomers', 'enantiopure', 'enantioseparation', 'encapsulate', 'encapsulation', 'encephalitides', 'encephalitis', 'encephalomyelitis', 'encephalopathies', 'encephalopathy', 'enclose', 'encode', 'encompass', 'encounter', 'encourage', 'endemic', 'endfeet', 'endocab', 'endocannabinoids', 'endocrine', 'endocrine disturbances', 'endocrinology', 'endocytic', 'endocytosis', 'endogenous', 'endogenous alpha7', 'endogenous alpha7 nicotinic', 'endoglucuronidase', 'endonuclease', 'endonucleolytic', 'endopeptidaselike', 'endophyte', 'endophytes', 'endophytic', 'endophytic fungus', 'endoplasmic', 'endoplasmic reticulum', 'endoproteolysis', 'endoscopic', 'endoscopies', 'endoscopists', 'endoscopy', 'endosomemembrane', 'endosomes', 'endosometoplasma', 'endosulfatases', 'endothelial', 'endothelial cells', 'endothelial cells hbmecs', 'endothelial growth', 'endothelial growth factor', 'endothelin1', 'endothelium', 'endotoxemia', 'endotoxemiap', 'endotoxin', 'endow', 'endplate', 'endpoint', 'endpoints', 'endproducts', 'endstage', 'enemy', 'energetics', 'energies', 'energies1505', 'energies4189', 'energy', 'energy homeostasis', 'energy metabolism', 'engage', 'engagement', 'engender', 'engineer', 'engines', 'england', 'englishlanguage', 'engraft', 'engraftment', 'enhance', 'enhance phosphorylation', 'enhancement', 'enhancement activity', 'enhancer', 'enhancer67', 'enhancers', 'enigmatic', 'enolase', 'enormous', 'enough', 'enrich', 'enrichment', 'enrichment analysis', 'enrichments', 'enrol', 'ensure', 'entail', 'entameoba', 'entamoeba', 'entecavir', 'enter', 'enteral', 'enteric', 'enterococcus', 'enterohepatic', 'enterohepatic circulation', 'enterotoxin', 'entherochromaffin', 'entire', 'entirely', 'entirety', 'entities', 'entitle', 'entity', 'entkauranoid', 'entrance', 'entrap', 'entrapment', 'entries', 'entropic', 'entropically', 'entry', 'enugu', 'enumeration', 'envelop', 'environment', 'environmental', 'environmental carcinogens', 'environmental factor', 'environmentally', 'environmentresponsive', 'environments', 'envision', 'enzymatic', 'enzymatic activity', 'enzymatically', 'enzyme', 'enzyme bace1', 'enzyme microm', 'enzymebased', 'enzymefree', 'enzymeinhibitor', 'enzymepeptide', 'enzymes', 'enzymes control', 'enzymes regulate', 'enzymesubstrateinhibitor', 'enzymology', 'enzymopathies', 'eosin', 'ephephrin', 'ephephrinmediated', 'ephmediated', 'ephrin', 'ephrins', 'epidemic', 'epidemiologic', 'epidemiological', 'epidemiological study', 'epidemiology', 'epidermal', 'epigallocatechin', 'epigallocatechin3gallate', 'epigenetic', 'epigenetic drift', 'epigenetic mechanisms', 'epigenetic modifications', 'epigenetic regulation', 'epigenetic regulator', 'epigenetically', 'epigenetics', 'epigenome', 'epigenomewide', 'epilepsies', 'epilepsy', 'epileptic', 'epinephrine', 'episode', 'episodes', 'episodic', 'epistasis', 'epithelial', 'epithelial cells', 'epithelialmesenchymal', 'epithelialmesenchymal transition', 'epithelium', 'epitope', 'epitope vaccines', 'epitopes', 'epothilone', 'epothilones', 'epoxide', 'eppendorf', 'epsilon', 'epsilon4', 'epsiloncleavage', 'epsilonlike', 'epsteinbarr', 'eqbuche', 'eqtlbased', 'eqtls', 'equal', 'equally', 'equilib', 'equilibrium', 'equinebutyrylcholinesterase', 'equipment', 'equivalent', 'equivalents', 'equol', 'equol producers', 'equolproducing', 'equolproduction', 'equus', 'eradication', 'eralpha', 'eralpha erbeta', 'eralphainduced', 'erbb2', 'erbeta', 'erk12', 'erkmediated', 'erosive', 'erretention', 'erroneously', 'error', 'ertargeted', 'eruptions', 'erythematousexudative', 'erythrocyte', 'erythrocytes', 'erythropoietin', 'escalate', 'escape', 'escderived', 'escherichia', 'eseguito', 'eselectin', 'eseptal', 'esims', 'esophageal', 'esophagitis', 'esophagogastroduodenoscopy', 'esophagus', 'espcenet', 'especially', 'essential', 'essential sufficient', 'essentially', 'establish', 'establishment', 'establishments', 'ester', 'esterase', 'esterification', 'esters', 'estimate', 'estimate cumulative', 'estimate cumulative exposure', 'estimate glomerular', 'estimate glomerular filtration', 'estimation', 'estimators', 'estradiol', 'estrogen', 'estrogen receptors', 'estrogeninduced', 'estrogens', 'ethanol', 'ethanolamine', 'ethanolamine plasmalogens', 'ethanolic', 'ether', 'ethical', 'ethical practical', 'ethical practical aspects', 'ethically', 'ethmoid', 'ethnic', 'ethnomedical', 'ethnomedicinal', 'ethnopharmacological', 'ethnopharmacological relevance', 'ethnopharmacology', 'ethnopharmacology phytochemistry', 'ethyl', 'ethyl acetate', 'ethylene', 'etiological', 'etiologies', 'etiology', 'etiopathogenesis', 'etoac', 'etoposide', 'eucalyptol', 'eucommia', 'eucommia ulmoides', 'eucommiaceae', 'eudract', 'eudractemaeuropaeu', 'eugenol', 'euglycemic', 'eukaryotes', 'eukaryotic', 'eukaryotic cells', 'eupneic', 'euprosthenops', 'europe', 'european', 'eusfna', 'evacuation', 'evacuations', 'evaluate', 'evaluate acetylcholinesterase', 'evaluate association', 'evaluate effect', 'evaluate efficacy', 'evaluate potential', 'evaluate vitro', 'evaluate whether', 'evaluation', 'evaluations', 'evaporation', 'event', 'events', 'events admissions', 'eventual', 'eventually', 'every', 'everyday', 'evidence', 'evidence demonstrate', 'evidence indicate', 'evidence suggest', 'evidence support', 'evidencebased', 'evidencebased medicine', 'evident', 'evidently', 'evoke', 'evolution', 'evolutionarily', 'evolutionarily conserve', 'evolutionary', 'evolve', 'exacerbate', 'exacerbation', 'exacerbations', 'exact', 'exaggerate', 'examination', 'examinations', 'examine', 'examine effect', 'examine relationship', 'examine relationship plasma', 'examine whether', 'example', 'examples', 'exceed', 'exceedingly', 'excel', 'excellent', 'except', 'exception', 'exceptional', 'exceptions', 'excess', 'excessive', 'exchange', 'excipients', 'excise', 'excitability', 'excitation', 'excitatory', 'excite', 'excitotoxicity', 'exclude', 'exclusion', 'exclusive', 'exclusively', 'excrete', 'excretion', 'execute', 'execution', 'exemplar', 'exenatide', 'exercise', 'exert', 'exfoliation', 'exfoliation syndrome', 'exhaustively', 'exhibit', 'exhibit neuroprotective', 'exhibit neuroprotective effect', 'exhibit potent', 'exhibit strong', 'exist', 'existence', 'exitoneurotoxicity', 'exitotoxicity', 'exocrine', 'exocyclic', 'exocytosis', 'exogenous', 'exome', 'exons', 'exosite', 'exosome', 'expand', 'expansion', 'expect', 'expectancy', 'expenditure', 'expense', 'expensive', 'experience', 'experience pharmacist', 'experiment', 'experimental', 'experimental animals', 'experimental clinical', 'experimental model', 'experimental study', 'experimentally', 'experimentation', 'expert', 'expert opinion', 'experts', 'expession', 'expiration', 'expiratory', 'explain', 'explanation', 'explanations', 'explants', 'explicit', 'explicitimplicit', 'explicitly', 'exploit', 'exploitation', 'exploration', 'exploratory', 'explore', 'explore effect', 'export', 'expose', 'expose concentrations', 'exposure', 'exposure group', 'exposure novelty', 'exposures', 'express', 'express central', 'express human', 'express myeloid', 'express myeloid cells', 'expression', 'expression activity', 'expression amyloid', 'expression amyloid precursor', 'expression cells', 'expression change', 'expression conclusion', 'expression determine', 'expression ecadherin', 'expression genes', 'expression genes associate', 'expression human', 'expression increase', 'expression inflammatory', 'expression level', 'expression markers', 'expression nfkappab', 'expression profile', 'expression proinflammatory', 'expression protein', 'expression reduce', 'expression regulate', 'expression result', 'expression significantly', 'expression spinal', 'expression transcriptional', 'expressions', 'expressive', 'exquisitely', 'extend', 'extend lifespan', 'extendable', 'extensible', 'extension', 'extensive', 'extensively', 'extensively study', 'extent', 'external', 'externally', 'extra', 'extracellular', 'extracellular fructose', 'extracellular matrix', 'extracranial', 'extract', 'extract kaempferol', 'extract subsequent', 'extract subsequent fraction', 'extract100', 'extraction', 'extragastric', 'extrahepatic', 'extrahypothalamic', 'extraintestinal', 'extrapancreatic', 'extrapolate', 'extrasynaptic', 'extravasation', 'extraversion', 'extraverts', 'extremely', 'extremities', 'extrinsic', 'extrusion', 'eziopathogenesis', 'f2isoprostanes', 'fabbace1', 'fabp7', 'fabricate', 'fabrication', 'facets', 'facial', 'facilitate', 'facilitator', 'facilities', 'facility', 'factor', 'factor alzheimers', 'factor alzheimers disease', 'factor associate', 'factor cancer', 'factor development', 'factor disease', 'factor important', 'factor include', 'factor involve', 'factor patients', 'factor proteins', 'factor regulate', 'factor relate', 'factor release', 'factor signal', 'factor tnfalpha', 'factor tnfalpha interleukin', 'factor1alpha', 'factoralpha', 'factoralpha tnfalpha', 'factorbeta', 'factorencapsulated', 'factorial', 'factories', 'factorinduced', 'factorization', 'factorkappab', 'factorlike', 'factorloaded', 'factory', 'facts', 'faddependent', 'faecal', 'faecal analysis', 'faeces', 'failure', 'failure increase', 'failure pathogenesis', 'failures', 'fairly', 'false', 'familial', 'familial alzheimers', 'familial alzheimers disease', 'familiar', 'families', 'family', 'family members', 'familysignal', 'fapydg', 'farmer', 'farnesoid', 'farnesol', 'farnesollike', 'fasassociated', 'fascaplysin', 'fashion', 'faster', 'fastest', 'fatal', 'father', 'fatigue', 'fatigue syndrome', 'fatiguedepression', 'fatiguehyperalgesia', 'fatty', 'fatty acids', 'fatty liver', 'fatty liver disease', 'faultless', 'favor', 'favorable', 'favorable metabolic', 'favorably', 'favour', 'favourable', 'favourably', 'fcrap', 'fdaapproved', 'feasibility', 'feasible', 'feature', 'feature associate', 'february', 'fecal', 'fecal calprotectin', 'fecal transplantation', 'feces', 'federal', 'feedback', 'feedback mechanism', 'feeforservice', 'feiii', 'female', 'females', 'ferene', 'fermentation', 'fermentation process', 'fermentations', 'fermt2', 'ferric', 'ferricfrap', 'ferritin', 'ferrous', 'ferrous sulfate', 'ferroxidase', 'fertile', 'fertility', 'ferulic', 'fetal', 'fetal ventral', 'fetal ventral mesencephalic', 'fetus', 'fetuses', 'fever', 'fewer', 'fewer years', 'fgf19', 'fgf23', 'fgfr1', 'fgfr2', 'fgfr3', 'fgnet', 'fiber', 'fiber formation', 'fibers', 'fibre', 'fibres', 'fibril', 'fibril formation', 'fibrilforming', 'fibrilforming motifs', 'fibrillar', 'fibrillation', 'fibrillization', 'fibrillogenesis', 'fibrils', 'fibrinolytic', 'fibroblast', 'fibroblast growth', 'fibroblast growth factor', 'fibroblasts', 'fibroblastspecific', 'fibrogenesis', 'fibromyalgia', 'fibromyalgic', 'fibrosis', 'fibrous', 'field', 'fifth', 'fiftyeight', 'fiftyfive', 'fight', 'fightoff', 'figure', 'filamentous', 'filaments', 'filler', 'fillers', 'filter', 'filtrate', 'filtration', 'final', 'finally', 'financial', 'finedetailed', 'finely', 'fineneedle', 'finetune', 'finger', 'fingerprint', 'fingolimod', 'finish', 'firmicutes', 'first', 'first recurrent', 'first recurrent admissions', 'first report', 'first review', 'first study', 'first target', 'first target genes', 'firstgeneration', 'firstly', 'firsttime', 'firsttime myocardial', 'firsttime myocardial infarction', 'fischers', 'fisher', 'fishout', 'fission1', 'fistula', 'fistulas', 'fitcannexin', 'fitcdextran', 'fitness', 'fivefactor', 'fivefold', 'fiveyear', 'fixation', 'flagship', 'flank', 'flask', 'flasklike', 'flatulence', 'flatus', 'flavobacteriaceae', 'flavone', 'flavonoid', 'flavonoid content', 'flavonoids', 'flavor', 'fletcher', 'fletchers', 'flexibility', 'flexible', 'flexor', 'flexors', 'flicelike', 'flight', 'floodgate', 'floor', 'florida', 'floss', 'flowcytometry', 'flower', 'fluid', 'fluid barrier', 'fluideffusion', 'fluidity', 'fluidized', 'fluids', 'flulike', 'fluo4', 'fluorescein', 'fluorescence', 'fluorescence intensity', 'fluorescenceactivated', 'fluorescent', 'fluorescent light', 'fluorescently', 'fluoridel', 'fluorinated', 'fluorine', 'fluorine18', 'fluorinelabeled', 'fluorochrome', 'fluorochromes', 'fluorophores', 'fluorosis', 'focal', 'focus', 'focus potential', 'focus recent', 'folate', 'folate deficiency', 'folate deficiencyinduced', 'foldamers', 'folic', 'folklore', 'folkloric', 'follicle', 'follicle cells', 'follicular', 'follow', 'follow treatment', 'followedup', 'followonbased', 'followup', 'followup patients', 'followup period', 'followup years', 'foodbesides', 'foods', 'foods mention', 'foodwater', 'footprints', 'foramen', 'force', 'forearm', 'forearm fracture', 'forebrain', 'foremost', 'forensic', 'foreseeable', 'forest', 'forkhead', 'formaldehyde', 'formalin', 'formalininduced', 'formalininjected', 'formamidemediated', 'formation', 'formation amyloid', 'former', 'formerly', 'formula', 'formulate', 'formulation', 'formulation variables', 'formulations', 'formylation', 'forsythia', 'fortasyn', 'fortunately', 'fortyeight', 'fortyfour', 'fortynine', 'fortyseven', 'forum', 'forward', 'fossil', 'fossilfuel', 'foster', 'fotone', 'found', 'foundation', 'fourcomponent', 'fourfold', 'fourier', 'fourrepeat', 'fourteen', 'fourth', 'fowden', 'foxo1', 'foxo3a', 'foxoindependent', 'foxos', 'fracau', 'fractal', 'fraction', 'fraction exhibit', 'fractional', 'fractional anisotropy', 'fractionate', 'fractionation', 'fracture', 'fragile', 'fragment', 'fragment length', 'fragment result', 'fragmentation', 'frailty', 'framework', 'frameworks', 'framingham', 'framingham score', 'francaise', 'france', 'franch', 'freedom', 'freely', 'freezethaw', 'french', 'frequencies', 'frequency', 'frequent', 'frequently', 'frequently report', 'fresh', 'fresh culture', 'fresh culture cells', 'freshener', 'freshfrozen', 'freshly', 'freunds', 'friedreich', 'friend', 'front', 'frontal', 'frontal cortex', 'frontali', 'frontiers', 'frontoparietal', 'frontotemporal', 'fructan', 'fructans', 'fructosamine', 'fructose', 'fructosespecific', 'fruit', 'fruit extract', 'frustrate', 'fspondin', 'ftdp17', 'fticrms', 'fty720', 'fty720ameliorating', 'fty720p', 'fucjd', 'fucjd exclusive', 'fucosyltransferase', 'fuelsensing', 'fukami', 'fulfil', 'fulfill', 'fuller', 'fulllength', 'fulllength human', 'fulltext', 'fully', 'fully elucidate', 'fully understand', 'function', 'function human', 'function include', 'function remain', 'functional', 'functional constipation', 'functional group', 'functional inhibition', 'functional network', 'functional relationships', 'functional relationships metabolites', 'functionalities', 'functionality', 'functionalization', 'functionalized', 'functionally', 'functionexpression', 'functionsdysfunctions', 'fundamental', 'fundamentally', 'fungal', 'fungal material', 'fungi', 'fungus', 'fungus chaetomium', 'fungus chaetomium globosum', 'funnel', 'furan', 'furin', 'furrow', 'furthermore', 'fusion', 'fusions', 'fusobacterium', 'future', 'future research', 'future study', 'futuristic', 'fuzzy', 'fxtas', 'gabaa', 'gabaa receptor', 'gabaa receptors', 'gabaaergic', 'gabaergic', 'gabaergic interneurons', 'gacurcuminoid', 'gaharu', 'galantamine', 'galantaminevildagliptin', 'galanthamine', 'galanthamine biosynthetic', 'galanthamine biosynthetic pathway', 'galanthus', 'gallate', 'gallbladder', 'gallbladder thicken', 'gallic', 'gallium68', 'gamma', 'gammaaminobutyric', 'gammacleavage', 'gammagh', 'gammainducible', 'gammalike', 'gammasecretase', 'gammasecretase modulators', 'gammasecretasedependent', 'gammasecretaseindependent', 'gammasecretases', 'gammasite', 'gammatocopherol', 'ganaxolone', 'ganglia', 'ganglion', 'gangliontetraosylceramide', 'ganglioside', 'gangliosides', 'gangrenous', 'gangrenousperforated', 'garden', 'gardenia', 'gasliquid', 'gastic', 'gastric', 'gastric duodenal', 'gastric mucosa', 'gastrin17', 'gastritis', 'gastroduodenal', 'gastroenteritis', 'gastroenterologists', 'gastroesophageal', 'gastrointestinal', 'gastrointestinal symptoms', 'gastrointestinal tract', 'gastrooesophageal', 'gastropanelr', 'gastroparesis', 'gastropathy', 'gastroscopy', 'gatekeeper', 'gateway', 'gateway activity', 'gather', 'gavage', 'gbqmumol', 'gctofms', 'gelucirer5013aerosilr', 'gender', 'gendermatched', 'genders', 'genebased', 'genedisease', 'genegene', 'geneincluding', 'general', 'general health', 'general internal', 'general internal medicine', 'general population', 'general surgery', 'generalization', 'generally', 'generate', 'generation', 'generator', 'generatorproduced', 'generegulated', 'generic', 'genes', 'genes activin', 'genes activin signal', 'genes associate', 'genes encode', 'genes involve', 'genes whose', 'genesis', 'geneterm', 'genetic', 'genetic background', 'genetic environmental', 'genetic environmental factor', 'genetic epigenetic', 'genetic factor', 'genetic polymorphisms', 'genetic study', 'genetic susceptibility', 'genetic variants', 'genetically', 'genetically encode', 'geneticallysusceptible', 'genetics', 'geniposide', 'genistein', 'genitourinary', 'genome', 'genomeediting', 'genomes', 'genomewide', 'genomewide association', 'genomewide association study', 'genomewide homozygosity', 'genomic', 'genomic architecture', 'genomic architecture spast', 'genomic clinical', 'genomicrelated', 'genomics', 'genotoxic', 'genotoxicity', 'genotype', 'genotype infection', 'genotypeassociated', 'genotyped', 'genotypeenvironmentphenotype', 'genotypephenotype', 'genotypes', 'genotyping', 'genus', 'genuszero', 'geodesically', 'geographic', 'geographical', 'geographical barriers', 'geranial', 'geriatric', 'geriatricians', 'germany', 'germfree', 'germinal', 'germline', 'germlinedeficient', 'gerontology', 'gestation', 'gf109203x', 'gfdtreated', 'gfplabeled', 'ggcrn', 'gggggg', 'ghrelin', 'ghsafrc', 'ghsaglc', 'ghsakp', 'ghsaphb', 'giant', 'giardia', 'ginger', 'gingival', 'gingival tissue', 'gingivalis', 'ginkgo', 'ginkgo biloba', 'ginkgolide', 'ginsenoside', 'ginsenoside ginsenoside', 'ginsenosides', 'glabrata', 'gland', 'glands', 'glass', 'glaucocalyx', 'glaucocalyxin', 'glaucoma', 'glcnac', 'gliadin', 'gliainduced', 'glial', 'glial cells', 'glial expression', 'gliallike', 'gliamediated', 'gliamediated neuroinflammation', 'glibenclamide', 'glioblastoma', 'gliogenesis', 'glioma', 'gliomas', 'gliosis', 'gln131', 'gln304', 'gln526', 'gln526arg526', 'global', 'globosum', 'globosum jn711454', 'globule', 'glomerular', 'glomerular filtration', 'glomerulonephritis', 'glomerulus', 'glucagon', 'glucagonlike', 'glucocorticoid', 'glucocorticoids', 'glucosamine', 'glucosaminidase', 'glucose', 'glucose metabolism', 'glucoselipid', 'glucosestimulated', 'glun1', 'glun1glun2a', 'glun1glun2b', 'glun2a', 'glun2bcontaining', 'glun2dcontaining', 'glut3', 'glut4glut2', 'glut5', 'glutamate', 'glutamate receptors', 'glutamateglutamine', 'glutamatemediated', 'glutamatergic', 'glutamatergic system', 'glutamic', 'glutaminase', 'glutamine', 'glutaminyl', 'glutathione', 'glutathione peroxidase', 'glutathionestransferase', 'gluten', 'glutenfree', 'glutenintake', 'gly227', 'gly82ser', 'glycans', 'glycated', 'glycation', 'glycation products', 'glyceraldehyde', 'glycerin', 'glycerol', 'glycerophospholipid', 'glycerophospholipids', 'glycine', 'glycogen', 'glycogen synthase', 'glycogen synthase kinase', 'glycogen synthase kinase3', 'glycogen synthase kinase3beta', 'glycol', 'glycolysis', 'glycolytic', 'glycoprotein', 'glycoproteins', 'glycosaminoglycan', 'glycosaminoglycans', 'glycoside', 'glycosides', 'glycosidic', 'glycosphingolipids', 'glycosylaseno', 'glycosylation', 'glycosyltranferase', 'gmc101', 'gmcsf', 'gmcsfneutralizing', 'gmcsfr', 'gmcsfs', 'gmcsftrf', 'go6976', 'goals', 'goblet', 'gocoupled', 'goldstandard', 'gondii', 'goniothalamin', 'goniothalamininduced', 'goniothalamininduced apoptosis', 'goniothalamintreated', 'google', 'google scholar', 'gostats', 'gouteng', 'govern', 'government', 'gp130', 'gpache', 'gpcrs', 'gpianchored', 'gpianchorless', 'gproteincoupled', 'grade', 'grade stage', 'grade stage recurrence', 'gradient', 'gradients', 'gradual', 'gradually', 'graduate', 'graft', 'graftversushost', 'grain', 'gramnegative', 'grandfathers', 'granditlora', 'granule', 'granules', 'granulocyte', 'granulocyte macrophage', 'granulocyte macrophage colonystimulating', 'granulocytes', 'granulomas', 'granzyme', 'graphene', 'graphenemesoporous', 'graphical', 'graphite', 'grassleaf', 'grassleaf sweetflag', 'grassleaf sweetflag rhizome', 'gratday', 'grb2amyloid', 'great', 'great interest', 'greater', 'greatest', 'greatly', 'greatly improve', 'greatly improve motor', 'greatly reduce', 'greece', 'greeks', 'green', 'green aroma', 'green aroma fraction', 'grierson', 'griess', 'grind', 'groove', 'gross', 'ground', 'group', 'group compare', 'group conclusions', 'group control', 'group control group', 'group group', 'group include', 'group include patients', 'group patients', 'group receive', 'group result', 'group significant', 'group study', 'group temperature', 'groupsequential', 'growth', 'growth development', 'growth differentiation', 'growth factor', 'growthinhibition', 'growths', 'gshpx', 'gsk3alpha', 'gsk3alpha gsk3beta', 'gsk3alphabeta', 'gsk3alphadeficient', 'gsk3beta', 'gsk3beta activity', 'gsk3betadeficient', 'gtpgamma35s', 'guanine', 'guanosine', 'guest', 'guidance', 'guide', 'guidelines', 'guinea', 'guineapig', 'gutbrain', 'gutliverbrain', 'gutmicrobiotarelated', 'gutspecific', 'gw3333', 'gw6471', 'gxhyd', 'gxxxg', 'gypsogenin', 'gyrus', 'h15lr23l', 'h2o2induced', 'h4app', 'h4k12', 'habit', 'hache', 'hairpin', 'halflife', 'halfmaximal', 'halfmaximum', 'halide', 'hallmark', 'hallmarks', 'hallym', 'halobenzyl', 'halogen', 'haloperidol', 'halphasyn', 'hamper', 'handful', 'handle', 'handsearching', 'hangoo', 'haploid', 'haploinsufficiency', 'haploinsufficient', 'haplotype', 'haplotypes', 'happen', 'happiness', 'happy', 'happy foods', 'harbor', 'harbour', 'hardlyknown', 'harmala', 'harmful', 'harmine', 'harmine derivatives', 'harmonization', 'harmony', 'harness', 'harsh', 'harvest', 'harvey', 'harveybradshaw', 'hascs', 'hastatus', 'haucl4', 'hawaii', 'haystack', 'hazard', 'hazard ratio', 'hba1c', 'hbche', 'hbeag', 'hbeag seroconversion', 'hbeag seroconversion pegifn', 'hbeagpositive', 'hbmecs', 'hbsag', 'hbsag seroclearance', 'hcmecd3', 'hcmecd3 cells', 'hct116', 'hcvhbv', 'hcvhbv duallyinfected', 'hcvrelated', 'hdac2', 'hdac3', 'headache', 'headaches', 'health', 'health benefit', 'health condition', 'health disease', 'health effect', 'health effect benzene', 'health problems', 'health service', 'health service allergy', 'health status', 'health survey', 'health survey information', 'healthcare', 'healthpromoting', 'healthrelated', 'healthspan', 'healthy', 'healthy control', 'healthy individuals', 'healthy obesity', 'healthy subject', 'healthy volunteer', 'healthy women', 'heart', 'heart disease', 'heart disease cancer', 'heart failure', 'heartburnindigestion', 'heatlabile', 'heatmap', 'heatresponsive', 'heatsensitive', 'heatshock', 'heavily', 'heavy', 'hedgehog', 'height', 'heighten', 'heightsinwood', 'hek293', 'hek293 cells', 'hek293t', 'helical', 'helicobacter', 'helicobacter pylori', 'helix', 'helixloophelix', 'helminthderived', 'helper', 'helpful', 'helveticus', 'hematologic', 'hematological', 'hematopoiesis', 'hematopoietic', 'hematoxylin', 'hematoxylineosin', 'hemiarthroplasty', 'hemichannel', 'hemichannels', 'hemicolectomy', 'hemiparesis', 'hemisection', 'hemizygous', 'hemodialysis', 'hemoglobin', 'hemorrhage', 'hemorrhagic', 'hemostasis', 'hence', 'hence alternative', 'hence alternative source', 'hendrickson', 'henry', 'henryi', 'heparan', 'heparan sulfate', 'heparanase', 'heparanaseprocessed', 'heparanases', 'heparin', 'heparinbinding', 'heparinheparan', 'heparininduced', 'hepatic', 'hepatic encephalopathy', 'hepatic lipid', 'hepatitis', 'hepatitis coreang', 'hepatitis coreang group', 'hepatitis virus', 'hepatocellular', 'hepatocellular carcinoma', 'hepatocyte', 'hepatocytes', 'hepatologists', 'hepatoma', 'hepatomegaly', 'hepatoprotection', 'hepatoprotective', 'hepatorenal', 'hepatosplenomegaly', 'hepatotoxicity', 'hepes', 'hepg2', 'herbal', 'herbal therapeutics', 'herbicide', 'herbicides', 'herbs', 'hereditary', 'heredity', 'herein', 'herein describe', 'heritability', 'heritable', 'herpes', 'herpes simplex', 'herpesvirus', 'herve', 'heteroaromatic', 'heterochromatization', 'heterocycle', 'heterocycles', 'heterocyclic', 'heterocyclic curcumin', 'heterocyclic curcumin derivatives', 'heterodimer', 'heterodimeric', 'heterodimers', 'heterodimerselective', 'heterogeneity', 'heterogeneous', 'heterologous', 'heterologously', 'heteromeric', 'heterotetrameric', 'heterotrimeric', 'heterotypic', 'heterozygosity', 'heterozygous', 'hexachloride', 'hexamer', 'hexane', 'hexapeptide', 'hexokinase', 'hexosamine', 'hfdinduced', 'hiappinduced', 'hiappins1e', 'hierarchical', 'hif1alpha', 'highaffinity', 'highamplitude', 'highbandwidth', 'highdensity', 'highdimensional', 'higher', 'higher compare', 'higher expression', 'higher level', 'higher patients', 'higher plasma', 'higher score', 'higherorder', 'highest', 'highfat', 'highfluoride', 'highgrade', 'highincome', 'highlight', 'highlight current', 'highlight importance', 'highly', 'highly conserve', 'highly express', 'highly specific', 'highlyactive', 'highperformance', 'highpressure', 'highquality', 'highresolution', 'highrisk', 'highsensitivity', 'hightemperature', 'highthroughput', 'highyield', 'hinder', 'hindlimb', 'hindlimb ischemia', 'hindlimb ischemia model', 'hindlimbs', 'hip009', 'hip009 cells', 'hippocampal', 'hippocampal neurons', 'hippocampi', 'hippocampus', 'hippocampus striatum', 'hippocampusderived', 'his13', 'his14', 'his460', 'his70tyr', 'histamine', 'histidine', 'histoblood', 'histoblood group', 'histocompatibility', 'histologic', 'histological', 'histology', 'histolytica', 'histone', 'histone acetylation', 'histone acetyltransferase', 'histone deacetylase', 'histone deacetylase inhibitor', 'histone methylation', 'histone modifications', 'histopathological', 'histopathological change', 'histopathological examination', 'histopathology', 'historical', 'historically', 'histories', 'history', 'hitherto', 'hivaids', 'hivinfected', 'hivinfected patients', 'hivinfected persons', 'hivinfected persons myocardial', 'hivinfected persons uninfected', 'hivinfection', 'hk325', 'hk5320', 'hladpb1', 'hladq93', 'hladqa1', 'hladqa103dqb10303', 'hladqb1', 'hlspc', 'hlspclc', 'hmgb1', 'hmox1', 'hnos2', 'hoechst', 'holistic', 'holometabolous', 'holter', 'homage', 'homedwelling', 'homeostasis', 'homeostatic', 'homeostenosis', 'homochirality', 'homocysteine', 'homodimer', 'homodimeric', 'homodimers', 'homoeostasis', 'homogenate', 'homogenates', 'homogeneity', 'homogeneous', 'homogenous', 'homolog', 'homologies', 'homologous', 'homologspecific', 'homologue', 'homology', 'homomeric', 'homopentameric', 'homotetrameric', 'homotypic', 'homovanillic', 'homozygoot', 'homozygosity', 'homozygous', 'honolulu', 'hopefully', 'horizantalis', 'hormesis', 'hormetic', 'hormeticdependent', 'hormonally', 'hormone', 'hormonelike', 'hormones', 'hormonesensitive', 'horseshoe', 'hospital', 'hospital episode', 'hospitalacquired', 'hospitalization', 'hospitalizations', 'hospitals', 'hotellings', 'hours', 'house', 'household', 'household interview', 'however', 'however current', 'however ethical', 'however ethical practical', 'however increase', 'however little', 'however molecular', 'however precise', 'however underlie', 'however whether', 'hplcms', 'hplcuv', 'hpscderived', 'hpscs', 'hr091', 'hr106', 'hr130', 'hr191', 'hr271', 'hr331', 'hr357', 'hr498', 'hr600', 'hr649', 'hr670', 'hr736', 'hresims', 'hrplabeled', 'hsa21', 'hsadrug', 'hsakp', 'hsc70', 'hsf1regulated', 'hsmvt', 'hsmvtmediated', 'hsp27', 'hsp32', 'hsp40', 'hsp70', 'hsp7090', 'hsp90', 'hsp90tau', 'hspa5', 'hspa5dna', 'hspgs', 'htau40', 'htc116', 'htert', 'hthnr', 'hthnrjak2stat3', 'hthnrjaksstat3', 'httgdgp', 'httpappscytoscapeorgappsjepetto', 'httpbioinfohrbmueducnprofancy', 'httpgenome2ugresprophnet', 'httpmsdiscoveryorg', 'httppainresearchforumorg', 'httpproteomecentralproteomexchangeorgdatasetpxd000203', 'httpstembookorg', 'hubei', 'hues6', 'human', 'human apoe4', 'human astrocytes', 'human betaamyloid', 'human brain', 'human brain tissue', 'human cells', 'human chronic', 'human contactin2', 'human disease', 'human diseases', 'human diseases cancer', 'human dorsolateral', 'human dorsolateral prefrontal', 'human embryonic', 'human gammasecretase', 'human genome', 'human health', 'human microglia', 'human mouse', 'human neuroblastoma', 'human neuroblastoma cells', 'human neurodegenerative', 'human neurodegenerative diseases', 'human physiology', 'human plasma', 'human pluripotent', 'human pluripotent cells', 'human populations', 'human primary', 'human primary neurons', 'human promoter', 'human protein', 'human recombinant', 'human serum', 'human serum albumin', 'human shsy5y', 'human siglecs', 'human subject', 'human tissue', 'human whole', 'human whole blood', 'humanchimpanzee', 'humanin', 'humanininduced', 'humaninmediated', 'humanins', 'humanize', 'humans', 'humoral', 'humoral immune', 'hundred', 'huntington', 'huntingtons', 'huntingtons disease', 'hupaproducing', 'huperzia', 'huperzia serrata', 'huperziaceae', 'huperzine', 'hurdle', 'husband', 'husbandry', 'huvec', 'huvecs', 'hvps34', 'hybrid', 'hybridization', 'hybrids', 'hydration', 'hydration water', 'hydration water dynamics', 'hydrobromide', 'hydrocarbon', 'hydrochloric', 'hydrochloride', 'hydrodistillation', 'hydrogen', 'hydrogen peroxide', 'hydrogen peroxideinduced', 'hydrogenate', 'hydrogenation', 'hydrolase', 'hydrolysis', 'hydrolyze', 'hydroperoxide', 'hydroperoxide aldehydemodified', 'hydroperoxide aldehydemodified proteins', 'hydroperoxidemodified', 'hydroperoxides', 'hydrophilic', 'hydrophobic', 'hydrophobic residues', 'hydrophobicity', 'hydrothion', 'hydroxide', 'hydroxycinnamic', 'hydroxyl', 'hydroxylpropylcellulose', 'hydroxypropyl', 'hydroxypyridinone', 'hydroxysafflor', 'hygiene', 'hyhydrophobic', 'hyperactivated', 'hyperactivates', 'hyperactivation', 'hyperactivity', 'hyperalgesia', 'hyperammonemia', 'hyperammonemic', 'hypercalcemia', 'hypergeometric', 'hyperglycaemia', 'hyperglycemia', 'hyperglycemic', 'hyperinsulinemiainduced', 'hyperleptinemia', 'hyperlipemia', 'hyperparathyroidism', 'hyperphosphorylated', 'hyperphosphorylation', 'hyperphosphorylationstimulated', 'hyperplasia', 'hyperpolarized', 'hypersensitive', 'hypersensitivity', 'hypertension', 'hypertensive', 'hyperuricemia', 'hypnotic', 'hypoacetylation', 'hypocalcemia', 'hypocalciuric', 'hypocholinergic', 'hypoechoic', 'hypoglycemic', 'hypolipidemic', 'hypometabolism', 'hypopharynx', 'hypothalamicpituitaryadrenal', 'hypothalamus', 'hypotheses', 'hypothesesgenerating', 'hypothesis', 'hypothesise', 'hypothesize', 'hypothetical', 'hypothyroidism', 'hypotonia', 'hypovolemia', 'hypoxanthine', 'hypoxia', 'hypsochromic', 'i2values4', 'iba1positive', 'ibmbmt', 'ibsdfrom', 'ic50020001mum', 'ic501915', 'ic505003', 'ic505010', 'ic505468100mum', 'ic506304', 'ic5092', 'ic50s', 'icam1', 'icariin', 'icd10', 'iclips', 'ideal', 'ideas', 'ideation', 'identical', 'identifiable', 'identification', 'identifications', 'identifier', 'identify', 'identify common', 'identify environmental', 'identify first', 'identify first target', 'identify major', 'identify novel', 'identify patients', 'identify potent', 'identify several', 'identify various', 'identity', 'idiopathic', 'ifi27', 'ifi44', 'ifi44l', 'ifit1', 'ifit2', 'ifngamma', 'ifqins', 'igaigg', 'igdcd27', 'igfbp3', 'igg1skewed', 'ignite', 'iiiiv', 'iistatus', 'ikappabalpha', 'il12p40', 'il1beta', 'il1ss', 'il23r', 'il6like', 'ileal', 'ileal perforation', 'ileal transporter', 'ileitis', 'ileoanal', 'ileocolonoscopy', 'ileostomy', 'ileum', 'ileus', 'iliopsoas', 'illfitting', 'illness', 'illnesses', 'illnesses diabetes', 'illnesses diabetes cardiovascular', 'illumina', 'illuminate', 'illustrate', 'image', 'image pathology', 'imagingms', 'imbalance', 'imbalanced', 'imbalances', 'imidazole', 'imidazoles', 'imino', 'iminoheterocycle', 'iminoheterocycles', 'immature', 'immaturity', 'immediate', 'immediate early', 'immediate early genes', 'immediately', 'immense', 'immobilization', 'immobilizationinduced', 'immobilize', 'immortalize', 'immune', 'immune activation', 'immune cells', 'immune cells include', 'immune inflammatory', 'immune process', 'immune response', 'immune responses', 'immune system', 'immunemediated', 'immunetobrain', 'immunetolerated', 'immunity', 'immunityrelated', 'immunization', 'immunizations', 'immunize', 'immunoassay', 'immunoblot', 'immunoblotting', 'immunochemical', 'immunochip', 'immunocompetent', 'immunocompetent patients', 'immunocompromise', 'immunocytochemical', 'immunocytochemistry', 'immunodominant', 'immunofluorescence', 'immunofluorescent', 'immunogenicity', 'immunogens', 'immunoglobulin', 'immunogold', 'immunohistochemical', 'immunohistochemical stain', 'immunohistochemically', 'immunohistochemistry', 'immunoisolatory', 'immunolabeling', 'immunologic', 'immunological', 'immunologically', 'immunomodulating', 'immunomodulation', 'immunomodulators', 'immunomodulatory', 'immunophenotyping', 'immunopositive', 'immunoprecipitation', 'immunoprecipitation experiment', 'immunoprecipitations', 'immunoreactivity', 'immunoregulation', 'immunoregulatory', 'immunosenescence', 'immunosensor', 'immunosterol', 'immunostimulant', 'immunostimulatory', 'immunosuppressive', 'immunotherapeutic', 'immunotherapies', 'immunotherapy', 'impact', 'impact brain', 'impact health', 'impair', 'impair glucose', 'impairment', 'impairments', 'impart', 'impedance', 'impede', 'implant', 'implantation', 'implement', 'implementation', 'implicate', 'implicate alzheimers', 'implicate alzheimers disease', 'implicate pathogenesis', 'implicate several', 'implicate various', 'implication', 'implications', 'implicit', 'imply', 'import', 'importance', 'important', 'important factor', 'important pathogenesis', 'important physiological', 'important regulate', 'important roles', 'importantly', 'impose', 'impossible', 'imprecise', 'impression', 'impression cytology', 'improve', 'improve motor', 'improve motor symptoms', 'improve patient', 'improve survival', 'improvement', 'improvements', 'impurity', 'imr32', 'imr32 cells', 'inactivate', 'inactivation', 'inactive', 'inactive crohns', 'inadequate', 'inadvertent', 'inational', 'inattentivehyperactiveimpulsive', 'inbreeding', 'inbrome', 'incapacitate', 'incapacity', 'incarvillea', 'inception', 'incidence', 'incidencedensity', 'incident', 'incident cancer', 'incisional', 'incisionalorganspace', 'incite', 'include', 'include alzheimers', 'include alzheimers disease', 'include antibacterial', 'include atherosclerosis', 'include cancer', 'include diabetes', 'include disease', 'include heart', 'include heart failure', 'include hippocampus', 'include increase', 'include neurodegeneration', 'include neurodegenerative', 'include parkinson', 'include parkinson diseases', 'include patients', 'include patients group', 'include primary', 'include study', 'include trials', 'inclusion', 'inclusion myositis', 'inclusionexclusion', 'inclusions', 'income', 'incomplete', 'incompletely', 'inconclusive', 'inconsistencies', 'incontrovertible', 'incorporate', 'incorporation', 'increase', 'increase activity', 'increase amount', 'increase bacterial', 'increase brain', 'increase cardiovascular', 'increase concentration', 'increase evidence', 'increase expression', 'increase first', 'increase incidence', 'increase increase', 'increase level', 'increase neuronal', 'increase number', 'increase obesity', 'increase occurrence', 'increase oxidative', 'increase response', 'increase significantly', 'increase susceptibility', 'increase tnfalpha', 'increase transcription', 'increase treatment', 'increase viability', 'increase vitro', 'increase worldwide', 'increasingly', 'incremental', 'incubate', 'incubation', 'indapamide', 'indazole', 'indazoles', 'indeed', 'indeed transplantation', 'indeed transplantation fetal', 'indefinitely', 'indentified', 'independence', 'independent', 'independentall', 'independently', 'independently associate', 'independently associate serum', 'index', 'india', 'indian', 'indiana', 'indicate', 'indicate presence', 'indications', 'indicator', 'indicator1', 'indicators', 'indices', 'indifference', 'indigenous', 'indirect', 'indirectly', 'indispensable', 'indistinguishable', 'indium', 'individual', 'individualize', 'individually', 'individualparticipant', 'individualparticipant metaanalysis', 'individuals', 'indolamine', 'indole', 'indoor', 'indoor secondhand', 'indoor secondhand smoke', 'indoors', 'indoxyl', 'induce', 'induce abeta2535', 'induce amyloid', 'induce amyloidbeta', 'induce apoptosis', 'induce betaamyloid', 'induce cells', 'induce damage', 'induce expression', 'induce glutamate', 'induce hydrogen', 'induce hydrogen peroxide', 'induce inflammatory', 'induce knockdown', 'induce neuronal', 'induce neurotoxicity', 'induce oxidative', 'induce oxidative stress', 'induce phosphorylation', 'induce robust', 'inducedmitochondrial', 'inducer', 'inducers', 'inducible', 'inducible nitric', 'inducible nitric oxide', 'induction', 'induction activity', 'induction proinflammatory', 'industrial', 'industrialize', 'industries', 'industry', 'ineffective', 'inefficient', 'inequalities', 'inert', 'inexpensive', 'infarction', 'infarction compare', 'infarctionischemia', 'infec', 'infect', 'infection', 'infection inflammation', 'infection laboratory', 'infection occur', 'infectioninduced', 'infections', 'infectious', 'infectious agents', 'infectious diseases', 'infectivity', 'infer', 'inference', 'inferences', 'inferior', 'infiltrate', 'infiltration', 'inflammasomemediated', 'inflammasomes', 'inflammation', 'inflammation autoimmunity', 'inflammation cancer', 'inflammation induce', 'inflammation neurodegenerative', 'inflammation oxidative', 'inflammation oxidative stress', 'inflammation review', 'inflammation review recent', 'inflammationassociated', 'inflammationinduced', 'inflammationrelevant', 'inflammaton', 'inflammatory', 'inflammatory bowel', 'inflammatory bowel disease', 'inflammatory bowel diseases', 'inflammatory component', 'inflammatory condition', 'inflammatory cytokines', 'inflammatory damage', 'inflammatory damage induce', 'inflammatory diseases', 'inflammatory mediators', 'inflammatory process', 'inflammatory response', 'inflammatory responses', 'inflammatory responses autophagy', 'inflammatory signal', 'inflammatory state', 'inflammatory stimuli', 'inflammatoryimmune', 'inflammatoryimmunecompetent', 'inflammatroy', 'infliximab', 'infliximabadalimumab', 'infliximabbiosimilar', 'inflorescence', 'influence', 'influence brain', 'influenza', 'influenza virus', 'influenzaassociated', 'influenzaassociated mortality', 'influenzalike', 'influx', 'inform', 'information', 'information demographics', 'informative', 'infraction', 'infrared', 'infrared spectroscopy', 'infrequent', 'infuse', 'infusion', 'infusionms', 'infusions', 'ingest', 'ingestion', 'ingestion donepezil', 'ingestions', 'ingredients', 'inguinal', 'inhalation', 'inherent', 'inherently', 'inherit', 'inheritance', 'inhibit', 'inhibit activation', 'inhibit phosphorylation', 'inhibit production', 'inhibition', 'inhibition study', 'inhibitions', 'inhibitor', 'inhibitor ly294002', 'inhibitors', 'inhibitorsmodulators', 'inhibitory', 'inhibitory activities', 'inhibitory activity', 'inhibitory activity value', 'inhibitory antioxidant', 'inhibitory control', 'inhibitory effect', 'inhibitrices', 'inhouse', 'ini0602', 'initial', 'initial injury', 'initially', 'initiate', 'initiation', 'initiation progression', 'initiatives', 'initio', 'inject', 'injectable', 'injectable preparation', 'injection', 'injure', 'injuries', 'injurious', 'injury', 'innate', 'innate adaptive', 'innate immune', 'innate immune response', 'innate immune responses', 'innate immune system', 'innate immunity', 'inner', 'innocent', 'innocuous', 'innovative', 'inoscyclooxygenase2', 'inosine', 'inositol', 'inr32', 'inregister', 'ins1e', 'insect', 'insects', 'insert', 'insertion', 'inside', 'insidious', 'insight', 'insight mechanisms', 'insights', 'insoluble', 'inspire', 'instability', 'installable', 'instance', 'instant', 'instead', 'instigation', 'institute', 'institutional', 'instrument', 'instrumental', 'instrumentation', 'insufficiency', 'insufficiently', 'insula', 'insulin', 'insulin receptor', 'insulin resistance', 'insulin secretion', 'insulin signal', 'insulinigf', 'insulinigf1', 'insulininduced', 'insulininsulinlike', 'insulinlike', 'insulinsensitizing', 'insult', 'insurance', 'intact', 'intake', 'intakes', 'integral', 'integral membrane', 'integrate', 'integrate service', 'integration', 'integrative', 'integrator1', 'integrin', 'integrin signal', 'integrinbinding', 'integrins', 'integrity', 'intellectual', 'intelligence', 'intelligent', 'intend', 'intense', 'intensify', 'intensity', 'intensive', 'intensively', 'intentionally', 'inter', 'interact', 'interaction', 'interaction network', 'interactions', 'interactions involve', 'interactor', 'interactors', 'interassay', 'interatomic', 'intercellular', 'interchange', 'interchromosomal', 'interconnect', 'interconnections', 'intercourses', 'interday', 'interdependences', 'interdependent', 'interdisciplinary', 'interest', 'interestingly', 'interestrectal', 'interface', 'interfaced', 'interfaces', 'interfere', 'interference', 'interferencemediated', 'interferences', 'interferon', 'interferon gamma', 'interferonfree', 'interferongamma', 'interferongammaproducing', 'interferons', 'interim', 'interindividual', 'interleukin', 'interleukin1', 'interleukin10', 'interleukin1beta', 'interleukin4', 'interleukin6', 'intermediate', 'intermediaterisk', 'intermembrane', 'intermittent', 'intermittent thirddegree', 'intermittently', 'intermolecular', 'internal', 'internal medicine', 'internal standard', 'internalisation', 'internalization', 'internalize', 'internally', 'international', 'internet', 'interneuronal', 'interneurons', 'internists', 'internship', 'interplay', 'interpret', 'interpretability', 'interpretation', 'interpretations', 'interprofessional', 'interquartile', 'interquartile range', 'interrelate', 'interrelationships', 'interrogate', 'interrupt', 'intersample', 'intersect', 'interspecies', 'interstitial', 'intersubunit', 'intertwine', 'interval', 'intervals', 'intervention', 'interventions', 'interview', 'interweave', 'intestinal', 'intestinal bacterial', 'intestinal bacterial overgrowth', 'intestinal dysbiosis', 'intestinal inflammation', 'intestinal microbiotagenerated', 'intestinal uptake', 'intestinal uptake pcresol', 'intestinalis', 'intestine', 'intestinespecific', 'intima', 'intimately', 'intolerance', 'intoxicate', 'intoxication', 'intoxications', 'intra', 'intraassay', 'intracellular', 'intracellular calcium', 'intracellular concentration', 'intracellular domain', 'intracellular signal', 'intracerebrally', 'intracerebroventricular', 'intracerebroventricularly', 'intractable', 'intradermal', 'intraepithelial', 'intraflagellar', 'intragastrically', 'intragenic', 'intrahippocampal', 'intramembrane', 'intramembranecleaving', 'intramembranous', 'intramolecular', 'intranasal', 'intranasally', 'intranuclear', 'intraoperative', 'intraperitoneal', 'intraperitoneally', 'intrathecal', 'intrauterine', 'intravenously', 'intraventricular', 'intravital', 'intricately', 'intrigue', 'intriguingly', 'intrinsic', 'intrinsic comparison', 'intrinsically', 'intrinsically disorder', 'introduce', 'introduction', 'intron', 'intronic', 'introns', 'intuitively', 'inulintype', 'inulintype fructans', 'invade', 'invaginations', 'invaluable', 'invariance', 'invariant', 'invasion', 'invasion metastasis', 'invasive', 'invasively', 'invasiveness', 'inventions', 'inventory', 'inverse', 'inversely', 'inversely associate', 'invertebrates', 'investigate', 'investigate chemical', 'investigate effect', 'investigate possible', 'investigate potential', 'investigate protective', 'investigate relationship', 'investigate treat', 'investigate treat indeed', 'investigate whether', 'investigation', 'investigational', 'investigations', 'investigators', 'inveterate', 'invivo', 'involuntary', 'involve', 'involve activation', 'involve apoptosis', 'involve biosynthesis', 'involve cellbased', 'involve cellbased therapy', 'involve mechanisms', 'involve memory', 'involve pathogenesis', 'involve pathophysiology', 'involve process', 'involve regulation', 'involvement', 'involvement multiple', 'involvement seladin1', 'involvement seladin1 goniothalamininduced', 'involvementie', 'inward', 'iodide', 'ionic', 'ionization', 'ionotropic', 'ionotropic glutamate', 'ionpair', 'iontophoresis', 'iontophoretic', 'ipscderived', 'iridaceae', 'iridoids', 'irinduced', 'ironchelating', 'ironchelation', 'irondependent', 'irondepletion', 'ironevolved', 'ironically', 'ironloaded', 'ironmediated', 'irregularities', 'irreversible', 'irreversibly', 'irritability', 'irritable', 'irritable bowel', 'irritable bowel syndrome', 'isa51', 'ischaemia', 'ischaemic', 'ischemia', 'ischemia model', 'ischemiainduced', 'ischemic', 'ischemic heart', 'island', 'islet', 'isoaspglyarg', 'isocaloric', 'isocitrate', 'isocitric', 'isodgr', 'isodipeptide', 'isoenzymes', 'isoflavonerelated', 'isoflavones', 'isoform', 'isoformdependent', 'isoforms', 'isoformselective', 'isolate', 'isolation', 'isomer', 'isomerase', 'isomerases', 'isomeric', 'isomerization', 'isomerization reaction', 'isomerize', 'isomers', 'isonicotinamide', 'isoorientin', 'isopeptide', 'isoprenoid', 'isoquinoline', 'isorhynchophylline', 'isotherm', 'isothermal', 'isothermal titration', 'isothermal titration calorimetry', 'isotonic', 'isotope', 'isotopelabeled', 'isotopelabeled epothilone', 'isotopes', 'isotopic', 'isotopically', 'isotype', 'isovitexin', 'isoxazole', 'isoxazoles', 'isoxazoline', 'israel', 'israeli', 'issue', 'issue entitle', 'italian', 'italy', 'items', 'iterative', 'itga9', 'itgam', 'itm2b', 'itocoated', 'itunes', 'iukgday', 'j40j44', 'jacobian', 'jadad', 'jak2stat3', 'january', 'janus', 'janus kinase', 'janusassociated', 'japan', 'japan develop', 'japan develop countries', 'japanese', 'japonica', 'jcm5070but', 'jepetto', 'jeremiah', 'jn711454', 'jobexposure', 'joint', 'jointly', 'jordanian', 'journal', 'journals', 'journalwise', 'journey', 'judge', 'judgement', 'judgment', 'judicious', 'jumprope', 'junction', 'junction hemichannel', 'junctional', 'junctions', 'juniperus', 'justification', 'justificatory', 'justify', 'juvenile', 'juxtaposition', 'k18ffkryptofix', 'kaempferol', 'kainic', 'kaixinsan', 'kallikreins', 'kamat', 'kanamycin', 'kangdong', 'kaplanmeier', 'kappa', 'kappab', 'kappalightchainenhancer', 'karsare', 'karyotype', 'karyotypically', 'kca31', 'kcalmol', 'kcne1', 'kcnk3', 'kcnq1', 'kcnq1e1', 'kcnq1kcne1', 'kdm1a', 'kdm6b', 'kdm6b expression', 'ketamine', 'ketoconazole', 'ketoconazolecyp3a4', 'ketoenol', 'ketogenic', 'ketohexokinase', 'ketone', 'ketones', 'ketoprofen', 'keystep', 'kgdhc', 'khouzestan', 'khyber', 'kidney', 'kidney disease', 'kidney disease patients', 'kidney function', 'kidney injury', 'kidneys', 'killer', 'killers', 'kinase', 'kinase activity', 'kinase inhibitor', 'kinase3', 'kinase3beta', 'kinase3beta gsk3beta', 'kinases', 'kindle', 'kinds', 'kinetic', 'kinetics', 'knock', 'knockdown', 'knockdown induce', 'knockout', 'knowledge', 'knowledge first', 'korea', 'korean', 'korean vietnam', 'korean vietnam veterans', 'krebs', 'krewski', 'krill', 'kurtek', 'kynurenamines', 'kynurenic', 'kynurenines', 'l1cam', 'label', 'labelfree', 'laboratory', 'labour', 'lachnospiraceae', 'laciniata', 'lacrimal', 'lactams', 'lactate', 'lactic', 'lactobacilli', 'lactobacillus', 'lactoferrin', 'lactulose', 'laevis', 'lalpha', 'lalphaasp', 'lalwani', 'lamadefovir', 'lamadv', 'lamadv combination', 'lamadv combination therapy', 'lambdaem', 'lambdaex', 'lamblia', 'lamellar', 'lamem', 'lamiaceae', 'lamina', 'lamina propria', 'lamino', 'lamivudine', 'lamivudineadefovir', 'lamivudineresistance', 'lamivudineresistant', 'lamresistant', 'landmark', 'landscape', 'language', 'laparoscopic', 'large', 'large number', 'largely', 'largely unknown', 'larger', 'largescale', 'largesize', 'largest', 'larva', 'larvae', 'larval', 'laryngeal', 'laser', 'lasota', 'lasotas', 'lastly', 'latency', 'latent', 'lateonset', 'lateonset alzheimers', 'lateonset alzheimers disease', 'later', 'lateral', 'lateral cleave', 'lateral sclerosis', 'latest', 'latestage', 'lathosterol', 'latter', 'launch', 'lauric', 'lausanne', 'lavage', 'layer', 'layout', 'lbeta', 'lbetaasp', 'lc3ii', 'lc3ilc3ii', 'lc5040734', 'lc5053118', 'lc5076241', 'lcarnitine', 'lcarnosine', 'lchrms', 'lcmsms', 'lcmsmsbased', 'lcpufas', 'ldopa', 'leakage', 'leakiness', 'leaky', 'leaos', 'learn', 'learn memory', 'learn memory abilities', 'learningmemory', 'least', 'least months', 'leave', 'leave ventricular', 'leaveoneout', 'lecithin', 'lectin', 'lecture', 'leftward', 'legal', 'legally', 'legend', 'legumes', 'length', 'lengths', 'leptin', 'leptinbmi', 'leptomeningeal', 'leschnyhan', 'lesion', 'lesional', 'lesions', 'lessen', 'lesser', 'lessons', 'lethal', 'lethality', 'leucine', 'leucocyte', 'leucocytes', 'leucojum', 'leukaemialymphoma', 'leukemia', 'leukocyte', 'leukocytes', 'level', 'level associate', 'level blood', 'level brain', 'level choline', 'level choline betaine', 'level compare', 'level elevate', 'level hippocampus', 'level human', 'level increase', 'level patients', 'level predict', 'level protein', 'level reactive', 'level reactive oxygen', 'level remain', 'level result', 'level which', 'lfgrafted', 'lfngfliposomes', 'lhbtsoct', 'liability', 'libani', 'liberty', 'libraries', 'library', 'licence', 'license', 'lifelong', 'lifespan', 'lifespans', 'lifestyle', 'lifestylerelated', 'lifethreat', 'lifetime', 'ligand', 'ligandbased', 'ligandbinding', 'liganddependent', 'liganddirected', 'liganddocking', 'ligandgated', 'ligandinduced', 'ligandreceptor', 'ligands', 'ligation', 'light', 'lightly', 'lignans', 'ligomerization', 'ligusticum', 'likelihood', 'likely', 'likely cause', 'likewise', 'lilacs', 'limbs', 'limit', 'limit factor', 'limit widespread', 'limit widespread clinical', 'limitation', 'limitations', 'limonene', 'limpidity', 'lineage', 'lineages', 'lineagespecific', 'linear', 'linear range', 'linear relationship', 'linearity', 'linearly', 'linearscaling', 'lineweaverburk', 'linkage', 'linkages', 'linker', 'linkers', 'linoleic', 'linolenic', 'linolenoylsg', 'linsg', 'linsgmediated', 'lipase', 'lipid', 'lipid bilayers', 'lipid homeostasis', 'lipid hydroperoxide', 'lipid hydroperoxide aldehydemodified', 'lipid nanoparticles', 'lipid peroxidation', 'lipid profile', 'lipidation', 'lipidbased', 'lipidembedded', 'lipidmediated', 'lipidomic', 'lipidomics', 'lipids', 'lipidsignaling', 'lipoamide', 'lipocalin', 'lipocalin2', 'lipofuscinlike', 'lipogenesis', 'lipogenic', 'lipoic', 'lipolysis', 'lipomod', 'lipoperoxidation', 'lipophilic', 'lipophilicity', 'lipopolysaccharide', 'lipopolysaccharide induce', 'lipopolysaccharidebinding', 'lipopolysaccharides', 'lipoprotein', 'lipoprotein cholesterol', 'lipoprotein receptor', 'lipoprotein receptor vldlr', 'lipoproteins', 'liposomal', 'liposome', 'liposomes', 'lipoxygenase', 'lipoylmemantine', 'liquid', 'liquid chromatography', 'liquidliquid', 'liquidliquid extraction', 'lisica', 'lister', 'listeria', 'listserv', 'literature', 'literature review', 'literature search', 'literatures', 'littermates', 'little', 'little effect', 'liver', 'liver cirrhosis', 'liver disease', 'liver failure', 'liver heart', 'liver receptors', 'liverrelated', 'livingresidential', 'llactic', 'lleucine', 'llspc', 'llspclc', 'llysine', 'lncrnadisease', 'lncrnadisease associations', 'lncrnas', 'lncrnas implicate', 'lo1adeltad', 'lo1arrr', 'lobar', 'lobster', 'local', 'localisation', 'localise', 'localization', 'localizationdependent', 'localize', 'locally', 'locate', 'location', 'locations', 'locomotor', 'locomotor activity', 'locus', 'log10', 'logarithm', 'logic', 'logistic', 'logistic regression', 'logistic regression analysis', 'logistic regression model', 'loglinear', 'londontype', 'longa', 'longchain', 'longcirculating', 'longer', 'longerterm', 'longevity', 'longifolia', 'longitudinal', 'longitudinal study', 'longitudinally', 'longlived', 'longrange', 'longstanding', 'longterm', 'longterm effect', 'longterm followup', 'longurionis', 'loose', 'loosesoft', 'lossoffunction', 'lothian', 'lotus', 'lowaffinity', 'lowcopper', 'lowcost', 'lowdensity', 'lowdensity lipoprotein', 'loweducated', 'lower', 'lower abdominal', 'lower expression', 'lower level', 'lower plasma', 'lower respiratory', 'lower respiratory infections', 'lowest', 'lowfluoride', 'lowfrequency', 'lowgrade', 'lowincome', 'lowradiationdose', 'lowrisk', 'lowtomoderate', 'loxl1', 'lphenylalanine', 'lpsactivated', 'lpsinduced', 'lpsstimulated', 'lpstreated', 'lrp56', 'lrp56mediated', 'ls180', 'lu13c', 'luciferase', 'lumbar', 'lumen', 'luminex', 'luminex assay', 'lungs', 'lupus', 'lupuslike', 'luteal', 'luteolin', 'ly29400', 'ly294002', 'lycopene', 'lycopene treatment', 'lycopodium', 'lymph', 'lymphadenopathy', 'lymphatic', 'lymphatic drainage', 'lymphatics', 'lymphocyte', 'lymphocytes', 'lymphogranuloma', 'lymphoid', 'lymphoma', 'lymphomas', 'lymphoreticular', 'lyplspld', 'lys109', 'lys109 downward', 'lys109 downward arrowhis110', 'lysate', 'lysates', 'lysed', 'lysine', 'lysinecontaining', 'lysis', 'lysoplasmalogenspecific', 'lysosomal', 'lysosomalautophagy', 'lysosomes', 'lysozyme', 'lysyl', 'm1polarizing', 'macaques', 'machine', 'machinelearning', 'machinery', 'macranthoin', 'macro', 'macroautophagy', 'macrocyclic', 'macromolecular', 'macromolecule', 'macromolecules', 'macrophage', 'macrophage colonystimulating', 'macrophage colonystimulating factor', 'macrophagemediated', 'macrophages', 'macroscopic', 'macular', 'macular degeneration', 'madecassoside', 'mader', 'madindarby', 'magnesium', 'magnetic', 'magnetic resonance', 'magnetic resonance image', 'magnetic resonance spectroscopy', 'magnify', 'magnitude', 'mainly', 'mainstream', 'maintain', 'maintain remission', 'maintenance', 'mairei', 'maison', 'major', 'major development', 'major factor', 'major human', 'majority', 'makeup', 'maladaptive', 'malaise', 'malaria', 'malattia', 'malay', 'malaysia', 'maldims', 'malditof', 'maledominated', 'maleimidebased', 'males', 'males females', 'males45', 'malfunction', 'malic', 'malignancies', 'malignancy', 'malnutrition', 'malondiadehyde', 'malondialdehyde', 'malondialdehyde level', 'maltodextrin', 'mammal', 'mammalian', 'mammalian cells', 'mammals', 'mammen', 'manage', 'manageable', 'management', 'manager', 'managers', 'managua', 'mandatory', 'manganese', 'manifest', 'manifestation', 'manifestations', 'manifold', 'manipulate', 'manipulation', 'manipulations', 'manner', 'manner which', 'mannheim', 'mannitol', 'mannwhitneywilcoxon', 'mantelhaenszel', 'manually', 'manufacture', 'manufacturers', 'manuscript', 'map2c', 'map2c prevent', 'map2cmap2', 'map2mediated', 'maperk', 'mapks', 'march', 'marco', 'maresins', 'marginal', 'marianum', 'marine', 'marinederived', 'marital', 'markedly', 'markedly increase', 'marker', 'markers', 'markers cholinergic', 'markers cholinergic synapses', 'market', 'marrow', 'marrow transplantation', 'marrowbone', 'marrowderived', 'marrowderived macrophages', 'marsh', 'massachusetts', 'massspectrometrybased', 'master', 'match', 'material', 'material methods', 'materialinduced', 'materials', 'materials methods', 'maternal', 'mathematical', 'matlab', 'matrices', 'matrix', 'matrix factorization', 'matrixassisted', 'matrixes', 'matrixforming', 'matrixplatinum', 'matter', 'matter lesions', 'maturation', 'mature', 'maxim', 'maximal', 'maximally', 'maximize', 'maximum', 'maybe', 'mbnl1', 'mbnl1 mbnl2', 'mbnl2', 'mccmannitol', 'mcdonaldkreitman', 'mckenzie', 'mdamb231', 'mdash', 'mdashmdashmrjf4', 'mdashmrjf4', 'mdckmdr1', 'mdr1mediated', 'meals', 'meaningful', 'meansquared', 'measurable', 'measure', 'measure plasma', 'measure result', 'measure serum', 'measurement', 'measurements', 'mecamylamine', 'mecfs', 'mechanical', 'mechanics', 'mechanism', 'mechanism action', 'mechanism gammasecretase', 'mechanism underlie', 'mechanism which', 'mechanisms', 'mechanisms action', 'mechanisms contribute', 'mechanisms discuss', 'mechanisms involve', 'mechanisms replacement', 'mechanisms replacement trophic', 'mechanisms review', 'mechanisms underlie', 'mechanisms which', 'mechanistic', 'mechanistic study', 'mechanistically', 'mechanonociception', 'mechanosensitivity', 'mechanotransduction', 'meconium', 'meddiet', 'media', 'median', 'median baseline', 'median followup', 'median value', 'median years', 'mediate', 'mediate associations', 'mediation', 'mediations', 'mediator', 'mediators', 'medicaid', 'medical', 'medical applications', 'medical condition', 'medical record', 'medically', 'medicaments', 'medicare', 'medication', 'medications', 'medicinal', 'medicinal chemistry', 'medicinal plant', 'medicinalbiologicalpharmacological', 'medicine', 'medicinebased', 'mediterranean', 'medium', 'medium chain', 'mediumchain', 'medline', 'medoids', 'megacity', 'megacolon', 'megafermentir', 'melanoma', 'melanoma melanoma', 'melanoma progression', 'melanomas', 'melastatin7', 'melatonin', 'melatonin coenzyme', 'melissa', 'mellitus', 'memantine', 'memantine concentrations', 'member', 'member family', 'members', 'members family', 'membrane', 'membrane potential', 'membrane protein', 'membrane proteins', 'membraneacting', 'membranebound', 'membraneembedded', 'membranelipid', 'membraneretained', 'membranes', 'membranetype', 'memory', 'memory abilities', 'memory impairment', 'memorydeficit', 'memoryenhancing', 'memorynaive', 'memorynback', 'memoryrelated', 'menarche', 'mendelian', 'meningeal', 'menopause', 'menses', 'menstrual', 'menstrual function', 'mental', 'mental health', 'mental status', 'mentha', 'mention', 'mentor', 'merely', 'merit', 'mertk', 'mesencephalic', 'mesencephalic cells', 'mesencephalic cells brain', 'mesenchymal', 'mesenchymal stromal', 'mesenchymal stromal cells', 'mesoporous', 'mesotrypsin', 'message', 'messenger', 'messengers', 'mesylate', 'metaanalyses', 'metaanalysis', 'metabiomarkers', 'metabolic', 'metabolic control', 'metabolic diseases', 'metabolic disorder', 'metabolic engineer', 'metabolic factor', 'metabolic network', 'metabolic pathway', 'metabolic pathways', 'metabolic profile', 'metabolic syndrome', 'metabolically', 'metabolically healthy', 'metabolically healthy obesity', 'metabolise', 'metabolism', 'metabolism current', 'metabolism current study', 'metabolisms', 'metabolite', 'metabolite analysis', 'metabolite dietary', 'metabolite trimethylaminenoxide', 'metabolites', 'metabolites human', 'metabolitetometabolite', 'metabolize', 'metabolomic', 'metabolomic analysis', 'metabolomic approach', 'metabolomics', 'metabonomic', 'metabonomics', 'metabotypes', 'metabotyping', 'metagenome', 'metagenomewide', 'metagenomic', 'metal', 'metalchelation', 'metalenhanced', 'metalionassisted', 'metalionindependent', 'metallic', 'metalloproteases', 'metalloproteinase', 'metalloproteinases', 'metamarkers', 'metamorphosis', 'metaplasia', 'metastable', 'metastasis', 'metastasisfree', 'metastatic', 'metformin', 'methanol', 'methanol001', 'methanolic', 'methanolic extract', 'methionine', 'methionines', 'method', 'method detect', 'method identify', 'method result', 'methodologic', 'methodological', 'methodological clinical', 'methodology', 'methods', 'methods analysis', 'methods conduct', 'methods crosssectional', 'methods patients', 'methods perform', 'methods result', 'methods retrospective', 'methods retrospective study', 'methods study', 'methods total', 'methodsdesign', 'methoxy', 'methyl', 'methyl group', 'methylation', 'methylbranched', 'methylcellulose', 'methyld9choline', 'methylene', 'methylene inhibit', 'methylesterase1', 'methylesterase1leucine', 'methylglyoxal', 'methylglyoxalinduced', 'methylglyoxaltreated', 'methyltransferase', 'methyltransferases', 'metric', 'metric tensor', 'metrics', 'metropolitan', 'metzger', 'metzincins', 'mexico', 'mgday', 'mgkg1day1', 'mgkgday', 'mgwas', 'mhealth', 'micelle', 'micelleenhanced', 'micelles', 'microarray', 'microarray analyse', 'microarrays', 'microbeams', 'microbegenerated', 'microbes', 'microbial', 'microbial profile', 'microbial translocation', 'microbialdependent', 'microbially', 'microbiological', 'microbiology', 'microbiome', 'microbiotabrain', 'microbiotadependent', 'microbiotadependent metabolite', 'microbiotaderived', 'microbiotagenerated', 'microbiotagutbrain', 'microcirculation', 'microcrystalline', 'microdiffraction', 'microdomains', 'microenvironment', 'microflora', 'microglia', 'microglia astrocytes', 'microglia cells', 'microglia express', 'microglia polarization', 'microglia several', 'microgliabrain', 'microgliaconditioned', 'microglial', 'microglial activation', 'microglial cells', 'microglialike', 'microglialmacrophage', 'microglialmediated', 'microglialmediated neuroinflammation', 'microgliamacrophages', 'microgliamediated', 'microglianeuron', 'microgliathe', 'microgml', 'microl', 'microliters', 'microm', 'microm compound', 'microm galanthamine', 'microm respectively', 'micromol', 'micromol1', 'micromolar', 'micronutrients', 'microorganisms', 'microparticles', 'microplate', 'microrna', 'microrna206', 'microrna3233p', 'micrornainterfering', 'micrornas', 'micrornas mirnas', 'microsatellite', 'microscale', 'microscope', 'microscopic', 'microscopic stool', 'microscopic stool examination', 'microscopically', 'microscopy', 'microsoft', 'microsomal', 'microsomes', 'microstructure', 'microtubular', 'microtubule', 'microtubuleassociated', 'microtubuleassociated protein', 'microtubules', 'microtubulestabilizing', 'microvessel', 'microwaveassisted', 'mid2010', 'mid2015', 'midbrain', 'middle', 'middleincome', 'midlife', 'miettinen', 'might', 'might contribute', 'might important', 'might mediate', 'miglioramento', 'migraine', 'migrants', 'migrate', 'migration', 'milder', 'milestone', 'milieu', 'military', 'million', 'million people', 'millions', 'mimetics', 'mimic', 'mimicmediate', 'mimicry', 'mineral', 'mineralization', 'minerals', 'minigene', 'minigenes', 'minimal', 'minimal hepatic', 'minimal hepatic encephalopathy', 'minimise', 'minimize', 'minimum', 'minipig', 'minipigs', 'minireview', 'minireviewcommentary', 'minor', 'minority', 'minute', 'minutes', 'mir125b', 'mir135a', 'mir195', 'mir214', 'mir216b', 'mir218', 'mir218ptpa', 'mir24', 'mir3233p', 'mir4093p', 'mirna', 'mirna sequence', 'mirna125b', 'mirna146a', 'mirna155', 'mirna15a', 'mirna16', 'mirna34a', 'mirna660', 'mirna9', 'mirnabased', 'mirnabinding', 'mirnamediated', 'mirnas', 'mirror', 'mirwalk', 'miscarriage', 'miscellaneous', 'misclassified', 'misfold', 'misfolded', 'misfolding', 'mismatch', 'misregulated', 'misregulation', 'missense', 'missplicing', 'mistake', 'mistrust', 'mitigate', 'mitocellular', 'mitochondria', 'mitochondriaassociated', 'mitochondriacaspaseapoptotic', 'mitochondriadependent', 'mitochondrial', 'mitochondrial lysates', 'mitochondrial membrane', 'mitochondrial membrane potential', 'mitochondrial morphology', 'mitochondrial proteins', 'mitochondrialassociated', 'mitochondrialcentered', 'mitochondrialderived', 'mitochondrially', 'mitochondrialocalized', 'mitochondrias', 'mitochondriopathies', 'mitofusin1', 'mitogenactivated', 'mitogenactivated protein', 'mitogenactivated protein kinase', 'mitophagy', 'mitosis', 'mitotic', 'mitoxantrone', 'mitral', 'mixedtype', 'mixture', 'mixtures', 'mk801', 'ml341', 'mlmin', 'mlmin173', 'mmckenziemtsinaionca', 'mmoll', 'mmp14', 'mmp14 expression', 'mmuml', 'mnos2', 'mnsod', 'mobile', 'mobile phase', 'mobile phone', 'mobility', 'mobilization', 'mobilize', 'mockinfected', 'modalities', 'model', 'model alzheimers', 'model alzheimers disease', 'model disease', 'model human', 'model induce', 'model investigate', 'model perform', 'model result', 'model reveal', 'model study', 'moderate', 'moderate disease', 'moderately', 'moderatesevere', 'moderation', 'modern', 'modes', 'modest', 'modestly', 'modifiable', 'modification', 'modifications', 'modifications include', 'modifications proteins', 'modifications regulate', 'modifier', 'modifiers', 'modify', 'modular', 'modulate', 'modulate activity', 'modulate cognitive', 'modulate expression', 'modulateexacerbate', 'modulation', 'modulation inflammation', 'modulation inflammation review', 'modulator', 'modulators', 'modulatory', 'moduleassisted', 'modules', 'mograbi', 'moieties', 'moiety', 'molarity', 'molecular', 'molecular basis', 'molecular cellular', 'molecular dynamics', 'molecular dynamics simulations', 'molecular level', 'molecular marker', 'molecular mechanism', 'molecular mechanisms', 'molecular mechanisms involve', 'molecular mimicry', 'molecular model', 'molecular model study', 'molecular structure', 'molecular study', 'molecular weight', 'molecule', 'molecule ligands', 'molecule1', 'molecules', 'molitor', 'molitor larvae', 'moment', 'monitor', 'monoamine', 'monoclonal', 'monocyte', 'monocytes', 'monocytespecific', 'monocytic', 'monocytic cells', 'monocytogenes', 'monodisperse', 'monoinfected', 'monolayer', 'monolayers', 'monomer', 'monomeric', 'mononitrated', 'mononuclear', 'monooxygenation', 'monosymptomatic', 'monoterpeneglucoside', 'monotherapy', 'monounsaturated', 'monoxide', 'monozygotic', 'montana', 'montanide', 'montanum', 'month', 'monthly', 'months', 'montreal', 'moore', 'moprp', 'morbidity', 'morbidity mortality', 'moreover', 'morison', 'morphogenesis', 'morphologic', 'morphological', 'morphologically', 'morphology', 'morphology kidney', 'morphometric', 'morris', 'mortalin', 'mortality', 'mortality among', 'mortality cancer', 'mortality elevate', 'mortality underlie', 'mosaicism', 'mostly', 'mostra', 'mostused', 'mother', 'motif', 'motifs', 'motility', 'motion', 'motivate', 'motor', 'motor cortex', 'motor cortex wistar', 'motor symptoms', 'motor symptoms however', 'motorproteins', 'mount', 'mouse', 'mouse brain', 'mouse human', 'mouse model', 'mouse model alzheimers', 'mouse model human', 'mouse primary', 'mouth', 'movement', 'movements', 'mpdai', 'mpfad10', 'mptpp', 'mptpp treatment', 'mrjf4', 'mrnas', 'msbased', 'mt1mmp', 'mtdna', 'mtmmps', 'mtmr14', 'mtorc1', 'mtorc2', 'mucoadhesive', 'mucociliary', 'mucosa', 'mucosaassociated', 'mucosae', 'mucosal', 'mucus', 'mugcm2h', 'mugml', 'mugml respectively', 'mugml respectively similarly', 'mugmlstimulated', 'mugmyr', 'multicellular', 'multicenter', 'multicentre', 'multichannel', 'multidimensional', 'multidisciplinary', 'multidrug', 'multiethnic', 'multifactorial', 'multifocal', 'multiforme', 'multifunctional', 'multifunctional liposomes', 'multigene', 'multigenic', 'multimer', 'multimeric', 'multimodal', 'multimorbidity', 'multinominal', 'multinucleate', 'multinucleate microglia', 'multinucleated', 'multinucleation', 'multiorgan', 'multipass', 'multiplatform', 'multiple', 'multiple chronic', 'multiple chronic condition', 'multiple myeloma', 'multiple sclerosis', 'multipleascendingdose', 'multipleascendingdose study', 'multiplecause', 'multiplex', 'multiplexed', 'multiplicity', 'multiply', 'multipolar', 'multipotency', 'multipotent', 'multipotent mesenchymal', 'multipotent mesenchymal stromal', 'multirank', 'multistate', 'multistep', 'multisubunit', 'multisystemic', 'multitarget', 'multitep', 'multitude', 'multivalent', 'multivariable', 'multivariate', 'multivariate analysis', 'mumol', 'mumoll', 'murine', 'murine hindlimb', 'murine hindlimb ischemia', 'muscarinic', 'muscarinic acetylcholine', 'muscarinic acetylcholine receptors', 'muscarinic receptor', 'muscarinic receptors', 'muscarinic transmission', 'muscle', 'muscle atrophy', 'muscle cells', 'muscular', 'muscularis', 'mushroom', 'muslim', 'mutagenesis', 'mutagenic', 'mutagenicity', 'mutagens', 'mutans', 'mutant', 'mutant human', 'mutants', 'mutate', 'mutation', 'mutational', 'mutations', 'muxspe16', 'myalgia', 'myalgic', 'myasthenic', 'myd88', 'myelin', 'myelinassociated', 'myelination', 'myelinforming', 'myelinrelated', 'myeloablation', 'myelocytes', 'myeloid', 'myeloid cells', 'myeloid cells trem2', 'myeloidderived', 'myeloma', 'myelomonocytic', 'myeloneuropathy', 'myelooptic', 'myeloperoxidase', 'myelosuppresive', 'myocardial', 'myocardial fibrosis', 'myocardial infarction', 'myocardial infarction compare', 'myocardial perfusion', 'myocardial perfusion defect', 'myocytes', 'myodegenerative', 'myogenic', 'myoinositol', 'myomirs', 'myopathy', 'myosin', 'myositis', 'myotonic', 'myotubularinrelated', 'myriad', 'myristate', 'n1301', 'n1372272', 'n1e115', 'n2331', 'n2aappswe', 'n2aappswe cells', 'n2aappwt', 'n2fluorobenzyl', 'n3166', 'n3pufas', 'n3pufasrich', 'n5stz', 'n5stzinduced', 'n72949', 'na297', 'na684', 'nabbs', 'nacetyl', 'nacetylbetad', 'nacetylcysteine', 'nacetylglucosamine', 'nacetylglucosaminyltransferase', 'nachr', 'nachrs', 'nacinduced', 'nacoupled', 'naddependent', 'nadhindependent', 'nadhnad', 'nadir', 'nadphoxidase', 'nafld', 'nakatpase', 'naked', 'naltrexone', 'namely', 'namultivitamin', 'nanocarrier', 'nanocontainer', 'nanoformulation', 'nanoformulations', 'nanomachinemodule', 'nanomaterials', 'nanomedicines', 'nanomolar', 'nanomolar aluminum', 'nanoparticle', 'nanoparticles', 'nanoprobe', 'nanoprobes', 'nanoscale', 'nanosized', 'nanospray', 'nanostructural', 'nanostructure', 'nanostructured', 'nanostructures', 'nanotechnology', 'nanouplc', 'nanouplcmsms', 'nanowire', 'nanowirebased', 'naproxen', 'narcissus', 'narrative', 'narrow', 'nasal', 'natgacurcuminoids', 'natgal2', 'national', 'native', 'nativelike', 'natriuretic', 'natural', 'natural products', 'natural source', 'naturally', 'naturally occur', 'nature', 'nausea', 'nav15', 'nav16', 'nav16 sodium', 'nav16 sodium channel', 'nav16mediated', 'navigate', 'nback', 'nbenzyl', 'nbenzyl123triazole', 'nbutyllithium', 'ncam1', 'ncofilin', 'ncounter', 'ncrnas', 'nct00441623', 'nct01715415', 'nct01742754', 'nct02008331', 'nddmodel', 'nderivatized', 'nearby', 'nearin', 'nearisometric', 'nearly', 'necessarily', 'necessary', 'necessitate', 'necessity', 'necrosis', 'necrosis factor', 'necrosis factor tnfalpha', 'necrosis factoralpha', 'necrosis factoralpha tnfalpha', 'needle', 'needleace', 'needleless', 'negative', 'negative effect', 'negative feedback', 'negatively', 'negatively regulate', 'negativelycharged', 'neglect', 'negligible', 'neighbor', 'neither', 'nella', 'nematicidal', 'nematode', 'nematodes', 'neocortex', 'neocortical', 'neocortical cells', 'neoepitopes', 'neomycin', 'neonatal', 'neoplasm', 'neoplasms', 'neoplastic', 'neopterin', 'neotenous', 'neoterminal', 'nephro', 'nephropathy', 'nephroprotective', 'nephrostomy', 'nephrovascular', 'neprilysin', 'neral', 'nerve', 'nerve cells', 'nerve system', 'nerve terminals', 'nervous', 'nervous system', 'nervous system diseases', 'nervous system disorder', 'nervous systems', 'nervous tissue', 'netwas', 'network', 'networkbased', 'networkbased prioritization', 'neuopathophysiology', 'neural', 'neural cells', 'neural stemprogenitor', 'neural stemprogenitor cells', 'neuregulin', 'neurexin', 'neurexins', 'neurite', 'neurite outgrowth', 'neurites', 'neuro', 'neuro2a', 'neuroactive', 'neuroactive steroid', 'neuroactivities', 'neurobehavioral', 'neurobiol', 'neurobiological', 'neurobiology', 'neuroblast', 'neuroblastoma', 'neuroblastoma cells', 'neuroblastoma shsy5y', 'neuroblastoma shsy5y cells', 'neuroblastoma2a', 'neuroblasts', 'neurochemical', 'neurocognitive', 'neurod1', 'neurodegeneration', 'neurodegeneration review', 'neurodegenerationnew', 'neurodegenerationwhich', 'neurodegenerative', 'neurodegenerative condition', 'neurodegenerative disease', 'neurodegenerative diseases', 'neurodegenerative diseases alzheimers', 'neurodegenerative diseases include', 'neurodegenerative diseases induce', 'neurodegenerative diseases neurodegenerative', 'neurodegenerative diseases parkinson', 'neurodegenerative disorder', 'neurodegenerative disorder alzheimers', 'neurodegenerative phenotype', 'neurodegenerative process', 'neurodegenerativeneuroinflammatory', 'neurodeleterious', 'neurodestructive', 'neurodetrimental', 'neurodevelopment', 'neurodevelopmental', 'neurodevelopmental disorder', 'neurodiagnostic', 'neuroectoderm', 'neuroectodermal', 'neuroendocrinal', 'neuroendocrine', 'neuroepithelial', 'neurofibrillary', 'neurofibrillary tangle', 'neurofibromatosis', 'neurofilament', 'neurofilament proteins', 'neurofilaments', 'neuroflammation', 'neurogenesis', 'neurogenic', 'neurogenin', 'neuroglioma', 'neurohumoral', 'neuroimmune', 'neuroimmunology', 'neuroinflammation', 'neuroinflammation which', 'neuroinflammationbased', 'neuroinflammatory', 'neuroinflammatory diseases', 'neuroinflammatory neurodegenerative', 'neuroinflammatory neurodegenerative diseases', 'neuroinflammatory process', 'neuroinflammatory response', 'neuroions', 'neurologic', 'neurologic disorder', 'neurological', 'neurological diseases', 'neurological disorder', 'neurological disorder include', 'neurologically', 'neurologists', 'neurology', 'neuromediators', 'neurometabolic', 'neurometabolites', 'neuromolecular', 'neuromotor', 'neuromotorassociated', 'neuromuscular', 'neuron', 'neuron death', 'neuron growth', 'neuronal', 'neuronal apoptosis', 'neuronal cells', 'neuronal death', 'neuronal differentiation', 'neuronal glial', 'neuronal plasticity', 'neuronal proteins', 'neuronal survival', 'neuronalglial', 'neuronallike', 'neuronlike', 'neurons', 'neurons brain', 'neurons neuronal', 'neurons substantia', 'neurons substantia nigra', 'neurons which', 'neuronspecific', 'neuropathic', 'neuropathies', 'neuropathogenesis', 'neuropathologic', 'neuropathological', 'neuropathologies', 'neuropathology', 'neuropathy', 'neuropeptide', 'neuropharmacological', 'neuropharmacology', 'neuroplasticity', 'neuroprogressive', 'neuroprotectin', 'neuroprotection', 'neuroprotective', 'neuroprotective activity', 'neuroprotective effect', 'neuroprotective properties', 'neuroprotective protein', 'neuroprotective treatment', 'neuropsychiatric', 'neuropsychiatric diseases', 'neuropsychiatric disorder', 'neuropsychiatry', 'neuropsychology', 'neuroregeneration', 'neuroregenerative', 'neuroscience', 'neuroscientists', 'neurosignaling', 'neurospecific', 'neurospheres', 'neurospora', 'neurosteroid', 'neurotensin', 'neurotensinbinding', 'neuroticism', 'neurotoxic', 'neurotoxic factor', 'neurotoxic factor release', 'neurotoxicity', 'neurotoxicity however', 'neurotoxicity induce', 'neurotoxin', 'neurotoxinpoisoned', 'neurotransmission', 'neurotransmission hippocampus', 'neurotransmitter', 'neurotransmitters', 'neurotrauma', 'neurotrophic', 'neurotrophic factor', 'neurotrophic support', 'neurotrophiclike', 'neurotropic', 'neutral', 'neutralization', 'neutralize', 'neutron', 'neutropenia', 'neutrophil', 'neutrophils', 'neutror', 'neutrotransmitter', 'nevertheless', 'newcastle', 'newly', 'newly develop', 'newlydeveloped', 'nexin', 'nextgeneration', 'nextgeneration sequence', 'nfatc1', 'nfkappab', 'nfkappab activation', 'nfkappab activity', 'nfkappabdependent', 'nfkappabmediated', 'nfkappabp65', 'nfkappabp65dependent', 'nfkb1', 'nfkbsensitive', 'ng10815', 'ngfencapsulated', 'ngfinduced', 'ngfmediated', 'ngfpotentiating', 'nh3nh4', 'nhexane', 'niacin', 'nicaragua', 'nicastrin', 'nickel', 'nicotine', 'nicotinic', 'nicotinic acetylcholine', 'nicotinic acetylcholine receptor', 'nicotinic acetylcholine receptors', 'nicotinic receptor', 'niemannpick', 'nigeria', 'nigra', 'nigra compacta', 'nigra compacta current', 'nigral', 'ninety', 'nireg', 'nissl', 'nissls', 'nitrate', 'nitration', 'nitric', 'nitric oxide', 'nitric oxide synthase', 'nitrite', 'nitrogen', 'nitrosative', 'nitroxide', 'nitroxides', 'nkcell', 'nlobe', 'nmdar', 'nmdar antagonists', 'nmdareceptor', 'nmdarmediated', 'nmdars', 'nmethyldaspartate', 'nmethyldaspartate receptors', 'nmethyltransferase', 'nmoll', 'nmrbased', 'nmthick', 'nn35difluorophenacetyllalanylsphenylglycine', 'nndimethylpphenylendiamine', 'nndimethyltryptamine', 'nociception', 'nociceptive', 'nociceptors', 'nocturnal', 'nod2atg16l1variant', 'nod2variant', 'node10', 'node3', 'node5', 'node6', 'node7', 'node8', 'node9', 'nodularity', 'noesy', 'noise', 'nominally', 'nominate', 'nonabsorbable', 'nonadjuvanted', 'nonaids', 'nonalcoholic', 'nonalcoholic fatty', 'nonalcoholic fatty liver', 'nonamyloidogenic', 'nonanticoagulant', 'nonantigenic', 'nonathlete', 'nonathletes', 'nonbetaamyloid', 'noncancer', 'noncancerous', 'noncanonical', 'noncatalytic', 'nonckd', 'nonclassical', 'nonclinical', 'noncoding', 'noncommunicable', 'noncompetitive', 'noncompetitive nmdar', 'noncompetitively', 'noncompliance', 'nonconserved', 'noncontrollers', 'nonconventional', 'noncrystalline', 'nondiabetic', 'nondialyzed', 'nondrug', 'nonenzymatic', 'nonenzymatic glycation', 'nonetheless', 'nonfamilial', 'nonfeminizing', 'nonfeminizing estrogens', 'nonfibril', 'nonfunctional', 'nongenetic', 'nonglycated', 'nonhealthy', 'nonhivinfected', 'nonhodgkin', 'nonhuman', 'nonimmune', 'noninfected', 'noninfectious', 'noninferior', 'noninflammatory', 'noninhibitory', 'nonintoxication', 'noninvasive', 'nonionic', 'nonirradiative', 'nonischaemic', 'nonlipid', 'nonmechanical', 'nonmedical', 'nonmodel', 'nonmuscle', 'nonnegative', 'nonneural', 'nonneurocentric', 'nonneuronal', 'nonnodal', 'nonobese', 'nonparallelly', 'nonparametric', 'nonpeptidergic', 'nonpharmacological', 'nonplanar', 'nonprimate', 'nonproducers', 'nonprotein', 'nonprotein amino', 'nonprotein amino acids', 'nonproteinacious', 'nonquaternary', 'nonreducing', 'nonredundant', 'nonrepetitive', 'nonreproductive', 'nonrespiratory', 'nonresponse', 'nonsecretor', 'nonself', 'nonsense', 'nonsignificant', 'nonspecific', 'nonstandardized', 'nonsteroidal', 'nonstigmatizing', 'nonsynonymous', 'nontarget', 'nontargeted', 'nontg', 'nontoxic', 'nontraditional', 'nontransgenic', 'nontreated', 'nontrough', 'nontumor', 'nonulcerated', 'nonuniform', 'nonunion', 'nonvalvular', 'nonvascular', 'nonventilatory', 'nonviral', 'nonvolatile', 'nonwestern', 'norbelladine', 'norepinephrine', 'normal', 'normal cells', 'normal condition', 'normal gastric', 'normal karyotype', 'normalization', 'normalize', 'normally', 'normalphase', 'normalweight', 'normative', 'normolipidemic', 'normotensive', 'north', 'northeast', 'northeastern', 'northeastern italy', 'northern', 'northumbria', 'northumbrian', 'norwegian', 'nosocomial', 'notable', 'notably', 'notarial', 'notary', 'notch', 'notch signal', 'notch1', 'notch1 signal', 'notch1 signal pathway', 'notchindependent', 'notchsparing', 'noteworthy', 'nothing', 'notice', 'notion', 'notion personal', 'notion personal utility', 'novel', 'novel approach', 'novel effect', 'novel object', 'novel object recognition', 'novel series', 'novel strategy', 'novel therapeutic', 'novelty', 'nowadays', 'nowadays properties', 'nowadays properties develop', 'noxide', 'noxious', 'npalmitoylation', 'npn4omt', 'npropargyl9hcarbazole', 'nr1d1', 'nrepoxypropyl', 'nsaid', 'nsmase', 'nsmase2', 'nsmase2inhibition', 'nspcs', 'nterminal', 'nterminal domain', 'nterminus', 'ntprobnp', 'nuadtrial', 'nucbased', 'nuchal', 'nucifera', 'nuclear', 'nuclear factor', 'nuclear factorkappab', 'nuclear receptor', 'nuclear receptors', 'nuclear signal', 'nucleate', 'nucleation', 'nucleatum', 'nuclei', 'nucleic', 'nucleophiles', 'nucleophilic', 'nucleoproteins', 'nucleoside', 'nucleosome', 'nucleosomefree', 'nucleosomeremodeling', 'nucleostide', 'nucleotide', 'nucleotidebinding', 'nucleotides', 'nucleus', 'number', 'number human', 'number patients', 'number people', 'number study', 'number total', 'numerous', 'nurse', 'nurse facilities', 'nurture', 'nutraceutical', 'nutraceuticals', 'nutrient', 'nutrients', 'nutrition', 'nutritional', 'nutritional guidance', 'nutritional status', 'nutritionist', 'nutritionists', 'nutritious', 'oacyl', 'oacyltransferase', 'oaincubated', 'obese', 'obesity', 'obesity associate', 'obesity diabetes', 'obesity metabolic', 'obesity nutrition', 'obesitycognition', 'obesityresistant', 'object', 'object recognition', 'objective', 'objective investigate', 'objective study', 'objectives', 'obligate', 'obligatory', 'oblige', 'obscure', 'observable', 'observation', 'observational', 'observational study', 'observations', 'observe', 'observe increase', 'observe patients', 'observers', 'obstacle', 'obstacles', 'obstruction', 'obstructive', 'obstructive pulmonary', 'obstructive pulmonary disease', 'obtain', 'obtain household', 'obtain household interview', 'obtain patients', 'obtainable', 'obvious', 'obviously', 'occasion', 'occludinzonulin', 'occlusion', 'occrus', 'occupancy', 'occupation', 'occupational', 'occupy', 'occur', 'occur frequently', 'occur patients', 'occurrence', 'occurrences', 'ocean', 'octanoic', 'octarepeat', 'october', 'ocular', 'oculogyric', 'oedema', 'oesophageal', 'oesophagus', 'offer', 'officinalis', 'offset', 'offspring', 'offtarget', 'offtargeting', 'offtargets', 'often', 'often associate', 'ogaoverexpressing', 'oglcnac', 'oglcnac modification', 'oglcnacase', 'oglcnacylated', 'oglcnacylation', 'oglycosylated', 'oglycosylation', 'ogtoga', 'ogtogaoverexpressing', 'oilbased', 'oilinwater', 'okadaic', 'okainduced', 'okainduced neurotoxicity', 'older', 'older adults', 'older group', 'older patients', 'olefin', 'oleic', 'oleraceus', 'olfactory', 'olfactory bulbs', 'oligodendrocyte', 'oligodendrocyte differentiation', 'oligodendrocyte progenitor', 'oligodendrocyte progenitor cells', 'oligodendrocytes', 'oligofructose', 'oligomeric', 'oligomeric state', 'oligomerisation', 'oligomerization', 'oligonucleotide', 'oligonucleotides', 'oligosaccharides', 'oliguric', 'oliguric acute', 'oliguric acute kidney', 'olinked', 'olive', 'ombitasvir', 'omega3', 'omega3 fatty', 'omega3 fatty acids', 'omega3 pufas', 'omega6', 'omethyltransferases', 'omics', 'omihtra2', 'omihtra2 protease', 'omihtra2 vimentin', 'omissions', 'omnibus', 'oncedaily', 'oncogenesis', 'oncogenic', 'oncologic', 'oncological', 'oncology', 'oncomirnas', 'oncomirs', 'onecarbon', 'onecarbon metabolism', 'onefifth', 'onehundred', 'onepot', 'onestep', 'onethird', 'ongoing', 'online', 'onset', 'onset neurodegenerative', 'onset neurodegenerative diseases', 'ontology', 'oocyte', 'oocytes', 'oogenesis', 'openangle', 'openchannel', 'opener', 'openfield', 'openlabel', 'openlaparoscopic', 'openness', 'openness experience', 'opensource', 'operate', 'operation', 'operations', 'operative', 'operator', 'operculum', 'ophthalmic', 'ophthalmologic', 'opinion', 'opioid', 'opioidergic', 'opioidergic system', 'opportunities', 'opportunity', 'oppose', 'opposite', 'opposite effect', 'opsonization', 'optical', 'optically', 'optimal', 'optimise', 'optimization', 'optimize', 'optimize condition', 'optimize medium', 'optimum', 'option', 'option investigate', 'option investigate treat', 'options', 'or103', 'or104', 'or105', 'or108', 'or109', 'or113', 'or116', 'or117', 'or123', 'or127', 'or133', 'or143', 'or164', 'or193', 'or302', 'oralgal', 'orally', 'orally disintegrate', 'orallydelivered', 'orand', 'orange', 'orange exposure', 'orange24dtcdd', 'orbital', 'orchestrate', 'orchestration', 'order', 'ordinal', 'ordinary', 'organ', 'organelle', 'organelles', 'organic', 'organic compound', 'organism', 'organismal', 'organismic', 'organisms', 'organismwide', 'organization', 'organize', 'organochlorinated', 'organophosphate', 'organophosphorus', 'organs', 'organspace', 'orient', 'orientation', 'orientin', 'origin', 'original', 'originally', 'originate', 'originator', 'origins', 'oring', 'ornithine', 'orocecal', 'ortho', 'orthogonal', 'ortholog', 'orthologs', 'orthopedic', 'orthostatic', 'oscillation', 'oscillations', 'osmate', 'osmolality', 'osteoarthritis', 'osteoarthrosis', 'osteoclast', 'osteomyelitis', 'osteoporosis', 'osu03012', 'others', 'otherscurrent', 'otherwise', 'ottawa', 'ought', 'ounce', 'ounces', 'outcome', 'outcome measure', 'outcomes', 'outcomes chronic', 'outcomes include', 'outgrowth', 'outline', 'outpatient', 'outpatient general', 'outpatient general internal', 'outpatients', 'outperform', 'outside', 'outsideout', 'outstanding', 'ovale', 'ovarian', 'ovcar3', 'overactivated', 'overactivation', 'overall', 'overall result', 'overcome', 'overdose', 'overdrive', 'overexpress', 'overexpressed', 'overexpressing', 'overexpression', 'overgrowth', 'overlap', 'overload', 'overlook', 'overoxidation', 'overproduce', 'overproduction', 'overrepresentation', 'oversight', 'overt', 'overtly', 'overview', 'overview different', 'overview different cells', 'overweight', 'overwhelm', 'ovulation', 'oxazolopiperidone', 'oxidant', 'oxidase', 'oxidaselike', 'oxidation', 'oxidationinduced', 'oxidative', 'oxidative condition', 'oxidative damage', 'oxidative stress', 'oxidative stress contribute', 'oxidative stress induce', 'oxidative stress inflammation', 'oxidative stress which', 'oxidative stressinduced', 'oxidativeinduced', 'oxidatively', 'oxidativerelated', 'oxide', 'oxide synthase', 'oxides', 'oxidize', 'oxyacantha', 'oxygen', 'oxygen species', 'oxygenase', 'oxygenase1', 'oxygennitrogen', 'oxysterols', 'oxytocin', 'ozone', 'p0000', 'p0001', 'p0002', 'p0003', 'p0005', 'p0007', 'p0009', 'p0011', 'p0021', 'p0032', 'p0036', 'p0051', 'p0177', 'p0992', 'p12dh15lr23l', 'p16ink4a', 'p27kip1', 'p38mapk', 'p50p50', 'p53associated', 'p53upregulated', 'p65p50', 'pacemaker', 'pacheco', 'package', 'paecilomyces', 'paediatric', 'paediatric patients', 'paenidase', 'paeoniflorin', 'pafah1b2', 'painduced', 'painful', 'pak1blockers', 'pak1deficient', 'pak1dependent', 'pakistan', 'palate', 'palau', 'palladiumcatalyzed', 'palmitate', 'palmitic', 'palmitoleic', 'palmitoyl', 'palmitoylation', 'palmitoylationdepalmitoylation', 'palmitoylethanolamide', 'palsy', 'pancreas', 'pancreatic', 'pancreatic cancer', 'pancreatitis', 'panel', 'panther', 'papaverine', 'paper', 'papillomavirus', 'parabacteroides', 'paraceliac', 'paracrine', 'paradigm', 'paradigms', 'paradox', 'paradoxically', 'paraffinembedded', 'parallel', 'parallelly', 'paralogues', 'paralysis', 'paramagnetic', 'parameterization', 'parameterizationinvariant', 'parameterized', 'parameterizing', 'parameters', 'paramount', 'paraoxon', 'paraoxonase', 'paraplegia', 'paraposition', 'parasite', 'parasites', 'parasitic', 'parasitological', 'parathyroid', 'paratope', 'parenchyma', 'parenchymal', 'parent', 'parental', 'parenteral', 'parenteral nutrition', 'paresis', 'parg504his', 'parietal', 'park2', 'park2mediated', 'park2mediated mitophagy', 'park2parkin', 'parkinson', 'parkinson disease', 'parkinson diseases', 'parkinsonism', 'parkinsonismassociated', 'parkinsons', 'parkinsons alzheimers', 'parkinsons alzheimers diseases', 'parkinsons disease', 'parkinsons disease alzheimers', 'parkinsons diseases', 'partial', 'partially', 'partially similar', 'participant', 'participantcentred', 'participants', 'participate', 'participation', 'particle', 'particles', 'particular', 'particular interest', 'particularly', 'particularly vulnerable', 'particulate', 'particulates', 'partition', 'partly', 'partner', 'passage', 'passaged', 'passages', 'passaging', 'passive', 'pastoris', 'pastries', 'patch', 'patchclamp', 'patchy', 'patent', 'patent review', 'pathoetiology', 'pathogen', 'pathogenesis', 'pathogenesis alzheimers', 'pathogenesis alzheimers disease', 'pathogenesis diseases', 'pathogenesis neurodegenerative', 'pathogenesis neurodegenerative diseases', 'pathogenetic', 'pathogenfree', 'pathogenic', 'pathogenic effect', 'pathogenicity', 'pathogens', 'pathologic', 'pathological', 'pathological condition', 'pathological condition include', 'pathological feature', 'pathological hallmarks', 'pathological mechanisms', 'pathological process', 'pathologically', 'pathologies', 'pathologies include', 'pathologists', 'pathology', 'pathology human', 'pathology include', 'pathomechanism', 'pathomechanisms', 'pathophysiologic', 'pathophysiological', 'pathophysiologies', 'pathophysiology', 'paths', 'pathway', 'pathway involve', 'pathway mediate', 'pathwaybased', 'pathwayrelated', 'pathways', 'pathways involve', 'patient', 'patient compliance', 'patients', 'patients achieve', 'patients active', 'patients active crohns', 'patients although', 'patients alzheimers', 'patients alzheimers disease', 'patients associate', 'patients background', 'patients baseline', 'patients chronic', 'patients chronic infection', 'patients chronic kidney', 'patients compare', 'patients conclusion', 'patients conclusions', 'patients control', 'patients crohns', 'patients crohns disease', 'patients despite', 'patients diabetes', 'patients diagnose', 'patients diagnosis', 'patients disease', 'patients dyspepsia', 'patients evaluate', 'patients female', 'patients genotype', 'patients genotype infection', 'patients greatly', 'patients greatly improve', 'patients group', 'patients group group', 'patients healthy', 'patients healthy control', 'patients healthy volunteer', 'patients heart', 'patients however', 'patients include', 'patients increase', 'patients investigate', 'patients median', 'patients methods', 'patients neurodegenerative', 'patients normal', 'patients older', 'patients patients', 'patients persistent', 'patients persistent symptoms', 'patients previously', 'patients prior', 'patients receive', 'patients report', 'patients result', 'patients reveal', 'patients screen', 'patients severe', 'patients significantly', 'patients suffer', 'patients suffer persistent', 'patients symptoms', 'patients treat', 'patients ulcerative', 'patients ulcerative colitis', 'patients undergo', 'patients without', 'patients years', 'patients1', 'patientyears', 'patreated', 'pattern', 'pattern recognition', 'paucity', 'paulo', 'pause', 'pazidophenylalanine', 'pbd150', 'pcptreatment', 'pcramplified', 'pcrbased', 'pcresol', 'pcresol concentrations', 'pcresyl', 'pcresyl sulfate', 'pcrrflp', 'pcsk7', 'pcsk9', 'pd98059', 'pdacs', 'pde3a', 'pdzbinding', 'peanuts', 'peanutstheir', 'peatreated', 'pectoris', 'peculiar', 'peculiarities', 'pediatric', 'pediatriconset', 'peerreviewed', 'peganum', 'pegfpn1', 'pegifn', 'peginterferon', 'peginterferonribavirin', 'peglike', 'pegpeisirock2', 'pemtderived', 'pemtpc', 'pencil', 'pendent', 'penetrance', 'penetrate', 'penetrate disease', 'penetration', 'penicillin', 'penicillins', 'pennsylvania', 'pentacyclic', 'pentacyclictriterpene', 'pentameric', 'pentazocine', 'pentose', 'pentraxin', 'pentrdtopo', 'pentylenetetrazol', 'people', 'people consume', 'pepsin', 'pepsinogen', 'peptic', 'peptic ulcer', 'peptidase', 'peptidaselike', 'peptidases', 'peptidasestype', 'peptide', 'peptide1', 'peptide2535', 'peptidebased', 'peptideconjugated', 'peptideinduced', 'peptidergic', 'peptides', 'peptides contain', 'peptidic', 'peptidomimetic', 'peptidyl', 'peptoid', 'perceive', 'percent', 'percentage', 'perceptions', 'perfect', 'perfectly', 'perforant', 'perforate', 'perforation', 'perforations', 'perform', 'perform patients', 'performance', 'performances', 'perfume', 'perfusion', 'perfusion defect', 'perfusion defect associate', 'perfusionali', 'perfusione', 'perhaps', 'perianal', 'perianal edema', 'pericapillary', 'perihepatic', 'perinatal', 'period', 'period patients', 'periodate', 'periodic', 'periodicals', 'periodontal', 'periodontal disease', 'periodontitis', 'periodontitisaffected', 'periodontitisaffected gingival', 'periodontitisaffected gingival tissue', 'periodontitisrelated', 'periods', 'periostat', 'peripheral', 'peripheral arterial', 'peripheral arterial disease', 'peripheral blood', 'peripheral immune', 'peripheral immune system', 'peripheral neuropathy', 'peripherally', 'periphery', 'perisplenic', 'perivascular', 'perknfmdashkb', 'permanent', 'permation', 'permeability', 'permeabilization', 'permeable', 'permeate', 'permeation', 'permission', 'permissive', 'permit', 'permutation', 'peroxidase', 'peroxidases', 'peroxidatic', 'peroxidation', 'peroxidationderived', 'peroxide', 'peroxideinduced', 'peroxidized', 'peroxiredoxin', 'peroxiredoxin5', 'peroxiredoxins', 'peroxisome', 'peroxisome proliferatoractivated', 'peroxisome proliferatoractivated receptor', 'peroxisomeproliferatoractivated', 'peroxyl', 'peroxynitrite', 'persist', 'persistence', 'persistent', 'persistent symptoms', 'person', 'personal', 'personal utility', 'personality', 'personality traits', 'personality traits associate', 'personalize', 'persons', 'persons myocardial', 'persons myocardial perfusion', 'persons uninfected', 'persons uninfected control', 'personyears', 'perspective', 'perspectives', 'perspectives treatment', 'persulfate', 'pertain', 'pertinent', 'perturb', 'perturbagens', 'perturbation', 'perturbations', 'pervasive', 'peryear', 'pesticides', 'petals', 'petrochemicals', 'pfam04622', 'pg101w', 'pge2induced', 'pgln121', 'pgly111arg', 'pglycoprotein', 'pgsk3beta', 'phagocytes', 'phagocytic', 'phagocytic activity', 'phagocytose', 'phagocytosis', 'phagocytotic', 'pharmaceutical', 'pharmaceutical bioactivities', 'pharmaceutical control', 'pharmaceutical control materials', 'pharmaceutical interventions', 'pharmaceuticals', 'pharmaceutiques', 'pharmacist', 'pharmacists', 'pharmacodynamics', 'pharmacokinetic', 'pharmacokinetic study', 'pharmacokinetically', 'pharmacokinetics', 'pharmacologic', 'pharmacological', 'pharmacological activities', 'pharmacological effect', 'pharmacological profile', 'pharmacological properties', 'pharmacological treatments', 'pharmacological treatments symptomatic', 'pharmacologically', 'pharmacology', 'pharmacophore', 'pharmacophorebased', 'pharmacophoric', 'pharmacopoeia', 'pharmacoresistant', 'pharmacotherapies', 'pharmacotherapy', 'pharmacovigilance', 'pharmacy', 'pharmacy place', 'phase', 'phdependent', 'phdependent dimerization', 'phdfinger', 'phdfinger transcription', 'phdfinger transcription factor', 'phdriven', 'phe101', 'phencyclidine', 'phencyclidinetreatment', 'phenol', 'phenolic', 'phenolic compound', 'phenolic flavonoid', 'phenolic flavonoid content', 'phenols', 'phenomena', 'phenomenon', 'phenotype', 'phenotype result', 'phenotypes', 'phenotypic', 'phenotypically', 'phenotypicconsequences', 'phenotyping', 'phenyl', 'phenylalanine', 'phenylbutazone', 'phenylpropanoid', 'pheochromocytoma', 'philadelphia', 'phlegmonous', 'phone', 'phorbol', 'phosphatase', 'phosphatase activator', 'phosphatases', 'phosphate', 'phosphate buffer', 'phosphatidic', 'phosphatidylcholine', 'phosphatidylethanolamine', 'phosphatidylinositol', 'phosphatidylserine', 'phosphodiesterase', 'phosphodiesterases', 'phosphoesterase', 'phosphofructokinase', 'phosphohydrolase', 'phospholipase', 'phospholipase streptomyces', 'phospholipasehydrolyzed', 'phospholipid', 'phospholipids', 'phosphomolibdenumreducing', 'phosphoprotein', 'phosphoribosyltransferase', 'phosphorous', 'phosphorus', 'phosphorylate', 'phosphorylated', 'phosphorylated threonine', 'phosphorylation', 'phosphorylation shsy5y', 'phosphorylation which', 'phosphorylationoglcnac', 'phosphorylationregulated', 'phosphoserinethreonine', 'phosphotau', 'phosphotyrosyl', 'phosphotyrosyl phosphatase', 'phosphotyrosyl phosphatase activator', 'photobleaching', 'photocoagulation', 'photoionization', 'photoisomerization', 'photoisomerization biodistribution', 'photon', 'photoprotective', 'photothermal', 'phrodo', 'phyla', 'phylogenetic', 'phylum', 'physical', 'physical activity', 'physically', 'physician', 'physicians', 'physicochemical', 'physicochemical properties', 'physiologic', 'physiological', 'physiological condition', 'physiological function', 'physiological process', 'physiological roles', 'physiological significance', 'physiologically', 'physiologically relevant', 'physiology', 'physiopathology', 'physiosomatic', 'physostigmine', 'phytoalexin', 'phytochemical', 'phytochemicals', 'phytochemistry', 'pi3kakt', 'pi3kakt pathway', 'pi3kaktfoxo3a', 'pi3kaktgsk3beta', 'pi3kbeclin1bcl2', 'picalm', 'picalm allelic', 'picalm allelic expression', 'picalm expression', 'picalm isoform', 'picea', 'pichia', 'picrocrocin', 'picture', 'pielectron', 'pifithrinbeta', 'pigment', 'pigtail', 'pilifera', 'pilot', 'pilot study', 'pimax', 'pimenta', 'pin1associated', 'pinanetype', 'pink1', 'pinsulin', 'pinteraction', 'pioglitazone', 'pipecolic', 'piper', 'piperaceae', 'piperazine', 'piperita', 'piracetam', 'pistacking', 'pitfalls', 'pitrilysin', 'pituitary', 'pivotal', 'pjak2', 'pkcdependent', 'pkcvarepsilon', 'pla2iil', 'pla2nagase', 'place', 'placebo', 'placebocontrolled', 'placebos', 'placebotreated', 'placedinfused', 'placement', 'placements', 'placenta', 'placental', 'placentas', 'planar', 'plant', 'plant extract', 'plant growth', 'plant sterols', 'plantderived', 'plantlets', 'plantspecific', 'plaque', 'plaque burden', 'plaque segment', 'plaques', 'plasma', 'plasma associate', 'plasma choline', 'plasma choline betaine', 'plasma compare', 'plasma concentrations', 'plasma level', 'plasma level associate', 'plasma level choline', 'plasma pcresol', 'plasma pcresol concentrations', 'plasmalogen', 'plasmalogendeficient', 'plasmalogens', 'plasmametabolitebiomarkers', 'plasmid', 'plasmids', 'plasmon', 'plastic', 'plasticity', 'plasticizer', 'plasticizers', 'plastics', 'plate', 'plateau', 'platelet', 'platform', 'platformbased', 'platforms', 'platinum', 'platinumgraphene', 'plausible', 'player', 'players', 'pld12', 'please', 'pleiotropic', 'plenty', 'plethora', 'pleural', 'plexus', 'ploop', 'plpadenovirus', 'plscho', 'plsetn', 'plsetn concentration', 'plsetn concentrations', 'plsetnhydrolyzing', 'plugin', 'plume', 'pluripotency', 'pluripotent', 'pluripotent cells', 'pmepa1', 'pmepa1 kdm6b', 'pmepa1 kdm6b expression', 'pmoll', 'pneumocytes', 'pneumonia', 'pneumoniae', 'pneumoniae isolate', 'pnipam', 'pnu282987', 'pocket', 'podocyte', 'podophyllotoxin', 'point', 'pointofcare', 'pointofview', 'poison', 'poisson', 'polar', 'polarities', 'polarity', 'polarization', 'polarize', 'policy', 'polium', 'pollutants', 'pollution', 'polya', 'polyadenosine', 'polyadenylation', 'polyamine', 'polyaniline', 'polychlorinated', 'polyclonal', 'polydispersity', 'polyelectrolytes', 'polyethylene', 'polygalaxanthone', 'polygenic', 'polymer', 'polymerase', 'polymerase chain', 'polymerase chain reaction', 'polymeric', 'polymeric stabilizer', 'polymerization', 'polymers', 'polymicrobial', 'polymorphic', 'polymorphism', 'polymorphism associate', 'polymorphisms', 'polymorphismsassociated', 'polymorphonuclear', 'polyneuropathies', 'polynisopropylacrylamide', 'polyol', 'polyoxyethylene', 'polypeptide', 'polypeptides', 'polypharmacy', 'polyphenol', 'polyphenolbased', 'polyphenolbased prebiotic', 'polyphenolic', 'polyphenols', 'polypill', 'polypoid', 'polysaccharide', 'polysialic', 'polyunsaturated', 'polyunsaturated fatty', 'polyunsaturated fatty acids', 'polyvggvg', 'polyvinilpyrrolidone', 'polyvinyl', 'poorer', 'poorly', 'poorly understand', 'popular', 'popularly', 'population', 'populationbased', 'populations', 'porcine', 'porecaps', 'porphyromonas', 'porphyromonas gingivalis', 'portalsystemic', 'portend', 'portend poorer', 'portion', 'portray', 'posit', 'position', 'positional', 'positive', 'positive association', 'positive cells', 'positive control', 'positive predictive', 'positive predictive value', 'positively', 'positively correlate', 'positivelycharged', 'positivity', 'positron', 'positronemitting', 'possess', 'possibilities', 'possibility', 'possible', 'possible mechanisms', 'possible therapeutic', 'possible therapy', 'possible therapy treatment', 'possibly', 'postappendectomy', 'poster', 'posterior', 'posteriorization', 'posteriorizing', 'postesd', 'postesd fever', 'postgs', 'postinfection', 'postingestion', 'postinsertion', 'postinspiration', 'postinspiratory', 'postinspiratory motor', 'postmenopausal', 'postmitotic', 'postmortem', 'postnatal', 'postnatally', 'postoperative', 'postpone', 'postrenal', 'postsynaptic', 'postsynaptically', 'postsynthetically', 'posttranslation', 'posttranslational', 'posttranslational modification', 'posttranslational modifications', 'posttraumatic', 'posttreatment', 'postulate', 'potassium', 'potassium channel', 'potato', 'potato extract', 'potatoes', 'potency', 'potent', 'potent antioxidant', 'potent gammasecretase', 'potent inhibitor', 'potent inhibitors', 'potential', 'potential antialzheimer', 'potential benefit', 'potential clinical', 'potential effect', 'potential noninvasive', 'potential therapeutic', 'potential therapeutic agent', 'potential therapeutic target', 'potential treatment', 'potentially', 'potentials', 'potentiate', 'potentiation', 'potently', 'pouch', 'pouchitis', 'poultry', 'powder', 'power', 'powerful', 'pp2ac', 'pp38mapk', 'ppainduced', 'ppargamma', 'ppars', 'ppatreated', 'pphenoxy', 'practical', 'practical aspects', 'practical aspects tissue', 'practically', 'practice', 'practicechanging', 'practise', 'practitioner', 'practitioners', 'pragmatical', 'prausnitz', 'prazosin', 'prdm6', 'prealzheimerlike', 'preanalytical', 'prearchaellins', 'prebake', 'prebiotic', 'precede', 'precipitate', 'precipitation', 'precise', 'precisely', 'precision', 'preclinical', 'preclinical clinical', 'preclinical study', 'precondition', 'precursor', 'precursor protein', 'precursorlike', 'precursors', 'predators', 'prediabetic', 'prediabetic diabetic', 'predialysis', 'predict', 'predict increase', 'predictable', 'prediction', 'predictive', 'predictive value', 'predictor', 'predictors', 'predispose', 'predispose factor', 'predisposition', 'prednisonebudesonide', 'predominant', 'predominantly', 'predominate', 'preeclampsia', 'preeclamptic', 'preexist', 'prefer', 'preference', 'preferences', 'preferential', 'preferentially', 'prefibrillar', 'preform', 'prefrontal', 'prefrontal cortex', 'pregnancies', 'pregnancy', 'pregnancy outcome', 'pregnant', 'preincubated', 'preliminarily', 'preliminary', 'prelude', 'premature', 'premenstrual', 'premorbid', 'premrna', 'prenatal', 'prenitroxides', 'preoperative', 'preorganisation', 'preparation', 'preparations', 'prepare', 'prepilin', 'prepilinprearchaellin', 'prepilins', 'prepostrifaximin', 'prerequisite', 'prerequisites', 'prerifaximin', 'prescribe', 'prescribedseven', 'prescription', 'prescriptions', 'presence', 'presenilin', 'presenilin complex', 'presenilin1', 'presenilinlike', 'presenilinmediated', 'present', 'present cells', 'present complex', 'present comprehensive', 'present evidence', 'present result', 'present review', 'present review focus', 'present study', 'present study demonstrate', 'present study investigate', 'presenta', 'presentation', 'presentations', 'presently', 'presequence', 'presequences', 'preservation', 'preserve', 'press', 'pressure', 'pressure conscious', 'pressure photoionization', 'pressure reduction', 'presumably', 'presume', 'presumption', 'presynaptic', 'pretreated', 'pretreatment', 'prevail', 'prevalence', 'prevalent', 'prevent', 'preventable', 'prevention', 'prevention treatment', 'prevention treatment alzheimers', 'preventive', 'previous', 'previous study', 'previously', 'previously demonstrate', 'previously describe', 'previously observe', 'previously report', 'previously treat', 'prevotella', 'price', 'prima', 'primarily', 'primary', 'primary culture', 'primary endpoint', 'primary hippocampal', 'primary human', 'primary microglial', 'primary microglial cells', 'primary neurons', 'primary outcome', 'primary sclerosing', 'primary sclerosing cholangitis', 'primates', 'prime', 'prime boost', 'primer', 'primers', 'principal', 'principle', 'principles', 'print', 'prion', 'prion protein', 'prionlike', 'prions', 'prior', 'priori', 'prioritization', 'prioritize', 'priority', 'prism', 'prisoner', 'prisoners', 'privilege', 'pro347', 'proadhesive', 'proangiogenic', 'proanthocyanidins', 'proanthocyanidinsmicrobiota', 'proapoptotic', 'proatherogenic', 'probabile', 'probability', 'probable', 'probably', 'probe', 'probinul', 'probinulneutror', 'probinulneutrortreated', 'probiotic', 'probiotics', 'probiotics irritable', 'probiotics irritable bowel', 'probiotics placebo', 'problem', 'problematic', 'problems', 'probtype', 'procedural', 'procedure', 'procedurerelated', 'procedures', 'proceed', 'process', 'process associate', 'process damage', 'process include', 'processive', 'processor', 'procoagulant', 'proctitis', 'proctocolectomy', 'procure', 'prodromal', 'produce', 'producedsecreted', 'producers', 'product', 'production', 'production reactive', 'production reactive oxygen', 'productions', 'products', 'profancy', 'profession', 'professional', 'professionals', 'profile', 'proform', 'profound', 'profoundly', 'progenitor', 'progenitor cells', 'progenitors', 'progeny', 'progeroid', 'progesterone', 'prognosis', 'prognostic', 'prognostic index', 'prognostic value', 'prognostication', 'prognosticepidemiologic', 'program', 'programme', 'progress', 'progression', 'progressive', 'progressive dopaminergic', 'progressive dopaminergic neurons', 'progressively', 'progressors', 'prohibitin', 'prohibitins', 'proinflammatory', 'proinflammatory cytokines', 'proinflammatory environment', 'proinflammatory genes', 'proinflammatory mediators', 'proinflammatory phenotype', 'proinflammatory responses', 'project', 'project workshop', 'projection', 'projections', 'prokaryotes', 'prokaryotic', 'proliferate', 'proliferation', 'proliferation differentiation', 'proliferative', 'proliferatoractivated', 'proliferatoractivated receptor', 'proligands', 'proline', 'prolines', 'prolong', 'prolong alter', 'prolong alter mental', 'prolyl', 'prominence', 'prominent', 'prominently', 'promiscuous', 'promise', 'promise applications', 'promise result', 'promise therapeutic', 'promonocytic', 'promote', 'promote human', 'promoter', 'promoter regions', 'promoters', 'promotion', 'prompt', 'promyelinating', 'prone', 'pronefamilies', 'pronounce', 'pronouncedly', 'proof', 'proof concept', 'proof concept replacement', 'proofofconcept', 'proofofprinciple', 'prooxidant', 'prooxidative', 'propagate', 'propagation', 'propargyl', 'propensity', 'proper', 'properties', 'properties develop', 'properties develop possible', 'properties review', 'property', 'prophnet', 'prophylactic', 'prophylactics', 'prophylactictherapeutic', 'propidium', 'propionic', 'propolis', 'proportion', 'proportion patients', 'proportional', 'proposal', 'proposals', 'propose', 'propose galanthamine', 'propose galanthamine biosynthetic', 'propose novel', 'propose potential', 'propranolol', 'propria', 'proprotein', 'propylene', 'proresolving', 'prospect', 'prospective', 'prospectively', 'prospects20th', 'prostaglandin', 'prostaglandins', 'prostate', 'prostate cancer', 'prostatic', 'prosurvival', 'protease', 'protease activity', 'protease inhibitors', 'proteases', 'proteasomal', 'proteasome', 'protect', 'protect cells', 'protect copyright', 'protect copyright right', 'protect neurons', 'protectins', 'protection', 'protective', 'protective effect', 'protectors', 'protein', 'protein aggregate', 'protein aggregation', 'protein alphasynuclein', 'protein decrease', 'protein disease', 'protein expression', 'protein family', 'protein homeostasis', 'protein increase', 'protein induce', 'protein interaction', 'protein involve', 'protein kinase', 'protein kinases', 'protein level', 'protein misfolding', 'protein oglcnacylation', 'protein pathological', 'protein phosphatase', 'protein phosphorylation', 'protein precursor', 'protein prion', 'protein promote', 'protein study', 'protein tyrosine', 'protein tyrosine phosphatase', 'protein tyrosine phosphatases', 'protein which', 'protein2', 'protein70', 'proteinaceous', 'proteinacious', 'proteinapp', 'proteinase', 'proteinbased', 'proteinbound', 'proteincoding', 'proteincoupled', 'proteincoupled receptor', 'proteindependent', 'proteininduced', 'proteinlike', 'proteinmacromolecule', 'proteinmodifying', 'proteinmonoamine', 'proteinnanoparticle', 'proteinnucleotide', 'proteinopathies', 'proteinpresenilin1', 'proteinprotein', 'proteinprotein interaction', 'proteinprotein interactions', 'proteinrich', 'proteins', 'proteins contain', 'proteins however', 'proteins include', 'proteins involve', 'proteins occur', 'proteins regulate', 'proteins shock', 'proteins1mediated', 'proteinsthrough', 'proteinstimulated', 'proteinuria', 'proteobacteria', 'proteoglycans', 'proteoliposomes', 'proteolysis', 'proteolytic', 'proteolytic process', 'proteolytically', 'proteolyticfueled', 'proteome', 'proteome project', 'proteome project workshop', 'proteomes', 'proteomexchange', 'proteomic', 'proteomic analysis', 'proteomics', 'proteopathies', 'proteostasis', 'proteotoxic', 'proteotoxicity', 'protocol', 'protocols', 'proton', 'protonated', 'protonation', 'protonpump', 'protons', 'protooncogene', 'prototypes', 'prototypic', 'protozoan', 'protrude', 'protrusion', 'protumorigenic', 'prove', 'provide', 'provide evidence', 'provide important', 'provide insights', 'provide novel', 'provide overview', 'provide overview different', 'provide proof', 'provide proof concept', 'provide significant', 'provide therapeutic', 'providers', 'province', 'provision', 'provisional', 'provoke', 'proxies', 'proximal', 'proximity', 'proxy', 'prpcs', 'prpres', 'prpsc', 'pruritus', 'ps1associated', 'ps1bacluciferase', 'ps1d257a', 'ps1gammasecretasedependent', 'ps1induced', 'ps1induced apoptosis', 'ps1m146v', 'ps1mutated', 'ps1null', 'ps1wtbac', 'psapbax', 'pscderived', 'psd95', 'pselectin', 'psen1de9', 'pser161leu', 'pserpthrpro', 'pseudoceratina', 'pseudomembranous', 'pseudomembranous colitis', 'pseudonarcissus', 'psmad2', 'psoas', 'psoriasis', 'pstat3', 'psycarticles', 'psychiatric', 'psychiatric disorder', 'psychiatricneurodegenerative', 'psychiatrists', 'psychiatry', 'psychoactive', 'psychobiotics', 'psychological', 'psychological outcomes', 'psychologically', 'psychopathology', 'psychosis', 'psychosocial', 'psycinfo', 'psyllogel', 'psyllogel megafermentir', 'pterin', 'pterygium', 'ptp1b', 'ptpainduced', 'ptpalpha', 'ptrexdest30', 'public', 'public health', 'publication', 'publications', 'publish', 'pubmed', 'pubmed google', 'pubmed google scholar', 'pufaoxidative', 'pufas', 'pukhtoon', 'pulmonary', 'pulmonary disease', 'pulse', 'puncta', 'punctata', 'punctate', 'pungens', 'pupillary', 'pupils', 'purchase', 'purification', 'purify', 'purine', 'purinergic', 'purinergic signal', 'purines', 'purinesneurodegeneration', 'purinoceptors', 'purity', 'purkinje', 'purport', 'purpose', 'purpose review', 'purpose study', 'purpura', 'pursue', 'pursuit', 'putative', 'putatively', 'pvalue', 'pxd000203', 'pxpaxpr', 'pxpxpr', 'pylori', 'pylori infection', 'pyloriinduced', 'pylorus', 'pyramidal', 'pyramidal cells', 'pyrazine', 'pyrazine derivatives', 'pyrazinebased', 'pyridinium', 'pyrido3245thieno32dpyrimidin4amines', 'pyridylmethylamine', 'pyrimethamine', 'pyrimidines', 'pyroglutamate', 'pyrolysine', 'pyrosequencing', 'pyrrole', 'pyrrolidone', 'pyruvate', 'pyruvatecentred', 'pyruvateforming', 'qmatoms', 'qrtpcr', 'qtofms', 'quadrant', 'quadriceps', 'quadrupole', 'qualify', 'qualitative', 'quality', 'quality control', 'quanta', 'quantification', 'quantify', 'quantiles', 'quantitate', 'quantitated', 'quantitation', 'quantitative', 'quantitatively', 'quantities', 'quantity', 'quantum', 'quantumchemical', 'quarter', 'quartile', 'quartiles', 'quaternary', 'quencher', 'quercetin', 'query', 'quest', 'question', 'questionnaire', 'questionnaires', 'quick', 'quickly', 'quiescence', 'quiescent', 'quietly', 'quinic', 'quite', 'quotient', 'raavabaddp6his', 'rab5activating', 'rab5apositive', 'rabbit', 'rabdosia', 'raccdc42p21activated', 'raceethnicity', 'racemic', 'racemosa', 'radial', 'radiation', 'radiatum', 'radical', 'radical scavenge', 'radically', 'radicals', 'radicalscavenging', 'radioactive', 'radioactivity', 'radiochemical', 'radiochemical purity', 'radiochemical yield', 'radiocopper', 'radioenzymatic', 'radiofrequency', 'radiolabeled', 'radiolabeling', 'radiolabelled', 'radiologic', 'radiological', 'radiologists', 'radiometal', 'radionuclide', 'radiosynthesis', 'radiotracers', 'radius', 'ragedependent', 'ragedependent signal', 'ragemediated', 'raise', 'ramifications', 'ranbp9', 'ranbp9tip60', 'random', 'randomeffects', 'randomise', 'randomize', 'randomize control', 'randomize placebocontrolled', 'randomly', 'randomly assign', 'range', 'range biological', 'range detection', 'range disorder', 'range pathological', 'ranunculaceae', 'rapamycine', 'rapid', 'rapidly', 'rapidly increase', 'rarely', 'rasgrf1', 'rasgrf1camkii', 'raster', 'ratelimiting', 'rather', 'ratio', 'ratio confidence', 'ratio confidence interval', 'rational', 'rationale', 'rationales', 'rationalize', 'rationally', 'ratios', 'rattail', 'rbased', 'rbioc', 'rbioconductor', 'rcan1', 'rcan1 expression', 'rcan1 isoform', 'rcnet', 'reabsorption', 'reach', 'reachable', 'reacidifying', 'react', 'reactant', 'reactants', 'reaction', 'reaction mechanism', 'reaction monitor', 'reaction various', 'reaction various arylnitrile', 'reactiondenaturing', 'reactions', 'reactivate', 'reactivation', 'reactive', 'reactive gliosis', 'reactive oxygen', 'reactive oxygen species', 'reactivity', 'reader', 'readers', 'readily', 'readily available', 'readilymodifiable', 'readout', 'ready', 'reaffirm', 'reagent', 'reagents', 'realise', 'realize', 'realm', 'realtime', 'realworld', 'rearborization', 'rearrangement', 'rearrangements', 'reason', 'reasonable', 'reasonably', 'recalculation', 'recapitulate', 'receive', 'receive aliva', 'receive peptide', 'receive placebo', 'receive single', 'receiver', 'receiveroperatorcharacteristic', 'recent', 'recent advance', 'recent clinical', 'recent current', 'recent current remarkable', 'recent developments', 'recent evidence', 'recent evidence suggest', 'recent indicate', 'recent literature', 'recent progress', 'recent research', 'recent study', 'recent study indicate', 'recent study reveal', 'recent study suggest', 'recent years', 'recently', 'recently demonstrate', 'recently publish', 'recently report', 'receptor', 'receptor affinity', 'receptor agonists', 'receptor antagonist', 'receptor antagonist kynurenic', 'receptor apoer2', 'receptor apoer2 density', 'receptor express', 'receptor express myeloid', 'receptor expression', 'receptor nachr', 'receptor subtypes', 'receptor vldlr', 'receptor1', 'receptorassociated', 'receptorbinding', 'receptorbound', 'receptorcoupled', 'receptorligand', 'receptorlike', 'receptormediated', 'receptornamely', 'receptorrelated', 'receptors', 'receptorsnamely', 'recess', 'recessive', 'recipient', 'recipients', 'reciprocal', 'reclassification', 'recognise', 'recognition', 'recognitions', 'recognizable', 'recognize', 'recombinant', 'recombination', 'recombine', 'recommend', 'recommendations', 'reconcile', 'reconciliation', 'reconstitute', 'reconstitution', 'reconstruct', 'reconstruction', 'record', 'record patients', 'recover', 'recoveries', 'recovery', 'recruit', 'recruitment', 'rectal', 'rectangular', 'rectifier', 'rectify', 'rectum', 'recurrence', 'recurrent', 'recurrent admissions', 'recurrent admissions bipolar', 'recycle', 'rededge', 'redefine', 'redirect', 'redistribute', 'redistribution', 'redox', 'redox signal', 'redox status', 'redoxactive', 'redoxgenerated', 'redshift', 'reduce', 'reduce activity', 'reduce burden', 'reduce expression', 'reduce level', 'reduce number', 'reduce phosphorylation', 'reducers', 'reductase', 'reduction', 'reduction sappalpha', 'reduction sappalpha secretion', 'reductions', 'redundancy', 'reelin', 'reelin expression', 'reelinlike', 'reelinpositive', 'reelinsignaling', 'reentry', 'reestablishment', 'reevaluate', 'reevaluation', 'reexamination', 'reexamine', 'reface', 'reface effect', 'refer', 'reference', 'referral', 'refine', 'refinement', 'reflect', 'reflectancefourier', 'reflection', 'reflex', 'reflux', 'refolding', 'refractoriness', 'refractory', 'reframe', 'refrigerator', 'refuge', 'refute', 'regain', 'regard', 'regardless', 'regenerate', 'regeneration', 'regenerative', 'regenerative medicine', 'regimen', 'regimens', 'region', 'regional', 'regioni', 'regions', 'regionspecific', 'regiospecificity', 'register', 'registration', 'registry', 'regress', 'regression', 'regression analysis', 'regression model', 'regression model perform', 'regular', 'regularly', 'regulate', 'regulate cycle', 'regulate expression', 'regulate function', 'regulate inflammatory', 'regulate level', 'regulate phosphorylation', 'regulate process', 'regulate signal', 'regulate surface', 'regulate transcription', 'regulation', 'regulation expression', 'regulation function', 'regulation transcription', 'regulations', 'regulator', 'regulators', 'regulatory', 'regulatory mechanism', 'regulatory mechanisms', 'regulatory network', 'regulatory pathways', 'rehabilitation', 'rehydration', 'reina', 'reinforce', 'reinforcement', 'reinitiation', 'reintroduction', 'reject', 'rejection', 'rejigging', 'rejoinder', 'relapse', 'relate', 'relate diseases', 'relate disorder', 'relate oxidative', 'relate oxidative stress', 'relatedmetabolites', 'relatedness', 'relation', 'relations', 'relationship', 'relationship plasma', 'relationship study', 'relationships', 'relationships metabolites', 'relative', 'relatively', 'relatives', 'relax', 'release', 'release cells', 'relevance', 'relevant', 'reliability', 'reliable', 'reliance', 'relief', 'relieve', 'relocate', 'remain', 'remain elusive', 'remain unclear', 'remain unknown', 'remarkable', 'remarkable clinical', 'remarkable clinical study', 'remarkably', 'remedy', 'remedy treatment', 'remethylation', 'remethylation cycle', 'remicade', 'remicaderemsima', 'remicadetreated', 'remind', 'reminiscent', 'remission', 'remissionachieved', 'remissionmaintained', 'remissionmaintained phase', 'remit', 'remnants', 'remodel', 'remote', 'removal', 'remove', 'remsima', 'remsimaremicade', 'renal', 'renal cancer', 'renal disease', 'renal dysfunction', 'renal failure', 'renal function', 'render', 'renetworking', 'renew', 'renewal', 'reorganizations', 'repair', 'repair apoptosis', 'repair mechanism', 'reparameterization', 'repeat', 'repeatability', 'repeatedly', 'repellent', 'repellent freshener', 'repercussions', 'repertoire', 'repetitive', 'replace', 'replacement', 'replacement therapy', 'replacement therapy beneficial', 'replacement trophic', 'replacement trophic action', 'replicate', 'replication', 'replicative', 'reply', 'repolarization', 'report', 'report study', 'reportedly', 'reporter', 'repository', 'represent', 'represent novel', 'representation', 'representative', 'repress', 'repression', 'repressive', 'repressor', 'reproduce', 'reproducibility', 'reproducible', 'reproduction', 'reproductive', 'reprogram', 'reprogrammed', 'reprogramming', 'repurposing', 'request', 'require', 'requirement', 'requirements', 'rescue', 'research', 'research clinical', 'research focus', 'research forum', 'research suggest', 'researcher', 'researchers', 'reseau', 'resection', 'resective', 'resemble', 'resensitization', 'resequencing', 'reserpine', 'reserve', 'reside', 'residence', 'residences', 'resident', 'residentcentered', 'residents', 'residue', 'residues', 'residues proteins', 'resistance', 'resistanceassociated', 'resistant', 'resistive', 'resolution', 'resolve', 'resolvins', 'resonance', 'resonance image', 'resonance spectroscopy', 'resonant', 'resorption', 'resource', 'resources', 'respect', 'respective', 'respectively', 'respectively compare', 'respectively conclusion', 'respectively conclusions', 'respectively result', 'respectively similarly', 'respectivelyin', 'respiration', 'respirationinduced', 'respiratory', 'respiratory function', 'respiratory infections', 'respirofermentative', 'respond', 'responder', 'responders', 'response', 'response biological', 'response patients', 'response systemic', 'response which', 'responseassociated', 'responses', 'responses autophagy', 'responsibility', 'responsible', 'responsible maintain', 'responsive', 'responsiveness', 'restactivity', 'restart', 'restless', 'restoration', 'restorative', 'restore', 'restrain', 'restraint', 'restraint stress', 'restrict', 'restriction', 'restriction fragment', 'restriction fragment length', 'restrictions', 'restrictive', 'result', 'result apply', 'result clearly', 'result compare', 'result confirm', 'result could', 'result decrease', 'result demonstrate', 'result effective', 'result identify', 'result increase', 'result indicate', 'result obtain', 'result patients', 'result present', 'result protein', 'result provide', 'result report', 'result result', 'result reveal', 'result significant', 'result study', 'result suggest', 'result total', 'result total patients', 'result treatment', 'resume', 'resumption', 'resurgence', 'resuscitation', 'resveratrol', 'retain', 'retard', 'retardation', 'retention', 'reticulum', 'retinal', 'retinoic', 'retinoid', 'retinopathy', 'retinopathy nephropathy', 'retirement', 'retract', 'retraction', 'retreatment', 'retrieve', 'retrograde', 'retromer', 'retromerassociated', 'retrospective', 'retrospective cohort', 'retrospective cohort study', 'retrospective study', 'retrovirally', 'return', 'reuptake', 'reusable', 'reuse', 'reveal', 'reveal distinct', 'reveal novel', 'reveal presence', 'reveal significant', 'reverbalpha', 'reversal', 'reverse', 'reverse phase', 'reversedphase', 'reversephase', 'reversible', 'reversibly', 'reversion', 'revert', 'review', 'review article', 'review author', 'review compare', 'review cover', 'review current', 'review describe', 'review discuss', 'review evidence', 'review focus', 'review highlight', 'review literature', 'review medical', 'review medical record', 'review metaanalysis', 'review present', 'review provide', 'review recent', 'review recent current', 'review report', 'review study', 'review summarize', 'review summarize recent', 'revisit', 'revman', 'revolutionary', 'revolutionize', 'reward', 'rewire', 'rgdbinding', 'rhamnosus', 'rheumatoid', 'rheumatoid arthritis', 'rhizome', 'rhizomelic', 'rhizomes', 'rhodamine123', 'rhokinase', 'rhynchophylla', 'rhynchophylline', 'rhythm', 'rhythmic', 'rhythmicity', 'rhythms', 'rhythms expression', 'rhythms methylation', 'riassunto', 'ribavirin', 'riboflavin', 'ribonuclease', 'ribose', 'riboseprotonated', 'ribosomal', 'richest', 'richness', 'riemannian', 'rifaximin', 'rifaximin patients', 'right', 'right reserve', 'rightward', 'rigid', 'rigidification', 'rigorous', 'rikshospitalet', 'rilevante', 'ringopened', 'ringshaped', 'riskmodifying', 'risperidone', 'risperidone inhibit', 'rispetto', 'risposta', 'ritonavir', 'rivastigmina', 'rmp7tfliposomes', 'rmp7tfngfliposomes', 'rnapii', 'rnapiictd', 'rnasequencing', 'rnomir106b5p', 'rnomir107', 'rnomir125a3p', 'rnomir29a3p', 'rnomir95p', 'roadblocks', 'roasty', 'robin', 'robin space', 'robust', 'robustly', 'robustness', 'rock2', 'rockcrosstalk', 'rockinhibition', 'rodent', 'rodent model', 'rodents', 'roles', 'roles human', 'romans', 'rosiglitazone', 'rosinflammation', 'rosmarinic', 'rosmediated', 'rotation', 'rotors', 'round', 'route', 'routine', 'routinely', 'royal', 'rpechoroid', 'rphplc', 'rs114139997', 'rs142953140', 'rs145464906', 'rs1800624', 'rs1800625', 'rs184003', 'rs186808413', 'rs2070600', 'rs3851179', 'rs588076', 'rs588076 associate', 'rta181t', 'rtl180m', 'rtm204', 'rtm204i', 'rtm204iv', 'rtpcr', 'ruccao', 'rumex', 'rumex hastatus', 'runin', 'runtime', 'rupture', 'rural', 'rutgeerts', 'rutheniumii', 'rutin', 'rutpabtclo4', 'ryanodine', 'ryanodine receptors', 's100a9', 's100a9 protein', 's100a9 protein expression', 's1prdirected', 's1prs', 'saccharin', 'saccharolytic', 'sackett', 'sacred', 'sacrifice', 'sacrificied', 'sacylgsh', 'sadenosyl', 'safelock', 'safely', 'safer', 'safety', 'safety tolerability', 'safflower', 'saffron', 'safranal', 'saginata', 'salidroside', 'salient', 'saline', 'saliva', 'salivary', 'salivary cortisol', 'salivary cortisol level', 'salmon', 'salutogenic', 'salvage', 'salvia', 'sample', 'sample patients', 'samsah', 'sandwichtype', 'sangivamycin', 'santolinifolia', 'sapla1', 'saponin', 'saponins', 'saponins flavonoids', 'sappalpha', 'sappalpha secretion', 'sappalpha secretion shsy5y', 'sapphireii', 'sarcoendoplasmic', 'sarkar', 'sarstedt', 'saspected', 'satellite', 'satellite cells', 'sativum', 'sativus', 'saturate', 'saturation', 'satureja', 'saudi', 'savory', 'scaffold', 'scalable', 'scale', 'scarce', 'scarcity', 'scatchard', 'scatter', 'scavenge', 'scavenge activity', 'scavenge assay', 'scavenger', 'sccai', 'scd14', 'scenario', 'scenarios', 'schematic', 'scheme', 'schirmers', 'schirmers1', 'schizophrenia', 'schizophreniclike', 'scholar', 'scholarly', 'scielo', 'science', 'sciencedirect', 'sciences', 'scientific', 'scientifically', 'scientists', 'scifinder', 'scifinderr', 'scintigraphic', 'scintigraphy', 'scirus', 'sclarea', 'sclerosing', 'sclerosing cholangitis', 'sclerosis', 'sclerosis parkinsons', 'sclerosis parkinsons disease', 'scope', 'scopolamine', 'scopolamineinduced', 'scopolamineinduced amnesia', 'scopoletinisoscopoletin', 'scopolin', 'scopus', 'score', 'scorematched', 'scottish', 'scottish adults', 'scottish health', 'scottish health survey', 'scout', 'scrap', 'scrapie', 'scrapieresistant', 'screen', 'screen method', 'screenprinted', 'screw', 'scrutiny', 'scylloinositol', 'sdf1alpha', 'seafood', 'search', 'seasonal', 'second', 'second common', 'second trimester', 'secondarily', 'secondary', 'secondary metabolites', 'secondary structure', 'secondgeneration', 'secondhand', 'secondhand smoke', 'secretagogue', 'secretase', 'secretases', 'secrete', 'secretion', 'secretion cytokines', 'secretion shsy5y', 'secretion shsy5y cells', 'secretions', 'secretor', 'secretory', 'secretory phenotype', 'section', 'sectors', 'security', 'sedentary', 'sedimentation', 'seedpod', 'seemingly', 'segment', 'segregate', 'seizure', 'seizure control', 'seizurecontrol', 'seizurelike', 'seizures', 'seladin1', 'seladin1 goniothalamininduced', 'seladin1 goniothalamininduced apoptosis', 'select', 'selection', 'selective', 'selective inhibitors', 'selectively', 'selectivelyexpressed', 'selectivity', 'selenium', 'selenocysteine', 'selfantigens', 'selforganizing', 'selfperpetuating', 'selfpropagating', 'selfrated', 'selfrating', 'selfreactive', 'selfreplicate', 'selfreporting', 'selftolerance', 'semantic', 'seminars', 'seminiferous', 'semipermeable', 'semiporous', 'semireduced', 'sempervirens', 'senantiomers', 'senescence', 'senescenceassociated', 'senescent', 'senescent cells', 'senescenttype', 'senile', 'senility', 'sense', 'sensitive', 'sensitivity', 'sensitivity specificity', 'sensitization', 'sensitize', 'sensitizers', 'sensor', 'sensorimotor', 'sensors', 'sensory', 'sentinel', 'separate', 'separately', 'separation', 'sepsis', 'september', 'septic', 'septicemia', 'sequelae', 'sequence', 'sequencecontaining', 'sequencedependent', 'sequential', 'sequester', 'sequestrant', 'sequestration', 'ser154', 'ser262', 'ser262356', 'ser312', 'ser396', 'ser404', 'ser485', 'serca', 'sercas', 'serial', 'series', 'serine', 'serine threonine', 'serine threonine residues', 'serinethreonine', 'serious', 'serious illnesses', 'serious illnesses diabetes', 'seroclearance', 'seroconversion', 'seroconversion pegifn', 'serologic', 'serological', 'serology', 'seropositive', 'serosa', 'serotonergic', 'serotonin', 'serrata', 'serthr', 'serum', 'serum albumin', 'serum antibodies', 'serum colon', 'serum level', 'serum plsetn', 'serum plsetn concentration', 'serum sample', 'serum total', 'serumdeprived', 'serve', 'servers', 'service', 'service allergy', 'seseberecine', 'sesquiterpenoid', 'sesquiterpenoids', 'sessions', 'setbeta', 'setbetaspecific', 'settings', 'setup', 'seven', 'sevenday', 'seventeen', 'seventy', 'seventyfive', 'several', 'several aspects', 'several biological', 'several different', 'several diseases', 'several diseases include', 'several human', 'several mechanisms', 'several mechanisms replacement', 'several neurodegenerative', 'several neurodegenerative diseases', 'several neurological', 'several pathologies', 'several proteins', 'several recent', 'several species', 'several study', 'severe', 'severe disease', 'severe functional', 'severe functional constipation', 'severely', 'severity', 'sexassociated', 'sexmatched', 'sexrelated', 'sexspecific', 'sexual', 'sfstp', 'sh3bp5', 'sh3p9', 'shaft', 'shannon', 'shape', 'share', 'share similar', 'shear', 'sheddases', 'sheet', 'shell', 'shhsf1', 'shift', 'shiraia', 'shiraia slf14', 'shock', 'shock factor', 'shock proteins', 'shoot', 'shootace', 'shootetoac', 'short', 'shortcomings', 'shorter', 'shortest', 'shortly', 'shortterm', 'shrimp', 'shrnamediated', 'shsy5y', 'shsy5y cells', 'shsy5y human', 'shsy5y human neuroblastoma', 'shsy5y neuroblastoma', 'shsy5y neuroblastoma cells', 'shsy5y neuronal', 'shsy5y neuronal cells', 'shunt', 'sialic', 'sibling', 'siblings', 'sicklecell', 'sidebyside', 'sidechain', 'sidechains', 'sideropenic', 'siderophore', 'siderophores', 'siemens', 'siglec', 'siglec14', 'siglec8', 'siglecs', 'sigma1', 'sigma1 receptor', 'sigma2sigma1', 'signal', 'signal brain', 'signal events', 'signal hippocampus', 'signal molecules', 'signal neuronal', 'signal pathway', 'signal pathways', 'signal pathways involve', 'signal peptide', 'signal transduction', 'signalingpathways', 'signalosomes', 'signalregulated', 'signalreporter', 'signaltonoise', 'signature', 'signatures', 'significance', 'significant', 'significant association', 'significant change', 'significant correlation', 'significant decrease', 'significant difference', 'significant difference compare', 'significant differences', 'significant impact', 'significant improvement', 'significant increase', 'significant reduction', 'significantly', 'significantly associate', 'significantly correlate', 'significantly decrease', 'significantly dysregulated', 'significantly elevate', 'significantly enhance', 'significantly greater', 'significantly higher', 'significantly increase', 'significantly inhibit', 'significantly lower', 'significantly reduce', 'significativo', 'silac', 'silence', 'silent', 'silica', 'silico', 'silicon', 'silver', 'silybum', 'silybum marianum', 'simcap', 'similar', 'similar group', 'similarities', 'similarity', 'similarly', 'simple', 'simplex', 'simplify', 'simply', 'simulate', 'simulation', 'simulations', 'simultaneous', 'simultaneously', 'simvastatin', 'since', 'single', 'single colonoscopic', 'single nucleotide', 'singleascending', 'singlecandidate', 'singledecrement', 'singlemolecule', 'singlenucleotide', 'singleparticle', 'singlepill', 'singleplex', 'singleplex luminex', 'singleplex luminex assay', 'singlerun', 'singlestranded', 'singlesubstitution', 'singletablet', 'singleton', 'singleuse', 'singolo', 'singular', 'singularity', 'sinopulmonary', 'sinps', 'sinptreated', 'sinus', 'sir21', 'sirna', 'sirt1', 'sirtuin', 'sister', 'sitedirected', 'sitespecific', 'sitr7', 'situate', 'situation', 'situations', 'sixmembered', 'sixteen', 'sixth', 'sixty', 'sixtyfour', 'sixtyseven', 'sjogrens', 'skeletal', 'skeletal muscle', 'skills', 'sknbe', 'sknmc', 'sknmc cells', 'sknsh', 'sknsh cells', 'slc22a7', 'slc30a6', 'sleep', 'slf14', 'slice', 'slide', 'slight', 'slightly', 'slinolenoyl', 'slowly', 'smad2', 'smad23', 'smad2activated', 'smad3', 'small', 'small bowel', 'small interfere', 'small intestinal', 'small intestinal bacterial', 'small molecule', 'small molecule ligands', 'small molecules', 'small number', 'smaller', 'smallmolecule', 'smart', 'smartphones', 'smc160', 'smelter', 'smoke', 'smoke plume', 'smokers', 'smooth', 'smooth muscle', 'smoothen', 'smurp', 'snack', 'snail', 'snapshot', 'snare', 'snat5', 'snats', 'sneeze', 'sniff', 'snowdrop', 'snowflake', 'snsgp130', 'snx27', 'snx27 domain', 'snx27retromer', 'socalled', 'sociability', 'social', 'social media', 'socialise', 'societal', 'societe', 'societies', 'society', 'socioeconomic', 'socioeconomical', 'sodium', 'sodium channel', 'sodium channel surface', 'sodium currents', 'sofias', 'softeners', 'softtissue', 'software', 'solely', 'solid', 'solid dispersion', 'solid dispersions', 'solidemissive', 'solidphase', 'solidstate', 'solitary', 'solubility', 'soluble', 'soluble contactin2', 'solutes', 'solution', 'solution structure', 'solutions', 'solve', 'solvency', 'solvent', 'solventexposed', 'solvents', 'somatic', 'somatic cells', 'somatic reprogramming', 'somatodendritic', 'somatosensory', 'someone', 'sometimes', 'somewhat', 'sommer', 'somnifera', 'somnifera dunal', 'somnolent', 'sonchus', 'sonographic', 'sonography', 'sophisticate', 'sorbent', 'sorbitol', 'sorcs1', 'sorcs1deficient', 'sorcs1knockout', 'sortilin', 'sortilinaf40431', 'sotho', 'source', 'source different', 'source different cells', 'source target', 'south', 'south african', 'southern', 'soybean', 'sp110', 'sp600125', 'spaac', 'space', 'spacers', 'spalmitoylation', 'spark', 'sparse', 'sparse projection', 'spaseiii', 'spast', 'spastic', 'spastin', 'spastslc30a6', 'spathulenol', 'spatial', 'spearman', 'spearmans', 'special', 'special emphasis', 'special issue', 'special issue entitle', 'specialist', 'specialities', 'specialize', 'specially', 'species', 'speciesspecific', 'speciestospecies', 'specific', 'specific activity', 'specific biological', 'specifically', 'specificities', 'specificity', 'specifics', 'specify', 'specimen', 'specimens', 'specimens collect', 'speckle', 'spect', 'spectacular', 'spectator', 'spectra', 'spectrometer', 'spectrometric', 'spectrometry', 'spectrometrybased', 'spectrophotometric', 'spectrophotometrically', 'spectroscopic', 'spectroscopies', 'spectroscopy', 'spectroscopymrs', 'spectrum', 'spectrum disorder', 'speculate', 'speech', 'speed', 'spend', 'spermatogenesis', 'spermatozoon', 'spheres', 'spherical', 'spherically', 'sphingolipid', 'sphingomyelin', 'sphingomyelinase', 'sphingomyelinase2', 'sphingosine', 'sphingosine1phosphate', 'sphingosine1phosphate receptor', 'spice', 'spider', 'spider proteins', 'spiders', 'spidroin', 'spidroins', 'spike', 'spinal', 'spinal injury', 'spindle', 'spindle formation', 'spindles', 'spine', 'spine formation', 'spinocerebellar', 'spinogenesis', 'spiral', 'spirochetal', 'spirochete', 'spite', 'spleen', 'splenic', 'splenocyte', 'splenocytes', 'splenomegaly', 'splice', 'splice exons', 'sponge', 'spongiform', 'sponsor', 'spontaneous', 'spontaneously', 'spontaneously hypertensive', 'spontaneously proteins', 'sporadic', 'sporadically', 'spousal', 'sppl2a', 'sppl2b', 'spraguedawley', 'spray', 'spraydried', 'spread', 'spread depression', 'spread pathology', 'sprem', 'spring', 'sprout', 'sputum', 'squalene', 'squaleneoilinwater', 'squamous', 'squamous carcinoma', 'square', 'squibb', 'srebp1mediated', 'srebp2', 'sredependent', 'sscatenin', 'ssila', 'ssioa', 'stability', 'stabilization', 'stabilize', 'stabilizer', 'stabilizers', 'stable', 'stable accumulation', 'stable isotopelabeled', 'stable isotopelabeled epothilone', 'stably', 'stably transfected', 'stachys', 'stack', 'stack interactions', 'stackingmediated', 'staff', 'stage', 'stage recurrence', 'stagnation', 'stain', 'stake', 'staminate', 'stand', 'standard', 'standard deviation', 'standard methods', 'standardization', 'standardize', 'standards', 'stapf', 'staphylococci', 'staphylococcus', 'start', 'stat3', 'stat6', 'state', 'statea', 'statecharts', 'statedependent', 'stateoftheart', 'statespecific', 'statetrait', 'static', 'statically', 'statins', 'stationary', 'statistic', 'statistic078', 'statistical', 'statistical analysis', 'statistically', 'statistically significant', 'statistically significant difference', 'statistics', 'stature', 'status', 'statutory', 'staurosporine', 'staurosporineinduced', 'steady', 'steadystate', 'stealth', 'stearic', 'steatohepatitis', 'steatosis', 'steer', 'stembook', 'stemprogenitor', 'stemprogenitor cells', 'stepwise', 'stereochemical', 'stereoisomeric', 'stereoisomers', 'stereospecific', 'stereospecificity', 'steric', 'stericchemical', 'sterile', 'sterility', 'steroid', 'steroidal', 'steroidfree', 'steroidrefractory', 'steroids', 'sterol', 'sterols', 'stiffness', 'stigmas', 'stigmasterol', 'stilbene', 'stilbenes', 'still', 'still disorder', 'still disorder technology', 'still largely', 'still largely unknown', 'still remain', 'still unclear', 'still unknown', 'stimulate', 'stimulate human', 'stimulate oligodendrocyte', 'stimulate oligodendrocyte differentiation', 'stimulation', 'stimulator', 'stimulatory', 'stimuli', 'stimulus', 'stipulate', 'stochastic', 'stochastically', 'stockar', 'stockholm', 'stoichiometric', 'stoichiometry', 'stomach', 'stomach discomfort', 'stool', 'stool cmvpcr', 'stool consistency', 'stool examination', 'stool sample', 'stool specimens', 'storage', 'storage proteins', 'store', 'straightforward', 'strain', 'strainpromoted', 'strainspecific', 'strand', 'strategic', 'strategies', 'strategies neurodegenerative', 'strategies target', 'strategy', 'stratification', 'stratify', 'stratum', 'strength', 'strengthen', 'strengths', 'streptavidin', 'streptococcus', 'streptomyces', 'streptomyces albidoflavus', 'streptozotocininduced', 'stress', 'stress condition', 'stress contribute', 'stress depression', 'stress increase', 'stress induce', 'stress inflammation', 'stress resistance', 'stress response', 'stress which', 'stressinduced', 'stressmediated', 'stressors', 'stressrelated', 'stressresistant', 'stressresponsive', 'stresssensitive', 'striatum', 'strict', 'strictly', 'stricturing', 'strike', 'strikingly', 'strip', 'strive', 'stroke', 'stromal', 'stromal cells', 'strong', 'strong inhibitory', 'strong inhibitory activity', 'stronger', 'strongest', 'strongly', 'strongly suggest', 'structural', 'structural basis', 'structural biology', 'structural change', 'structural defect', 'structural feature', 'structural functional', 'structurally', 'structure', 'structure function', 'structure human', 'structureactivity', 'structureactivity relationship', 'structureactivity relationships', 'structureactivityrelationships', 'structurebased', 'structurefunction', 'student', 'students', 'study', 'study analyze', 'study assess', 'study associate', 'study background', 'study carry', 'study cohort', 'study compare', 'study conduct', 'study confirm', 'study consist', 'study demonstrate', 'study describe', 'study design', 'study design investigate', 'study determine', 'study develop', 'study effect', 'study evaluate', 'study examine', 'study focus', 'study genetic', 'study group', 'study highlight', 'study however', 'study human', 'study hypothesis', 'study identify', 'study include', 'study include patients', 'study indicate', 'study investigate', 'study investigate effect', 'study investigate protective', 'study investigate relationship', 'study investigate whether', 'study involve', 'study involve cellbased', 'study methods', 'study molecular', 'study patients', 'study perform', 'study plasma', 'study present', 'study provide', 'study publish', 'study report', 'study result', 'study reveal', 'study review', 'study strongly', 'study study', 'study subject', 'study suggest', 'study total', 'study vitro', 'study which', 'studydrug', 'stx17', 'style', 'subacute', 'subarachnoid', 'subcellular', 'subchronic', 'subclass', 'subclinical', 'subclones', 'subcomponent', 'subcortical', 'subcutaneous', 'subdivide', 'subdivision', 'subdomain', 'subepithelial', 'subfamily', 'subgranular', 'subgroup', 'subgroup patients', 'subgroups', 'subhepatic', 'subintegra', 'subject', 'subject receive', 'subject record', 'subject report', 'subjective', 'subjective happiness', 'subjective symptoms', 'subjectively', 'subliminally', 'submicroliter', 'submicroliter human', 'submicroliter human whole', 'submicroliters', 'submicromolar', 'submit', 'submucosa', 'submucosal', 'submyeloablative', 'subnanomolar', 'suboptimal', 'subpcp', 'subpcpinduced', 'subpcptreatment', 'subpopulation', 'subsequent', 'subsequent fraction', 'subsequently', 'subset', 'subset patients', 'subsets', 'subsite', 'substance', 'substances', 'substantia', 'substantia nigra', 'substantia nigra compacta', 'substantial', 'substantially', 'substantiate', 'substitute', 'substitution', 'substitutions', 'substrate', 'substratebinding', 'substrategating', 'substrates', 'substructure', 'subtilis', 'subtilisinkexin', 'subtle', 'subtly', 'subtractive', 'subtype', 'subtypedependent', 'subtypes', 'subunit', 'subunitnull', 'subunits', 'subunitspecific', 'subventricular', 'subvert', 'subvisible', 'succeed', 'success', 'successful', 'successfully', 'successfully apply', 'successive', 'successively', 'succinate', 'succinct', 'succinic', 'succinyl', 'succinylate', 'succinylation', 'succinylation proteins', 'succinylcoa', 'succinyltransferase', 'sucrose', 'suddenly', 'suffer', 'suffer persistent', 'suffer persistent symptoms', 'sufficiency', 'sufficient', 'sufficiently', 'sugar', 'suggest', 'suggest increase', 'suggest might', 'suggest multiple', 'suggest possible', 'suggest potential', 'suggestions', 'suicidal', 'suitability', 'suitable', 'suite', 'sulfate', 'sulfatemimicking', 'sulfenation', 'sulfinic', 'sulfolobus', 'sulfonic', 'sulfur', 'sulphate', 'summaries', 'summarise', 'summarize', 'summarize current', 'summarize recent', 'summary', 'summer', 'superactive', 'superbugs', 'superfamily', 'superficial', 'superimpose', 'superior', 'superiority', 'supernatant', 'supernatants', 'superoxide', 'superoxide dismutase', 'superoxide dismutase catalase', 'superoxides', 'superrestoration', 'supervise', 'supplement', 'supplemental', 'supplementary', 'supplementation', 'supply', 'support', 'support hypothesis', 'supportive', 'suppose', 'suppress', 'suppression', 'suppressive', 'suppressor', 'supramolecular', 'supratherapeutic', 'surface', 'surface expression', 'surface level', 'surfacebiotinylation', 'surfactant', 'surfactants', 'surgeon', 'surgeons', 'surgery', 'surgical', 'surgical infection', 'surgical resection', 'surgical smoke', 'surgical smoke plume', 'surgical treatment', 'surmountably', 'surpass', 'surprise', 'surprisingly', 'surround', 'surveillance', 'survey', 'survey information', 'survey information demographics', 'surveyweighted', 'surveyweighted logistic', 'survival', 'survival cells', 'survival chronic', 'survival patients', 'survival signal', 'survive', 'susceptibilities', 'susceptibility', 'susceptible', 'suspect', 'suspicion', 'sustain', 'sustainable', 'suzukimiyaura', 'svpla1', 'swallow', 'sweat', 'sweden', 'swedish', 'sweeten', 'sweetflag', 'sweetflag rhizome', 'swell', 'swiss', 'switch', 'sydney', 'symmetric', 'sympathoadrenal', 'symposia', 'symposium', 'symposiumanticoagulant', 'symptom', 'symptomatic', 'symptomatic unfortunately', 'symptomatic unfortunately still', 'symptomatology', 'symptoms', 'symptoms however', 'symptoms however ethical', 'symptoms patients', 'symptoms study', 'symptoms treat', 'synapse', 'synapses', 'synapsin2', 'synaptic', 'synaptic function', 'synaptic plasticity', 'synaptically', 'synapticcomposition', 'synaptogenesis', 'synaptogenic', 'synaptogenic function', 'synaptopathies', 'synaptophysin', 'synaptosomal', 'synbiotic', 'synbiotic therapy', 'synbiotics', 'synchrotron', 'syncope', 'syndrome', 'syndromerelated', 'syndromes', 'synergistic', 'synergistically', 'synergize', 'synergy', 'syntaxin', 'synthase', 'synthase kinase', 'synthase kinase3', 'synthase kinase3beta', 'synthase kinase3beta gsk3beta', 'syntheses', 'synthesis', 'synthesis novel', 'synthesise', 'synthesize', 'synthesize compound', 'synthesize evaluate', 'synthetase', 'synthetic', 'synthetic inhibitors', 'synthetically', 'synucleinopathies', 'syphilis', 'syphilispositive', 'syrups', 'system', 'system diseases', 'system disorder', 'system function', 'system response', 'system which', 'systematic', 'systematic review', 'systematic review metaanalysis', 'systematically', 'systembased', 'systemic', 'systemic administration', 'systemic disease', 'systemic inflammation', 'systemic inflammatory', 'systemically', 'systemmediated', 'systemrelated', 'systems', 'systemslevel', 'systemsperspective', 'systolic', 'systolic pressure', 't668a', 't668e', 't808p', 'table', 'tablet', 'tablets', 'tachycardia', 'tachypnea', 'tachyzoites', 'tackle', 'tacrine', 'tacrine analogs', 'tacrine hydrochloride', 'tacrine permeation', 'tacrineacridine', 'tacrines', 'tacrinetacrine', 'tacrolimus', 'tactic', 'taguchi', 'tailcuff', 'tailor', 'tailor nutritional', 'tailor nutritional guidance', 'tandem', 'tandem spectrometry', 'tandemrepeats', 'tangle', 'tannerella', 'tannin', 'taqman', 'target', 'target genes', 'target genes activin', 'target novel', 'target repression', 'target therapeutic', 'target treatment', 'targetinduced', 'targetresponsive', 'targetscan', 'targretinr', 'taste', 'tau244372', 'taulpffdnh2', 'taumediated', 'tauopathies', 'tauopathy', 'taurine', 'taxol', 'taxonomic', 'taxus', 'taxus baccata', 'tbooh', 'tbutyl', 'tcell', 'tcfeb', 'tdp43', 'tdp43transfected', 'teach', 'technetium99m', 'technique', 'techniques', 'technoligies', 'technological', 'technologies', 'technology', 'technology become', 'technology become attractive', 'teeth', 'telangiectasia', 'telaprevir', 'telomerase', 'telomere', 'telomere length', 'telomeres', 'temperature', 'temperature degrees', 'temperatures', 'template', 'templateassisted', 'templating', 'temporal', 'temporality', 'temporary', 'temporoparietali', 'tendency', 'tendon', 'tenea', 'tenebrio', 'teneleven', 'tenfold', 'tensile', 'tensile strength', 'tension', 'tensor', 'tensors', 'tentatively', 'tenths', 'tenuis', 'tenyear', 'teratogen', 'teratogenicity', 'terminal', 'terminal ileum', 'terminals', 'terminate', 'termination', 'termination pregnancy', 'terminus', 'ternary', 'terpene', 'terpenes', 'terpenoids', 'territory', 'terrytown', 'tertbutyldimethylsilyl', 'tertbutylhydroperoxide', 'terthydroxy', 'tertiary', 'tertiary structure', 'tertile', 'testes', 'testicular', 'testis', 'testsoutcomes', 'tetanus', 'tether', 'tetrachloroaurate', 'tetradentate', 'tetrahydrofolates', 'tetramer', 'tetrapeptide', 'tetraploid', 'tetraploidization', 'tetrodotoxinsensitive', 'teucrium', 'texts', 'tg101348', 'tg2576', 'tgfbeta', 'tgfbeta signal', 'tgfbeta1', 'tgfbeta1smad3', 'tgfbetasignaling', 'tgfbetasmad2', 'tgfss', 'th2adjuvants', 'th2like', 'th2only', 'thalamus', 'thalassemia', 'thall', 'thank', 'thapsigargin', 'thbs1', 'theilers', 'thelper', 'thematic', 'theme', 'thence', 'thenfused', 'theoretical', 'theoretically', 'theory', 'theranostic', 'therapeutic', 'therapeutic agent', 'therapeutic approach', 'therapeutic effect', 'therapeutic implications', 'therapeutic interventions', 'therapeutic molecules', 'therapeutic perspectives', 'therapeutic potential', 'therapeutic strategies', 'therapeutic strategy', 'therapeutic target', 'therapeutical', 'therapeutically', 'therapeutics', 'therapies', 'therapies beneficial', 'therapies beneficial several', 'therapist', 'therapy', 'therapy beneficial', 'therapy beneficial patients', 'therapy months', 'therapy patients', 'therapy provide', 'therapy provide overview', 'therapy treatment', 'thereafter', 'thereby', 'therefore', 'therefore investigate', 'therefore present', 'therefore present study', 'therefore study', 'thereof', 'thermal', 'thermoacidophilic', 'thermodynamic', 'thermodynamics', 'thermometry', 'thermosensitive', 'thiazole', 'thick', 'thicken', 'thickness', 'thigh', 'thing', 'things', 'think', 'thinlayer', 'thinlayer chromatography', 'thioacetamide', 'thiobarbituric', 'thiocholine', 'thioester', 'thioesterases', 'thioflavin', 'thiol', 'thioldependent', 'thiophene', 'thioredoxin', 'thioredoxindependent', 'thioredoxininteracting', 'thiourea', 'third', 'thirddegree', 'thirdgeneration', 'thirds', 'thirtieth', 'thirty', 'thirtyseven', 'thirtysix', 'thomas', 'thoroughly', 'though', 'thousand', 'thousands', 'thr172', 'thr205', 'thr231', 'thr356', 'thr668', 'threaten', 'threats', 'three', 'three different', 'threecomponent', 'threedimensional', 'threemonthold', 'threerepeat', 'threestep', 'threonine', 'threonine residues', 'thrive', 'thrombin', 'thrombocytopenic', 'thrombosis', 'thrombospondin', 'throughout', 'throughput', 'thrp356gsk3beta', 'thymelaeceae', 'thymus', 'thyroid', 'thyroiditis', 'tight', 'tight junction', 'tightly', 'tightly regulate', 'tightness', 'timelapse', 'timely', 'timeof', 'timeofflight', 'timepoint', 'timeresolved', 'timps', 'tip60', 'tip60enriched', 'tissue', 'tissue availability', 'tissue availability limit', 'tissue brain', 'tissue condition', 'tissue damage', 'tissue development', 'tissue include', 'tissue repair', 'tissue sample', 'tissuedependent', 'tissueresiding', 'tissuespecific', 'tissuespecific network', 'titer', 'titers', 'title', 'titrate', 'titration', 'titration calorimetry', 'titre', 'titres', 'tlr4nfkappab', 'tmevidd', 'tnfalpha', 'tnfalpha il1beta', 'tnfalpha interleukin', 'tnfalphainduced', 'tnfrsf425', 'tobacco', 'tobramycin', 'todays', 'together', 'together demonstrate', 'together result', 'together result suggest', 'together study', 'tolerability', 'tolerable', 'tolerance', 'tolerate', 'tolllike', 'tolllike receptor', 'toluene', 'tomografia', 'tomography', 'tongue', 'tonic', 'tonic nmdarmediated', 'tonically', 'tonically active', 'tooth', 'toothsupporting', 'topdown', 'topgo', 'topic', 'topical', 'topics', 'topological', 'topologies', 'topology', 'total', 'total activity', 'total antioxidant', 'total antioxidant capacity', 'total patients', 'total plasma', 'total plasma pcresol', 'totally', 'tourettes', 'toward', 'towards', 'toxic', 'toxicants', 'toxicated', 'toxicities', 'toxicity', 'toxicological', 'toxicologically', 'toxicology', 'toxin', 'toxins', 'toxoplasma', 'toxoplasmosis', 'tracciante', 'trace', 'tracer', 'trachea', 'trachea bronchus', 'trachea bronchus cancers', 'tracheobronchial', 'trachomatis', 'track', 'tract', 'tractable', 'tracts', 'traditional', 'traditional chinese', 'traditional chinese medicine', 'traditional factor', 'traditional medicine', 'traditional usage', 'traditionally', 'traffic', 'traffic leukocytes', 'trail', 'train', 'trait', 'traits', 'traits associate', 'trajectories', 'trajectory', 'trangenic', 'trans', 'transact', 'transaction', 'transactivation', 'transamination', 'transancestry', 'transcellular', 'transcript', 'transcriptase', 'transcription', 'transcription factor', 'transcriptional', 'transcriptional activity', 'transcriptionaland', 'transcriptionpcr', 'transcriptome', 'transcriptome study', 'transcriptomes', 'transcriptomewide', 'transcriptomic', 'transcriptomics', 'transcripton', 'transcripts', 'transdermal', 'transdimerization', 'transdirected', 'transdominant', 'transduce', 'transducer', 'transducers', 'transduction', 'transendoscopy', 'transendothelial', 'transepithelial', 'transeqtls', 'transfected', 'transfected human', 'transfecting', 'transfection', 'transfer', 'transferase', 'transferrin', 'transferrinindependent', 'transform', 'transformation', 'transgeneration', 'transgenes', 'transgenic', 'transgenic model', 'transgenic mouse', 'transgenic mouse model', 'transgenic wildtype', 'transglutaminase', 'transient', 'transiently', 'transients', 'transinteraction', 'transit', 'transition', 'transitionstate', 'translate', 'translation', 'translational', 'translationally', 'translocate', 'translocation', 'translucency', 'transmembrane', 'transmembrane domains', 'transmembrane proteins', 'transmissibility', 'transmissible', 'transmission', 'transmission electron', 'transmission electron microscopy', 'transmissions', 'transmit', 'transmitter', 'transmitter release', 'transmitters', 'transmural', 'transplant', 'transplant human', 'transplantation', 'transplantation fetal', 'transplantation fetal ventral', 'transplantfree', 'transport', 'transport impairment', 'transport protein', 'transporter', 'transporter2', 'transporters', 'transpose', 'transresveratrol', 'transresveratrols', 'transsuccinylase', 'transsulfuration', 'transthyretin', 'transverse', 'trattamento', 'trauma', 'traumatic', 'traumatic brain', 'traumatic brain injury', 'travel', 'traverse', 'treasure', 'treat', 'treat alzheimers', 'treat alzheimers disease', 'treat celiac', 'treat celiac disease', 'treat cells', 'treat hypertension', 'treat indeed', 'treat indeed transplantation', 'treat neurodegenerative', 'treat patients', 'treat subject', 'treatable', 'treatment', 'treatment alzheimers', 'treatment alzheimers disease', 'treatment associate', 'treatment cancer', 'treatment diabetes', 'treatment diabetic', 'treatment disease', 'treatment diseases', 'treatment goals', 'treatment however', 'treatment induce', 'treatment moderate', 'treatment neurodegenerative', 'treatment neurodegenerative diseases', 'treatment neurological', 'treatment parkinson', 'treatment patients', 'treatment significantly', 'treatment strategy', 'treatment various', 'treatmentinduced', 'treatments', 'treatments symptomatic', 'treatments symptomatic unfortunately', 'tregs', 'trem2', 'trem2 expression', 'trem2ctf', 'trem2dap12', 'tremendously', 'tremorataxia', 'trend', 'treponema', 'trflp', 'triad', 'trial', 'trial background', 'trial registration', 'trialend', 'trials', 'trials study', 'triazolecontaining', 'tricarboxylic', 'tricarboxylic cycle', 'trichlorocetyl', 'trichura', 'trichuris', 'tricyclic', 'tridentata', 'tridentata culture', 'tridentate', 'trigger', 'trigger receptor', 'trigger receptor express', 'triglyceride', 'triglycerides', 'trillions', 'trimer', 'trimester', 'trimesters', 'trimethylamine', 'trimethylaminecontaining', 'trimethylaminenoxide', 'trimnhl', 'triphosphatase', 'triple', 'triplearg', 'triplequadrupole', 'triplication', 'tris2', 'tris2pyridylmethylamine', 'trisomic', 'trisomy', 'trisomy cells', 'triterpene', 'triterpenoid', 'triterpenoids', 'trivalent', 'trkbmediated', 'trkbshc', 'trolox', 'trophic', 'trophic action', 'trophic action modulation', 'tropomyosinrelated', 'trough', 'trp104', 'trp214', 'trp50', 'trp82', 'trpa1', 'trpa1 expression', 'trpm6', 'trpm7', 'trpm7 channel', 'truly', 'truncate', 'trust', 'trypanocidal', 'trypanosoma', 'trypsin', 'trypsin trypsin', 'tryptic', 'tryptophan', 'tryptophanolderived', 'ts65dn', 'tsivintzelis', 'ttest', 'ttlus', 'ttxresistant', 'tubelike', 'tuberculosis', 'tuberous', 'tubular', 'tubule', 'tubules', 'tubulin', 'tubulointerstitial', 'tuchong', 'tumor', 'tumor growth', 'tumor necrosis', 'tumor necrosis factor', 'tumor necrosis factoralpha', 'tumor number', 'tumor progression', 'tumorassociated', 'tumorigenesis', 'tumorigenicity', 'tumorpromoting', 'tumors', 'tumour', 'tumours', 'tunability', 'tunable', 'tunel', 'tungsten', 'turbo', 'turkey', 'turkish', 'turmeric', 'turnout', 'turnover', 'twelve', 'twentieth', 'twenty', 'twentyeight', 'twentyfirst', 'twentyfive', 'twentynine', 'twentysix', 'twice', 'twice daily', 'twindifferences', 'twist1', 'twoarm', 'twocoordinate', 'twodimensional', 'twoelectrode', 'twolevel', 'twophoton', 'twosided', 'twostep', 'twothirds', 'twoway', 'txnip', 'type2', 'typhoid', 'typhoid ileal', 'typhoid ileal perforation', 'typical', 'typically', 'typify', 'tyr128', 'tyr32', 'tyr320', 'tyr94', 'tyro3', 'tyrosine', 'tyrosine nitration', 'tyrosine phosphatase', 'tyrosine phosphatases', 'tyrosinehydroxylase', 'u0126', 'u111111424363', 'u251mg', 'uacc62', 'ubiquinone', 'ubiquitination', 'ubiquitindependent', 'ubiquitinligation', 'ubiquitinproteasome', 'ubiquitous', 'ubiquitously', 'ubiquity', 'ucf101', 'uclike', 'ucpatients', 'udpglcnac', 'ugi4cr', 'ulcer', 'ulceration', 'ulcerations', 'ulcerative', 'ulcerative colitis', 'ulceriform', 'ulmoides', 'ultimate', 'ultimately', 'ultra', 'ultrafast', 'ultrahigh', 'ultrahighperformance', 'ultrahplcms', 'ultraperformance', 'ultraperformance liquid', 'ultrasensitive', 'ultrasound', 'ultrastructural', 'ultraviolet', 'ultravioletvisible', 'umbilical', 'umbrella', 'unable', 'unacceptable', 'unadjusted', 'unaffected', 'unambiguously', 'unanswered', 'unbind', 'uncaria', 'uncertain', 'uncertainty', 'unchanged', 'unclassified', 'unclear', 'unclear study', 'uncommon', 'uncomplicated', 'uncontrolled', 'uncover', 'undefined', 'underappreciated', 'underarm', 'underestimate', 'underexpression', 'undergo', 'undergo endoscopic', 'underground', 'underlie', 'underlie cause', 'underlie disease', 'underlie mechanism', 'underlie mechanisms', 'underline', 'underneath', 'undernourish', 'undernutrition', 'underpin', 'underpinnings', 'underpowered', 'underrepresented', 'underscore', 'understand', 'understand contribution', 'understand however', 'understand mechanisms', 'understand molecular', 'understand therefore', 'undertake', 'undesired', 'undetermined', 'undifferentiated', 'undoubtedly', 'unemployed', 'unemployment', 'unequivocally', 'unexpected', 'unexpectedly', 'unexplained', 'unexplored', 'unfavorable', 'unfold', 'unformed', 'unfortunately', 'unfortunately still', 'unfortunately still disorder', 'unhappiness', 'unhappy', 'unhealthy', 'uniformly', 'unify', 'unilateral', 'uninfected', 'uninfected control', 'unintended', 'unique', 'uniquely', 'unitary', 'unite', 'unite state', 'units', 'univariate', 'univariate analysis', 'universal', 'university', 'university hospital', 'unknown', 'unknown identify', 'unknown study', 'unless', 'unlike', 'unlikely', 'unlimited', 'unlinked', 'unmet', 'unmodified', 'unnatural', 'unnecessary', 'unoxidized', 'unprocessed', 'unprotected', 'unravel', 'unrealistic', 'unrecognized', 'unregulated', 'unrelated', 'unresolved', 'unsafe', 'unsaturated', 'unselected', 'unspecific', 'unstability', 'unstable', 'unstructured', 'unsubstituted', 'unsuccessful', 'unsupervised', 'untransfected', 'untranslated', 'untranslated regions', 'untreated', 'unusual', 'unusually', 'unveil', 'unwanted', 'unwarranted', 'upcoming', 'update', 'uplcmsms', 'upmdashregulation', 'upper', 'upper endoscopy', 'upper gastrointestinal', 'upregulate', 'upregulated', 'upregulated expression', 'upregulates', 'upregulating', 'upregulation', 'upstream', 'uptake', 'uptake pcresol', 'uptodate', 'uraemic', 'urban', 'urease', 'uremic', 'uremic toxins', 'urgent', 'urinary', 'urinary bladder', 'urinary bladder cancer', 'urinary excretion', 'urine', 'urine sample', 'urogenital', 'us4855290', 'us5096890', 'us5571918', 'us5980933', 'us6106864', 'usage', 'usedependent', 'useful', 'useful prevention', 'useful prevention treatment', 'usefulness', 'useless', 'usp30', 'usp35', 'uspio', 'usually', 'uterine', 'uterus', 'utilities', 'utility', 'utilization', 'utilize', 'utmost', 'uvrag', 'uvvisible', 'v642i', 'vaccinate', 'vaccination', 'vaccine', 'vaccine adjuvant', 'vaccine peptides', 'vaccines', 'vacuolar', 'vacuoles', 'vagal', 'vaginal', 'vaginally', 'valeriana', 'valid', 'validate', 'validation', 'validation cohort', 'validity', 'valine', 'valiumimpaired', 'valproic', 'valuable', 'value', 'value range', 'values005', 'vancomycinresistant', 'vancouver', 'variability', 'variable', 'variables', 'variables include', 'variably', 'variance', 'variant', 'variants', 'variants associate', 'variation', 'variations', 'varieties', 'variety', 'variety biological', 'various', 'various arylnitrile', 'various arylnitrile oxides', 'various biological', 'various cancers', 'various concentrations', 'various diseases', 'various diseases include', 'various neurodegenerative', 'various neurodegenerative diseases', 'various neurological', 'various tissue', 'variously', 'vascular', 'vascular endothelial', 'vascular endothelial growth', 'vascularization', 'vasculature', 'vasoactive', 'vasomotor', 'vastly', 'vcam1', 'vcrinduced', 'vector', 'vectors', 'vectortransfected', 'vedolizumab', 'vegetable', 'vegetables', 'vegfproducing', 'vehicle', 'vehicletreated', 'veillonella', 'vekilov', 'velocity', 'venereum', 'veneto', 'venom', 'venous', 'ventral', 'ventral mesencephalic', 'ventral mesencephalic cells', 'ventricosus', 'ventricular', 'venusil', 'verapamil', 'verbally', 'verify', 'versa', 'versant', 'version', 'versions', 'versus', 'versus control', 'vertebrate', 'vertebrates', 'vesicle', 'vesicles', 'vesicular', 'vessel', 'vessels', 'vestibular', 'veterans', 'veterinary', 'vfitc', 'vfitcpi', 'vfitcpropidium', 'vggvg', 'vggvg3', 'vggvgcontaining', 'vhatpase', 'viability', 'viability decrease', 'viability hbmecs', 'viable', 'viagra', 'vicinity', 'vicious', 'victims', 'viene', 'vietnam', 'vietnam veterans', 'viewpoint', 'vigilance', 'vigilant', 'vigoni', 'vigorous', 'vildagliptin', 'villa', 'villi', 'vimentin', 'vimentin ecadherin', 'vimentin expression', 'vimentin expression ecadherin', 'vincristine', 'vincristineinduced', 'vinyl', 'violaceoruber', 'violanthin', 'violations', 'viraemia', 'viral', 'viralbacterial', 'viralinduced', 'virchow', 'virchow robin', 'virchow robin space', 'virchowrobin', 'viremia', 'virgin', 'virologic', 'virological', 'virological response', 'virtual', 'virtual screen', 'virtue', 'virulence', 'virus', 'viruses', 'viruslike', 'visavis', 'visfatin', 'vision', 'visit', 'visual', 'visualization', 'visualize', 'vitagenes', 'vital', 'vital roles', 'vitals', 'vitamin', 'vitamins', 'vitexin', 'vitexin isovitexin', 'vitro', 'vitro acetylcholinesterase', 'vitro assay', 'vitro experiment', 'vitro model', 'vitro result', 'vitro study', 'vitroin', 'vitroproduced', 'vldlr', 'vocalization', 'voice', 'volatile', 'volatile organic', 'volatile organic compound', 'voltage', 'voltageclamp', 'voltagedependent', 'voltagegated', 'voltagegated sodium', 'voltammetric', 'voltammetry', 'volume', 'volumes', 'volunteer', 'vomit', 'voter', 'vpatreated', 'vpositive', 'vps10p', 'vps11', 'vps16', 'vps18', 'vps26', 'vps26a', 'vps33a', 'vps33ad251e', 'vps33ad251e mutation', 'vps33ay440d', 'vps39', 'vps41', 'vrenegative', 'vrenegative patients', 'vrepositive', 'vulgaris', 'vulnerability', 'vulnerable', 'waiver', 'warehouse', 'warrant', 'warriors', 'washington', 'washout', 'waste', 'watchgeneral', 'water', 'water dynamics', 'water dynamics around', 'waterexposed', 'watersoluble', 'watery', 'wavelength', 'weaken', 'weaker', 'weakly', 'weakness', 'wealth', 'webbased', 'webinar', 'webserver', 'website', 'websites', 'webster', 'weekly', 'weeks', 'weeks washout', 'wehrhahn', 'weigh', 'weight', 'weightday', 'wellbeing', 'wellcharacterized', 'wellcoordinated', 'welldefined', 'welldescribed', 'wellestablished', 'wellknown', 'wellness', 'wellnourished', 'wellperformed', 'wellseparated', 'wellstudied', 'western', 'western analysis', 'westernblot', 'westsouth', 'whatever', 'whenever', 'wheras', 'where', 'whereas', 'whereby', 'whether', 'whether effect', 'whicap', 'which', 'which affect', 'which associate', 'which cause', 'which characterize', 'which contribute', 'which could', 'which detrimental', 'which encode', 'which enhance', 'which exert', 'which important', 'which include', 'which induce', 'which involve', 'which might', 'which persist', 'which receive', 'which receive peptide', 'which reduce', 'which regulate', 'which regulate cycle', 'which result', 'which selectively', 'which serve', 'white', 'white blood', 'white matter', 'whole', 'whole blood', 'wholebody', 'wholecell', 'whose', 'widely', 'widely distribute', 'wider', 'wideranging', 'widespread', 'widespread clinical', 'widespread clinical hence', 'wielen', 'wildtype', 'wildtype animals', 'wiley', 'wilsons', 'window', 'windows', 'winter', 'wisconsin', 'wistar', 'wistarkyoto', 'withaferin', 'withanamides', 'withania', 'withania somnifera', 'withania somnifera dunal', 'withdrawal', 'within', 'within active', 'within central', 'within central nervous', 'within context', 'within nervous', 'withincohort', 'without', 'withwithout', 'witness', 'wittig', 'wnt7a', 'wnt8a', 'wntbetacatenin', 'woman', 'women', 'wonder', 'workers', 'workflow', 'workshop', 'workup', 'world', 'worldwide', 'worse', 'worsen', 'worth', 'worthless', 'worthy', 'would', 'wound', 'wrist', 'write', 'wrl68', 'wscoq10', 'wsnabeta110', 'wsnwt', 'wsomnifera', 'wsomnifera fruit', 'wsomnifera fruit extract', 'wuhan', 'wwwelissk', 'xanomeline', 'xassociated', 'xenobiotic', 'xenobiotics', 'xenofree', 'xenofree condition', 'xenograft', 'xenopus', 'xggzg', 'xhosa', 'xiaogan', 'xiaoyaosan', 'xiecaoline', 'xiecaoside', 'xplore', 'y115ey117e', 'yanhuii', 'yearly', 'yearold', 'years', 'years followup', 'years group', 'years older', 'years prevalence', 'years research', 'years respectively', 'years younger', 'yeast', 'yeastdisplayed', 'yellow', 'yield', 'ymaze', 'yokohama', 'young', 'younger', 'younger group', 'youngest', 'zdouble', 'zealand', 'zebrafish', 'zebrafishimplication', 'zetadelta', 'zhongnan', 'zn2dependent', 'zoledronic', 'zymosterol']\n"
     ]
    }
   ],
   "source": [
    "print(len(word_list))\n",
    "print(word_list)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Now we have the aggregated BoW matrix `domains_bow_matrix` and the aggregated `domains_binary_matrix`. The rows of these matrices correspond to the domains (*Autism*, *Calcineurin*) and the columns correspond to the words from the vocabulary.\n",
    "\n",
    "In the `domains_bow_matrix` the frequencies of the individual words are summed up, indicating how often the word occurs in the domain documents, while in the `domains_binary_matrix` the number of domain documents in which the word occurs is indicated (each word in a document counts as 1, even if it occurs many times in the document)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 242,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1 freqTerm: 0.0 0.0\n",
      "\n",
      "2 freqDoc: 0.0 0.0\n",
      "\n",
      "3 freqRatio: 0.0 0.0\n",
      "\n",
      "4 tfidfSum: 0.0 0.0\n",
      "\n",
      "5 tfidfMax: 0.0 0.0\n",
      "\n",
      "6 out_freqTerm: 0.0 0.0\n",
      "\n",
      "7 out_freqDoc: 0.0 0.0\n",
      "\n",
      "8 out_freqRatio: 0.0 0.0\n",
      "\n",
      "9 out_tfidfSum: 0.0 0.0\n",
      "\n",
      "10 out_tfidfMax: 0.0 0.0\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# define heuristics and then move them in LBD_04_text_mining.ipynb\n",
    "# define ensemble framework and move it to the same file\n",
    "\n",
    "def freqTerm(t: str) -> float:\n",
    "    return cell_value_in_a_matrix(domains_bow_matrix, unique_domains_list[0], t) + cell_value_in_a_matrix(domains_bow_matrix, unique_domains_list[1], t)\n",
    "\n",
    "print('1 freqTerm:', freqTerm('calmodulin'), freqTerm('vcfs'))\n",
    "print()\n",
    "\n",
    "def freqDoc(t: str) -> float:\n",
    "    return cell_value_in_a_matrix(domains_binary_matrix, unique_domains_list[0], t) + cell_value_in_a_matrix(domains_binary_matrix, unique_domains_list[1], t)\n",
    "\n",
    "print('2 freqDoc:', freqDoc('calmodulin'), freqDoc('vcfs'))\n",
    "print()\n",
    "\n",
    "def freqRatio(t: str) -> float:\n",
    "    if freqDoc(t) > 0:\n",
    "        return freqTerm(t) / freqDoc(t)\n",
    "    else:\n",
    "        return 0.0\n",
    "\n",
    "print('3 freqRatio:', freqRatio('calmodulin'), freqRatio('vcfs'))\n",
    "print()\n",
    "\n",
    "def tfidfSum(t: str) -> float:\n",
    "    if t in word_list:\n",
    "        return sum_word_tfidf[t]\n",
    "    else:\n",
    "        return 0.0\n",
    "\n",
    "print('4 tfidfSum:', tfidfSum('calmodulin'), tfidfSum('vcfs'))\n",
    "print()\n",
    "\n",
    "def tfidfMax(t: str) -> float:\n",
    "    if t in word_list:\n",
    "        return max_word_tfidf[t]\n",
    "    else:\n",
    "        return 0.0\n",
    "\n",
    "print('5 tfidfMax:', tfidfMax('calmodulin'), tfidfMax('vcfs'))\n",
    "print()\n",
    "\n",
    "def out_freqTerm(t: str) -> float:\n",
    "    return cell_value_in_a_matrix(domains_outlier_bow_matrix, unique_domains_list[0], t) + cell_value_in_a_matrix(domains_outlier_bow_matrix, unique_domains_list[1], t)\n",
    "\n",
    "print('6 out_freqTerm:', out_freqTerm('calmodulin'), out_freqTerm('vcfs'))\n",
    "print()\n",
    "\n",
    "def out_freqDoc(t: str) -> float:\n",
    "    return cell_value_in_a_matrix(domains_outlier_binary_matrix, unique_domains_list[0], t) + cell_value_in_a_matrix(domains_outlier_binary_matrix, unique_domains_list[1], t)\n",
    "\n",
    "print('7 out_freqDoc:', out_freqDoc('calmodulin'), out_freqDoc('vcfs'))\n",
    "print()\n",
    "\n",
    "def out_freqRatio(t: str) -> float:\n",
    "    if out_freqDoc(t) > 0:\n",
    "        return out_freqTerm(t) / out_freqDoc(t)\n",
    "    else:\n",
    "        return 0.0\n",
    "\n",
    "print('8 out_freqRatio:', out_freqRatio('calmodulin'), out_freqRatio('vcfs'))\n",
    "print()\n",
    "\n",
    "def out_tfidfSum(t: str) -> float:\n",
    "    return cell_value_in_a_matrix(domains_outlier_sum_tfidf_matrix, unique_domains_list[0], t) + cell_value_in_a_matrix(domains_outlier_sum_tfidf_matrix, unique_domains_list[1], t)\n",
    "\n",
    "print('9 out_tfidfSum:', out_tfidfSum('calmodulin'), out_tfidfSum('vcfs'))\n",
    "print()\n",
    "\n",
    "def out_tfidfMax(t: str) -> float:\n",
    "    return max(cell_value_in_a_matrix(domains_outlier_max_tfidf_matrix, unique_domains_list[0], t), cell_value_in_a_matrix(domains_outlier_max_tfidf_matrix, unique_domains_list[1], t))\n",
    "\n",
    "print('10 out_tfidfMax:', out_tfidfMax('calmodulin'), out_tfidfMax('vcfs'))\n",
    "print()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "We have defined ten functions that compute heuristic scores of a given word from the vocabulary:\n",
    "\n",
    "1. freqTerm: \n",
    "2. freqDoc: \n",
    "3. freqRatio: \n",
    "4. tfidfSum: \n",
    "5. tfidfMax: \n",
    "6. out_freqTerm: \n",
    "7. out_freqDoc: \n",
    "8. out_freqRatio: \n",
    "9. out_tfidfSum: \n",
    "10. out_tfidfMax: \n",
    "\n",
    "These scores can be used as an estimations of the potential of b-term candidates."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 243,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Count in original list: Counter({'Alzheimer': 644, 'GIMB': 122})\n",
      "Count in filtered list: Counter({'Alzheimer': 644, 'GIMB': 122})\n"
     ]
    }
   ],
   "source": [
    "# Input: domains_list, outlier_docs_list \n",
    "from collections import Counter\n",
    "\n",
    "# 1: count occurrences of domain names in the first list\n",
    "domains_counts = Counter(domains_list)\n",
    "\n",
    "# 2: filter the list using the selected indices\n",
    "filtered_list = [domains_list[i] for i in outlier_docs_list]\n",
    "\n",
    "# 3: count occurrences of domain names in the filtered list\n",
    "filtered_counts = Counter(filtered_list)\n",
    "\n",
    "# Output the results\n",
    "print(f\"Count in original list: {domains_counts}\")\n",
    "print(f\"Count in filtered list: {filtered_counts}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 244,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Dictionary of words, count and max(tfidf) ...\n"
     ]
    }
   ],
   "source": [
    "# Populate dictionaries for various heuristics\n",
    "\n",
    "import random\n",
    "import time\n",
    "\n",
    "# Seed the random number generator for repeated randomness\n",
    "random.seed(321)\n",
    "\n",
    "# Generate a random 7-digit number\n",
    "random_number = random.randint(1000000, 9999999)\n",
    "\n",
    "print(\"Dictionary of words, count and max(tfidf) ...\")\n",
    "\n",
    "selected_freqTerm = {}\n",
    "selected_freqDoc = {}\n",
    "selected_freqRatio = {}\n",
    "selected_tfidfSum = {}\n",
    "selected_tfidfMax = {}\n",
    "\n",
    "max_word_tfidf_selected = {}\n",
    "sum_word_tfidf_selected = {} \n",
    "aux_word_tfidf_selected = {} \n",
    "min_word_tfidf_selected = {} ### TODO from here on ...\n",
    "for word in max_word_tfidf.keys():\n",
    "    if sum_count_docs_containing_word[word] >= 1: # the word should appear in at least n documents, n = 1\n",
    "        passed = True\n",
    "        for domain_name in unique_domains_list:\n",
    "            if cell_value_in_a_matrix(domains_bow_matrix, domain_name, word) <= 0: # the word should appear at least once in each domain\n",
    "                passed = False\n",
    "        if passed:\n",
    "            # max_word_tfidf_selected[word] = max_word_tfidf[word]\n",
    "            sum_word_tfidf_selected[word] = sum_word_tfidf[word]\n",
    "            aux_word_tfidf_selected[word] = random.randint(1, 999999)\n",
    "            min_word_tfidf_selected[word] = max_word_tfidf[word] * sum_word_tfidf[word]\n",
    "\n",
    "            max_word_tfidf_selected[word] = max_word_tfidf[word] # out_freqRatio(word)\n",
    "\n",
    "            selected_freqTerm[word] = freqTerm(word)\n",
    "            selected_freqDoc[word] = freqDoc(word)\n",
    "            selected_freqRatio[word] = freqRatio(word)\n",
    "            selected_tfidfSum[word] = tfidfSum(word)\n",
    "            selected_tfidfMax[word] = tfidfMax(word)\n",
    "\n",
    "            # def freqTerm(t: str) -> float:\n",
    "            # def freqDoc(t: str) -> float:\n",
    "            # def freqRatio(t: str) -> float:\n",
    "            # def tfidfSum(t: str) -> float:\n",
    "            # def tfidfMax(t: str) -> float:\n",
    "            # def out_freqTerm(t: str) -> float:\n",
    "            # def out_freqDoc(t: str) -> float:\n",
    "            # def out_freqRatio(t: str) -> float:\n",
    "            # def out_tfidfSum(t: str) -> float:\n",
    "            # def out_tfidfMax(t: str) -> float:\n",
    "\n",
    "# print(tfidfMax('vcfs'))\n",
    "\n",
    "# max_word_tfidf_selected = aux_word_tfidf_selected\n",
    "# max_word_tfidf_selected = sum_word_tfidf_selected\n",
    "# max_word_tfidf_selected = min_word_tfidf_selected"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 255,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "All the words in the vocabulary:  15274\n",
      "Selected b-term candidate words:  2920   {'1980s': 0.09949473511852142, '21days': 0.08941436127135795, '5year': 0.4049543229785445, 'aberrations': 0.25530145532351156, 'abilities': 0.22595493974331635, 'ability': 1.324839642306342, 'ablation': 0.22069085103056812, 'abnormal': 1.0367103330677871, 'abnormalities': 0.38300944132653436, 'abolish': 0.2718555479744976, 'absence': 0.8375716251092741, 'absent': 0.11923260706965896, 'absorption': 0.414370118668838, 'abundance': 0.38292845952305044, 'accept': 0.24124982222164315, 'access': 0.884590742340919, 'accompany': 0.3349862615628154, 'accord': 0.7630622489550052, 'account': 0.6360863648275327, 'accumulate': 0.6229983913714026, 'accumulate evidence': 0.21157057036440188, 'accumulation': 1.2208634555747504, 'accuracy': 0.3734192708688846, 'accurate': 0.3437475116529604, 'accurately': 0.1337942739137346, 'acetylcholinesterase': 1.5016683395470225, 'achieve': 1.3006793253476738, 'acids': 2.434814402276688, 'acquisition': 0.08791598272555934, 'across': 0.8994331286124367}\n",
      "Sorted b-term candidate words:  2920   {'cells': 11.505482547564501, 'patients': 11.052819121162656, 'disease': 10.37643949419901, 'study': 8.76179728122658, 'diseases': 8.005747318122978, 'effect': 7.658697786686969, 'expression': 7.510829626897239, 'human': 6.920696698305445, 'brain': 6.882690818408486, 'increase': 6.393316776599983, 'protein': 6.3764108308450185, 'activity': 6.143803328507806, 'result': 6.05157757732785, 'which': 5.8981109834786904, 'include': 5.624032808817241, 'level': 5.526277980062726, 'alzheimers': 5.494764002315006, 'signal': 5.482106559518565, 'function': 5.278937023734369, 'associate': 5.159066970744709, 'alzheimers disease': 5.088994813283004, 'cancer': 5.0373204820019435, 'treatment': 5.000578534464777, 'group': 4.925367044367479, 'disorder': 4.893191833280733, 'factor': 4.86952157758128, 'model': 4.822757945973067, 'review': 4.792924104547856, 'clinical': 4.7533676289864975, 'proteins': 4.61998799029231}\n",
      "The first and the last sorted b-term word:  ('cells', 11.505482547564501)   ('diaries', 0.06992554366769578)\n",
      "Mean value of max TF-IDF values:  0.6492606555861321\n"
     ]
    }
   ],
   "source": [
    "max_word_tfidf_selected = selected_tfidfSum\n",
    "\n",
    "import itertools\n",
    "print('All the words in the vocabulary: ', len(max_word_tfidf))\n",
    "print('Selected b-term candidate words: ', len(max_word_tfidf_selected), ' ', dict(itertools.islice(max_word_tfidf_selected.items(), 30)))\n",
    "\n",
    "max_word_tfidf_selected_sorted = LBD_02_data_preprocessing.sort_dict_by_value(max_word_tfidf_selected, True)\n",
    "\n",
    "print('Sorted b-term candidate words: ', len(max_word_tfidf_selected_sorted), ' ', dict(itertools.islice(max_word_tfidf_selected_sorted.items(), 30)))\n",
    "print('The first and the last sorted b-term word: ', list(max_word_tfidf_selected_sorted.items())[0], ' ', list(max_word_tfidf_selected_sorted.items())[-1])\n",
    "print('Mean value of max TF-IDF values: ', np.array(list(max_word_tfidf_selected_sorted.values())).mean())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 256,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'cells': 11.505482547564501,\n",
       " 'patients': 11.052819121162656,\n",
       " 'disease': 10.37643949419901,\n",
       " 'study': 8.76179728122658,\n",
       " 'diseases': 8.005747318122978,\n",
       " 'effect': 7.658697786686969,\n",
       " 'expression': 7.510829626897239,\n",
       " 'human': 6.920696698305445,\n",
       " 'brain': 6.882690818408486,\n",
       " 'increase': 6.393316776599983,\n",
       " 'protein': 6.3764108308450185,\n",
       " 'activity': 6.143803328507806,\n",
       " 'result': 6.05157757732785,\n",
       " 'which': 5.8981109834786904,\n",
       " 'include': 5.624032808817241,\n",
       " 'level': 5.526277980062726,\n",
       " 'alzheimers': 5.494764002315006,\n",
       " 'signal': 5.482106559518565,\n",
       " 'function': 5.278937023734369,\n",
       " 'associate': 5.159066970744709,\n",
       " 'alzheimers disease': 5.088994813283004,\n",
       " 'cancer': 5.0373204820019435,\n",
       " 'treatment': 5.000578534464777,\n",
       " 'group': 4.925367044367479,\n",
       " 'disorder': 4.893191833280733,\n",
       " 'factor': 4.86952157758128,\n",
       " 'model': 4.822757945973067,\n",
       " 'review': 4.792924104547856,\n",
       " 'clinical': 4.7533676289864975,\n",
       " 'proteins': 4.61998799029231,\n",
       " 'control': 4.409207381192937,\n",
       " 'potential': 4.384292967617772,\n",
       " 'chronic': 4.371454155247264,\n",
       " 'receptor': 4.232871762022867,\n",
       " 'suggest': 4.228137029208508,\n",
       " 'process': 4.141421201494419,\n",
       " 'immune': 4.130000653633517,\n",
       " 'tissue': 4.123982706176929,\n",
       " 'analysis': 4.102446355480473,\n",
       " 'induce': 4.096208643011923,\n",
       " 'compound': 4.092308670921074,\n",
       " 'neurodegenerative': 4.086087634848002,\n",
       " 'system': 3.9359555146004253,\n",
       " 'target': 3.89859910336128,\n",
       " 'condition': 3.8449022234208323,\n",
       " 'stress': 3.7969398576044773,\n",
       " 'present': 3.758481157594282,\n",
       " 'inflammatory': 3.715328054990758,\n",
       " 'involve': 3.6928391805140826,\n",
       " 'identify': 3.6719292555442955,\n",
       " 'report': 3.664467386913677,\n",
       " 'mechanisms': 3.6641718857656658,\n",
       " 'development': 3.6613709865903146,\n",
       " 'different': 3.647175989674288,\n",
       " 'reduce': 3.6198381608501258,\n",
       " 'response': 3.549597398504856,\n",
       " 'regulate': 3.5217130945392037,\n",
       " 'change': 3.505479490458436,\n",
       " 'therapeutic': 3.452593321637576,\n",
       " 'inflammation': 3.4472789045563514,\n",
       " 'health': 3.4201655395804416,\n",
       " 'several': 3.4102184739614687,\n",
       " 'however': 3.388432756783197,\n",
       " 'evidence': 3.3831710971779563,\n",
       " 'genes': 3.372612960787949,\n",
       " 'molecular': 3.3685097632278156,\n",
       " 'important': 3.366538188782905,\n",
       " 'decrease': 3.311974629835836,\n",
       " 'neuronal': 3.294564611878021,\n",
       " 'novel': 3.275805968667794,\n",
       " 'recent': 3.2689118603762055,\n",
       " 'demonstrate': 3.254804121720148,\n",
       " 'compare': 3.2213201613311,\n",
       " 'therapy': 3.2101653374413033,\n",
       " 'receptors': 3.1521008324627973,\n",
       " 'could': 3.098039448601929,\n",
       " 'complex': 3.0906584491859017,\n",
       " 'provide': 3.0632976817712256,\n",
       " 'cause': 3.016588276240369,\n",
       " 'pathways': 3.011769442783294,\n",
       " 'significant': 2.966347691428745,\n",
       " 'methods': 2.9623129275508857,\n",
       " 'activation': 2.95736937268006,\n",
       " 'structure': 2.9440548573265355,\n",
       " 'investigate': 2.9208748718114004,\n",
       " 'various': 2.9147732322870805,\n",
       " 'indicate': 2.9098104224898527,\n",
       " 'significantly': 2.8558537705091127,\n",
       " 'specific': 2.8358120889956053,\n",
       " 'biological': 2.826701022629043,\n",
       " 'blood': 2.8028303105253682,\n",
       " 'mechanism': 2.79307552524203,\n",
       " 'inhibitors': 2.7807780847924795,\n",
       " 'oxidative': 2.778814011512213,\n",
       " 'years': 2.7265313277379923,\n",
       " 'assay': 2.7115624845438555,\n",
       " 'respectively': 2.7054102820293737,\n",
       " 'develop': 2.699093470437325,\n",
       " 'sample': 2.6912287091833345,\n",
       " 'inhibit': 2.662355417774533,\n",
       " 'enhance': 2.6475766091133464,\n",
       " 'understand': 2.6442388641877326,\n",
       " 'treat': 2.6441827579111172,\n",
       " 'infection': 2.6403625348001936,\n",
       " 'approach': 2.6316285619091055,\n",
       " 'neurons': 2.6257438009913194,\n",
       " 'antioxidant': 2.6208707978604706,\n",
       " 'diabetes': 2.6190170738070817,\n",
       " 'discuss': 2.604070716317651,\n",
       " 'genetic': 2.5997855854789735,\n",
       " 'central': 2.587145917173763,\n",
       " 'research': 2.556407405466645,\n",
       " 'inhibition': 2.5378859775698386,\n",
       " 'regulation': 2.53106384964128,\n",
       " 'number': 2.5167250340667855,\n",
       " 'functional': 2.5104275687042428,\n",
       " 'properties': 2.495638274762982,\n",
       " 'evaluate': 2.489610271807913,\n",
       " 'higher': 2.4860620646718736,\n",
       " 'affect': 2.4746214203787793,\n",
       " 'network': 2.4598272182359158,\n",
       " 'reveal': 2.4594476321766976,\n",
       " 'metabolic': 2.459392235137392,\n",
       " 'screen': 2.4563938003640646,\n",
       " 'describe': 2.4497819254749515,\n",
       " 'acids': 2.434814402276688,\n",
       " 'among': 2.430471185233724,\n",
       " 'observe': 2.4224810817755675,\n",
       " 'pathway': 2.4220563869936207,\n",
       " 'multiple': 2.4023767799169886,\n",
       " 'determine': 2.398779270102406,\n",
       " 'death': 2.3929662855323293,\n",
       " 'active': 2.38333793668283,\n",
       " 'vitro': 2.3744365352983157,\n",
       " 'cognitive': 2.373098586683481,\n",
       " 'perform': 2.361874037464701,\n",
       " 'interaction': 2.3520744659069504,\n",
       " 'pathogenesis': 2.3458680225614335,\n",
       " 'cardiovascular': 2.3409968494541524,\n",
       " 'apoptosis': 2.3387842006356374,\n",
       " 'contribute': 2.3315904939843763,\n",
       " 'relate': 2.3283726232715356,\n",
       " 'addition': 2.326670854627434,\n",
       " 'extract': 2.3260582493198783,\n",
       " 'plasma': 2.3236735523328798,\n",
       " 'subject': 2.3084713220573057,\n",
       " 'value': 2.2952932682427165,\n",
       " 'metabolism': 2.290789255618295,\n",
       " 'follow': 2.287433511176418,\n",
       " 'serum': 2.2773092764550036,\n",
       " 'responses': 2.2738139355126448,\n",
       " 'common': 2.2602173683574973,\n",
       " 'first': 2.2596955917194155,\n",
       " 'focus': 2.258890311713546,\n",
       " 'major': 2.2341214536005616,\n",
       " 'activities': 2.22784431719235,\n",
       " 'phosphorylation': 2.2049324188245185,\n",
       " 'mortality': 2.199336792031129,\n",
       " 'current': 2.191065757707972,\n",
       " 'nervous': 2.189411659096204,\n",
       " 'interactions': 2.1795036059130584,\n",
       " 'association': 2.1725582204927285,\n",
       " 'primary': 2.1723414359809454,\n",
       " 'contain': 2.1707010286593365,\n",
       " 'within': 2.1597130378999903,\n",
       " 'peptide': 2.1588397525473773,\n",
       " 'synthesis': 2.1559783006255815,\n",
       " 'formation': 2.1478907062163377,\n",
       " 'neuroprotective': 2.1440316627379135,\n",
       " 'obesity': 2.1298695937936865,\n",
       " 'neuroinflammation': 2.128696796555834,\n",
       " 'exposure': 2.0946792961964804,\n",
       " 'production': 2.088058108633223,\n",
       " 'modulate': 2.0864926023848986,\n",
       " 'plant': 2.0837934693879765,\n",
       " 'improve': 2.0745857432140244,\n",
       " 'profile': 2.0727056934422157,\n",
       " 'potent': 2.071156063375541,\n",
       " 'oxidative stress': 2.068318924521163,\n",
       " 'symptoms': 2.052847438868508,\n",
       " 'method': 2.0016306912983146,\n",
       " 'amyloid': 2.000803691412488,\n",
       " 'consider': 1.9990677707327997,\n",
       " 'article': 1.9926738764343628,\n",
       " 'mediate': 1.98839634280443,\n",
       " 'characterize': 1.9856400137103731,\n",
       " 'mouse': 1.980489946787921,\n",
       " 'action': 1.9804155218370239,\n",
       " 'inhibitor': 1.9774196652108713,\n",
       " 'sequence': 1.976446889846748,\n",
       " 'alter': 1.9637193393100847,\n",
       " 'neurological': 1.9635075191128577,\n",
       " 'nervous system': 1.9620700096246628,\n",
       " 'obtain': 1.95748914755033,\n",
       " 'possible': 1.9517985604936765,\n",
       " 'healthy': 1.9483917398643429,\n",
       " 'molecules': 1.9472169704939124,\n",
       " 'impact': 1.9457531067573137,\n",
       " 'background': 1.9428960864288418,\n",
       " 'remain': 1.941211048295043,\n",
       " 'surface': 1.9401744492801802,\n",
       " 'propose': 1.913962140299283,\n",
       " 'detection': 1.9128795583896663,\n",
       " 'might': 1.9125390828922604,\n",
       " 'antiinflammatory': 1.9076665195948104,\n",
       " 'structural': 1.8873724003227763,\n",
       " 'conclusion': 1.8870479355109115,\n",
       " 'growth': 1.8742692726522068,\n",
       " 'design': 1.8679247981025722,\n",
       " 'insulin': 1.8662400812334987,\n",
       " 'range': 1.8645768748826828,\n",
       " 'small': 1.8625564714945988,\n",
       " 'support': 1.8623596741113289,\n",
       " 'lower': 1.8485858658630474,\n",
       " 'promote': 1.8432307584802365,\n",
       " 'recently': 1.8409361360630954,\n",
       " 'prevent': 1.8390154175692874,\n",
       " 'inhibitory': 1.8373714771996312,\n",
       " 'syndrome': 1.8362325077619928,\n",
       " 'concentrations': 1.8358940717531784,\n",
       " 'damage': 1.8318320829182513,\n",
       " 'neurodegeneration': 1.8295431598475331,\n",
       " 'survival': 1.824155862052502,\n",
       " 'although': 1.8228588840625275,\n",
       " 'conclusions': 1.8200173120917034,\n",
       " 'species': 1.8192340027364102,\n",
       " 'three': 1.8143030664386783,\n",
       " 'total': 1.797394132274254,\n",
       " 'membrane': 1.7930448490251059,\n",
       " 'occur': 1.7920800023626262,\n",
       " 'influence': 1.7849382887561045,\n",
       " 'measure': 1.7776658193355843,\n",
       " 'furthermore': 1.7761907903154224,\n",
       " 'presence': 1.7750957730147363,\n",
       " 'progression': 1.7718493663314163,\n",
       " 'underlie': 1.765105228726595,\n",
       " 'culture': 1.7602799281847716,\n",
       " 'assess': 1.7506639418469447,\n",
       " 'therefore': 1.7505688545830136,\n",
       " 'neural': 1.7473055269842697,\n",
       " 'medicine': 1.7460763634159155,\n",
       " 'injury': 1.7453471118342483,\n",
       " 'pathological': 1.743602077860895,\n",
       " 'implicate': 1.7378898014947417,\n",
       " 'analyze': 1.7368536018247314,\n",
       " 'moreover': 1.7273196107304944,\n",
       " 'intestinal': 1.7249438095541392,\n",
       " 'domain': 1.7199062346211005,\n",
       " 'enzymes': 1.7095781161506964,\n",
       " 'proinflammatory': 1.70861458571446,\n",
       " 'information': 1.7083019842028893,\n",
       " 'concentration': 1.7060428613363268,\n",
       " 'systems': 1.6998910665437474,\n",
       " 'elevate': 1.6948865256821017,\n",
       " 'positive': 1.6933454093886535,\n",
       " 'promise': 1.6914541544769783,\n",
       " 'examine': 1.69041021093058,\n",
       " 'epigenetic': 1.6878941298664645,\n",
       " 'dietary': 1.6830018153367097,\n",
       " 'natural': 1.6716884997777126,\n",
       " 'fatty': 1.6660954377631307,\n",
       " 'similar': 1.6647428171843788,\n",
       " 'require': 1.6626223743769544,\n",
       " 'effective': 1.6547846959751134,\n",
       " 'source': 1.6484447565993148,\n",
       " 'adult': 1.6472207475045748,\n",
       " 'exhibit': 1.6403338714615687,\n",
       " 'central nervous': 1.6375073666881546,\n",
       " 'liver': 1.6301194258841694,\n",
       " 'normal': 1.6293664420191991,\n",
       " 'metabolites': 1.6291623769968269,\n",
       " 'crohns': 1.6247467672457008,\n",
       " 'state': 1.6245451141008305,\n",
       " 'without': 1.6244273180336537,\n",
       " 'beneficial': 1.620044675990353,\n",
       " 'analyse': 1.6099223069311654,\n",
       " 'detect': 1.6057151407233217,\n",
       " 'produce': 1.5973681394019181,\n",
       " 'interest': 1.5969654175475099,\n",
       " 'whether': 1.5695056965849374,\n",
       " 'early': 1.567358506509139,\n",
       " 'pathology': 1.556119470887821,\n",
       " 'systemic': 1.5559053350839704,\n",
       " 'antibodies': 1.5503598825213143,\n",
       " 'central nervous system': 1.5470799838858842,\n",
       " 'feature': 1.5429699006268776,\n",
       " 'experimental': 1.5422591020599992,\n",
       " 'isolate': 1.5408267757093483,\n",
       " 'pharmacological': 1.5407498518057412,\n",
       " 'physiological': 1.5259555224130048,\n",
       " 'diagnosis': 1.5254781681243055,\n",
       " 'protect': 1.5173982880466943,\n",
       " 'agent': 1.514806467808419,\n",
       " 'crohns disease': 1.51326345303374,\n",
       " 'strategy': 1.5085729773064622,\n",
       " 'peripheral': 1.5069792371160333,\n",
       " 'confirm': 1.5062699571329785,\n",
       " 'bacterial': 1.5019352903415202,\n",
       " 'acetylcholinesterase': 1.5016683395470225,\n",
       " 'previously': 1.500748910365675,\n",
       " 'events': 1.5002334532868573,\n",
       " 'advance': 1.4982658968722986,\n",
       " 'hypothesis': 1.4826896696532452,\n",
       " 'generate': 1.4775060345002007,\n",
       " 'phenotype': 1.47588582708428,\n",
       " 'population': 1.4727178609278,\n",
       " 'particular': 1.4722643155300388,\n",
       " 'applications': 1.4698974998771916,\n",
       " 'kidney': 1.4687991210444742,\n",
       " 'choline': 1.463849485370178,\n",
       " 'mutations': 1.4610941219081857,\n",
       " 'either': 1.457470853581345,\n",
       " 'limit': 1.4476858336940184,\n",
       " 'relationship': 1.4387336770656645,\n",
       " 'parkinsons': 1.4362420318754456,\n",
       " 'essential': 1.4349979634155587,\n",
       " 'amino': 1.4302505537648795,\n",
       " 'still': 1.4295990363667384,\n",
       " 'cycle': 1.426410410514755,\n",
       " 'neurotoxicity': 1.4243411203914653,\n",
       " 'homeostasis': 1.4242820552037216,\n",
       " 'general': 1.4242117487933688,\n",
       " 'reduction': 1.4229080298636594,\n",
       " 'amyloidbeta': 1.4204611867113985,\n",
       " 'whereas': 1.4203169417092816,\n",
       " 'depression': 1.4145285030613988,\n",
       " 'renal': 1.4142220355740955,\n",
       " 'allow': 1.4138545974420984,\n",
       " 'variants': 1.412289578177982,\n",
       " 'administration': 1.4100488577365686,\n",
       " 'direct': 1.4077301954688977,\n",
       " 'individuals': 1.403361720101211,\n",
       " 'benefit': 1.4026265024987068,\n",
       " 'environmental': 1.3974418994042346,\n",
       " 'heart': 1.3896115944946488,\n",
       " 'become': 1.3872565464007909,\n",
       " 'apply': 1.3771952714663485,\n",
       " 'cohort': 1.3753842604018305,\n",
       " 'reaction': 1.373715064075683,\n",
       " 'class': 1.3683523318513913,\n",
       " 'involvement': 1.362509047596149,\n",
       " 'andor': 1.3615858063220578,\n",
       " 'alternative': 1.3555884156088225,\n",
       " 'pathologies': 1.355430453502598,\n",
       " 'reactive': 1.3552097512319894,\n",
       " 'animal': 1.3548766474681746,\n",
       " 'estimate': 1.3477310788888484,\n",
       " 'variety': 1.347155398113785,\n",
       " 'strategies': 1.3444424793380236,\n",
       " 'transport': 1.3420138066535474,\n",
       " 'combination': 1.338905692935835,\n",
       " 'longterm': 1.33698143461118,\n",
       " 'highly': 1.334620700476539,\n",
       " 'literature': 1.3344980793483214,\n",
       " 'ability': 1.324839642306342,\n",
       " 'diverse': 1.3245548150121493,\n",
       " 'adverse': 1.3243626705149463,\n",
       " 'select': 1.3154064397195744,\n",
       " 'acute': 1.3021763170265155,\n",
       " 'single': 1.3020746832756662,\n",
       " 'nfkappab': 1.3016273562938754,\n",
       " 'achieve': 1.3006793253476738,\n",
       " 'objective': 1.2992173456615526,\n",
       " 'immune system': 1.2984238317061005,\n",
       " 'trials': 1.2936591271413265,\n",
       " 'tnfalpha': 1.2934876084228615,\n",
       " 'highlight': 1.2925765356069456,\n",
       " 'muscle': 1.284326231043727,\n",
       " 'agents': 1.2815537461871784,\n",
       " 'disease patients': 1.2812777941107365,\n",
       " 'differences': 1.2792964398162006,\n",
       " 'dysfunction': 1.266576828469741,\n",
       " 'kinase': 1.2638899902642378,\n",
       " 'neuroprotection': 1.2632667397268755,\n",
       " 'oxygen': 1.2570746901003307,\n",
       " 'prevalence': 1.2568707101351402,\n",
       " 'autophagy': 1.2566882268913813,\n",
       " 'appear': 1.2533946364747106,\n",
       " 'despite': 1.2500042185103795,\n",
       " 'receive': 1.247502548868162,\n",
       " 'capacity': 1.2454090149073582,\n",
       " 'prevention': 1.2450045501454332,\n",
       " 'useful': 1.2429957418934143,\n",
       " 'outcomes': 1.2424451428955794,\n",
       " 'resistance': 1.241880220408148,\n",
       " 'medical': 1.2412718304128414,\n",
       " 'finally': 1.2356084620382306,\n",
       " 'importance': 1.2353688000381395,\n",
       " 'strong': 1.2292912131084899,\n",
       " 'bowel': 1.2226738640664039,\n",
       " 'accumulation': 1.2208634555747504,\n",
       " 'toxicity': 1.2180847450122205,\n",
       " 'pylori': 1.2122923380114548,\n",
       " 'endothelial': 1.211849053051739,\n",
       " 'attenuate': 1.2114607638619381,\n",
       " 'phase': 1.209480460747118,\n",
       " 'future': 1.2085920546419227,\n",
       " 'memory': 1.2082178053280161,\n",
       " 'index': 1.2078396543870273,\n",
       " 'region': 1.2072189759916427,\n",
       " 'followup': 1.2072064094424757,\n",
       " 'large': 1.2047154152404445,\n",
       " 'interact': 1.203908640295732,\n",
       " 'where': 1.2016370729950783,\n",
       " 'patient': 1.2006664531564697,\n",
       " 'baseline': 1.187177636494511,\n",
       " 'spectrometry': 1.1858817036650635,\n",
       " 'available': 1.1801943313366086,\n",
       " 'since': 1.1795252953934972,\n",
       " 'mouse model': 1.1791364488729685,\n",
       " 'together': 1.1784145903019918,\n",
       " 'vaccine': 1.1770282826382523,\n",
       " 'directly': 1.176733245534752,\n",
       " 'undergo': 1.176289498671833,\n",
       " 'modification': 1.1748474987906135,\n",
       " 'protective': 1.1747861338950176,\n",
       " 'define': 1.1702818001040451,\n",
       " 'tumor': 1.1687890310616058,\n",
       " 'efficacy': 1.1643541793604433,\n",
       " 'incidence': 1.1632007677548197,\n",
       " 'evaluation': 1.1630089236559884,\n",
       " 'antibody': 1.159557428960397,\n",
       " 'score': 1.1586702811201053,\n",
       " 'discovery': 1.1577658585659711,\n",
       " 'experiment': 1.157427709300507,\n",
       " 'regions': 1.1558967479786642,\n",
       " 'represent': 1.153562338417065,\n",
       " 'emerge': 1.1530620680951214,\n",
       " 'alterations': 1.152970852151347,\n",
       " 'application': 1.1515052230707072,\n",
       " 'children': 1.1457179862915292,\n",
       " 'failure': 1.1447560864257078,\n",
       " 'summarize': 1.1428256451299617,\n",
       " 'secondary': 1.1411496476648106,\n",
       " 'mugml': 1.1402142943465872,\n",
       " 'fragment': 1.138569351464313,\n",
       " 'dynamics': 1.1368564999792028,\n",
       " 'series': 1.1345824813316452,\n",
       " 'fatty acids': 1.1340700749709303,\n",
       " 'pressure': 1.1324255145920368,\n",
       " 'critical': 1.130223739811881,\n",
       " 'unknown': 1.1293263678140835,\n",
       " 'combine': 1.127592142226694,\n",
       " 'hippocampus': 1.1271215504688912,\n",
       " 'modify': 1.1254796145496797,\n",
       " 'particularly': 1.1231633445274625,\n",
       " 'context': 1.1210526423103122,\n",
       " 'knowledge': 1.1203095587926601,\n",
       " 'establish': 1.1140108939052409,\n",
       " 'correlate': 1.1132126865367222,\n",
       " 'status': 1.1113305680153587,\n",
       " 'modulation': 1.1095808845878783,\n",
       " 'negative': 1.1067305544359403,\n",
       " 'markers': 1.1019014608039244,\n",
       " 'impair': 1.0968992175015837,\n",
       " 'substrates': 1.0934036205715714,\n",
       " 'nutritional': 1.0851385158509206,\n",
       " 'conserve': 1.0839138147205962,\n",
       " 'elucidate': 1.0783414505864048,\n",
       " 'maintain': 1.0755100475679993,\n",
       " 'cardiovascular disease': 1.0739454902975938,\n",
       " 'delivery': 1.0735808987147182,\n",
       " 'subsequent': 1.0708539964257529,\n",
       " 'synaptic': 1.0692301356594478,\n",
       " 'interventions': 1.0642468435550059,\n",
       " 'aggregation': 1.0632031566214537,\n",
       " 'months': 1.055968512389518,\n",
       " 'agerelated': 1.0557193215534986,\n",
       " 'present study': 1.0539431746079184,\n",
       " 'selective': 1.0528560824103261,\n",
       " 'onset': 1.051653863380723,\n",
       " 'diagnose': 1.0498954390467907,\n",
       " 'identification': 1.0479930895410312,\n",
       " 'label': 1.0476997578659335,\n",
       " 'components': 1.0474992495426352,\n",
       " 'concern': 1.0472621589211977,\n",
       " 'stable': 1.0470387379321937,\n",
       " 'likely': 1.0467443010197366,\n",
       " 'regard': 1.0438548330798805,\n",
       " 'mainly': 1.042296577694818,\n",
       " 'overall': 1.0422637911200718,\n",
       " 'dementia': 1.0397020322445727,\n",
       " 'stimulate': 1.0389923536934424,\n",
       " 'stability': 1.0386633155049652,\n",
       " 'phenotypes': 1.0384129166934943,\n",
       " 'abnormal': 1.0367103330677871,\n",
       " 'exert': 1.036299841052282,\n",
       " 'enable': 1.0345161879715754,\n",
       " 'parkinsons disease': 1.0327503227389836,\n",
       " 'neuroprotective effect': 1.0319959686389644,\n",
       " 'extend': 1.028885747489141,\n",
       " 'order': 1.0271745882050407,\n",
       " 'explore': 1.0265256404119334,\n",
       " 'aspects': 1.0259611025868927,\n",
       " 'neurodegenerative disorder': 1.024945255812176,\n",
       " 'therapies': 1.0239787412900232,\n",
       " 'recognize': 1.023303310349366,\n",
       " 'image': 1.0182960433070027,\n",
       " 'biomarkers': 1.0182762405093637,\n",
       " 'people': 1.0155932696055818,\n",
       " 'yield': 1.0137799184582466,\n",
       " 'traditional': 1.0136677604280344,\n",
       " 'utility': 1.0125471348723383,\n",
       " 'trigger': 1.0120337385953042,\n",
       " 'insights': 1.0109046901194876,\n",
       " 'publish': 1.0106494573156122,\n",
       " 'respiratory': 1.0105309660716437,\n",
       " 'degrees': 1.0098147640780524,\n",
       " 'biochemical': 1.009194432260812,\n",
       " 'manner': 1.0075217228269702,\n",
       " 'calcium': 1.0071537158821826,\n",
       " 'animal model': 1.0070526481523396,\n",
       " 'nutrition': 1.0066387521663707,\n",
       " 'susceptibility': 1.0056153194137207,\n",
       " 'innate': 1.0046360110798387,\n",
       " 'upregulated': 1.0046131624733718,\n",
       " 'treatments': 1.0038233890068249,\n",
       " 'relevant': 1.0027569166694412,\n",
       " 'distinct': 1.0021040365270855,\n",
       " 'pattern': 1.000778757796874,\n",
       " 'numerous': 0.996905255223708,\n",
       " 'implications': 0.9912446798047875,\n",
       " 'mutation': 0.9908219488582051,\n",
       " 'biology': 0.9839434527679606,\n",
       " 'sodium': 0.9819263542872845,\n",
       " 'depend': 0.980273163910044,\n",
       " 'recent study': 0.9802158083252233,\n",
       " 'genomic': 0.9765050460931247,\n",
       " 'basis': 0.9746763520080359,\n",
       " 'purpose': 0.9737252778789555,\n",
       " 'standard': 0.9718985261403674,\n",
       " 'serve': 0.9680713426495516,\n",
       " 'ratio': 0.965775131448242,\n",
       " 'result suggest': 0.9627577228148994,\n",
       " 'field': 0.9624611676152085,\n",
       " 'water': 0.9594740812780775,\n",
       " 'responsible': 0.9590129947972835,\n",
       " 'specifically': 0.9577913619253589,\n",
       " 'independent': 0.9567509514062571,\n",
       " 'chain': 0.9561599976946266,\n",
       " 'western': 0.9547361627727177,\n",
       " 'developmental': 0.9542742061215309,\n",
       " 'behavior': 0.9541916189790843,\n",
       " 'previous': 0.9541859982308598,\n",
       " 'trial': 0.9505472077980945,\n",
       " 'reactive oxygen': 0.9505086776382532,\n",
       " 'carry': 0.9497151249657042,\n",
       " 'generation': 0.9491651997933755,\n",
       " 'cluster': 0.9483908139323316,\n",
       " 'protease': 0.9448881375716915,\n",
       " 'point': 0.9447039618011129,\n",
       " 'predict': 0.939620119029048,\n",
       " 'oxygen species': 0.9389644389659573,\n",
       " 'validate': 0.9379006505316045,\n",
       " 'strongly': 0.9372465551409692,\n",
       " 'additional': 0.9366701117417395,\n",
       " 'hospital': 0.9358872941555983,\n",
       " 'search': 0.9357591963698006,\n",
       " 'hippocampal': 0.9341470313519314,\n",
       " 'amount': 0.9310232796743102,\n",
       " 'median': 0.9281147900413445,\n",
       " 'bacteria': 0.927338816082283,\n",
       " 'surgery': 0.9271603713444153,\n",
       " 'weeks': 0.9268354612730174,\n",
       " 'content': 0.9245850425137959,\n",
       " 'associations': 0.9226118834307461,\n",
       " 'least': 0.9225291481181201,\n",
       " 'issue': 0.9191177955341441,\n",
       " 'material': 0.9134839733924714,\n",
       " 'conduct': 0.9132201815581142,\n",
       " 'specificity': 0.9114921358193376,\n",
       " 'challenge': 0.9109743285169871,\n",
       " 'practice': 0.907899874056166,\n",
       " 'smoke': 0.9063962255098901,\n",
       " 'concept': 0.9062057438461493,\n",
       " 'reactive oxygen species': 0.9058379872217853,\n",
       " 'pathophysiology': 0.904880893044699,\n",
       " 'infections': 0.9036139405745788,\n",
       " 'overview': 0.9026516161669835,\n",
       " 'older': 0.9023952671983023,\n",
       " 'chromatography': 0.9010631341791859,\n",
       " 'across': 0.8994331286124367,\n",
       " 'glucose': 0.8987541926316437,\n",
       " 'expose': 0.898751049491652,\n",
       " 'fraction': 0.8911784341969876,\n",
       " 'potentially': 0.8887301043000452,\n",
       " 'energy': 0.8884202288108136,\n",
       " 'paper': 0.8882765545703105,\n",
       " 'second': 0.8880641003753323,\n",
       " 'neuron': 0.8858896803474919,\n",
       " 'uptake': 0.8853832476348892,\n",
       " 'quality': 0.8851220550537818,\n",
       " 'differentiate': 0.8847169413892143,\n",
       " 'access': 0.884590742340919,\n",
       " 'metaanalysis': 0.8791913308981009,\n",
       " 'gastrointestinal': 0.8763880490425461,\n",
       " 'polymorphism': 0.8761608975550454,\n",
       " 'study suggest': 0.8753558971645123,\n",
       " 'atherosclerosis': 0.8751597103233505,\n",
       " 'contrast': 0.8741223425549919,\n",
       " 'hepatic': 0.8721253201117318,\n",
       " 'largely': 0.8714228731736561,\n",
       " 'monitor': 0.8694699786223777,\n",
       " 'prepare': 0.8693614348105461,\n",
       " 'populations': 0.8683239050268872,\n",
       " 'folate': 0.868307779986169,\n",
       " 'nerve': 0.8672572302476351,\n",
       " 'severe': 0.8646743225019233,\n",
       " 'sulfate': 0.8646228509787316,\n",
       " 'decline': 0.8634062180305505,\n",
       " 'lesions': 0.8617637853983116,\n",
       " 'differential': 0.8593615391492626,\n",
       " 'impairment': 0.8564138931684702,\n",
       " 'defect': 0.8555583687718857,\n",
       " 'physical': 0.8555074984898968,\n",
       " 'comparison': 0.8541203225054947,\n",
       " 'patent': 0.85275323770407,\n",
       " 'derive': 0.8517452358408784,\n",
       " 'chronic kidney': 0.8489924397351917,\n",
       " 'humans': 0.848833331793686,\n",
       " 'elderly': 0.8482378439744516,\n",
       " 'toxic': 0.8473819785594423,\n",
       " 'consumption': 0.8472547822617534,\n",
       " 'sensitivity': 0.8471347201351089,\n",
       " 'certain': 0.846254311582706,\n",
       " 'evidence suggest': 0.845729092355059,\n",
       " 'would': 0.8448144491904935,\n",
       " 'absence': 0.8375716251092741,\n",
       " 'mental': 0.8360827963392691,\n",
       " 'especially': 0.835138729175708,\n",
       " 'display': 0.8333715407757445,\n",
       " 'diagnostic': 0.8319482313766828,\n",
       " 'protein expression': 0.8313819979260799,\n",
       " 'better': 0.8283432869570632,\n",
       " 'delay': 0.8272409602521087,\n",
       " 'reactions': 0.8257116543410917,\n",
       " 'nterminal': 0.8244704613835999,\n",
       " 'relevance': 0.8219050581543846,\n",
       " 'greater': 0.820273479889217,\n",
       " 'characteristics': 0.8189799781464057,\n",
       " 'facilitate': 0.8188683474405152,\n",
       " 'efficient': 0.8183089875165276,\n",
       " 'characterization': 0.8180969495141902,\n",
       " 'approximately': 0.8179366404634725,\n",
       " 'inflammatory bowel': 0.8153109403186556,\n",
       " 'beneficial effect': 0.8144519035078034,\n",
       " 'chronic kidney disease': 0.8141911951251706,\n",
       " 'kidney disease': 0.8141911951251706,\n",
       " 'management': 0.8130210811713166,\n",
       " 'cterminal': 0.812959170507316,\n",
       " 'therapeutic target': 0.8113344753850541,\n",
       " 'learn': 0.8082466080674301,\n",
       " 'suppress': 0.8063426953879753,\n",
       " 'fluorescence': 0.8061278001986154,\n",
       " 'vaccines': 0.8058405239612947,\n",
       " 'genomewide': 0.8028843885285029,\n",
       " 'examination': 0.8023073379237189,\n",
       " 'oxide': 0.8013225408168954,\n",
       " 'progressive': 0.8010483739503993,\n",
       " 'blood pressure': 0.8005670033340739,\n",
       " 'fruit': 0.7968689914066189,\n",
       " 'individual': 0.7966272290465536,\n",
       " 'often': 0.7959960039640825,\n",
       " 'toward': 0.794288727305935,\n",
       " 'surgical': 0.793617880407881,\n",
       " 'deliver': 0.7922522268618625,\n",
       " 'infectious': 0.7914184987298937,\n",
       " 'versus': 0.7886369581162768,\n",
       " 'drive': 0.7872183326249369,\n",
       " 'regulator': 0.7865717229470673,\n",
       " 'explain': 0.7862204917578589,\n",
       " 'vascular': 0.7859530133369741,\n",
       " 'adjust': 0.7856483777889516,\n",
       " 'myocardial': 0.7849658227418085,\n",
       " 'cover': 0.7837426632854716,\n",
       " 'mediators': 0.7802989370209757,\n",
       " 'shock': 0.7786014300114541,\n",
       " 'stage': 0.7767136969239091,\n",
       " 'progress': 0.7765439631873216,\n",
       " 'p0001': 0.7751660150254823,\n",
       " 'others': 0.7745360069232993,\n",
       " 'immunity': 0.7736735409479079,\n",
       " 'towards': 0.7726505964368916,\n",
       " 'clear': 0.7703756024860526,\n",
       " 'regression': 0.7693368417352086,\n",
       " 'widely': 0.7692722029841487,\n",
       " 'prove': 0.7691936564360188,\n",
       " 'parameters': 0.767784790262897,\n",
       " 'encode': 0.7673555841323241,\n",
       " 'adults': 0.7659451039272892,\n",
       " 'dependent': 0.7631475447454553,\n",
       " 'accord': 0.7630622489550052,\n",
       " 'glutamate': 0.7626371250104431,\n",
       " 'autism': 0.7619699209889443,\n",
       " 'weight': 0.7593956059156002,\n",
       " 'offer': 0.7593509173568224,\n",
       " 'selection': 0.7587652146114285,\n",
       " 'leave': 0.7586897427208549,\n",
       " 'study demonstrate': 0.7583820565524904,\n",
       " 'pathogenic': 0.7583697856819233,\n",
       " 'fully': 0.7559655156265992,\n",
       " 'belong': 0.7558861143004377,\n",
       " 'genome': 0.7552867599956985,\n",
       " 'candidate': 0.7545882813419896,\n",
       " 'distribution': 0.753479415165056,\n",
       " 'special': 0.751817963974415,\n",
       " 'additionally': 0.7497882535189779,\n",
       " 'clinically': 0.7497414949477945,\n",
       " 'broad': 0.7491299503556867,\n",
       " 'urine': 0.7487629065982535,\n",
       " 'autoimmune': 0.7482822464945889,\n",
       " 'double': 0.7478213416616781,\n",
       " 'intake': 0.7466448841072708,\n",
       " 'animals': 0.7451784638206033,\n",
       " 'coronary': 0.7446410513687781,\n",
       " 'women': 0.7430261007313816,\n",
       " 'transplantation': 0.7424654384256908,\n",
       " 'prognostic': 0.7420017266818248,\n",
       " 'period': 0.7419044547360301,\n",
       " 'therapeutic potential': 0.7400762544624202,\n",
       " 'complications': 0.7396070218051354,\n",
       " 'outcome': 0.7393774592168717,\n",
       " 'collect': 0.7388482304263542,\n",
       " 'domains': 0.7387705530142457,\n",
       " 'alphasynuclein': 0.7376772866755461,\n",
       " 'think': 0.7374524149225802,\n",
       " 'hsp70': 0.7372534422293008,\n",
       " 'correlation': 0.735921000429717,\n",
       " 'marker': 0.7355448374463127,\n",
       " 'moderate': 0.7336253737814825,\n",
       " 'neuroinflammatory': 0.7334595611293131,\n",
       " 'initial': 0.7323622742030078,\n",
       " 'serious': 0.7314637857196321,\n",
       " 'consequences': 0.7296247791292537,\n",
       " 'areas': 0.7292973367314785,\n",
       " 'investigation': 0.7272667013332939,\n",
       " 'environment': 0.7251601758994227,\n",
       " 'disorder include': 0.7250215567038133,\n",
       " 'record': 0.7240724809664503,\n",
       " 'vitamin': 0.7235511926595563,\n",
       " 'synthase': 0.7230012545168909,\n",
       " 'little': 0.7226307826525513,\n",
       " 'organisms': 0.7225261798278857,\n",
       " 'metabolite': 0.7211703192172896,\n",
       " 'stain': 0.7208661325437455,\n",
       " 'brain function': 0.72054234952869,\n",
       " 'promoter': 0.7198368716532967,\n",
       " 'deficits': 0.7182750558110598,\n",
       " 'length': 0.7179891880799484,\n",
       " 'hydrogen': 0.7172811354434248,\n",
       " 'materials': 0.7168792741859396,\n",
       " 'statistical': 0.7162480716151258,\n",
       " 'global': 0.7123704609325494,\n",
       " 'alcohol': 0.7098687458080792,\n",
       " 'severity': 0.7071798110480587,\n",
       " 'significance': 0.7037409693002891,\n",
       " 'placebo': 0.7010093431744809,\n",
       " 'importantly': 0.700580997681644,\n",
       " 'study indicate': 0.6986828442138819,\n",
       " 'tumors': 0.698419320821314,\n",
       " 'metabolomic': 0.6982384498074194,\n",
       " 'study investigate': 0.6967125527097489,\n",
       " 'stroke': 0.6965779343006848,\n",
       " 'hypothesize': 0.6954516841055978,\n",
       " 'complete': 0.6948912996953424,\n",
       " 'transcriptional': 0.6934241103317195,\n",
       " 'techniques': 0.6933107150875769,\n",
       " 'hepatitis': 0.6932879088220106,\n",
       " 'problems': 0.6916517647418344,\n",
       " 'start': 0.6910066417789024,\n",
       " 'commonly': 0.6903921333507202,\n",
       " 'metabolomics': 0.6889510566953605,\n",
       " 'toxins': 0.6887130714299424,\n",
       " 'address': 0.6874233592611175,\n",
       " 'spectrum': 0.6872184312613434,\n",
       " 'along': 0.6871744643744434,\n",
       " 'recognition': 0.6853720492421336,\n",
       " 'evolution': 0.6848870912838321,\n",
       " 'glutamine': 0.6825850910223851,\n",
       " 'discussion': 0.6816303306324505,\n",
       " 'robust': 0.6807858273969379,\n",
       " 'hence': 0.6804729448165745,\n",
       " 'behaviour': 0.6790489290612958,\n",
       " 'cholinergic': 0.6774408160561514,\n",
       " 'prior': 0.6765925279838575,\n",
       " 'fibrosis': 0.6753715658983802,\n",
       " 'plaque': 0.6749276883436691,\n",
       " 'criteria': 0.6748799633767432,\n",
       " 'relationships': 0.6745687908193618,\n",
       " 'physiology': 0.6710511160728236,\n",
       " 'participants': 0.6705405793248925,\n",
       " 'correspond': 0.6704678220643622,\n",
       " 'female': 0.6699655505699891,\n",
       " 'majority': 0.6698937798327553,\n",
       " 'health disease': 0.6697262027170592,\n",
       " 'systematic': 0.6689984707571333,\n",
       " 'center': 0.6683953332919205,\n",
       " 'variables': 0.6677891465010821,\n",
       " 'attention': 0.6661878154320757,\n",
       " 'probe': 0.6641011220641188,\n",
       " 'disease activity': 0.663284135635988,\n",
       " 'microbial': 0.6625517983056962,\n",
       " 'spread': 0.6610288303669329,\n",
       " 'independently': 0.6606828227884413,\n",
       " 'conclude': 0.6603442439595515,\n",
       " 'comprehensive': 0.6601096513648069,\n",
       " 'rapid': 0.658504018343888,\n",
       " 'inactive': 0.6575611548136968,\n",
       " 'virus': 0.657119403257706,\n",
       " 'predictive': 0.6570547751741129,\n",
       " 'performance': 0.6548472493256879,\n",
       " 'survey': 0.6543812691900447,\n",
       " 'share': 0.653942247803607,\n",
       " 'matrix': 0.6535435811752789,\n",
       " 'control group': 0.6520889091895407,\n",
       " 'transmembrane': 0.6520507631485999,\n",
       " 'pathophysiological': 0.6498994321016545,\n",
       " 'persistent': 0.6497970544058449,\n",
       " 'experience': 0.649370712266128,\n",
       " 'history': 0.6484095013388723,\n",
       " 'randomize': 0.6478320038896455,\n",
       " 'unclear': 0.6474941509872043,\n",
       " 'improvement': 0.6465217672491235,\n",
       " 'behavioral': 0.6452831094552134,\n",
       " 'compare control': 0.644851424760462,\n",
       " 'difference': 0.644364312281068,\n",
       " 'cortex': 0.6433162052963741,\n",
       " 'gastric': 0.6425932305364866,\n",
       " 'spectroscopy': 0.6419116561106356,\n",
       " 'expression level': 0.6416984854793175,\n",
       " 'caffeine': 0.6414014538001622,\n",
       " 'variant': 0.6408929015977157,\n",
       " 'nitric': 0.6407371462643222,\n",
       " 'nitric oxide': 0.6407371462643222,\n",
       " 'burden': 0.6399009675474335,\n",
       " 'cardiac': 0.6398325981970795,\n",
       " 'account': 0.6360863648275327,\n",
       " 'pivotal': 0.6355063752605196,\n",
       " 'mucosa': 0.6339186471450187,\n",
       " 'elisa': 0.6327473084338825,\n",
       " 'countries': 0.6327311053297615,\n",
       " 'mimic': 0.6310935473782295,\n",
       " 'relative': 0.62972936728445,\n",
       " 'capable': 0.6294063700468052,\n",
       " 'cross': 0.6285997323577459,\n",
       " 'extraction': 0.6280984818657053,\n",
       " 'resolution': 0.6269740213505496,\n",
       " 'polymorphisms': 0.6253543765391102,\n",
       " 'result indicate': 0.6241922642847705,\n",
       " 'accumulate': 0.6229983913714026,\n",
       " 'scientific': 0.6225268991914698,\n",
       " 'traits': 0.6205521023809931,\n",
       " 'product': 0.6197126827890834,\n",
       " 'eight': 0.618695324921534,\n",
       " 'upregulation': 0.614988534107769,\n",
       " 'introduction': 0.6148346953677315,\n",
       " 'restore': 0.6143681722686248,\n",
       " 'right': 0.6133243531569634,\n",
       " 'shift': 0.612526074425673,\n",
       " 'optimize': 0.6107085904085784,\n",
       " 'clinical trials': 0.6105697794627744,\n",
       " 'space': 0.6100937452046247,\n",
       " 'quantitative': 0.6097001830904465,\n",
       " 'offspring': 0.6091428349967425,\n",
       " 'cirrhosis': 0.6077096544294729,\n",
       " 'colon': 0.6064329154819483,\n",
       " 'exercise': 0.6063984859347674,\n",
       " 'occurrence': 0.6062054234808645,\n",
       " 'short': 0.6051699611779914,\n",
       " 'schizophrenia': 0.6046579262449542,\n",
       " 'successfully': 0.604577447079181,\n",
       " 'clearance': 0.6042613244064765,\n",
       " 'reference': 0.6016327902485414,\n",
       " 'determination': 0.6012348247720849,\n",
       " 'primarily': 0.5998886514712274,\n",
       " 'insulin resistance': 0.5983374883273554,\n",
       " 'chinese': 0.5980448456957235,\n",
       " 'glutathione': 0.5979225747725764,\n",
       " 'stabilize': 0.5970893423267501,\n",
       " 'consistent': 0.5966054852268095,\n",
       " 'cortical': 0.5965881269537907,\n",
       " 'brain tissue': 0.596422915943921,\n",
       " 'basic': 0.5950711252111526,\n",
       " 'introduce': 0.5946944708520936,\n",
       " 'injection': 0.5938500715121444,\n",
       " 'cognitive function': 0.5937380812973525,\n",
       " 'average': 0.5930124510553806,\n",
       " 'reflect': 0.5916502286776216,\n",
       " 'possibly': 0.5887327924303742,\n",
       " 'environmental factor': 0.5884946431795082,\n",
       " 'adipose': 0.587980495454257,\n",
       " 'frequently': 0.5875280041240076,\n",
       " 'update': 0.5871398892506301,\n",
       " 'repeat': 0.5869478418672537,\n",
       " 'retrospective': 0.5840024835764499,\n",
       " 'cohorts': 0.5832814209932257,\n",
       " 'regulators': 0.582648720531743,\n",
       " 'stomach': 0.5825953997360258,\n",
       " 'mumoll': 0.5817418487672056,\n",
       " 'great': 0.5814804710584841,\n",
       " 'cognitive decline': 0.5805377991415617,\n",
       " 'pancreatic': 0.579568439549296,\n",
       " 'degeneration': 0.5771548888530544,\n",
       " 'crucial': 0.5763402650769255,\n",
       " 'liquid': 0.5763207618087846,\n",
       " 'variation': 0.5755987974031396,\n",
       " 'cardiovascular diseases': 0.5749044926172583,\n",
       " 'diabetes mellitus': 0.5741843412090125,\n",
       " 'mellitus': 0.5741843412090125,\n",
       " 'healthy control': 0.5737510331024476,\n",
       " 'world': 0.5734284288903636,\n",
       " 'genotype': 0.572673281022942,\n",
       " 'measurements': 0.5716728116469258,\n",
       " 'question': 0.57106248883264,\n",
       " 'substantial': 0.5708149282681557,\n",
       " 'specimens': 0.5707061715115279,\n",
       " 'course': 0.570061263695668,\n",
       " 'electron': 0.5664588597142248,\n",
       " 'effectiveness': 0.5661766764046313,\n",
       " 'inflammatory responses': 0.5656397822615765,\n",
       " 'systemic inflammation': 0.56258566751947,\n",
       " 'enrichment': 0.5620497606154345,\n",
       " 'recent years': 0.56127654020461,\n",
       " 'clinic': 0.5603929960655024,\n",
       " 'adipose tissue': 0.5602212080267021,\n",
       " 'cystatin': 0.5599803460347877,\n",
       " 'albumin': 0.5599047165386611,\n",
       " 'frequency': 0.5582539762406049,\n",
       " 'epidemiological': 0.5580005470136296,\n",
       " 'personality': 0.5573923725076088,\n",
       " 'serotonin': 0.5551895285575278,\n",
       " 'gabaa': 0.5551696674516561,\n",
       " 'heart failure': 0.5545131469378644,\n",
       " 'plasma level': 0.554166023388702,\n",
       " 'consist': 0.5535550231933104,\n",
       " 'evidence indicate': 0.5533001479526873,\n",
       " 'females': 0.5521670637371383,\n",
       " 'summary': 0.5514179920338219,\n",
       " 'algorithm': 0.5506675704422337,\n",
       " 'neurotoxic': 0.5501705122192664,\n",
       " 'viral': 0.5500316143487989,\n",
       " 'similarly': 0.5493279198050791,\n",
       " 'objectives': 0.5488620746909025,\n",
       " 'diabetic': 0.5463974186880257,\n",
       " 'cognition': 0.5460376682412391,\n",
       " 'micrornas': 0.5458268431598535,\n",
       " 'mechanistic': 0.5455105449215547,\n",
       " 'multivariate': 0.5451701619890991,\n",
       " 'cerebral': 0.5448798357323433,\n",
       " 'neurodegenerative disease': 0.5442715687989088,\n",
       " 'prevalent': 0.543971629288345,\n",
       " 'modulators': 0.5439167289940823,\n",
       " 'association study': 0.5431356699546589,\n",
       " 'examples': 0.5418014071726387,\n",
       " 'innate immune': 0.5412752763894351,\n",
       " 'necessary': 0.5408222935012542,\n",
       " 'clinical study': 0.5407953042060911,\n",
       " 'dysregulated': 0.5399239083128428,\n",
       " 'constitute': 0.5391311591469794,\n",
       " 'discover': 0.5381805190821997,\n",
       " 'program': 0.5372265991119367,\n",
       " 'phagocytic': 0.5348407964611039,\n",
       " 'bioenergetic': 0.5343818604983861,\n",
       " 'rapidly': 0.5339367759088046,\n",
       " 'density': 0.5339147634314816,\n",
       " 'resonance': 0.5336172067293101,\n",
       " 'characteristic': 0.5334688581520031,\n",
       " 'perspectives': 0.5324476182164845,\n",
       " 'successful': 0.5318253965249277,\n",
       " 'already': 0.5317101720809722,\n",
       " 'brief': 0.531541392433696,\n",
       " 'neuropsychiatric': 0.5314879663213843,\n",
       " 'dysregulation': 0.5312632217453392,\n",
       " 'morphology': 0.5300285618146812,\n",
       " 'diseases diabetes': 0.5290157302404146,\n",
       " 'procedure': 0.5288486316736701,\n",
       " 'necrosis': 0.5270310260856956,\n",
       " 'microbiome': 0.5269273050252616,\n",
       " 'assume': 0.5266131753393332,\n",
       " 'condition include': 0.5260457782260792,\n",
       " 'temperature': 0.5245735295072071,\n",
       " 'construct': 0.5244736097695563,\n",
       " 'currently': 0.5243423412030801,\n",
       " 'example': 0.5229565601831953,\n",
       " 'around': 0.522437161404367,\n",
       " 'power': 0.5223903141958888,\n",
       " 'replacement': 0.5214795612702485,\n",
       " 'atrophy': 0.5203949158407744,\n",
       " 'alone': 0.5203168897403155,\n",
       " 'healthcare': 0.5200864711938309,\n",
       " 'prevention treatment': 0.5200056843299818,\n",
       " 'safety': 0.5193731427082551,\n",
       " 'disease alzheimers': 0.5192686103501223,\n",
       " 'continue': 0.5190577026087893,\n",
       " 'attractive': 0.5173216149409879,\n",
       " 'candidates': 0.5165416709873946,\n",
       " 'sufficient': 0.5164871939788798,\n",
       " 'antigen': 0.5161294204204872,\n",
       " 'another': 0.5159344389433481,\n",
       " 'significantly reduce': 0.5157302624909216,\n",
       " ...}"
      ]
     },
     "execution_count": 256,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "max_word_tfidf_selected_sorted"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 257,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>b-term</th>\n",
       "      <th>max TF-IDF</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>cells</td>\n",
       "      <td>11.505483</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>patients</td>\n",
       "      <td>11.052819</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>disease</td>\n",
       "      <td>10.376439</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>study</td>\n",
       "      <td>8.761797</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>diseases</td>\n",
       "      <td>8.005747</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>effect</td>\n",
       "      <td>7.658698</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>expression</td>\n",
       "      <td>7.510830</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>human</td>\n",
       "      <td>6.920697</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>brain</td>\n",
       "      <td>6.882691</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>increase</td>\n",
       "      <td>6.393317</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>protein</td>\n",
       "      <td>6.376411</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>activity</td>\n",
       "      <td>6.143803</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>result</td>\n",
       "      <td>6.051578</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>which</td>\n",
       "      <td>5.898111</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>include</td>\n",
       "      <td>5.624033</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>level</td>\n",
       "      <td>5.526278</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>alzheimers</td>\n",
       "      <td>5.494764</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>signal</td>\n",
       "      <td>5.482107</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>function</td>\n",
       "      <td>5.278937</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>associate</td>\n",
       "      <td>5.159067</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>alzheimers disease</td>\n",
       "      <td>5.088995</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>cancer</td>\n",
       "      <td>5.037320</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>treatment</td>\n",
       "      <td>5.000579</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>group</td>\n",
       "      <td>4.925367</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>disorder</td>\n",
       "      <td>4.893192</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>factor</td>\n",
       "      <td>4.869522</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>model</td>\n",
       "      <td>4.822758</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>review</td>\n",
       "      <td>4.792924</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>clinical</td>\n",
       "      <td>4.753368</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>proteins</td>\n",
       "      <td>4.619988</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>control</td>\n",
       "      <td>4.409207</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>potential</td>\n",
       "      <td>4.384293</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>chronic</td>\n",
       "      <td>4.371454</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>receptor</td>\n",
       "      <td>4.232872</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>suggest</td>\n",
       "      <td>4.228137</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>process</td>\n",
       "      <td>4.141421</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>immune</td>\n",
       "      <td>4.130001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>tissue</td>\n",
       "      <td>4.123983</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>analysis</td>\n",
       "      <td>4.102446</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>induce</td>\n",
       "      <td>4.096209</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>compound</td>\n",
       "      <td>4.092309</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>neurodegenerative</td>\n",
       "      <td>4.086088</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>system</td>\n",
       "      <td>3.935956</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>target</td>\n",
       "      <td>3.898599</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>condition</td>\n",
       "      <td>3.844902</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                b-term  max TF-IDF\n",
       "0                cells   11.505483\n",
       "1             patients   11.052819\n",
       "2              disease   10.376439\n",
       "3                study    8.761797\n",
       "4             diseases    8.005747\n",
       "5               effect    7.658698\n",
       "6           expression    7.510830\n",
       "7                human    6.920697\n",
       "8                brain    6.882691\n",
       "9             increase    6.393317\n",
       "10             protein    6.376411\n",
       "11            activity    6.143803\n",
       "12              result    6.051578\n",
       "13               which    5.898111\n",
       "14             include    5.624033\n",
       "15               level    5.526278\n",
       "16          alzheimers    5.494764\n",
       "17              signal    5.482107\n",
       "18            function    5.278937\n",
       "19           associate    5.159067\n",
       "20  alzheimers disease    5.088995\n",
       "21              cancer    5.037320\n",
       "22           treatment    5.000579\n",
       "23               group    4.925367\n",
       "24            disorder    4.893192\n",
       "25              factor    4.869522\n",
       "26               model    4.822758\n",
       "27              review    4.792924\n",
       "28            clinical    4.753368\n",
       "29            proteins    4.619988\n",
       "30             control    4.409207\n",
       "31           potential    4.384293\n",
       "32             chronic    4.371454\n",
       "33            receptor    4.232872\n",
       "34             suggest    4.228137\n",
       "35             process    4.141421\n",
       "36              immune    4.130001\n",
       "37              tissue    4.123983\n",
       "38            analysis    4.102446\n",
       "39              induce    4.096209\n",
       "40            compound    4.092309\n",
       "41   neurodegenerative    4.086088\n",
       "42              system    3.935956\n",
       "43              target    3.898599\n",
       "44           condition    3.844902"
      ]
     },
     "execution_count": 257,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "bterms_list = list(max_word_tfidf_selected_sorted.keys())\n",
    "bterms_list_length = len(bterms_list)\n",
    "\n",
    "df = pd.DataFrame({'b-term': bterms_list, 'max TF-IDF': list(max_word_tfidf_selected_sorted.values())})\n",
    "df[0:45]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 258,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "name = 'bcl2'\n",
    "if name in list(max_word_tfidf_selected_sorted.keys()):\n",
    "    print(name, ': ', 'position in the list of rare terms ', list(max_word_tfidf_selected_sorted.keys()).index(name), ' (', len(max_word_tfidf_selected_sorted), \\\n",
    "          '), max tfidf: ', format(max_word_tfidf_selected_sorted[name], '.3f'), sep='')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 259,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "nitric: position in the list of rare terms 832 (2920), max tfidf: 0.641\n"
     ]
    }
   ],
   "source": [
    "name = 'nitric'\n",
    "print(name, ': ', 'position in the list of rare terms ', list(max_word_tfidf_selected_sorted.keys()).index(name), ' (', len(max_word_tfidf_selected_sorted), \\\n",
    "      '), max tfidf: ', format(max_word_tfidf_selected_sorted[name], '.3f'), sep='')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 260,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "nitric oxide: position in the list of rare terms 833 (2920), max tfidf: 0.641\n"
     ]
    }
   ],
   "source": [
    "name = 'nitric oxide'\n",
    "print(name, ': ', 'position in the list of rare terms ', list(max_word_tfidf_selected_sorted.keys()).index(name), ' (', len(max_word_tfidf_selected_sorted), \\\n",
    "      '), max tfidf: ', format(max_word_tfidf_selected_sorted[name], '.3f'), sep='')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 261,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "nitric oxide synthase: position in the list of rare terms 1570 (2920), max tfidf: 0.293\n"
     ]
    }
   ],
   "source": [
    "name = 'nitric oxide synthase'\n",
    "print(name, ': ', 'position in the list of rare terms ', list(max_word_tfidf_selected_sorted.keys()).index(name), ' (', len(max_word_tfidf_selected_sorted), \\\n",
    "      '), max tfidf: ', format(max_word_tfidf_selected_sorted[name], '.3f'), sep='')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 262,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "nitric: position in the list of potential bterms 832 (2920), max tfidf: 0.641 part: 28.5\n",
      "nitric oxide: position in the list of potential bterms 833 (2920), max tfidf: 0.641 part: 28.5\n",
      "nitric oxide synthase: position in the list of potential bterms 1570 (2920), max tfidf: 0.293 part: 53.8\n",
      "3 3\n",
      "[832, 833, 1570]\n"
     ]
    }
   ],
   "source": [
    "petric_bterms = [\"22q112\", \"deletion syndrome\", \"asbestos\", \"bcl2\", \"bombesin\", \"calmodulin\", \"radiation\", \\\n",
    "                 \"hypothyroxinemia\", \"synaptic\", \"synaptic plasticity\", \"type 1 diabetes\", \\\n",
    "                 \"ulcerative colitis\", \"working memory\", \\\n",
    "                 \"t17p22q21\"]\n",
    "\n",
    "petric_bterms = [\"22q112\", \"deletion\", \"syndrome\", \"asbestos\", \"bcl2\", \"bombesin\", \"calmodulin\", \"radiation\", \\\n",
    "                 \"hypothyroxinemia\", \"synaptic\", \"plasticity\", \"diabetes\", \\\n",
    "                 \"ulcerative\", \"colitis\", \"work\", \"memory\", \"t17p22q21\"] # single\n",
    "\n",
    "petric_bterms = [\"22q112\", \"deletion syndrome\", \"asbestos\", \"bcl2\", \"bombesin\", \"calmodulin\", \"radiation\", \\\n",
    "                 \"hypothyroxinemia\", \"synaptic\", \"synaptic plasticity\", \"diabetes\", \\\n",
    "                 \"ulcerative colitis\", \"work memory\", \"t17p22q21\"] # n-terms\n",
    "\n",
    "petric_bterms = [\"synaptic\", \"synaptic plasticity\", \"calmodulin\", \"radiation\", \"working memory\", \n",
    "                 \"bcl 2\", \"type 1 diabetes\", \"ulcerative colitis\", \"asbestos\", \"deletion syndrome\", \n",
    "                 \"22q11 2\", \"maternal hypothyroxinemia\", \"bombesin\"]\n",
    "\n",
    "petric_bterms = [\"synaptic\", \"synaptic plasticity\", \"calmodulin\", \"radiation\", \"memory\", \n",
    "                 \"bcl2\", \"diabetes\", \"ulcerative colitis\", \"asbestos\", \"deletion syndrome\", \n",
    "                 \"22q112\", \"maternal hypothyroxinemia\", \"bombesin\"]\n",
    "\n",
    "petric_bterms = [\"5ht\", \"5hydroxytryptamine\", \"5hydroxytryptamine receptors\", \"aggregation\", \"inflammatory\", \\\n",
    "                   \"anticonvulsant\", \"antimigraine\", \"arterial spasms\", \"brain serotonin\", \"calcium antagonist\", \"calcium blockers\", \\\n",
    "                   \"calcium channel\", \"calcium channel blockers\", \"cerebral vasospasm\", \"convulsions\", \"convulsive\", \"coronary spasm\", \\\n",
    "                   \"cortical spread depression\", \"diltiazem\", \"epilepsy\", \"epileptic\", \"epileptiform\", \"hypoxia\", \"indomethacin\", \\\n",
    "                   \"inflammatory\", \"nifedipine\", \"paroxysmal\", \"platelet aggregation\", \"platelet function\", \"prostacyclin\", \\\n",
    "                   \"prostaglandin\", \"prostaglandin e1\", \"prostaglandin synthesis\", \"reactivity\", \"seizure\", \"serotonin\", \\\n",
    "                   \"spasm\", \"spread\", \"spread depression\", \"stress\", \"substancep\", \"vasospasm\", \"verapamil\"]\n",
    "\n",
    "petric_bterms = [\"nitric\", \"nitric oxide\", \"nitric oxide synthase\"]\n",
    "nn = 0\n",
    "indb = []\n",
    "size = len(max_word_tfidf_selected_sorted)\n",
    "for name in petric_bterms:\n",
    "    if name in max_word_tfidf_selected_sorted.keys():\n",
    "       nn += 1\n",
    "       position = list(max_word_tfidf_selected_sorted.keys()).index(name)\n",
    "       indb.append(position)\n",
    "       print(name, ': ', 'position in the list of potential bterms ', list(max_word_tfidf_selected_sorted.keys()).index(name), ' (', len(max_word_tfidf_selected_sorted), \\\n",
    "             '), max tfidf: ', format(max_word_tfidf_selected_sorted[name], '.3f'), ' part: ', format(position/size*100, '.1f'), sep='')\n",
    "    else:\n",
    "        print('NOT:', name, 'NOT in the list.')   \n",
    "print(nn, len(petric_bterms))\n",
    "mm = len(petric_bterms)\n",
    "print(indb)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Changed b-terms:\n",
    "\n",
    "- working memory -> memory\n",
    "- type 1 diabetes -> diabetes\n",
    "\n",
    "Missing b-terms:\n",
    "\n",
    "- 5hydroxytryptamine receptors - found only in Migraine !Mig documents\n",
    "- antimigraine - found only in Migraine !Mig documents"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "TODO: implement selected heuristics for bterm ranking"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 263,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Size: 2920\n",
      "len(indb): 3\n",
      "\n",
      "[0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3, 3]\n",
      "0.03424657534246575 0.0\n",
      "3.458904109589041 0.0\n",
      "6.883561643835616 0.0\n",
      "10.308219178082192 0.0\n",
      "13.732876712328768 0.0\n",
      "17.15753424657534 0.0\n",
      "20.58219178082192 0.0\n",
      "24.006849315068493 0.0\n",
      "27.431506849315067 0.0\n",
      "30.856164383561648 66.66666666666666\n",
      "34.28082191780822 66.66666666666666\n",
      "37.705479452054796 66.66666666666666\n",
      "41.130136986301366 66.66666666666666\n",
      "44.554794520547944 66.66666666666666\n",
      "47.97945205479452 66.66666666666666\n",
      "51.40410958904109 66.66666666666666\n",
      "54.82876712328767 100.0\n",
      "58.25342465753425 100.0\n",
      "61.678082191780824 100.0\n",
      "65.1027397260274 100.0\n",
      "68.52739726027397 100.0\n",
      "71.95205479452055 100.0\n",
      "75.37671232876713 100.0\n",
      "78.8013698630137 100.0\n",
      "82.22602739726027 100.0\n",
      "85.65068493150685 100.0\n",
      "89.07534246575342 100.0\n",
      "92.5 100.0\n",
      "95.92465753424658 100.0\n",
      "99.34931506849315 100.0\n",
      "63.07077625570776\n"
     ]
    }
   ],
   "source": [
    "print(f'Size: {size}')\n",
    "print(f'len(indb): {len(indb)}')\n",
    "print()\n",
    "\n",
    "pt = []\n",
    "for i in range(size):\n",
    "    pt.append(0)\n",
    "for i in range(len(indb)):\n",
    "    for j in range(indb[i], size):\n",
    "        pt[j] += 1\n",
    "print(pt)\n",
    "suma = 0\n",
    "part = 0\n",
    "for i in range(size):\n",
    "    if i % 100 == 0:\n",
    "        # print((i+1)/size*100.0, pt[i]/len(indb)*100.0)\n",
    "        print((i+1)/size*100.0, pt[i]/mm*100.0)\n",
    "    part += pt[i]\n",
    "    suma += len(indb)\n",
    "print(part/suma*100.0)\n",
    "\n",
    "no_all_bterm_candidates = size\n",
    "no_swansons_bterms = mm # len(indb)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 264,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "import numpy as np\n",
    "\n",
    "# Example ROC curve points (y-values), replace with the actual list of 120 numbers\n",
    "roc_points = pt\n",
    "\n",
    "# X-values for the ROC curve (0 to 120)\n",
    "x_values = np.arange(0, no_all_bterm_candidates)\n",
    "\n",
    "# Calculating the AUC for the given ROC curve using the trapezoidal rule\n",
    "auc = np.trapz(roc_points, x_values) / (no_all_bterm_candidates*no_swansons_bterms) * 100  # Normalizing by the area of the full plot\n",
    "\n",
    "# Plotting the default curve (50% AUC)\n",
    "default_x = np.array([0, no_all_bterm_candidates])\n",
    "default_y = np.array([0, no_swansons_bterms])\n",
    "plt.plot(default_x, default_y, label='Default Curve (50% AUC)', linestyle='--', color='gray')\n",
    "\n",
    "# Plotting the given ROC curve\n",
    "plt.plot(x_values, roc_points, label=f'Given ROC Curve (AUC: {auc:.2f})', color='blue')\n",
    "\n",
    "# Adding labels and legend\n",
    "plt.title('ROC Curve Comparison')\n",
    "plt.xlabel('False Positive Rate (Discrete)')\n",
    "plt.ylabel('True Positive Rate (Discrete)')\n",
    "plt.legend()\n",
    "plt.grid(True)\n",
    "\n",
    "# Show the plot\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 265,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2920\n",
      "2920\n"
     ]
    }
   ],
   "source": [
    "print(len(x_values))\n",
    "print(len(roc_points))\n",
    "\n",
    "# x_values -> roc_points (y_values)\n",
    "# len_x_values, len_roc_points (len_y_values)\n",
    "# actual values: x_values/len_x_values, y_values / len_y_values\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Certainly! To display a table with the words and the votes from each function in separate columns, we can use the `pandas` library. Here’s how you can modify the previous code to achieve that:\n",
    "\n",
    "```python\n",
    "import pandas as pd\n",
    "from typing import Callable, List\n",
    "\n",
    "def voting_framework(words: List[str], voting_functions: List[Callable[[str], bool]], num_functions_to_select: int) -> pd.DataFrame:\n",
    "    # Select a subset of functions from the pool (e.g., the first num_functions_to_select functions)\n",
    "    selected_functions = voting_functions[:num_functions_to_select]\n",
    "    \n",
    "    # Initialize a dictionary to store the voting results for each word\n",
    "    vote_results = {word: [] for word in words}\n",
    "    \n",
    "    # Apply each selected function to every word and store the results\n",
    "    for word in words:\n",
    "        for func in selected_functions:\n",
    "            vote_results[word].append(func(word))\n",
    "    \n",
    "    # Convert the results to a DataFrame for better visualization\n",
    "    df = pd.DataFrame(vote_results).T  # Transpose to have words as rows\n",
    "    df.columns = [f\"Function {i+1}\" for i in range(num_functions_to_select)]\n",
    "    \n",
    "    # Add a column for the total number of votes (summing the True values)\n",
    "    df['Total Votes'] = df.sum(axis=1)\n",
    "    \n",
    "    # Sort the DataFrame by the total number of votes, from max to min\n",
    "    df = df.sort_values(by='Total Votes', ascending=False)\n",
    "    \n",
    "    return df\n",
    "\n",
    "# Example voting functions\n",
    "def is_vowel_start(word: str) -> bool:\n",
    "    return word[0].lower() in 'aeiou'\n",
    "\n",
    "def is_long_word(word: str) -> bool:\n",
    "    return len(word) > 5\n",
    "\n",
    "def contains_z(word: str) -> bool:\n",
    "    return 'z' in word.lower()\n",
    "\n",
    "def ends_with_y(word: str) -> bool:\n",
    "    return word[-1].lower() == 'y'\n",
    "\n",
    "# Example usage\n",
    "words = [\"apple\", \"zebra\", \"yellow\", \"banana\", \"xylophone\", \"umbrella\", \"kitty\"]\n",
    "voting_functions = [is_vowel_start, is_long_word, contains_z, ends_with_y]\n",
    "\n",
    "# Select 3 out of 4 functions to vote\n",
    "df = voting_framework(words, voting_functions, num_functions_to_select=3)\n",
    "\n",
    "# Display the DataFrame\n",
    "print(\"Voting Results Table:\")\n",
    "print(df)\n",
    "```\n",
    "\n",
    "### Explanation:\n",
    "1. **Data Structure**: The voting results for each word are stored in a dictionary, where the key is the word and the value is a list of votes (boolean values) from each selected function.\n",
    "\n",
    "2. **Pandas DataFrame**: The results are converted into a `pandas` DataFrame, with words as the index (rows) and each selected function as a column. The `Total Votes` column is calculated by summing the `True` values for each word.\n",
    "\n",
    "3. **Sorting**: The DataFrame is sorted by the `Total Votes` column in descending order, so the words with the most votes appear at the top.\n",
    "\n",
    "4. **Output**: The DataFrame is printed, showing each word, the votes from each function, and the total number of votes.\n",
    "\n",
    "### Example Output:\n",
    "Here’s an example of what the output might look like when you run the code:\n",
    "\n",
    "```\n",
    "Voting Results Table:\n",
    "            Function 1  Function 2  Function 3  Total Votes\n",
    "umbrella         True        True       False            2\n",
    "banana           True        True       False            2\n",
    "apple            True       False       False            1\n",
    "xylophone       False        True       False            1\n",
    "yellow          False        True       False            1\n",
    "kitty           False       False        True            1\n",
    "zebra           False       False        True            1\n",
    "```\n",
    "\n",
    "In this table:\n",
    "- Each column (`Function 1`, `Function 2`, etc.) represents the vote from a specific function.\n",
    "- The `Total Votes` column shows the total number of `True` votes for each word.\n",
    "- The words are sorted by the number of votes, from most to least.\n",
    "\n",
    "This approach gives a clear overview of how each word was evaluated by the different functions in the ensemble."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Voting Results Table:\n",
      "           Function 1  Function 2  Function 3  Total Votes\n",
      "umbrella         True        True       False            2\n",
      "apple            True       False       False            1\n",
      "zebra           False       False        True            1\n",
      "yellow          False        True       False            1\n",
      "banana          False        True       False            1\n",
      "xylophone       False        True       False            1\n",
      "kitty           False       False       False            0\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "from typing import Callable, List\n",
    "\n",
    "def voting_framework(words: List[str], voting_functions: List[Callable[[str], bool]], num_functions_to_select: int) -> pd.DataFrame:\n",
    "    # Select a subset of functions from the pool (e.g., the first num_functions_to_select functions)\n",
    "    selected_functions = voting_functions[:num_functions_to_select]\n",
    "    \n",
    "    # Initialize a dictionary to store the voting results for each word\n",
    "    vote_results = {word: [] for word in words}\n",
    "    \n",
    "    # Apply each selected function to every word and store the results\n",
    "    for word in words:\n",
    "        for func in selected_functions:\n",
    "            vote_results[word].append(func(word))\n",
    "    \n",
    "    # Convert the results to a DataFrame for better visualization\n",
    "    df = pd.DataFrame(vote_results).T  # Transpose to have words as rows\n",
    "    df.columns = [f\"Function {i+1}\" for i in range(num_functions_to_select)]\n",
    "    \n",
    "    # Add a column for the total number of votes (summing the True values)\n",
    "    df['Total Votes'] = df.sum(axis=1)\n",
    "    \n",
    "    # Sort the DataFrame by the total number of votes, from max to min\n",
    "    df = df.sort_values(by='Total Votes', ascending=False)\n",
    "    \n",
    "    return df\n",
    "\n",
    "# Example voting functions\n",
    "def is_vowel_start(word: str) -> bool:\n",
    "    return word[0].lower() in 'aeiou'\n",
    "\n",
    "def is_long_word(word: str) -> bool:\n",
    "    return len(word) > 5\n",
    "\n",
    "def contains_z(word: str) -> bool:\n",
    "    return 'z' in word.lower()\n",
    "\n",
    "def ends_with_y(word: str) -> bool:\n",
    "    return word[-1].lower() == 'y'\n",
    "\n",
    "# Example usage\n",
    "words = [\"apple\", \"zebra\", \"yellow\", \"banana\", \"xylophone\", \"umbrella\", \"kitty\"]\n",
    "voting_functions = [is_vowel_start, is_long_word, contains_z, ends_with_y]\n",
    "\n",
    "# Select 3 out of 4 functions to vote\n",
    "df = voting_framework(words, voting_functions, num_functions_to_select=3)\n",
    "\n",
    "# Display the DataFrame\n",
    "print(\"Voting Results Table:\")\n",
    "print(df)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
